---
- abstractText: "This SBIR Phase I project focuses on the development and demonstration
    of a new high resolution X-ray detector to be utilized (initially) in medical
    diagnosis. The early work by NGS Detectors and collaborators has shown an improvement
    in resolution by a factor of almost 10 over the X-ray detectors in current use.
    The focus of this Phase I project is to now improve both the resolution and efficiency
    of the detector (in order to reduce the x-ray dose received by patients). The
    initial diagnostic application is for mammography, where the improved resolution
    is expected to allow accurate diagnosis of suspicious features in the breast at
    an early stage, while reducing the false diagnoses (both positive and negative)
    that are recognized to be problematic. The detectors have potential application
    in other medical diagnostics situations, such as neonatal and cardiovascular fields,
    where the higher resolution is expected to extend the application of X-ray diagnostics
    well beyond current practice. Applications for industrial nondestructive evaluation
    in fields such as semiconductor manufacturing are also envisaged. \n\nThis SBIR
    Phase I project focuses on the development and demonstration of a new high resolution
    X-ray scintillation detector. The indirect detector utilizes a new polymeric scintillating
    polymer developed by Lawrence Livermore National Laboratories for security applications,
    and incorporates the material into an optical channel plate. The optical channel
    plate contains an ordered array of high quality capillaries (e.g. 10 micron diameter).
    The scintillating polymer absorbs X-rays, and emit photons that are channeled
    to pixels of an optical detector with minimal scattering. A resolution of 10 micron
    has already been demonstrated, an improvement of nearly an order of magnitude
    over both direct and indirect detectors in current use in medical diagnostics.
    The focus of Phase 1 is to complete the detector characterization, with a special
    emphasis on improving the detector efficiency in order to minimize X-ray dose
    rates for patients. The successful completion of Phase I will lead to a Phase
    II that demonstrates that the higher resolution indeed yields higher feature discrimination
    in realistic diagnostic situations.\n\nThis award reflects NSF's statutory mission
    and has been deemed worthy of support through evaluation using the Foundation's
    intellectual merit and broader impacts review criteria."
  awardeeAddress: 229 Medway St Apt 207
  awardeeCity: Providence
  awardeeCountryCode: US
  awardeeName: NGS Detectors LLC
  awardeeStateCode: RI
  awardeeZipCode: 029065300
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819978'
  piEmail: tfmorse@ngsdetectors.com
  piFirstName: Theodore
  piLastName: Morse
  piMiddeInitial: F
  piPhone: '4015339971'
  poName: Henry Ahn
  date: 06/14/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  The Transformation of X-ray Detectors for Medical Imaging'
- abstractText: |-
    This SBIR Phase I project intends to design and develop an innovative medical device solution that can potentially save $1.16B to the overall US healthcare system by reducing the procedural time and decreasing the number of catheters and devices used in Peripheral Vascular lnterven6on procedures. Lower extremity peripheral arterial disease affects more than 8 million people in the United States alone. The annual healthcare expenditure spent on treating peripheral arterial disease is $4.37B. Since 2008, US Center for Medicare and Medicaid has been stressing for greater efficiency and lowering costs for Peripheral Vascular Intervention. Commonly performed Peripheral Vascular Intervention procedures in the CathLab, to treat PAD, encounter loss of guidewire access. This complication is amplified in the case of difficult to cross stenotic lesions and, in many cases, is frustrating for the physician as they have to spend several hours/procedures trying to regain guidewire access. Guidewire access is the key for a successful procedural outcome. The Project intends to reduce Peripheral Vascular Intervention cost by improving procedural efficiency by eliminating guidewire/catheter exchanges in current practice thereby reducing Cath Lab overhead costs and by reducing procedure time and effort required to acquire a good quality angiographic image. An important ancillary benefit of the innovation is that the radiation exposure to the healthcare providers and the patient can potentially be minimized due to the decreased fluoroscopic activity. The project aims to continue beyond SBIR Phase I to become a commercial product and be the standard of care for Peripheral Vascular Intervention procedures.

    This SBIR Phase I project is for the design and development of a .014-inch guidewire compatible low profile PTA balloon catheter with a proprietary contrast injection mechanism. This product is ideal for performing PTA interventions in difficult anatomical spaces e.g. below-the-knee peripheral vasculature. The proprietary inflation and injection system allows for treatment visualization without needing catheter exchanges or loss of guidewire access. The output of the Project intends to provide focused and sharper visualization along the entire treatment length and allows for judicious usage of radiopaque contrast in contrast sensitive patients. A feasibility prototype of the concept was tested in an animal model with promising results. The SBIR Phase I project is focused on overcoming technical challenges to design and develop the unique device design to maintain a statistically significant rated burst pressure, develop and evaluate device bond joints per ISO standard 10555-1 2013, Sterile Single Use Intravascular catheters, develop the manufacturing process and tools, to integrate the catheter multi functionality. The Project intends to design and fabricate a test fixture to simulate clinical usage of the Innovative device per FDA Class II Guidance Controls for Percutaneous Transluminal Balloon Catheters and confirm that the catheter satisfies customer requirements. The Development efforts as part of SBIR Phase I project involve utilization of iterative design process. 3-dimensional design modeling and optimization, creation of a test fixture to simulate clinical usage, iterative prototyping and testing efforts to ensure the desired device specifications are met.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2934 Scott Boulevard
  awardeeCity: Santa Clara
  awardeeCountryCode: US
  awardeeName: Embark Medical
  awardeeStateCode: CA
  awardeeZipCode: '950543312'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843246'
  piEmail: rbetelia@embarkmedical.com
  piFirstName: Rainier
  piLastName: Betelia
  piPhone: '4085053752'
  poName: Henry Ahn
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'SBIR Phase I:  A Diagnostic Catheter for Treating Obstructions/Occlusions
    Within a Body Lumen or Vessel'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to enable a safer, more reliable, and more efficient electric power grid. The power grid is critical infrastructure on which all of America's economic sectors depend, and so its reliability and stability is of the utmost importance. The technology being developed is the ideal modeling and simulation platform to analyze and predict grid abnormalities and blackouts due to its unprecedented ability to simulate complex systems accurately. Its physics-based simulation engine can incorporate more detailed models of loads on the grid, thereby allowing system operators to better assess grid state and stability. The proposed technology is also uniquely capable of modeling distributed energy resources at the transmission and distribution scale, an industry need that has been deemed critical to increase the penetration of renewables on the grid. The technology has substantial potential for commercial impact, as there are thousands of transmission, distribution, generation, and consulting organizations that are potential customers. Combined, these factors can help enable a more robust, secure grid that operates with reduced cost and emissions. This Phase I project represents the first step in making this technology a commercial reality.

    This Small Business Innovation Research Phase I project represents a significant departure from traditional methods that are used to model the electric power grid. The team's foundational research has already shown that the technology can simulate the U.S. Eastern Interconnection (half of the U.S. transmission grid) from any initial condition to evaluate complex contingencies - capabilities that are not possible with existing tools. The current- and voltage-based formulation used in the model is more flexible than is used in traditional power systems simulation software, enabling more realistic physics- and/or measurement-based models for more accurate simulation results. The Phase I project includes developing a secure and robust cloud platform for the technology that supports parallelized grid analyses, with a full library of component models and an intuitive web-based interface. This will enable system operators, utilities, and consultants to improve their planning studies and operations by enabling more accurate simulations at a higher throughput than is possible with today's software. The work done in Phase I will serve as a foundation for future advancements in power grid modeling and simulation, including integrated transmission and distribution system analysis and statistical analysis to assess the impact of uncertainties on the grid.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 6392 Melissa Street
  awardeeCity: Pittsburgh
  awardeeCountryCode: US
  awardeeName: Pearl Street Technologies, LLC
  awardeeStateCode: PA
  awardeeZipCode: '152064703'
  fundsObligatedAmt: '224956'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819399'
  piEmail: bromberg@pearlstreettechnologies.com
  piFirstName: David
  piLastName: Bromberg
  piMiddeInitial: M
  piPhone: '4126064390'
  poName: Peter Atherton
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Cloud-Based Electric Power Grid Simulation Software With
    Equivalent Circuit Methods'
- abstractText: "This SBIR Phase I project aims to demonstrate the technical feasibility
    of a microfluidic instrument as a clinical tool for measuring a new single-cell
    biophysical biomarker; mass accumulation rate (MAR). Successful completion of
    the proposed project will constitute the foundation of a medical instrument that
    will improve treatment strategies for cancer patients. Assigning the optimal therapy
    for individual patients is particularly important for the treatment of cancer,
    since every individual's cancer is unique. Although genetic profiling of tumor
    cells has been the gold standard for personalized medicine approaches in cancer,
    recent results demonstrate that only a small percentage of patients actually benefit
    from therapies specifically assigned for them. Aside from few cancer types, where
    drastic patient responses can be observed using genetic profiling, most cancer
    patients continue to suffer from ineffective or sub-optimal therapies, which in
    one of the main drivers of the cost of cancer treatment in the US. This stands
    in stark contrast to personalized medicine in infectious diseases, where almost
    all patients are prescribed optimal treatments determined by functional assays
    based on monitoring the proliferation of microbes ex vivo under the influence
    of a panel of drugs. Unfortunately, no proliferation-based test for cancer has
    proven to be sufficiently reliable to be widely adopted for clinical use, mostly
    because unlike bacteria most cancer cells quickly die when removed from the human
    body. This SBIR Phase I project will develop the techniques to measure MAR of
    cancer cells as a metric for drug response. MAR response reflects how individual
    cells change their growth in response to drugs in very short timescales without
    the long-term effects of ex vivo culturing. The research that will be conducted
    in this project will prove the technical feasibility of measuring MAR in a clinical
    setting for a panel of treatment options. Outcomes of this project will directly
    enable clinical studies to be conducted, before ultimately seeking FDA approval
    through clinical trials. \n\nThe focus of this project is a new technology known
    as the serial Suspended Microchannel Resonator (sSMR), which can measure mass
    and mass accumulation rates (MAR) of single cells with extreme precision. This
    SBIR Phase I project will test the technical feasibility of the sSMR platform
    for measuring drug susceptibility of primary tumor samples with a clinically and
    commercially relevant speed, versatility and robustness. The company aims to develop
    sSMR as a platform and introduce MAR as biophysical biomarker guiding clinicians
    in identifying the best therapy options for a specific cancer patient. Therefore,
    the goals of this first phase are critical, as tumor cells in biopsy samples taken
    from patients show differences in heterogeneity, count, and in most cases, lose
    their viability within 24-48 ex vivo. In Phase I, key technologies will be developed
    that will enable a sSMR chip to process samples with various cell types and counts
    at a high throughput and rate. The research activities to address the technical
    challenges for analyzing primary samples will be three-fold. First, while maintaining
    the measurement precision, the flow rate of cells in the chip will be increased
    to prevent primary tumor cells from adhering to channel walls. This is challenging,
    because the precision of measurement is inversely proportional to the time duration
    each cell spends in the chip. Second, an opto-fluidic switching technique will
    be implemented on chips with a new microfluidic T-junction design enabling imaging
    and characterization of particle morphology, and the avoidance of dead cells,
    debris, and doublets to improve assay robustness and throughput. Third, by leveraging
    the microfluidic T-junction and developed imaging capabilities, a microfluidic
    cell enrichment technique will be developed. This feature will allow for a larger
    panel of drug conditions to be tested on tumor biopsies with limited cell counts.
    For validation of these innovations, response of tumor cells taken from 10 multiple
    myeloma patients to a panel of three drugs and their combinations will be measured
    and analyzed.\n\nThis award reflects NSF's statutory mission and has been deemed
    worthy of support through evaluation using the Foundation's intellectual merit
    and broader impacts review criteria."
  awardeeAddress: 151 Blackburn Ter
  awardeeCity: Pacifica
  awardeeCountryCode: US
  awardeeName: Travera LLC
  awardeeStateCode: CA
  awardeeZipCode: '940443907'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1841883'
  piEmail: solcum@travera.com
  piFirstName: Selim
  piLastName: Olcum
  piMiddeInitial: A
  piPhone: '8576006235'
  poName: Henry Ahn
  date: 02/01/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Developing serial suspended microchannel resonators as a
    platform for personalized medicine in cancer'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be the development of an easy-to-apply anti-fouling, liquid- and sludge-repellent coating aimed to reduce the water footprint, required cleaning frequency, and need for aggressive cleaning chemicals to maintain bathroom fixtures. Advanced ecofriendly technologies that enhance cleaning efficiency are highly sought after in janitorial services for large institutions and homeowners alike. Specifically, the household cleaners market size was valued at $5.79 billion in 2016 in United States, of which ~20% is toilet bowl cleaners that aim to remove bacteria and hard-water stains.  From a societal perspective, we estimate that about 6.1 billion gallons of water is flushed down the toilet nationally each day - that is 2.2 trillion gal of water each year in the United States alone. Incorporation of this coating into bathroom fixtures, can significantly reduce the water footprint of bathroom fixtures. Viable low-flow or no-flow toilets may also help help address the open defecation problem affecting over 1 billion people globally.

    This Small Business Innovation Research (SBIR) Phase I project will develop and investigate a new class of viscoelastic-repellent surface coatings with anti-bacterial and anti-scaling functions for cleaning and sanitation industries. Surface coatings that can resist bacteria and mineral fouling while maintaining both liquid and viscoelastic solid repellency are rare. The proposed project will investigate and quantify the coating design parameters required to significantly prevent the attachment of bacteria and mineral deposits, while remaining durable against mechanical abrasions under realistic operating conditions. This SBIR Phase I project will demonstrate that a sprayable surface coating not only can repel both liquids and viscoelastic solids, but can also resist fouling from bacteria and hard water stains without the use of aggressive chemical cleaners or excessive amounts of water. The best coating parameters identified in Phase I project will be considered for pilot tests in Phase II. The development of such a robust, non-fouling coating will offer significant reduction in the use of cleaning chemicals, flush water, and cleaning time, which has the potential to reduce costs associated with sanitation facilities maintenance.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 326 VAIRO BLVD APT C
  awardeeCity: STATE COLLEGE
  awardeeCountryCode: US
  awardeeName: SPOTLESS MATERIALS LLC
  awardeeStateCode: PA
  awardeeZipCode: '168032847'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843624'
  piEmail: birgitt@spotlessmaterials.com
  piFirstName: Birgitt
  piLastName: Boschitsch
  piPhone: '6099022677'
  poName: Linda Molnar
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Anti-Fouling and Anti-Scaling Slippery Surface Coating for
    Cleaning and Sanitation Applications'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to provide access to a solar heat source for controlled high temperature applications using minimal, low-cost equipment. The proposed Solar Concentrator Unit (SCU) is the first step to providing individuals and underserved communities with the freedom of a low-cost alternative to many of their most pressing manufacturing and materials processing needs. The SCU produces no emissions in its heat generation, requires no fuel costs, and can be used in remote locations to deliver precision control to high temperature thermal processes. Many new applications become available to market participants through the proposed innovation with the most notable commercial outcome being a multi-material additive manufacturing (i.e. 3D printing) system capable of producing custom metal and glass parts. Additional applications for the SCU include welding; recycling of waste material into useful feedstocks; pyrolysis of waste streams to render them chemically and biologically inert; sanitizing medical equipment in disaster response operations; and very high temperature materials science research by individuals and research institutions.

    This Small Business Innovation Research (SBIR) Phase I project explores the design and performance of a SCU for delivering high temperatures in the range of 65 ?C to 2,200 ?C over long durations (6+ hours). The technology relies on concentrated solar energy as the primary heat source with the proposed innovation being a feedback control system for maintaining temperature of a receiver plane to within +/-5% of an operating value. The proposed innovation addresses the limitations of existing methods for concentrating solar energy which lack temperature control and whose consistency of output thermal flux varies with time of day, sun position, cloud cover, and atmospheric conditions. This Phase I project will consist of development of a SCU prototype to conduct characterization tests on output solar flux and flux density under varying solar conditions. The expected outcome of this project will be to prove feasibility of the proposed design concept and evaluate its use for controlled, high temperature applications. The performance characteristics of the SCU will be fully explored in Phase I and the design of the SCU will allow for development of modular Thermal Processing Units in Phase II to interface with the concentrated solar spot produced by the SCU.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 575 Burbank St
  awardeeCity: Broomfield
  awardeeCountryCode: US
  awardeeName: BLUESHIFT, LLC
  awardeeStateCode: CO
  awardeeZipCode: '800201666'
  fundsObligatedAmt: '224877'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843099'
  piEmail: abrewer@blueshiftusa.com
  piFirstName: Andrew
  piLastName: Brewer
  piMiddeInitial: T
  piPhone: '3039530297'
  poName: Linda Molnar
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Solar Concentrator Unit for Low-Cost Metal Additive Manufacturing'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to demonstrate the feasibility of MedSwarm, a software product for radiology that will significantly improve patient outcomes and reduce medical costs. MedSwarm is an AI-based collaborative decision-making system that will significantly amplify diagnostic accuracy across a wide range diagnoses, not by replacing radiologists with AI, but by amplifying their human expertise. MedSwarm employs a technology called Artificial Swarm Intelligence that collects input from small groups of doctors and uses AI to optimize their combined accuracy. This hybrid human-AI system will achieve diagnostic accuracies that significantly outperform (a) individual radiologists using standard techniques, and (b) current state-of-the-art in software-only AI. As a product, the MedSwarm system will be deployed as downloadable software compatible with all existing radiological workstations. Distribution to diagnostic teams will be as easy as opening a web-browser and connecting to a cloud-based server. The market opportunity is best modeled on the Computer Aided Detection (CAD) market, which is projected at $1.9 Billion by 2022. MedSwarm will not compete with current CAD products, as it will provide additional accuracy on all radiology workstations, whether or not other CAD tools are in use.

    This Small Business Innovation Research (SBIR) Phase I project aims to develop, test, and validate MedSwarm, the first commercially viable system for amplifying diagnostic accuracy of radiologists by combining human and machine intelligence. The technology, called Swarm AI, does not replace radiologists with AI, but connects small groups of radiologists together and optimizes their combined insights, enabling accuracy levels that greatly exceed baseline abilities. The company anticipates diagnostic error reductions of at least 30% using the system developed in Phase I, with the majority of the improvement being in the reduction of false-positives. The proposed research requires the development of new software modules, new optimization algorithms, and new interface protocols for enabling radiologists to connect online, view the same images at the same time, and work together as a real-time system to converge on unified diagnoses. Development also requires machine learning optimization across multiple experimental parameters, to reduce the time required for each diagnosis, increasing throughput and reducing costs. The company's goals for Phase I include a proof-of-concept system that (i) significantly outperforms individual radiologists, (ii) significantly outperforms state-of-the-art machine learning systems, and (iii) can identify which cases are most appropriate for this system, as compared to alternate methods.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1026 Chorro Street
  awardeeCity: San Luis Obispo
  awardeeCountryCode: US
  awardeeName: Unanimous A.I., Inc.
  awardeeStateCode: CA
  awardeeZipCode: '934013270'
  fundsObligatedAmt: '224594'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1840937'
  piEmail: louis@unanimousai.com
  piFirstName: Louis
  piLastName: Rosenberg
  piPhone: '7036460020'
  poName: Peter Atherton
  date: 02/08/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  MedSwarm, an Artificial Intelligence System for Medical Decision
    Making'
- abstractText: |-
    This Small Business Innovation Research Phase I project aims to develop a delaminated zeolite-based catalyst to facilitate more economical and environmentally friendly propylene-oxide (PO) production.  PO is a commodity chemical with a $5.6B/year market.  The two current pain points for PO producers are (i) that the currently used industrial catalyst lacks long-term stability under the harsh conditions at the tail-end of the PO synthesis reactor, and (ii) as a result of catalyst deficiency, that the process to manufacture PO consumes an extra $140M of raw materials per year, separate from the problem in (i) above.  Berkeley Materials Solutions developed a catalyst for the tail-end of the PO synthesis reactor that nearly eliminates both of these problems. The catalyst allows for nearly 100% conversion of all raw material into PO, which leads to $145 M/year of additional revenue for PO producers, corresponding to a revenue increase of 8.6%. This increased revenue comes at no additional cost since it is a drop-in replacement.  In addition, there are significant energy efficiency improvements associated with recovering the currently lost raw material in the PO synthesis process, which amounts to a CO2 footprint of ~740 kilo tons of CO2 per year worldwide.

    The intellectual merit of this project will be represented by the development of a generalizable crystalline catalyst platform to replace existing amorphous catalysts. Technical hurdles that will be addressed in the proposal are (i) the successful delamination of a layered zeolite precursor using a swelling method and sonication, (ii) establishing a sonication-free scalable delamination method for layered zeolite precursors, and (iii) the insertion of catalytically active heteroatom sites into the delaminates frameworks. If successful, this will enable the economical production of these zeolite catalysts for application in the PO synthesis reactor under flow conditions. The targeted scales even during Phase I activities are large enough to enable testing in collaboration with industrial partners who manufacture propylene oxide at large scales. These test results will be used to optimize the prototype catalyst.  The results from Phase I activities will help to uncover other possible opportunities to use delaminated zeolites as highly efficient catalysts for chemical manufacturing.
  awardeeAddress: 3438 Morningside Drive
  awardeeCity: Richmond
  awardeeCountryCode: US
  awardeeName: Berkeley Materials Solutions
  awardeeStateCode: CA
  awardeeZipCode: '948032517'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746827'
  piEmail: aokrut@gmail.com
  piFirstName: Alexander
  piLastName: Okrut
  piPhone: '4155301565'
  poName: Benaiah Schrag
  date: 12/20/2017
  startDate: 01/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Intensification of propylene oxide manufacture via solid-catalyst
    design'
- abstractText: |-
    This SBIR Phase I project will develop an Artificial Intelligence (AI) /Machine Learning (ML) driven solution to automate the process of giving qualitative feedback on student reflections. The automated reading of student reflections for quality and content is a new and innovative technology that is currently not available in the market, as all applications in this realm focus on grammar and writing structures. The innovation will understand the specific actions and strategies students are using (many of which are unique to an individual learner), and help students get the support they need to improve in those techniques or try new ones. This process would build learning skills and growth-oriented belief systems in students, both of which lead to significantly improved academic and career outcomes. Fundamentally, the proposed project will help students learn how to learn.


    This SBIR Phase I project will build the first phase of personalized insights for impactful student goal-setting and reflection. The company will leverage natural language processing (NLP) and ML algorithms to 1) parse, process, and analyze reflections written by students, 2) return a score for each reflection based on a research-based rubric, and 3) notify teachers when a student has a low score and needs support. At the end of Phase I, the company will examine whether the prototype functions as intended with 90%+ accuracy, if teachers can integrate the prototype into their classroom practice, and if it shows early promise of improving the quality of student reflections and learning. With a proprietary dataset of 400K+ written student reflections and data points, the company is uniquely positioned to develop and scale this product vision. Phase II research will develop personalized feedback, strategies and suggestions to help students and teachers find the best strategies faster.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 515 CROFTON AVE
  awardeeCity: OAKLAND
  awardeeCountryCode: US
  awardeeName: SOWN TO GROW, INC.
  awardeeStateCode: CA
  awardeeZipCode: '946101520'
  fundsObligatedAmt: '224539'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843989'
  piEmail: dennis@sowntogrow.com
  piFirstName: Dennis
  piLastName: Li
  piPhone: '9194346479'
  poName: Rajesh Mehta
  date: 12/21/2018
  startDate: 01/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  A K12 Goal-Setting And Reflection Platform That Builds Student
    Learning Skills And Mindset'
- abstractText: |-
    The broader impact/commercial potential of this project is the rapid, cost-effective detection of natural gas leakage to improve public safety, mitigate global climate change, and decrease product loss.  Natural gas is the largest provider of power in the United States.  However, more than 80 Tg of leakage occurs at well pads and pipelines during production alone.  Such leakage poses a public health risk, with 1300 significant incidents reported from 1997 ? 2016, resulting in 50 fatalities, 180 injuries, and $2B in costs. Additionally, methane is a greenhouse gas with a warming potential that is 84 times higher than CO2.  In 2015, natural gas leakage accounted for 198 million tons of CO2 equivalents, corresponding to a carbon tax value of more than $2B.  Finally, energy companies want to reduce leakage to avoid product loss, with 80 Tg of methane having a value of $12B.  This project will directly impact the aforementioned areas by improving the efficiencies and costs associated with natural gas leak detection.  With over 2.2 million miles of local utility gas distribution pipelines 1.2 million well pads in the U.S. alone, the commercial prospects for an improved natural gas leak detection system are very promising with expected revenues exceeding $70M.

    This Small Business Technology Transfer (STTR) Phase I project will involve the development of a comprehensive natural gas leakage detection solution that integrates compact, low-cost sensors with state-of-the-art analytics.  The solution, which can be used in drone-based and handheld monitoring, will enable energy providers to detect natural gas leakage from well pads and pipelines.  In Phase I, technical feasibility will be demonstrated by the development of a lightweight gas sensor based on incoherent, cavity-enhanced spectrometry and a natural gas camera based on filtered infrared imaging. These sensors will be integrated with global positioning system, wind speed/direction, and data analytics platform.  The Phase I solution will be laboratory tested to characterize its analytical performance, before undergoing field testing on controlled natural gas leaks.  In Phase II, the sensor hardware, electronics, and firmware will be refined to meet the stringent size, weight, power, and environmental constraints of drone-based and handheld deployment.  Likewise, the analytics platform will be refined to incorporate the STTR sensors, interpret the infrared camera data, and provide comprehensive leak detection reports.  The Phase II prototypes will be field tested under real-world conditions with a variety of potential customers for both well pad monitoring and pipeline distribution system monitoring.
  awardeeAddress: 1074 Wentworth St Unit B
  awardeeCity: Mountain View
  awardeeCountryCode: US
  awardeeName: Nikira Labs Inc.
  awardeeStateCode: CA
  awardeeZipCode: '940434629'
  fundsObligatedAmt: '224348'
  fundProgramName: STTR PHASE I
  id: '1745840'
  piEmail: manish.gupta@nikiralabs.com
  piFirstName: Manish
  piLastName: Gupta
  piPhone: '6509060274'
  poName: Anna Brady-Estevez
  date: 12/23/2017
  startDate: 01/01/2018
  expDate: 06/30/2019
  title: 'STTR Phase I:  Development and Validation of Low-Cost Natural Gas Leak Detection
    Sensors and Analytics for Drone-Based and Handheld Deployments'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be safer and more secure IoT platforms that will contribute to the growth of the IoT market. Current security technologies in the IoT arena are either weak or expensive (usually both). The weakness in conventional approaches lies in their impractical goal of finding and fixing all security vulnerabilities. Modern systems have complexity that vastly outstrips the capabilities of any human or verification tool to find all the security vulnerabilities. The only way to somewhat mitigate this weakness is to throw significant resources at the problem, which is very expensive and still yields an imperfect result. The proposed technology developed in this SBIR Phase I project will provide practical and strong security. It gains these important properties by assuming that all systems are riddled with vulnerabilities, so it builds in security by making IoT computing devices that are unsolvable puzzles to attackers. In addition, it doesn't rely on IoT developers to deploy hand-crafted defenses; instead, developers simply build their applications on the proposed platform, and they receive all of its security benefits.

    This Small Business Innovation Research (SBIR) Phase I project will develop a new direction in IoT security. Unlike the world of IoT security today, where developers and tools are attempting to find and fix every last security vulnerability (and always failing), the technology being developed is a hardware-based secure IoT technology that is impractically difficult to penetrate. It achieves this by engaging ensembles of moving target defenses (EMTDs) on the runtime information that attackers need to build their attacks. To overcome EMTDs, attackers must extensively probe the system to acquire the run-time information obscured by moving target defenses. To stop these probes, the technology utilizes a technology called churn to re-key moving target defenses while the system is in operation. Once the churn mechanism is engaged, attackers will have to start their attack over again from scratch. With churn cycles of 50ms (or less), the proposed secure IoT platform becomes impractically difficult to breach, across a broad array of attack classes. The work proposed in this SBIR Phase I project will advance the technology from simulation to a real hardware implementation, which will allow the technology to be deployed into the IoT marketplace.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1218 OLIVIA AVE
  awardeeCity: ANN ARBOR
  awardeeCountryCode: US
  awardeeName: AGITA LABS, INC.
  awardeeStateCode: MI
  awardeeZipCode: '481043935'
  fundsObligatedAmt: '224725'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1845552'
  piEmail: todd.m.austin@gmail.com
  piFirstName: Todd
  piLastName: Austin
  piMiddeInitial: M
  piPhone: '7346442749'
  poName: Peter Atherton
  date: 02/05/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'SBIR Phase I:  Vulnerability-Agnostic Secure Systems'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to enable economic development aid organizations to plan, implement, measure, and achieve better gender equality and social inclusion outcomes. Gender equality is recognized as an important factor in catalyzing development and lifting communities out of poverty. Empowered women contribute to healthy and productive families, communities, and nations. An important step in doing this is to integrate high quality and timely gender analysis (examination of how differences in gender roles, activities, needs, and opportunities affect men, women, girls and boys in specific contexts), into decision-making and project planning. For both public and private sectors, early, action-oriented gender analysis is vital to tackle improve outcomes. In 2015 - 2016, OECD aid agencies spent, on average, $41.7 billion per year targeting gender equality and women's empowerment. Conservatively estimating that 3-5% of this expenditure is for gender analysis and action planning, that makes a market of $1.3-2.1 billion in the development sector alone. This project can potentially improve outcomes from that development funding.

    This Small Business Innovation Research (SBIR) Phase I project is to develop and test a web-based application that automates the currently manual process of conducting gender analyses. This addresses a real world challenge faced by aid organizations to effectively integrate gender analyses into planning to inform effective and timely decision-making. Despite being a requirement by many organizations, there are procurement and contract delays, shortage of gender experts, and manual research and data collection.  This project will develop a machine learning model that leverages big data, APIs, and text-mining, driven by an analytic framework created by experts, to automate this process and deliver customized results instantly for a fraction of the cost. Phase I will build, train, and test the model for one sector and select countries. By the end of Phase I, the model will be tested and iterated to meet high quality control standards. Once validated, it will be ready to scale globally across sectors.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1780 E 1338 RD
  awardeeCity: LAWRENCE
  awardeeCountryCode: US
  awardeeName: EQUILO INC.
  awardeeStateCode: KS
  awardeeZipCode: '660449189'
  fundsObligatedAmt: '224814'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843248'
  piEmail: jessica@equilo.org
  piFirstName: Jessica
  piLastName: Menon
  piPhone: '3124680170'
  poName: Muralidharan Nair
  date: 02/01/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Using big data, AI, and machine learning in gender equality
    and social inclusion analysis'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is to put forth a solution to the critical problem
    of clinical trial enrollment, by improving awareness of clinical trials with physicians
    through technology that matches physician questions to relevant clinical trials
    via an online interactive social decision support platform. Patient enrollment
    is a significant weak link in the development pipeline and a significant pain
    point for organizations that sponsor clinical trials. More than two-thirds of
    trial sites fail to meet enrollment goals for a given trial, and up to 45% of
    study delays are caused by enrollment difficulties. This can result in lost revenues
    up to $1 million/day. Clinical trials are a critical link between scientific discovery
    and changes in clinical practice that advance prevention, treatments, and cures
    for diseases and disability. Increasing awareness of trials among physicians is
    key in increasing clinical trial enrollment, which in turn is essential in advancing
    health care practice as well as patient health and quality of life. While the
    area of cancer is an initial target for improved enrollment, ultimately the proposed
    solution can be applied to other medical specialties and be scaled globally using
    the same platform. \n\nThis Small Business Innovation Research (SBIR) Phase I
    project seeks to drive clinical trial accrual by changing how physicians learn
    about clinical trials. The major innovation is combining a credible online social
    platform with powerful natural language processing technology and machine learning
    techniques to deliver customized clinical trial information to physicians in their
    decision-making process. For this Phase I project, the key objectives are: 1)
    To build out a prototype to match clinical trial information to relevant physician
    questions. Natural language processing (NLP) technology will be created to match
    clinical questions to related clinical trials so that physicians learn about clinical
    trials at the time they are seeking information on how to best treat their patients.
    2) To conduct a pilot assessment of clinical trial knowledge pre- and post-use.
    A small subset of users of the social network platform will engage in a comparative
    assessment, pre- and post-exposure to the clinical trial component, to determine
    the technology?s impact on clinical trial knowledge.  Successful completion of
    Phase I will result in a user-friendly platform that matches clinical questions
    to oncologists and relevant, open clinical trials, and will establish the technical
    and commercial feasibility of the proposed concept.\n\nThis award reflects NSF's
    statutory mission and has been deemed worthy of support through evaluation using
    the Foundation's intellectual merit and broader impacts review criteria."
  awardeeAddress: 246 5TH AVE UNIT 513
  awardeeCity: NEW YORK
  awardeeCountryCode: US
  awardeeName: MEDNET, INC.
  awardeeStateCode: NY
  awardeeZipCode: '100017603'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843270'
  piEmail: nadine@themednet.org
  piFirstName: Nadine
  piLastName: Housri
  piPhone: '2124989844'
  poName: Peter Atherton
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  An Online Peer-to-Peer Resource for Oncologists to Improve
    Clinical Trial Knowledge and Enrollment'
- abstractText: |-
    The broader impact/commercial potential of this project will be to promote empowerment of millions of blind and visually-impaired (BVI) people by enabling greater independence, supporting increased educational attainment, proliferation of vocational opportunities, and enhancing their overall quality of life. There are currently no commercial solutions for providing BVI users with an assistive technology (AT) solution that allows BVI users to seamlessly access textual and graphical information via a unified system. Towards meeting this greater goal, this Phase I SBIR project addresses key challenges relating to technical feasibility in creating the core algorithms of Midlina and the functional viability proving that BVI users will find practical utility in its application. By providing a much-needed AT solution leveraging touchscreen devices such as smart phones as a platform (which is already owned and used by more than 80% of BVI users), this project has a high probability of user adoption and market acceptance when commercialized. Given that vision loss is expected to double in the next 20 years owing to age-related eye diseases experienced by the rapidly aging population, this project will have significant economic benefits for the State/Federal agencies providing support services to BVI and aging population.

    This Small Business Innovation Research (SBIR) Phase I project will show that a novel touchscreen-based information access software, called Midlina, will allow blind and visually-impaired (BVI) individuals to independently access textual and graphical information from digital media. The key innovation and strength of the proposed solution is in its ability to achieve this convergence of seamless text and graphical information access by integrating with native mobile operating systems (OS) used on smart touchscreen-based devices, the fastest growing computational platforms among BVI users. This project builds on strong theoretical underpinnings derived from 5-years of NSF-sponsored academic research involving hundreds of human testers and represents an excellent translational path towards commercialization. Two objectives will drive this Phase I project: (1) Developing a novel visual-to-multimodal conversion algorithm that is seamlessly integrated with a native mobile operating system, and (2) Establishing technical feasibility and practical usability of a prototype system through rigorous human user testing. A successful outcome of this Phase I project would lead to: (1) development of core algorithms for a novel touchscreen-based information access software, called Midlina, and (2) demonstrate feasibility that Midlina will enable BVI people to independently access both textual and graphical contents from digital media.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 20 GODFREY DR
  awardeeCity: ORONO
  awardeeCountryCode: US
  awardeeName: UNAR LABS, LLC
  awardeeStateCode: ME
  awardeeZipCode: '044733610'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843485'
  piEmail: HARIPRASATH.PALANI@MAINE.EDU
  piFirstName: Hari Prasath
  piLastName: Palani
  piPhone: '2074041587'
  poName: Muralidharan Nair
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Development of a Multimodal Interface for improving independence
    of Blind and Visually-Impaired people'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is to improve manufacturing technology for the purification
    of monoclonal antibodies, which are important therapeutics as well as valuable
    tools in research and diagnostics. Approximately four new antibody drugs are approved
    every year, and while they can have tremendous clinical outcomes and are sometimes
    heralded as \"magic bullets,\" they often come with a significant price tag. This
    puts a strain on patients and insurance companies, limiting the accessibility
    of antibody-based drugs. Furthermore, antibodies are critical research tools that
    enhance the understanding of biology. The technology developed in this research
    project will provide a completely novel method for the purification of antibodies
    from cell culture that will lower cost, increase manufacturing throughput, and
    accelerate the time to market for new therapeutics. Commercially, this technology
    will disrupt the current gold standard - Protein A resin - making antibody purification
    simpler, faster, and cheaper at all scales: research, clinical, and industrial.
    \n\nThe intellectual merit of this SBIR Phase I project is to develop technology
    for improved purification of monoclonal antibodies.  Although upstream production
    of antibodies in cell culture has improved dramatically, downstream purification
    has not kept pace, resulting in a production bottleneck and a major market opportunity.
    The objectives of this SBIR Phase I project are to demonstrate technical and commercial
    feasibility of a new technology that combines affinity with liquid-liquid phase
    separation to separate antibodies from cell culture contaminants. It involves
    an antibody-binding domain fused to a biopolymer with stimulus responsive phase
    behavior. When this fusion protein is added to cell culture harvest, it binds
    the antibody and, after triggering the phase separation with salt, pulls the antibody
    out of solution. The purified antibody can then be eluted from the fusion by lowering
    the pH. This project aims to 1) optimize regeneration conditions so that the fusion
    can be reused, 2) evaluate long-term stability, and 3) validate the technology
    at scale and conduct a head-to-head comparison to the industry gold standard,
    Protein A resin. The goal is to identify storage conditions that provide a long
    shelf life for a product that can be reused 10-100 times without compromising
    antibody yield or purity. The focus of the project is to demonstrate promising
    capabilities of the technology for use in industrially manufactured monoclonal
    antibodies, replacing conventional chromatography steps with a simpler and more
    cost-effective method.\n\nThis award reflects NSF's statutory mission and has
    been deemed worthy of support through evaluation using the Foundation's intellectual
    merit and broader impacts review criteria."
  awardeeAddress: 701 W. Main St.
  awardeeCity: Durham
  awardeeCountryCode: US
  awardeeName: Isolere Bio, Inc
  awardeeStateCode: NC
  awardeeZipCode: '277015013'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843074'
  piEmail: kluginbuhl@isolerebio.com
  piFirstName: Kelli
  piLastName: Luginbuhl
  piMiddeInitial: M
  piPhone: '7193224394'
  poName: Ruth Shuman
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Non-Chromatographic Method for the Purification of Monoclonal
    Antibodies'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will primarily benefit people with hand amputations. Touch feedback is a critical component of human manipulation, and its loss is most poignant in people with hand amputations. There are currently no prosthetic devices available to amputees that provide control through touch sensory feedback. Without touch feedback, prosthetic users tend to avoid manipulating many objects they otherwise could because they run the risk of destroying them. Consequently, there is a market need for a richly expressive sensory feedback system for upper limb prosthetics. The proposed research will yield a device capable of such feedback with electrotactile stimulation. These outcomes have the potential to restore a significant amount of function to over 10 million people with hand amputations worldwide and improve their quality of life.

    This Small Business Innovation Research (SBIR) Phase I project involves development of a portable, energy-efficient electrotactile stimulator that can be easily placed into the sockets of hand prosthetics to give users useful sensory feedback. The stimulator will integrate with existing prosthetic control systems. It will be built using standard off-the-shelf components, have a form factor small enough to easily fit into a variety of different prosthetic sockets, and operate for at least 12 hours while operating alongside a prosthetic hand and its control system. To improve sensation quality, a sensation controller that enables consistent long-term stimulation will be deployed, reducing the likelihood of device rejection due to discomfort. The expected outcomes of this research are 1) a portable, cost effective and energy efficient electrotactile stimulator that can be easily placed into the socket of a prosthetic user and integrated with their prosthetic hand; and 2) a user study which evaluates the effectiveness of this device deployed with a sensation controller for daily manipulation tasks. The capabilities of the Phase I prototype will be extended in Phase II for delivery of a market-ready sensory feedback system that is compliant with regulatory standards for medical equipment.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 60 Hazelwood Dr
  awardeeCity: Champaign
  awardeeCountryCode: US
  awardeeName: PSYONIC, Inc.
  awardeeStateCode: IL
  awardeeZipCode: '618207460'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843966'
  piEmail: aakhtar@psyonic.co
  piFirstName: Aadeel
  piLastName: Akhtar
  piPhone: '7738883252'
  poName: Benaiah Schrag
  date: 02/08/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  A compact electrotactile sensory feedback system for upper
    limb prostheses'
- abstractText: |-
    This Small Business Innovation Research Phase I project comprises the development of a wearable system capable of accurately tracking glaucoma progression via continuous monitoring of intraocular pressure (IOP). Glaucoma is the leading cause of irreversible blindness in the world and affects nearly 80 million people worldwide. Using a novel wearable system, optometrists, ophthalmologists, and medical professionals across multiple disciplines can review the IOP trends at visits, monitor high-risk patients in real-time, and program patient-specific threshold alarms that will prevent irreversible blindness caused by glaucoma and related conditions. Through successful product commercialization, the novel wearable blindness prevention system (BPS) is expected to be adopted by approximately 2 million glaucoma patients annually. Users of the device will have continuous access to IOP data trends. Clinicians will be alerted when at-risk patients fail to comply with prescribed daily medicinal treatment (due to excessive IOP levels) and can continuously track the efficacy of prescribed IOP-lowering treatments. Finally, the IOP tracking capability of the system will allow improvements in the quality of care for general clinicians, medical specialists, and clinical researchers and will be a major player in the current move toward data-driven, value care.

    The intellectual merit of this project centers on laboratory feasibility testing of the fundamental concept behind the novel blindness prevention system technology - image-based pressure sensing - on a benchtop 3D-printed glaucoma simulator that is monitored using an alpha prototype of the system.  The research plan includes testing of the feasibility of a complementary metal oxide semiconductor (CMOS) camera which fits inside a pair of eyeglass frames, plus processor, optics, and software, as a way to record pressure changes in eye tissue in a benchtop environment. The key objective is to accurately - and with high repeatability - detect unhealthy eye pressure levels in the simulator using an alpha prototype, a-BPS, that communicates with a standard mobile device.  The target research outcome for the a-BPS is to successfully trigger a high-pressure alarm in a repeatable manner whenever eye pressure in the simulator exceeds a clinically-relevant threshold. It is anticipated that the Phase I research results will show successfully operation in 90% or more of the test samples. The output from the Phase I effort will be used as design inputs for a Phase II prototype, which will be wearable and will allow testing on humans.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 25014 LAS BRISAS S
  awardeeCity: MURRIETA
  awardeeCountryCode: US
  awardeeName: GLOBE BIOMEDICAL LLC
  awardeeStateCode: CA
  awardeeZipCode: '925624029'
  fundsObligatedAmt: '224206'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842393'
  piEmail: jpark@globebiomedical.com
  piFirstName: Joshua
  piLastName: Park
  piMiddeInitial: J
  piPhone: '9513121800'
  poName: Benaiah Schrag
  date: 02/01/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'SBIR Phase I: Feasibility of a Wearable Blindness Prevention System'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop a practical method for ultra-secure global communication using quantum key distribution (QKD). QKD is an established communications protocol which promises unbreakable encryption via the exchange of single photons, the constituent particles of light. Owing in large part to the lack of a practical way to connect users globally, QKD has not yet been widely deployed. This project aims to demonstrate the viability of high-speed, satellite-to-ground QKD using the low-cost CubeSat platform. If successful, this design will dramatically reduce the initial costs to launch a QKD constellation offering worldwide QKD connectivity, thereby greatly expanding the utility of QKD and driving market growth. Early customers will be the US Government and large businesses who are willing to pay a premium for the ultimate in data security. Government use offers clear societal benefit, as several agencies rely on secure global communications to ensure societal well-being. As technology advances, the network may be used to secure the communications of private citizens. The proposed plan will furthermore develop enabling technologies for future space-based quantum science experiments.

    This Small Business Innovation Research (SBIR) Phase I project will produce designs for a high-speed QKD payload hosted on a CubeSat. The proposed design will take a substantial step forward from the first and only demonstration of satellite-to-ground QKD (Micius, 2017), which relied on technology that is too massive, expensive, and low-throughput for commercial use. Since CubeSats are heavily constrained in size, weight, and power, the major technical challenge will be to miniaturize the payload and reduce its power consumption while simultaneously improving data rates. To address this challenge, the small business will investigate a novel QKD payload concept that pushes the limits of emerging technologies in photonics and microelectromechanical systems. In Phase I, detailed modeling and simulation of candidate payload designs will be used to evaluate the commercial and technical feasibility of the proposed approach, and to select a preliminary design for initial implementation, which will commence in Phase II.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1021 HARLAN DR
  awardeeCity: SAN JOSE
  awardeeCountryCode: US
  awardeeName: SKY QUANTUM INC
  awardeeStateCode: CA
  awardeeZipCode: '951293021'
  fundsObligatedAmt: '224924'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842769'
  piEmail: max@skyquantum.space
  piFirstName: Maxwell
  piLastName: Shapiro
  piMiddeInitial: C
  piPhone: '4153505792'
  poName: Peter Atherton
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Quantum Key Distribution via Small Satellite'
- abstractText: "This SBIR Phase I project will support the research and development
    of a new medical device designed to prevent deep vein thrombosis in hospitalized
    patients. Deep vein thrombosis occurs when blood clots form in the veins and is
    a common complication in hospital patients that is also a leading cause of preventable
    death in the United States. This project will develop a device that modifies blood
    flow patterns in the legs in a new manner designed to specifically activate genetic
    changes inside the vein that protect against blood clot formation. The goal of
    this project is to generate a new device that it is capable of creating the desired
    blood flow patterns in patients while maintaining a high level of device comfort,
    reliability, and ease of use for clinical staff and patients. In addition to preventing
    death and disability in the hospitalized population of the US, this project will
    move a new device towards commercial production, thereby supporting economic growth,
    job formation, and tax revenue. \n\nThis SBIR Phase I project will leverage novel
    molecular and cellular discoveries regarding the pathogenesis of deep vein thrombosis
    (DVT) to create a more effective device to prevent DVT in immobilized individuals
    who are at high risk for the disease. DVTs form in the sinus behind venous valves,
    where blood flow is reduced during immobility, promoting blood clot formation.
    This site is typically protected against clot formation by a powerful genetic
    program in the endothelial cells that is unique to the valve sinus microenvironment.
    Loss of this genetic expression program results in a prothrombotic environment
    that supports clot formation and DVT. Research has further revealed that the valve
    sinus anti-thrombotic genetic program is activated by a specific pattern of venous
    blood flow at that site that is driven by muscular activity. During prolonged
    periods of immobility, common during hospitalization, loss of this flow profile
    extinguishes the protective endothelial phenotype and supports DVT formation.
    Ultrasound analysis reveals that current mechanical therapy devices marketed to
    prevent DVT do not generate the hemodynamics at the valve that are produced by
    muscular activity due to their methods of action. This project will develop a
    device that generates a protective hemodynamic pattern in the valve sinus of immobile
    patients by actuating blood flow that accurately reproduce muscular activity.
    To accomplish this goal the device design alters the primary physical manipulation
    strategy of other existing devices away from calf and thigh compression and instead
    induces rapid calf expansion to replicate the effect of muscular activity on venous
    blood flow. Vascular ultrasound studies demonstrate that this actuation method
    successfully recapitulates the venous hemodynamics of the active limb required
    to support expression of the protective genetic pathway in the valve sinus. This
    SBIR Phase I project will optimize the device design to create this actuation
    while also improving patient comfort, mitigating common risks, and facilitating
    ease of use by clinical staff. This project will address key risks in advancing
    a medical device into clinical testing and use, thereby enabling the device to
    bridge to a phase of commercial manufacturing and use.\n\nThis award reflects
    NSF's statutory mission and has been deemed worthy of support through evaluation
    using the Foundation's intellectual merit and broader impacts review criteria."
  awardeeAddress: '1500 LOCUST ST #2619'
  awardeeCity: PHILADELPHIA
  awardeeCountryCode: US
  awardeeName: OSCIFLEX LLC
  awardeeStateCode: PA
  awardeeZipCode: '191024339'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842867'
  piEmail: johnwelsh11@gmail.com
  piFirstName: John
  piLastName: Welsh
  piMiddeInitial: D
  piPhone: '6099777258'
  poName: Henry Ahn
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  VTE mitigation device'
- abstractText: |-
    This Small Business Innovation Research (SBIR) Phase I project intends to enhance listening comprehension skills via an innovative interactive learning platform that aligns with Common Core State Standards for listening comprehension and uses best practices in game-based learning. In 2017, 63% of U.S. 4th graders were reading below proficiency. Improving a students' level of listening comprehension in elementary school is the single greatest influence on his or her reading comprehension. Common Core State Standards now include guidelines for listening comprehension starting in kindergarten. However, most listening activities involve teachers reading aloud followed by written assessments that require decoding and encoding. Narrative audio content models fluency and prosody and helps bridge the gap between word recognition and comprehension without relying on decoding and encoding text. There are no other listening platforms designed for elementary schools and therefore there is a tremendous opportunity for this program to have significant commercial success. The project's long-range purpose is to improve listening skills at the time in a child's life when it matters the most. By utilizing compelling audio content that highlights the latest discoveries in science, technology and innovation, this project also meets the National Science Foundation's mission of 'promoting the progress of science'.

    This project will break new ground and modernize the way listening comprehension is taught and assessed with an innovative interactive learning platform that takes traditional elements of game play and applies them to listening comprehension activities (i.e. vocabulary, fluency and comprehension). More specifically, each audio story will have embedded audio cues that lead to audio/visual comprehension questions, games and polls. The platform will include account management, student rostering, student progress monitoring, administrative dashboards and interactive teacher guides for using audio in the classroom. Studies show that both game-based learning and audio content increase motivation in students, however no studies examine the use of both game-based learning and audio together. The research conducted for this Small Business Innovation Research Phase I project will use a qualitative design to best understand and describe how classroom teachers and students use and engage with the interactive audio platform. The goal is to conduct interviews with teachers and usability testing with students to ensure that platform features are engaging, feasible, easily integrated and demonstrate potential for intended educational outcomes. Lessons learned from this Phase I award will be applied during Phase II, when a more robust platform will be developed and commercialized.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 45 WATCHUNG AVE
  awardeeCity: MONTCLAIR
  awardeeCountryCode: US
  awardeeName: TINKERCAST, LLC
  awardeeStateCode: NJ
  awardeeZipCode: '070431337'
  fundsObligatedAmt: '224950'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843693'
  piEmail: Meredith@Tinkercast.com
  piFirstName: Meredith
  piLastName: Halpern-Ranzer
  piPhone: '2159643443'
  poName: Rajesh Mehta
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 09/30/2019
  title: 'SBIR Phase I:  Interactive Podcast Platform For Listening Comprehension'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project will be functional neuronal cells derived from human adult adipocytes that will have applications in regenerative medicine.  The goal is to develop dopaminergic (DA) neural progenitor cells (NPCs) from transdifferentiated human adult adipocytes using a DA cell induction cocktail.  This will have application in cellular therapeutics and research tools for Parkinson's Disease (PD), and other neuronal diseases. In addition, these studies will impact the field of stem cell research and regenerative medicine, since this will be the first demonstration that functional neuronal cells, the main building blocks of brain, spinal cord, and peripheral nervous systems, can be produced from mature fat cells that can be used as cellular therapeutics for several neurological disorders.

    This SBIR Phase I project proposes to develop new technology for generation of midbrain dopaminergic (DA) neural progenitor cells (NPCs) from adult adipocytes (fat cells), which will used as a platform to develop cellular therapeutics for Parkinson's Disease (PD), and PD research tools. Recently, using a chemical genetics approach (chemical approach or small molecule approach), engraftable midbrain DA neuronal progenitor cells (DA NPCs) from human bone marrow derived mesenchymal stem cells (BM-hMSCs) have been generated. Additionally, DA neuronal progenitor-like cells also had been produced from de-differentiated fat cells (DFAT cells) that have several advantages over BM-hMSCs such as homogeneity of DFAT cell cultures, ease of isolation and low immunogenicity. The goal of Phase I project is to validate and optimize the DA induction protocol for generation of midbrain DA NPC from DAFT cells. Phase II will focus on clinical grade manufacturing of these DA cells and testing their therapeutic effect in several preclinical animal models of PD. Commercial products emerging from Phase I/II work include cellular therapeutics for PD and research tools for PD.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 4404 S 113 str
  awardeeCity: Greenfield
  awardeeCountryCode: US
  awardeeName: Cell Reprogramming & Therapeutics LLC
  awardeeStateCode: WI
  awardeeZipCode: '532282565'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819574'
  piEmail: aalexan@cellrtherapeutics.com
  piFirstName: Arshak
  piLastName: Alexanian
  piMiddeInitial: R
  piPhone: '4142385067'
  poName: Ruth Shuman
  date: 09/06/2018
  startDate: 09/01/2018
  expDate: 08/31/2019
  title: 'SBIR Phase I:  Generation of Dopaminergic Neurons from Fat'
- abstractText: |-
    The?broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is represented by the development of a company in a unique field of single crystal growth addressing needs in solid-state lasers. Single crystal growth represents a small and highly specialized, but absolutely essential, area of modern materials technology. Solid-state lasers are commercially vital because they are compact, durable, relatively inexpensive, and field deployable in many technologies. Single crystals are essential components to solid-state lasers and thereby represent significant commercial potential.  This project will enhance the skill set of specialty manufacturers of high quality single crystals for solid-state lasers. It represents an unmet commercial need in short wavelength solid-state lasers and also will expand the technological skill set of single crystal growers. This last point is especially important, as there is a serious lack of skills, technology and infrastructure in solid state laser production in this country, and this makes the US increasingly dependent on offshore suppliers of essential materials. This program will help train the next generation of critical materials manufacturing experts in the US.

    The proposed project intends to address the development of new single crystals called Strontium Beryllium Borate (SBBO). These crystals are an enabling technology for the manufacture of short wavelength solid-state lasers lasing at and below 266 nm. Such lasers have many potential applications but at present there are no materials capable of practical performance at these very short wavelengths. This shortcoming represents a significant commercial opportunity. The project will examine production of single crystals of a new material to meet this need using hydrothermal synthesis, which employs very hot water at high pressures as a growth environment. In this Phase I project, research will be undertaken to develop a growth protocol of large single crystals of this vital material, A feedstock will be perfected, and seed crystals will be produced. Transport conditions will be optimized, and suitable temperature gradients will be identified. Preliminary evaluation of crystal quality will be performed. Suitable crystals will be sent to collaborators in the laser manufacturing industry for preliminary production of solid-state short wavelength lasers. The seed crystals and growth protocols from the research in this Phase I program will be used in a Phase II project for development of a full-scale commercial manufacturing process for this crystal.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 107-3 Sloan St
  awardeeCity: Clemson
  awardeeCountryCode: US
  awardeeName: HT CrystalSolutions LLC
  awardeeStateCode: SC
  awardeeZipCode: '296311483'
  fundsObligatedAmt: '217730'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819738'
  piEmail: giesber@htcrystalsolutions.com
  piFirstName: Henry
  piLastName: Giesber
  piMiddeInitial: G
  piPhone: '7049070563'
  poName: Rick Schwerdtfeger
  date: 07/09/2018
  startDate: 07/01/2018
  expDate: 08/31/2019
  title: 'SBIR Phase I: Hydrothermal Growth Strontium Beryllium Borate (SBBO) for
    deep UV Nonlinear Optical Applications.'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to sell affordable backup generators that provide 23 kilowatts, for operating a home's lights and appliances. With power outages due to natural disasters and an aging power grid becoming ever more frequent, and with society increasingly reliant on electricity to power not only lights and household appliances, but also computers, wireless routers, and medical devices, back-up power is an increasingly critical need. This SBIR's portable generator is expected to be more than an order of magnitude lower cubic size and weight, all at a reduced cost compared to existing generators.  The broader impact of this project is its significant benefits to the environment by providing backup power at high fuel efficiency (i.e. less consumption of non-renewable fossil fuels) and low emissions of hydrocarbons, particulate matter, carbon monoxide, and smoke.

    This SBIR Phase I project proposes to address the shortcomings of residential-use backup generators currently on the market. Available backup generators are either small and affordable but can only power a single appliance; or able to power most of a home's needs but cumbersome and expensive. This project will demonstrate the potential for implementing a free-piston internal combustion engine that will maximize fuel efficiency; minimize size; decrease dependence on lubricating oil; and incorporate an engine management system. The objective of the current effort is the engine, while the functioning compact generator will be developed in the next phase. In this free-piston engine design, the two pistons oscillate with forces in balance and reduced side-loads to the pistons, yielding a long-lasting high-speed engine. The pilot work included modification of the cylinder intake ports; addition of a modified squish band and dome to the cylinder head; and use of low-friction bearing materials yielding a successful prototype that runs on regular gasoline. The engineers will continue implementing, testing, and improving on these modifications. The successful completion of this project will yield an efficient, compact, low-weight, and low-emissions generator that produces 23 kilowatts of usable power that runs on standard pump gasoline.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3350 SW 139 Ave
  awardeeCity: Miramar
  awardeeCountryCode: US
  awardeeName: Alfadan Inc
  awardeeStateCode: FL
  awardeeZipCode: '330273249'
  fundsObligatedAmt: '224249'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819821'
  piEmail: afa928@aol.com
  piFirstName: Alberto
  piLastName: Araujo
  piMiddeInitial: F
  piPhone: '7862801246'
  poName: Anna Brady-Estevez
  date: 06/13/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  A Compact Home Power Generator using a Free-Piston Engine'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will result from advancing the application territory of Internet-of-Things (IoT) and 4G/5G/Beyond-5G ecosystems. If successful, the obtained results would directly benefit a large portion of the current 8.4 billion wirelessly "connected things" with an estimated $273 billion market. It will facilitate "always-on, anytime, anywhere" network services and further help enable many emerging IoT applications (e.g., safe driving, remote healthcare, smart city, wearables). The technology is expected to create new business opportunities for IoT vendors, service providers, and mobile virtual network operators. If successful, it will facilitate evolution from an operator-centric network ecosystem to a user/application-centric ecosystem.

    This Small Business Innovation Research Phase I project will develop a software-based solution to enabling dependable, software-defined network services for IoT applications. The objective for Phase I is to provide "always-on, anytime, anywhere" network service for billions of IoT devices and applications. Different from the current infrastructure-based solutions (using software-defined networking or network slicing), the proposed technology offers an in-device, SIM-based software solution without infrastructure upgrades or added device hardware. It enables in-SIM visibility to "black-box" mobile network operations, performs in-device optimizations using readily available mechanisms, and offers further value-added cloud services for network-wide optimization and management via crowdsourcing. The technology is readily deployable on today's IoT devices (both low-end and high-end) and provides "must-have" features for two customer segments (validated through NSF I-Corps interviews) - IoT mobile virtual network operators, and IoT application vendors.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 4425 ENSENADA DR
  awardeeCity: WOODLAND HLS
  awardeeCountryCode: US
  awardeeName: MobIQ Technologies
  awardeeStateCode: CA
  awardeeZipCode: '913645408'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843994'
  piEmail: liyuanjie08@gmail.com
  piFirstName: Yuanjie
  piLastName: Li
  piPhone: '3106148922'
  poName: Peter Atherton
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  MobIQ: A SIM-Based Solution To Software-Defined IoT Network
    Services'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to provide a better and safer alternative to conventional piezoelectric ultrasonic instruments that use liquid-coupled transducers for the inspection of pipelines, tanks, and other structures used in power generation and liquid process industries. This new instrument does not require the use of liquid coupling, and can work on rough, coated, or contaminated surfaces that cannot be inspected with conventional liquid-coupled techniques unless the part is subjected to costly and time consuming part preparation. By not using liquids, this instrument can also be used on components that are very hot, very cold, radioactive, or in a vacuum. A high-resolution ultrasonic instrument that does not use couplant and has comparable performance to a piezoelectric instrument will save inspection time, reduce inspection costs, and permit inspections while in-service, which will result in millions of dollars in savings for plant operators. Society as a whole will also benefit from improvements in safety and performance of the plants, and by reducing the amount of waste and contaminants released into the environment as direct sub-product of the inspection, or from failures in facilities and equipment.

    The proposed project consists of the development of a portable, high-resolution, ultrasonic phased array instrumentation, software, and transducers based on non-contact Electro Magnetic Acoustic Transducer (EMAT) technology to substitute or complement the tens of thousands of conventional piezoelectric instruments in the market. For the instrumentation, the research will revolve around the development of a high-power and compact 16-channel pulser/receiver with a very small dead zone that permit inspection near the surface of the part. This instrumentation will also require custom software with signal-enhancing algorithms that compensate for the small amplitude of EMAT signals. The 16-channel phased-array EMAT transducers will involve multi-physics simulation of electrical and magnetic components to develop very small and high-density coil elements that can produce enough signal amplitude at high-frequencies while handling the pulsing rates required for effective inspection, and the high-power generated by the custom instrumentation. All these components will need to be enclosed in a battery-powered package that can be used in the harsh conditions typically found in field inspections. The expected result is a portable instrument that can compete in performance with conventional piezoelectric instruments, especially in applications and inspection environments where a conventional instrument is not practical or very costly to use.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2940 Perrowville Road
  awardeeCity: Forest
  awardeeCountryCode: US
  awardeeName: Innerspec Technologies Inc
  awardeeStateCode: VA
  awardeeZipCode: '245512225'
  fundsObligatedAmt: '224048'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842797'
  piEmail: sali@innerspec.com
  piFirstName: Syed
  piLastName: Ali
  piMiddeInitial: M
  piPhone: '4349481301'
  poName: Rick Schwerdtfeger
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  PORTABLE EMAT PHASED ARRAY FOR CORROSION MAPPING'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to optimize water utilization, thereby improving agricultural production. It is projected that the human population will exceed 9 billion by 2050.  To meet the expected demand, global food production must increase by more than 50% by 2050. This SBIR project will have impact not only in expanding fundamental knowledge of plant utilization of water but also in contributing to agricultural productivity, an urgent and practical need for human survival, in a sustainable manner.

    This SBIR Phase I project proposes to commercialize the advanced water-treatment technology that could enhance plant growth, and therefore improve crop output in agricultural applications. In short, a thin layer (about 100 microns, as thin as a human hair) of interfacial water was found to exist with a slightly higher pH, net negative charge, and a tendency to exclude impurities. These findings were similar to those found by other independent research groups working with xylem cells in plants and muscle cells in animals. Several hydrogels and polymers were also found to contain interfacial water with similar properties. Initial studies regarding the practical use of the interfacial water were conducted in a plant system. On average, initial results show a rapid growth rate of around 10% to 20% improvement compared to the control group; preliminary findings that have now been confirmed to be similar amongst four different plants, namely chick pea, wheatgrass, basil, and pea shoots. This SBIR will enable continued testing and scale up the interfacial water generator to meet water demands for customer validations.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 6545 34th Ave NE
  awardeeCity: Seattle
  awardeeCountryCode: US
  awardeeName: 4th-Phase Inc.
  awardeeStateCode: WA
  awardeeZipCode: '981157301'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819846'
  piEmail: kurt.kung@4th-phase.com
  piFirstName: Chien-Chang
  piLastName: Kung
  piPhone: '2064078945'
  poName: Anna Brady-Estevez
  date: 06/21/2018
  startDate: 07/15/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  4th-Phase Water Technology'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR)
    Phase I project is to save lives through the proliferation of miniaturized automated external
    defibrillators that attach to smartphones. Sudden cardiac arrest (SCA) will kill more than 325,000
    Americans this year outside of the hospital. An SCA can cause death if it is not treated in
    minutes. If an AED is available, it can save a person's life; some estimates suggest a 27% increase
    in the number of people who could be saved if AEDs are available and used when needed. A
    miniaturized AED embedded in a smartphone case could save lives by making AEDs more
    available and ensuring those who carry them are reachable by emergency medical services. The
    strategy is to equip law enforcement, firefighters, EMS personnel, and potential citizen first responders
    with this device and use smartphone technology to ensure they are reachable when
    in proximity to someone experiencing an SCA. It provides an opportunity for a new paradigm in
    first response: AED carriers that can be located during the first critical moments of an SCA.
    Through this research, hundreds of thousands of lives can be saved each year.

    This Small Business Innovation Research (SBIR) Phase I project will prove out the concept of a
    regulatory-compliant miniaturized AED that integrates with a smartphone. The work includes
    researching and designing components and electronics that will enable creation of this critical
    medical device and accomplish three overarching goals: (1) design and develop the miniaturized
    components, interconnects, firmware and software necessary to implement the hand-held AED
    Smartphone case in Phase Two by evaluating high voltage power supply and switching
    electronics and completing a power converter and switching design capable of generating the
    required energy from an on-board lithium-ion battery and supporting a bi-phasic waveform; (2)
    develop the smartphone software and firmware necessary to implement the device itself, guide
    a user through the emergency protocol, and send GPS information to EMS to allow them to
    locate proximal first responders; (3) integrate the hardware and software into a prototype that
    demonstrates a path to a form factor function unit in Phase 2. Research and designs of
    interconnects and encapsulation methods developed as part of this effort will offer insight into
    the miniaturization of myriad electronics both within and outside the medical domains.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 15504 Vine Cottage Drive
  awardeeCity: Centreville
  awardeeCountryCode: US
  awardeeName: Altrix Medical, LLC
  awardeeStateCode: VA
  awardeeZipCode: '201203750'
  fundsObligatedAmt: '224502'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842149'
  piEmail: dan.fleck@altrixmedical.com
  piFirstName: Daniel
  piLastName: Fleck
  piPhone: '7039893061'
  poName: Benaiah Schrag
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Smartphone-based Automated External Defibrillator'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project will be the development of a cost-effective, user-friendly,
    high-performance microsystem suitable for in-field and on-site gas analysis applications.
    Gas analyses are a mature but still growing multi-billion dollar global market.
    The proposed product can have significant impact across multiple industries and
    disciplines, including food processing and safety, environmental monitoring, homeland
    security, and biomedical diagnostics. It will provide the following important
    benefits to diverse customers: speed for near-real time gas analysis with high
    performance, portability and robustness for in-field and on-site uses, low cost
    to purchase and maintain, ease to use, and versatility for different applications.
    Additionally, employment of the proposed microsystem in process and quality controls
    can help improve productivity while saving costs, and autonomously monitoring
    hazardous gases in vulnerable environments can help protect workers and the public.
    \n\nThe proposed project will be a proof-of-concept study on a modular microsystem
    for point-of-use gas analyses. Conventional gas analysis systems are bulky, resource
    and energy intensive, time consuming, and expensive to purchase, operate, and
    maintain. Increasing demands for in-field and on-site testing of volatile organic
    compounds and other gas phase species call for the development of a miniaturized
    gas analyzer capable of overcoming these major limitations. However, there are
    significant technical challenges associated with such system integrations and
    instrument miniaturizations, which traditionally result in significant compromises
    to the analytical capability/performance. The proposed solution is a modular microsystem
    integrating multifunctional high-performance microfluidic/sensor chips in a flexible
    and expandable format that is suitable for mass production and versatile applications.
    In Phase I, different chips will be fabricated and assembled into a testing system
    to investigate the technical feasibility of modular design. A commercial prototype
    will be developed in Phase II. Successful development of the proposed product
    will provide opportunities to address unmet needs in a variety of markets involving
    gas analyses.\n\nThis award reflects NSF's statutory mission and has been deemed
    worthy of support through evaluation using the Foundation's intellectual merit
    and broader impacts review criteria."
  awardeeAddress: 535 W. Research Center Blvd, 135
  awardeeCity: Fayetteville
  awardeeCountryCode: US
  awardeeName: Zebra Analytix, Inc.
  awardeeStateCode: AR
  awardeeZipCode: '727016948'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1841929'
  piEmail: xiaoli.su@zebraanalytix.com
  piFirstName: Xiaoli
  piLastName: Su
  piPhone: '4795712592'
  poName: Rick Schwerdtfeger
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Point-of-Use MEMS Gas Analyzer'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project lies in the replacement of key petroleum-based chemicals used in the paints and coatings industry, representing a $7B industry that is growing at 7% per year. The total addressable market includes 3 similar diols: 1,4-butanediol (1,4-BDO), 1,5-pentanediol (1,5-PDO), and 1,6-hexanediol (1,6-HDO). In this project, 1,5-PDO is produced from furfural, a chemical made from renewable agricultural residues such as corn cobs and wood chips.  Bio-based 1,5-PDO can be readily substituted for 1,6-HDO in many applications due to its analogous molecular structure and is similar enough to 1,4-BDO that it can be substituted for it in some applications. Rigorous technoeconomic analysis shows that this "green" 1,5-PDO can be made at 3x lower costs than oil-derived 1,5-PDO, opening new opportunities for its use as a renewable monomer for paints, coatings, adhesives and plastics.

    This Small Business Innovation Research (SBIR) Phase 1 project will allow the technology to be developed with commercially available fixed bed pellet catalysts to prepare the technology for scale-up.  Thus far, the technology has been demonstrated in small scale fixed bed reactors with powder catalysts.  A commercial scale process requires the use of pelletized catalysts due to inoperable pressure drops over powder catalysts in commercial-scale reactors. The higher flowrates inherent with larger scale reactors cannot flow through the tightly packed powder catalysts and cause a large degree of backpressure upstream of the catalyst bed; thus, pelletized catalysts must be sourced from commercial vendors and tested for activity and stability prior to scaling.  The next phase in technology development is to scale up the process by >100x, enabling testing and validation of larger amounts of the bio-based 1,5-PDO product in potential customers' product lines.  This SBIR Phase I project will also allow completion of the process design work needed to estimate the economics at commercial scale.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 309 W WASHINGTON AVE UNIT 406
  awardeeCity: MADISON
  awardeeCountryCode: US
  awardeeName: PYRAN LLC
  awardeeStateCode: WI
  awardeeZipCode: '537033590'
  fundsObligatedAmt: '224752'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1849600'
  piEmail: kjbarnett@pyranco.com
  piFirstName: Kevin
  piLastName: Barnett
  piMiddeInitial: J
  piPhone: '2148863260'
  poName: Linda Molnar
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  A New Bio-based Monomer for the Coatings Industry'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project relates to the historic challenges associated with composite manufacturing, including long cycle times, poor recyclability, labor-intensive manufacturing, and energy-intensive curing processes. Thermoplastic composites have the potential to reduce cycle time, reduce labor requirements, and improve recyclability; however, traditional thermoplastic processes are energy intensive. This Phase 1 SBIR is seeking new, more efficient process heating methods that can be integrated into a continuous composite manufacturing process to improve production speed and reduce operating costs, enabling the growth of composite materials in weight sensitive industries that require high-volume, low-cost structural components, including automotive, unmanned aircraft, wind turbines, and cargo transportation.

    This Small Business Innovation Research (SBIR) Phase I project will determine the technical feasibility of ultrasonic heating and induction heating as an alternative to infrared heating in a continuous composite forming process. Process heating constitutes a significant portion of the direct energy consumed by in manufacturing. This is particularly true in the production of fiber-reinforced thermoplastic composites, where the polymer matrix must be melted as part of the consolidation process. As part of this Phase 1 project, heater modules for induction heating, ultrasonic heating, and infrared heating will be developed and integrated into a bench-scale, continuous composite forming prototype. Composite material will be produced using each heating method and energy consumption will be monitored during the forming process. The composite material produced during testing will be weighed and embodied energy will be calculated by dividing the total energy consumed by the mass of the material. The objective of this work is to identify a heating method that can reduce embodied energy by at least 40%, relative to the infrared heating system.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 311 Ferst Drive NW
  awardeeCity: Atlanta
  awardeeCountryCode: US
  awardeeName: WEAV3D Inc.
  awardeeStateCode: GA
  awardeeZipCode: '303320560'
  fundsObligatedAmt: '224718'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843054'
  piEmail: chris.oberste@weav3d.com
  piFirstName: Christopher
  piLastName: Oberste
  piMiddeInitial: M
  piPhone: '6788368103'
  poName: Rick Schwerdtfeger
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Thermal Intensification for Continuous Thermoplastic Composite
    Forming'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is a transparent photovoltaic technology that converts near-ultraviolet (NUV) light into point-of-use power for dynamic 'smart' windows. Energy use in buildings represents roughly 40% of total U.S. energy demand. It is projected that over half the buildings that will be in use in 2050 are already built. Retrofitting existing buildings with smart windows that regulate/monitor sunlight transmission could reduce building energy consumption by 10 - 40% and represents a $64B total addressable market, but is presently prohibitively complex and labor intensive. Transparent, NUV solar cells will simplify smart glass/film adoption by obviating the need for external wiring, thereby catalyzing deployment of smart window technologies in existing buildings to increase energy efficiency and enhance occupant health and productivity. Similarly, IoT smart devices/sensors promise to make the built environment more efficient by giving users more control over appliances, information, and energy use. Transparent NUV solar cells can provide point-of-use power to in-window IoT devices/sensors without altering aesthetics. For the photovoltaic community, the operation physics and performance of the NUV photovoltaic technology developed through this program will be of broader interest, as NUV wavelengths are inefficiently harvested by conventional photovoltaics.

    The proposed project will explore a photovoltaic technology that selectively absorbs near-ultraviolet (NUV) light - energy that is otherwise wasted - and efficiently converts it into high-voltage power. Solar cells harvesting NUV photons could satisfy the unmet need of powering smart windows monolithically without competing for visible or near-infrared photons that the windows seek to regulate or imposing design constraints on window aesthetics. First-generation NUV solar cells exhibit power scalability with area, and single-junction photovoltages exceeding 1.6 V (record for thin-film PV). This Phase I project aims to (1) translate NUV solar technology from rigid glass to a flexible substrate, and (2) demonstrate use of low-cost transparent electrode alternatives. These breakthroughs will allow for facile integration of NUV solar cells with smart windows for self-powered operation and intelligent management of the solar spectrum, with NUV photons powering the regulation of visible and near-infrared photons for natural lighting and heating purposes, respectively. Additionally, the aesthetically-discreet nature of flexible, transparent NUV solar cells can enable remotely-powered internet-of-things (IoT) smart devices/sensors. Accordingly, funding for this Phase I project will produce a flexible, transparent NUV solar cell prototype for field-testing with smart window and IoT device technologies.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 302 Nassau St
  awardeeCity: Princeton
  awardeeCountryCode: US
  awardeeName: Andluca Technologies LLC
  awardeeStateCode: NJ
  awardeeZipCode: 085404605
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1843743'
  piEmail: nickcdavy@gmail.com
  piFirstName: Nicholas
  piLastName: Davy
  piPhone: '8328590382'
  poName: Rick Schwerdtfeger
  date: 02/04/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'STTR Phase I:  DDevelopment of a Transparent, Near-Ultraviolet Photovoltaic
    Power Source for Wireless Operation of Smart Windows and Internet-of-Things Devices'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project lies not only with athletes, but with the 3 million Americans who suffer a traumatic brain injury each year, and the 40+ million more who are concerned about dementia and seek a way to measure their brain health. Current solutions (typically available only at facilities with trained professionals) assess only significant health changes to cognition. In contrast, our solution provides an affordable, reliable way to measure brain health and to monitor changes after treatment, training, and rehabilitation. Thus, it will be an excellent tool other companies can use to assess various interventions aimed at affecting brain function. The "quantified self" market sells technologies (wearables, DNA tests, software) that collect data to inform and guide health and self-improvement. The total addressable global market is estimated at ~$19B for 2019. The initial target market of customers are those seeking a competitive athletic edge by measuring, tracking, and training cognitive abilities such as reaction time, decision-making, and multitasking. These customers are coaches in high schools, colleges, and high-performance gyms across the US.

    This Small Business Innovation Research (SBIR) Phase I project will address the need to combine and harness the power of eye-, hand-, and head-tracking instruments, virtual reality, and cognitive neuroscience to accurately measure and monitor brain function. This Phase I SBIR project will complete four technical objectives: (1) to develop a highly controlled testing environment that can accurately measure the time users (athletes) spend on detecting, processing, and acting on different cognitive tasks; (2) to develop software that can collect reliable data from naturalistic inputs; (3) to develop a set of tasks that users can complete within 30 minutes and that will generate sufficient data for analysis; and (4) quickly process, summarize, and contextualize the collected data and report meaningful results to the athletes and their trainers. Successful completion of these objectives will realize a first-of-its-kind product that provides meaningful insight into the brain with laboratory-quality cognitive assessment in a real-world context.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 87 GRAHAM ST STE 160
  awardeeCity: SAN FRANCISCO
  awardeeCountryCode: US
  awardeeName: NEUROTRAINER, INC
  awardeeStateCode: CA
  awardeeZipCode: '941291768'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1844085'
  piEmail: jnyquist@neurotrainer.com
  piFirstName: Jeff
  piLastName: Nyquist
  piPhone: '8552187246'
  poName: Muralidharan Nair
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I: An innovative virtual reality platform that accurately and
    rapidly assesses meaningful brain function outside the lab'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project stems from the need to substantially improve nitrogen (N) use efficiency in crop production and thereby improve profitability for farmers, while simultaneously reducing the adverse effects of agriculture on the environment.  Currently, less than half of the N fertilizer applied to agricultural fields is used by the crops to which it is applied.  The remaining N is either leached from the soil or lost to the atmosphere as nitrous oxide - potent greenhouse gas. This inefficient use of N fertilizer by crops is an economic burden for farmers, cause serious water and air quality problems, and contribute about 2.5% of total U.S. greenhouse gas emissions. Furthermore, these N losses represent a tremendous energy inefficiency, because the production of synthetic N fertilizer is the largest energy input in production agriculture. The key to improving N use efficiency in crop production is applying the right amount of N fertilizer in the right place at the right time. The proposed sensor technology would be disruptive to existing agricultural technology and practices, wherein N fertilizer is applied at a uniform rate across agricultural fields, and improve profitability for farmers.

    This SBIR Phase I project proposes to demonstrate the feasibility of a robust field-mobile soil nitrate (NO3-) sensor utilizing mid-infrared technology to facilitate precision N fertilizer applications. Mid-infrared spectrometers have historically been large, expensive, and fragile laboratory instruments that require substantial sample preparation, thus preventing their use as mobile optical soil NO3- sensors. The scope of the Phase I research will focus on three objectives: 1) The design and development of a robust and low-cost mid-infrared spectrometer that uses a diamond attenuated total internal reflectance (D-ATR) probe to measure NO3- levels; 2) The design, construction, and testing of a chisel shank-tool bar system that houses the spectrometer and D-ATR probe; and 3) the development of control and data processing and analysis software to manage the system. Anticipated technical results of Phase I will provide a prototype that can measure NO3- in the upper 30 cm of soil, not just at the surface, by enabling modulation of the depth of the shank and the probe as the system is pulled through a field, and self-cleaning of the system as soil is continuously moved across the optical surface of the diamond by the forward motion of the tractor.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 4204 Arizona Circle
  awardeeCity: Ames
  awardeeCountryCode: US
  awardeeName: N-Sense LLC
  awardeeStateCode: IA
  awardeeZipCode: '500143612'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842556'
  piEmail: nrogovska@n-sense.us
  piFirstName: Natalia
  piLastName: Rogovska
  piPhone: '5152910142'
  poName: Anna Brady-Estevez
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Field Mobile Soil Nitrate Sensor for Precision Fertilizer
    Management'
- abstractText: |-
    The broader impact and commercial potential of this Small Business Technology Transfer
    (STTR) Phase I project is to empower providers with the unprecedented ability to treat patients
    with chronic inflammatory skin disease effectively and at a lower cost. Today, primary care
    physicians often refer patients with these conditions to dermatologists for the initial diagnosis
    and multiple follow-up appointments, especially when patients are prescribed high cost, high
    touch therapies like biologics or procedures, such as phototherapy. By introducing this
    automated severity scoring system, these providers will have the expertise of dermatologists at
    their fingertips, giving them the ability to assess disease severity and provide systemic
    treatments previously available only through specialists. It will also establish more objective
    assessments, evaluating patient progress to adjust dosage and treatments as necessary. For
    pharmaceutical companies, the ability to have non-specialists make these severity assessments
    during clinical trials reduces expensive and restrictive staffing requirements. Less expensive trials can
    help expedite new drugs to market. This innovation will enhance scientific and technological
    understanding by applying known machine learning techniques in a novel manner to solve a
    difficult visual problem.

    This Small Business Technology Transfer (STTR) Phase I project will prototype a clinical tool
    that can assess images of a chronic skin inflammation, determine its severity, and suggest
    treatment. This system will be able to guide users with minimal training through the image
    collection process, determine if the information is sufficient, and request additional information if
    required via novel machine learning techniques. Currently, clinicians trying to assess the
    severity of chronic inflammatory skin diseases rely on a series of estimations and manual
    weighted averages, a time consuming and biased process. This Phase I research will explore
    what information is necessary for an algorithm to determine the severity of a psoriasis case. It
    will determine if it is possible for a machine to guide an imager through imaging regions of
    interest at higher detail, rather than the entire body at large. It will also explore how quickly and
    practically such a calculation can be performed. The end goal of the project is a working
    prototype that can consistently score a few psoriasis cases and serve as a proof of concept for
    expansion of the prototype in future work.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 101 Huntington Ave
  awardeeCity: Boston
  awardeeCountryCode: US
  awardeeName: 3Derm Systems, Inc.
  awardeeStateCode: MA
  awardeeZipCode: 021997611
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1843221'
  piEmail: kelsey@3derm.com
  piFirstName: Kelsey
  piLastName: Gross
  piPhone: '5419419922'
  poName: Peter Atherton
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'STTR Phase I:  Intelligent Scoring of Inflammatory Skin Disease Progression'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is to develop a hypo allergenic peanut (HAP) variety,
    which is expected to save human lives by preventing allergy-related deaths, reduce
    the incidence of peanut allergy, and increase security, comfort and peace of mind
    for those individuals sensitive to peanuts and their families, extended families,
    friends, schools, and restaurants.  HAP also may reduce and/or eliminate the number
    of institutional lawsuits resulting from peanut allergy events, and reduce and/or
    eliminate the number of costly food recalls due to peanut contaminations. Reducing
    allergens may gain back the loss endured by the peanut market, improve the U.S.
    competitive edge on the international peanut market, and increase sales by 15%
    to 20% due to an increase market by restaurants, airlines and more. Food allergies
    cost the US $25 billion annually and peanut is a major contributor. HAP will provide
    a significant solution to peanut allergy with the potential to reduce the overall
    cost of food allergy.  \n\nThe intellectual merit of this SBIR Phase I project
    is to produce a commercial prototype for a hypoallergenic peanut as a solution
    to the serious health concern nationwide for peanut allergy. In previous work,
    a HAP was developed by concomitant silencing of the genes coding for the three
    most potent peanut allergens Ara h 1, Ara h 2 and Ara h 3. The HAP was 2 to 85-fold
    reduced in allergenic potency, and the HAP trait was transmitted to several successive
    generations in field trials. However, some of the transgenic peanuts were found
    to be chimeric and to produce non-homogeneous population of seeds with variable
    levels of allergenic potency. To solve this problem, repetitive somatic embryogenic
    tissue was used to produce first generation chimera-free HAP (T0 plants). During
    this Phase I project, the progeny T1 plants will be analyzed using Southern blot
    and quantitative PCR to confirm the chimera-free status of the plants. Reverse
    transcriptase quantitative PCR, Western blot, sandwich ELISA and immunoCap assay
    will be performed to confirm the population of the progeny T2 seeds is homogenous
    and has undetectable levels of the targeted allergens. A commercial prototype
    variety for the hypoallergenic peanut will be identified and selected for further
    studies.\n\nThis award reflects NSF's statutory mission and has been deemed worthy
    of support through evaluation using the Foundation's intellectual merit and broader
    impacts review criteria."
  awardeeAddress: 410 Interpath Parkway Unit J
  awardeeCity: Elizabeth City
  awardeeCountryCode: US
  awardeeName: IngateyGen LLC
  awardeeStateCode: NC
  awardeeZipCode: '279092738'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843503'
  piEmail: hdodo@ingateygen.com
  piFirstName: Hortense
  piLastName: Dodo
  piPhone: '2564798686'
  poName: Ruth Shuman
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Progeny Analysis Of A Chimera-Free Hypoallergenic Peanut'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will result from the development of a traveling-wave parametric amplifier (TWPA) prototype suitable to be marketed to the Quantum Information Processing community. Quantum computers require extremely sensitive amplifiers operating near absolute zero to amplify weak signals. There are two critical features of this amplifier that will benefit the community directly: 1) the ability to have more qubits per amplifier - essential for large scale quantum computers, and 2) the ability to use a commercial manufacturing process. As quantum hardware continues to scale, so does the number of qubits, making multichannel amplifiers essential. European and Asian investment in quantum technology is growing at an alarming rate. The US is at risk of losing the leading position in this technical space. The commercialization of TWPA technology is an example of technologies required for the US to remain competitive in quantum technology.

    This Small Business Innovation Research (SBIR) Phase I project will introduce a TWPA product prototype for the Quantum Information Processing market by addressing some of the interfacing, packaging and manufacturing limitations of experimental devices. Critical to the ability to distribute these amplifiers to the market is a means of manufacturing such devices at scale. A key advantage of the proposed technology is its ease of fabrication and the fact that it can be fabricated using an industry standard process, which will be demonstrated during the Phase I project.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 9 RESEARCH DR STE 8
  awardeeCity: AMHERST
  awardeeCountryCode: US
  awardeeName: MILLIMETER WAVE SYSTEMS, LLC
  awardeeStateCode: MA
  awardeeZipCode: '010022775'
  fundsObligatedAmt: '224986'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843017'
  piEmail: ckoh@millimeterwavesystems.com
  piFirstName: Christopher
  piLastName: Koh
  piPhone: '4133456467'
  poName: Peter Atherton
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Versatile Low-Noise Traveling-Wave Parametric Amplifier for
    Quantum Information Processing'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is to dramatically improve Lithium-Ion Battery
    (LIB) technology in order to advance renewable energy penetration and reduce greenhouse
    gas emissions. LIBs are not only a major component of the current consumer electronics
    industry - they are also becoming a key linchpin in the development of clean energy
    applications such as electric vehicles and grid storage. Their limited cost-competitiveness
    relative to fossil fuels, finite energy density, and limited lifetime are all
    still road blocks against mainstream adoption of these emerging applications.
    These issues all point toward a need for significant technical advancements that
    cannot be satisfied by simple economies of scale alone. Coreshell?s innovation
    is to introduce a cheap and scalable electrode coating technology that protects
    batteries against cycling degradation. The technology has the potential to yield
    a marked improvement in battery cost and performance, as well as a reduction in
    manufacturing rates by replacing a slow electrochemical step that can take days
    with a fast coating step that can be completed within minutes. If fully actualized,
    Coreshell?s coatings have the potential to revolutionize the LIB industry and
    enable widespread commercialization of clean energy technologies. \nThis Small
    Business Innovation Research (SBIR) Phase I project is to demonstrate the effectiveness
    of Coreshell?s unique electrode coating technology. The state-of-the-art electrode
    surface protection in LIBs is formed electrochemically and is termed ?SEI? (Solid-Electrolyte-Interphase).
    SEI is slow and expensive to make, inherently unstable, and consumes lithium thereby
    reducing capacity. This proposal is based on a novel proprietary coating in place
    of SEI, using a roll-to-roll process that can be seamlessly integrated into existing
    LIB manufacturing lines. By depositing well-formed coatings on the surface of
    battery electrodes, Coreshell?s technology can protect against many of the degrading
    reactions that occur during LIB cycling. The proposed technology has the promise
    to deliver greater initial capacity, greater depth-of-charge over equivalent cycle-life,
    reduced manufacturing costs and, ultimately, the potential to reduce LIB cost
    per kWh by up to 25%. In Phase I, Coreshell will demonstrate part of this value
    through two main objectives. The first is to increase initial battery capacity
    by >5% and retain the total capacity to >90% of original after 200 cycles. The
    second is to show that batteries incorporating Coreshell?s coated electrodes can
    eschew SEI formation, which would demonstrate the feasibility of ~7% reduction
    in manufacturing costs.\n\nThis award reflects NSF's statutory mission and has
    been deemed worthy of support through evaluation using the Foundation's intellectual
    merit and broader impacts review criteria."
  awardeeAddress: 1095 67th Street
  awardeeCity: Oakland
  awardeeCountryCode: US
  awardeeName: CORESHELL TECHNOLOGIES INC
  awardeeStateCode: CA
  awardeeZipCode: '946081211'
  fundsObligatedAmt: '224945'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843063'
  piEmail: roger@coreshelltech.com
  piFirstName: SOURAV
  piLastName: BASU
  piMiddeInitial: R
  piPhone: '4152654887'
  poName: Linda Molnar
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Improved Lithium-Ion Batteries via Solution-Deposited Nanolayers
    on the Surface of Formed Electrodes'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be realized first in household cleaning applications, a market valued in more than 26 billion/year, where currently only about 3% of the market is filled with eco-friendly alternatives. Cleancult new scrubbing system will allow the development of more efficient and potent cleaning products, capable of competing with traditional petroleum-based brands while helping to reduce the water pollution effects due to laundry/cleaning activities, reduce the appearance of skin conditions in customers due to the continuous exposure to harmful chemicals found in traditional cleaning products, and reduce the energetic cost related to the use of hot water in laundry applications. Cleancult objective is to open the door to novel green clean technologies, by first introducing our all-natural scrubbing system in our products and potentially license the technology to other green detergents manufacturers, and later introduce our own all-natural green surfactant molecule, with the solid intention of increasing the green cleaners? participation in the marker by at least 20% in the next 5 years.

    This Small Business Innovation Research (SBIR) Phase I project will provide funding for the development of a micellar system(s) composed of a biopolymer particle and a naturally derived from sustainable sources surfactant compound. The conjugation and stabilization mechanism of these micellar systems are the main focus on the research objectives, together with the inclusion of different functionalization to improve oil removal, avoid re-deposition and also enhance the antibacterial properties of the scrubbing system. The complete characterization of the micellar system and its efficacy in removing soil/dirt stains will be achieved through the use of spectroscopic, rheological and hydrodynamic techniques, surface chemistry modifications, and applying the global standards for detergency determination. The research team will work to provide a commercially ready product at the end of this SBIR Phase I project, and due to already in place collaborations with manufacture facilities will avoid delays in the introduction of Cleancults' new line of green powerful cleaners.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1250 AVE PONCE DE LEON SAN JUAN
  awardeeCity: San Juan
  awardeeCountryCode: US
  awardeeName: Cleancult LLC
  awardeeStateCode: PR
  awardeeZipCode: 009079321
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842921'
  piEmail: carlos.pinzon@upr.edu
  piFirstName: Carlos
  piLastName: Pinzon
  piPhone: '7876690531'
  poName: Linda Molnar
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Development of a composite system (surfactant-particle) including
    non-ionic green surfactants for enhancing efficiency of green detergents through
    colloidal...'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is providing a high potent antimicrobial solution for textiles, coatings, polymers, and wound care and bandages. There is considerable proliferation of antibiotic resistant bacteria, and, antimicrobials that do not develop resistance is of significant societal interest. Silver-based antimicrobials are filling this need, and are being used in a variety of medical, consumer and food-related applications. Silver is a broad-spectrum antimicrobial, effective against gram positive, gram negative bacteria (including methicillin-and vancomycin resistant bacteria) as well as fungi, viruses, and biofilms. This has led health care, consumer and food industries to use silver antimicrobial products.  The global market for silver-based powder antimicrobial coatings is currently valued at $910 million and expected to grow at a compound annual growth rate (CAGR) of 13.1% until 2020. Concerns however, are increasing about the release of silver and the resulting influence on the environment. Development of high potency silver products using the minimum amount of silver can significantly broaden its use. The benefits of this versatile antimicrobial platform include: 1000-fold increased potency, decreased cost, invisibility and compatibility with formulations.

    This Small Business Innovation Research (SBIR) Phase I project will develop and test a highly potent silver-based antimicrobial product. Higher potency is due to control of size of ligand-free AgNP (1-3 nm) anchored to the surface of ~30 nm nanozeolite (NZ), and fast release of Ag+ within the zeolite.  The bactericidal activity of AgNP-NZ has been examined with E. coli (gram negative) and antibiotic resistant MRSA (gram positive), with significant improvement. The potency is further enhanced by modifying the NZ support to introduce multiple features: increased antimicrobial activity via NZ ion-exchanged Zn2+, and surface modification of NZ to enhance interactions with bacteria, including penetration within the bacteria. At the conclusion of this SBIR Phase I project, the product will be ready for further commercialization and marketing by (1) demonstrating the scalability of the synthesis procedure so that there is enough supply of product in the product development process; (2) optimizing synthesis procedure of antimicrobial material according to antimicrobial property, including Ag+ and Zn2+ loading and surface modifications; (3) obtaining third party test reports on optimized samples as objective evidence for marketing and (4) studying the toxicity of the product toward mammalian cells to address toxicity concerns.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1275 Kinnear Rd
  awardeeCity: Columbus
  awardeeCountryCode: US
  awardeeName: ZeoVation, Inc.
  awardeeStateCode: OH
  awardeeZipCode: '432121180'
  fundsObligatedAmt: '224985'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1841732'
  piEmail: bowang@zeovation.com
  piFirstName: Bo
  piLastName: Wang
  piPhone: '6142307123'
  poName: Linda Molnar
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Highly Potent Nanozeolite-based Silver Antimicrobials'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will result from addressing video editing as a software problem. All the hurdles that surround this space - the clunkiness of having to poke at a timeline of clips with your fingers on a rectangle of glass, the time and technical skill required to even know how to put those clips together in a pleasing sequence, and the cost to have someone else do it for you - are all problems that can be solved with computational video editing. The cameras in mobile phones are the most important contemporary tool for artistic expression and cultural communication. The company's mobile video editing platform gives young and economically disadvantaged creators (who may only have a mobile device camera) access to the narrative format of video. With the growing adoption of mobile video by creators and viewers in every corner of the globe, high-quality video editing tools are increasingly needed for mobile platforms.

    This Small Business Innovation Research (SBIR) Phase I project will investigate the use of video understanding techniques that support the creation of artistic and cultural output. This project will develop algorithms, representations, and datasets that allow consumer-grade devices such as smartphones, tablets, and commodity PCs to understand video and generate narrative video sequences. The goal of this Phase I project is at the intersection of human-computer interaction, computer vision, and computational videography. This project will explore rich semantic embedding spaces, end-to-end trained multi-task neural networks, and large-scale data and their application to video manipulation, enhancement, and the ultimate goal of automated film editing.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 98 4TH ST STE 401
  awardeeCity: BROOKLYN
  awardeeCountryCode: US
  awardeeName: TRASH INC.
  awardeeStateCode: NY
  awardeeZipCode: '112315113'
  fundsObligatedAmt: '224734'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842850'
  piEmail: gen@trash.app
  piFirstName: Genevieve
  piLastName: Patterson
  piPhone: '5202753170'
  poName: Peter Atherton
  date: 12/21/2018
  startDate: 01/01/2019
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Filmmaking for Everyone: Computational Video Editing'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is the development of an artificial intelligence-based
    software platform to elucidate inherited diseases by identifying the causative
    genetic factors in the whole genome at large, not just the tiny portion of the
    genome called the exome. This technology will help solve the longstanding problems
    of multigenic inherited diseases and help unlock the full potential of gene therapy
    modalities such as CRISPR, which require knowledge of the causal mutation for
    targeting. With a defined genetic target, truly curative therapeutics and early,
    accurate diagnostics will be made possible. Through this platform, pharmaceutical
    companies will benefit from a shortened drug development cycle and a lower risk
    of clinical trial failure while diagnostics companies will be able to develop
    fast and accurate molecular diagnostics targeting the mutations identified by
    the platform. \n\nThis SBIR Phase I project proposes to build a build a proof-of-concept
    software platform that employs a combination of supervised and unsupervised machine
    learning algorithms to process, sort, and analyze human whole genome sequencing
    data from an Amyotrophic Lateral Sclerosis (ALS) cohort from a set genetic background.
    ALS is an incurable, debilitating disease whose genetic causes remain largely
    unknown. Identifying these mutations will enable the development of efficacious
    treatments for the conditions. Three main objectives will be accomplished for
    the platform. One, the ability to process full-size, high coverage human whole
    genome data automatically through the pipeline in a scalable manner. Two, the
    ability to identify the genetic background of a test subject with a top-5 error
    rate of <1%, an important verification step to minimize incorrect cohort stratification
    from false ancestry self-reports. Three, the ability to rapidly identify at least
    one genetic feature known to be associated with ALS (e.g., SOD1, C9ORF72), which
    will help provide early validation for the platform.\n\nThis award reflects NSF's
    statutory mission and has been deemed worthy of support through evaluation using
    the Foundation's intellectual merit and broader impacts review criteria."
  awardeeAddress: 153E W 110th St
  awardeeCity: New York
  awardeeCountryCode: US
  awardeeName: GENETIC INTELLIGENCE
  awardeeStateCode: NY
  awardeeZipCode: '100290000'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819331'
  piEmail: bertrand@geneticintelligence.com
  piFirstName: Bertrand
  piLastName: Adanve
  piPhone: '9178931659'
  poName: Ruth Shuman
  date: 06/25/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Platform to Elucidate the Causal Mutations Behind Human Inherited
    Diseases'
- abstractText: |-
    This SBIR Phase I project intends to improve the outcomes of children diagnosed with autism spectrum disorder (ASD) by providing critical data from non-clinical settings that are currently unavailable to autism treatment providers. The project also focuses on accelerating the analysis of that data. It is estimated that the costs associated with ASD will be more than $2 million over a patient's life. However, studies have shown that the costs of lifetime care for a child diagnosed with ASD can be reduced by 2/3 with early intervention. Designing an appropriate treatment program, and then monitoring its efficacy, requires the collection of a range of data to avoid dependence on inference and anecdotes. Treatment providers often collect detailed data while working with an individual diagnosed with ASD, but they count on parents and caregivers to provide them with data regarding the child's progress outside the clinical setting. The data submitted are usually incomplete and inadequate (if submitted at all). This SBIR Phase I project will result in a prototype that will rapidly provide autism treatment providers with critical data and analysis, reducing the amount of time it takes to design an optimal treatment program, and thereby reducing the long-term costs associated with a diagnosis of ASD.


    This Phase I project will result in a prototype that will make the process of logging data almost frictionless for parents. That narrative data will be combined with video data, biometric data, and additional data collected passively from external sources. All the data will be merged, and then analyzed via machine learning to locate patterns and provide a complete picture to the child's behavior analyst. Developing a camera that will be unobtrusive enough for a child with ASD to tolerate will present a challenge, as will developing the associated software to tag items within the camera's view and save only relevant clips (such as the times immediately before, during and after a meltdown). It will also be challenging to develop a wearable device that a child with ASD will tolerate, along with the associated sensors and software to track metrics associated with arousal and stress. The most significant technical challenge, however, will be to develop the software that combines the multiple data streams and outputs a standardized ABC report (Antecedent, Behavior, Consequence) that would be judged as high quality by a Board Certified Behavior Analyst.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 14 Kachina Way
  awardeeCity: Madison
  awardeeCountryCode: US
  awardeeName: SPINRISE TECHNOLOGIES LLC.
  awardeeStateCode: CT
  awardeeZipCode: 064431962
  fundsObligatedAmt: '223565'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819553'
  piEmail: gary@spinrisetechnologies.com
  piFirstName: Gary
  piLastName: Higginson
  piPhone: '8605753931'
  poName: Rajesh Mehta
  date: 06/18/2018
  startDate: 06/15/2018
  expDate: 11/30/2019
  title: 'SBIR Phase I:  IMPROVING BEHAVIORAL ASSESSMENT OF CHILDREN DIAGNOSED WITH
    AUTISM SPECTRUM DISORDER THROUGH ENHANCED DATA ACQUISITION'
- abstractText: |-
    This SBIR Phase I project addresses the pressing need for providing incarcerated youth and adults with continual systematic and secure personal education and training opportunities, giving inmates the skills they need to productively re-enter society. It will also reduce recidivism rates, and increase their confidence and the potential for contributing to local communities. Every year, more than 700,000 state and federal prisoners are released back into their communities, often with no greater skills than when they went in. The majority of prisoners lack basic high school degrees. The goal of the project is to provide the most effective, secure and flexible offline e-Learning applications for acquiring high school equivalency, the area of greatest need, within the constraints of the prison environment; covering both instructor-led and self-directed learning sessions. At the completion of Phase I, correctional facilities will have an opportunity to utilize a secure, easy-to-administer, offline e-Learning solution for the General Education Development (GED) or for any other education and training in a digital format. A wealth of high-quality instructional programs will be incorporated into the platform that will ultimately lead to a high school equivalency diploma, and additional support to address technical and vocational skills.

    The Phase I project innovation is centered around the delivery of a single, highly-flexible, secure learning management platform, where multiple applications can be stored on a single server. It will provide the General Education Development (GED) content and will be expandable to incorporate additional e-Learning applications including those that can address recidivism. The adaptable learning management platform will automate the provisioning and installation of these GED and non-GED educational applications on private servers, either on-site at the correctional facility or on off-site private server networks. Different sets of content would be automatically customized for each prison, with no outside Internet connectivity required. Another key innovation will be the ability to have the e-Learning system follow the inmate as they are moved. They will always have access to their specific content and progress status as their data will be centrally-hosted on the fully secured prison servers. Their individual records can be confirmed and reviewed for parole evaluations. By providing uniform student analytics and continuous monitoring of learning outcomes with different content and educational application vendors, the system will advance the capability of offline learning to be a data-driven endeavor and will deliver a personalized experience comparable to systems in civilian life.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3912 Portola Drive
  awardeeCity: Santa Cruz
  awardeeCountryCode: US
  awardeeName: Nucleos Incorporated
  awardeeStateCode: CA
  awardeeZipCode: '950622048'
  fundsObligatedAmt: '224999'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1821213'
  piEmail: noah@nucleos.com
  piFirstName: Noah
  piLastName: Freedman
  poName: Rajesh Mehta
  date: 06/01/2018
  startDate: 06/01/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  An E-Learning Program for High School Equivalency (GED) and
    Remedial Education for Prisoners'
- abstractText: |-
    This Small Business Innovation Research Phase I project will evaluate the technical feasibility and commercial viability of a novel sample preparation method for cryo-EM (cryogenic electron microscopy) studies.  As a rapidly growing technique in the structural biology field, the cryo-EM market as a whole is estimated to be more than $5 billion a year, with > $500 million attributed to the sample preparation space.  In spite of an overall revenue growth rate of more than 70% per year, cryo-EM sample preparation remains an area that has yet to see any major technological breakthroughs commercialized in the past decade.  In fact, the current industry solution is reported to have a failure rate of > 95%.  By providing a sample preparation system that actually works, this Small Business Innovation Research (SBIR) Phase I project will significantly reshape the massive and rapidly expanding cryo-EM market and allow scientists to more readily collect detailed protein structures in their native state.  This new knowledge on the molecular basis of cells and of life itself will be used to facilitate as well as accelerate the development of new pharmaceuticals as well as therapeutic treatments for diseases and thus greatly benefit human health in the long run.

    The intellectual merit of this project is the development of a cryo-EM sample preparation device built on the application of state-of-the-art microfluidic jet systems to deposit and vitrify protein solution on EM grids in milliseconds, which is at least 1000x faster than the current methods.  Furthermore, it offers scientists the novel ability to control the thickness of the vitrified aqueous layer and, overall, more control over the sample vitrification process.  With this new sample preparation device, a larger region of the cryo-EM grids will have intact protein molecules with the right layer thickness for structural determination, allowing researchers to save time and money in terms of both grid preparation and screening in a high-throughput manner.  Currently, the proposed technology has not been tested nor used anywhere.  Therefore, the first and foremost goal of this SBIR Phase I project is to better understand and well characterize the technical capabilities and limitations of this proposed innovation, with additional R&D work needed before product commercialization, which is expected in five years.  The project will focus on defining and optimizing both the geometric and experimental setup in order to de-risk the technology.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2094 Yale Street
  awardeeCity: Palo Alto
  awardeeCountryCode: US
  awardeeName: Neptune Fluid Flow Systems LLC
  awardeeStateCode: CA
  awardeeZipCode: '943061422'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820414'
  piEmail: neptuneffs@gmail.com
  piFirstName: Trevor
  piLastName: McQueen
  piMiddeInitial: A
  piPhone: '6502852857'
  poName: Steven Konsek
  date: 05/22/2018
  startDate: 06/01/2018
  expDate: 08/31/2019
  title: 'SBIR Phase I:  CryoPREP-EM: Time-Resolved Sample Preparation for Single-Particle
    Cryo-Electron Microscopy (Cryo-EM)'
- abstractText: |-
    This SBIR Phase I project proposes to develop a novel cancer targeting technology, Active Tissue Targeting via Anchored ClicK Chemistry (ATTACK), for targeted treatment of triple negative breast cancer (TNBC). TNBC is a subtype of breast cancer that occurs in 10-20% of diagnosed breast cancers and is more likely to affect younger people, African Americans, Hispanics, and those with BRCA1 gene mutation. Currently, TNBC patients are mainly treated with chemotherapeutics and cannot benefit from existing targeting therapeutics due to the lack of Estrogen receptor (ER), progesterone receptor (PR) or hormone epidermal growth factor receptor 2 (Her2/neu). This project will develop the first cell labeling based targeting technology (ATTACK) for TNBC treatment. A novel unnatural sugar will be developed for cancer-specific labeling of TNBC through metabolization to insert an artificial receptor onto TNBC and then target the artificial receptor to deliver therapeutic taxanes through a specific reaction between the receptor and the taxanes-drugs. The project involves interdisciplinary combination of knowledge from chemistry, biology, materials engineering, and pharmaceutical science. The successful development of the project will afford an effective targeted therapeutic drug for TNBC patients with improved quality of life in the future.

    This SBIR Phase I project proposes to develop a novel cancer targeting technology, Active Tissue Targeting via Anchored ClicK Chemistry (ATTACK), for targeted treatment of triple negative breast cancer (TNBC). ATTACK can treat untargetable cancers that do not have established cell surface receptors through cancer-specific artificial receptor insertion of de novo designed unnatural sugars and subsequent azide-Click reaction mediated targeted delivery of therapeutic drugs. Currently, TNBC patients are mainly treated with chemotherapeutics and cannot benefit from existing targeting therapeutics due to the lack of Estrogen receptor (ER), progesterone receptor (PR) or hormone epidermal growth factor receptor 2 (Her2/neu). This project will develop the first cell labeling based targeting technology (ATTACK) for TNBC treatment. Unnatural sialic acid (a type of sugar) precursors with azide will be first used for tumor-specific labeling on cell surface and subsequent targeting. Multiple taxane candidates will be synthesized and preliminary in vitro DMPK properties of the conjugates will be studied including solubility, plasma stability, liver microsome metabolization, and cytotoxic MTT assay. In vivo biodistribution and efficacy of the taxane candidates in combination with unnatural sugar labeling will also be studied in mice tumor models to validate the anti-TNBC efficacy of the drug candidates. The accomplishment of the Phase I research will enable further translational development of the novel cancer-targeting therapeutics into clinical applications.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 60 Hazelwood Drive
  awardeeCity: Champaign
  awardeeCountryCode: US
  awardeeName: Iria Pharma, LLC
  awardeeStateCode: IL
  awardeeZipCode: '618207460'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819081'
  piEmail: kmcai@iriapharma.com
  piFirstName: Kaimin
  piLastName: Cai
  piPhone: '2179791417'
  poName: Henry Ahn
  date: 05/21/2018
  startDate: 06/01/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Targeted Small Molecular Taxane Delivery for Triple Negative
    Breast Cancer Treatment'
- abstractText: |-
    The broader impact/commercial potential of this project is to introduce a fully integrated current sensor with an order of magnitude performance improvement over state-of-the-art technologies. The developed technology will enable more reliable, efficient and compact power electronics systems. Power electronics is an integral part of today's power delivery systems such as renewable energy systems, electric vehicles, data centers and most consumer electronics. In these applications, electric current information is often an essential parameter that needs to be known and measured for control, diagnostic and prognostic purposes. With advances in power electronic circuits with specific attention to high frequency power converters, there is a need to investigate alternative approaches and techniques to measure the current. These approaches should result in availability of current sensors that have fast-response, are accurate, loss-less, and preferably non-intrusive. The impact of such a sensor is to enable systems and circuits that will be miniaturized and be made more efficient by using wide bandgap semiconductors and high switching frequencies. Additionally, the availability of current measurement information will lead to greater reliability and prognostic capability. Applications include but are not limited to power converters in electric vehicles and data centers.

    This Small Business Technology Transfer Phase I project seeks to demonstrate the feasibility of a novel contactless, hybrid current sensor offering an order of magnitude better performance than the state-of-the-art in capturing currents up to and beyond 30 MHz for use in emerging high-frequency power converter applications utilizing wide bandgap semiconductors. The proposed sensor combines complementary magnetoresisor and Rogowski coil technology along with magnetic concentrators into a single chip. By combining these previously underexplored technologies in discrete current sensing would result in a non-invasive, lossless current sensor for MHz converters, where today none exists. Phase I objectives will address technical challenges in developing a chip-scale integrated sensor, including miniaturized Rogowski coil design and magnetic concentrator shape and material evaluation for signal amplification and electromagnetic interference rejection. Design of the analog signal conditioning circuits required for the integrated circuits are also part of this phase.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 9319 Robert D Snyder Rd
  awardeeCity: Charlotte
  awardeeCountryCode: US
  awardeeName: Telli Technologies Inc
  awardeeStateCode: NC
  awardeeZipCode: '282230001'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1843330'
  piEmail: babak.parkhideh@tell-i.com
  piFirstName: Babak
  piLastName: Parkhideh
  piPhone: '9193682352'
  poName: Muralidharan Nair
  date: 02/12/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'STTR Phase I:  Tuned Miniaturized Point-Field Detectors as Contactless Current
    Sensor for Post-silicon Power Electronics'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project involves improving oil and gas sustainability.  To achieve that goal, we are proposing purifying produced water at the wellsite using waste natural gas to reduce disposal costs, carbon footprint and human induced seismicity from disposal wells. This process is enabled by patented equipment that fundamentally changes thermal distillation by performing the entire process inside a heat exchanger to reduce equipment and energy costs.   In Texas, using the amount of gas that is flared annually, the proposed X-VAPTM system can theoretically purify a significant percentage of U.S. produced water problem of 33 billion barrels in 2020.  The brine discharge from the purification process will be concentrated into specific densities to be recycled as a drilling fluid.  This new circular economy will provide environmental benefits by reducing the need for large diesel water trucks to move the source water, dispose the produced water and deliver heavy brine for drilling.  Society will benefit with a new renewable source of fresh water and reduce the need for oil and gas producers to compete with farmers and ranchers for increasingly scarce fresh water resources.

    This SBIR Phase I project proposes to prove the X-VAPTM thermal distillation system can fundamentally improve thermal distillation by reducing equipment costs and energy requirements.  Before this patented invention, the entire thermal distillation including the distillation and separation from contaminates has never been performed inside a heat exchanger. The unique design provides a removable spring water tray and distillation column to address maintenance issues including scaling in the field.  Our team of industry-experienced engineers will further test, improve and validate the existing thermal distillation prototype by performing prototype lab experiments and coordinated simulations to calibrate and improve equipment designs (Phase I).  These novel simulations will need to be calibrated against coordinated prototype laboratory tests to achieve a 90% agreement between simulations and laboratory tests.  This testing data and correlated simulations will be utilized to scale the prototype design to efficiently handle large volumes of produced water typically encountered at oil and gas well sites.  The proposed research and simulation testing will validate the patented system and create a proposed program for customer field testing prior to commercialization (Phase II).

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 4801 Woodway Drive, Suite 300
  awardeeCity: Houston
  awardeeCountryCode: US
  awardeeName: Katz Water Technologies
  awardeeStateCode: TX
  awardeeZipCode: '770561884'
  fundsObligatedAmt: '224994'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843943'
  piEmail: gary@katzwater.com
  piFirstName: Gary
  piLastName: Katz
  piMiddeInitial: P
  piPhone: '8327239528'
  poName: Anna Brady-Estevez
  date: 02/01/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'SBIR Phase I:  Modified Finned Tube Heat Exchangers for Economically Purifying
    Produced Water'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR/STTR) Phase I project is to commercialize the world?s first sunscreen
    that protects against UVA-induced photoaging, provides sufficient UVB protection
    and to reverse UVB-induced damage, and is safe to coral reefs. Leading sunscreens
    that are currently on the market have been shown to be inadequate in protection
    against UVA damage (photoaging). Moreover, Oxybenzone and octinoxate, which are
    found in over 80% of chemical sunscreens, have been shown to be highly toxic to
    coral cells. Estimated 14,000 tons of sunscreen settle into the world?s coral
    reefs every year and the oxybenzone that is present in many of these sunscreens
    cause coral bleaching and accelerate the destruction of the world?s already fragile
    coral reefs. The Magic Blue sunscreen uses an alternative eco-friendly technology
    to protect the skin from UVA and UVB damage, and the successful commercialization/market
    adoption of the Magic Blue sunscreen will significantly benefit the global environment
    by protecting our aquatic ecosystems, especially coral reefs, from further oxybenzone/octinoxate-induced
    damage. \n\nThis Small Business Innovation Research (SBIR/STTR) Phase I project
    will develop a novel coral reef-friendly sunscreen that can provide broad spectrum
    protection. Magic Blue, LLC is partnering with the University of Maryland, College
    Park and collaborating with the Carnegie Institution for Science to conduct the
    key feasibility experiments, including biological analysis of UVA protection in
    2D and 3D human skin tissues, chemical assays on SPF determination, and environmental
    study on the effects of the new sunscreen on soft and hard coral reefs.  Once
    these experiments are complete, Phase II of the project will revolve around obtaining
    necessary FDA approval for commercial launch. The overall outcome from a successful
    STTR project will be the commercialization of the world?s first sunscreen that
    will encompass the following attributes: scientifically proven to protect against
    UVA-induced photoaging, abilities to provide sufficient UVB protection and to
    reverse UVB-induced damage, and safe to coral reefs.\n\nThis award reflects NSF's
    statutory mission and has been deemed worthy of support through evaluation using
    the Foundation's intellectual merit and broader impacts review criteria."
  awardeeAddress: 6307 KENHOWE DRIVE
  awardeeCity: BETHESDA
  awardeeCountryCode: US
  awardeeName: MAGIC BLUE, LLC
  awardeeStateCode: MD
  awardeeZipCode: '208175419'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1842745'
  piEmail: kcaozhan@gmail.com
  piFirstName: Jasmin
  piLastName: El Kordi
  piPhone: '2028215699'
  poName: Linda Molnar
  date: 02/01/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'STTR Phase I:  Development of a coral reef-friendly sunscreen with broad
    spectrum protection'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is to engineer resistance to two bacterial diseases
    in citrus trees, Huanglongbing (HLB) and citrus canker.  HLB and canker have cost
    growers billions of dollars in destroyed trees and are decimating the Florida
    citrus industry. In Florida, annual citrus production has fallen from 242 million
    boxes in the 2003-2004 growing season to 45 million boxes in 2017-2018.  Further,
    citrus canker may be found in 98% of the citrus production regions in Florida.
    Working with the University of Florida, the goal of this project is to use CRISPR/Cas9
    gene editing to advance natural selection to make citrus trees resistant to both
    HLB and citrus canker. If successful, this approach could be used to protect the
    93 million tons of citrus production worldwide. \n\nThe intellectual merit of
    this SBIR project is to develop HLB and canker-resistant citrus varieties by using
    gene editing with CRISPR/Cas9. Florida citrus growers need a solution to these
    diseases, and producing a genetically-resistant citrus variety is a promising
    strategy. The approach is to modify plant genes that are the targets of proteins
    secreted by the disease-causing bacteria. The first objective is to conduct the
    gene editing in commercially viable citrus varieties. This will be accomplished
    non-transgenically by transforming a non-integrated plasmid or purified Cas9 protein
    and in vitro transcribed sgRNA in citrus protoplasts. To identify gene edits,
    protoplasts will be grown into callus, which will be screened by PCR and DNA heteroduplex
    digestion as well as Sanger and/or high-throughput sequencing. The second objective
    will be to take plants with confirmed edits, clonally propagate them, and conduct
    preliminary testing for HLB or canker resistance. Plants will be inoculated with
    the disease-causing bacteria and then monitored for disease progression by observation
    of physical characteristics and measurement of bacterial titers by PCR. The best
    performing mutations from Phase I will be combined and used for more extensive
    greenhouse and field testing during SBIR Phase II.\n\nThis award reflects NSF's
    statutory mission and has been deemed worthy of support through evaluation using
    the Foundation's intellectual merit and broader impacts review criteria."
  awardeeAddress: 9559 25th St. E
  awardeeCity: Parrish
  awardeeCountryCode: US
  awardeeName: Soil Culture Solutions, LLC
  awardeeStateCode: FL
  awardeeZipCode: '342199047'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843045'
  piEmail: kara@soilcea.com
  piFirstName: Kara
  piLastName: Boltz
  piMiddeInitial: A
  piPhone: '9797396416'
  poName: Ruth Shuman
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Generating HLB and canker resistant citrus trees using CRISPR/Cas9'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is to develop technology that will enable robust, contamination-free,
    continuous biomanufacturing.  While biomanufacturing may be one of the most technologically
    complex and profitable industries, the underlying production process, batch fermentation,
    has not changed in decades. In theory, continuous fermentation would decrease
    operational cost and increase production capacity.  However, owing to the high
    risk of contamination, continuous fermentation is considered unreliable and is
    rarely used. The proposed technology solves this issue and enables contamination-free,
    continuous fermentation. Successful implementation of continuous fermentation
    facilitates automated production and paves the way for future technological development
    in continuous product purification and recovery. The reduced operational cost
    is essential for the economic viability of bio-based commodity chemicals such
    as bioplastics, as their market demand depends primarily on their price competitiveness
    with petroleum-derived counterparts. The proposed technology also eliminates the
    use of antibiotics in fermentation, which in turn alleviates antibiotic misuse
    and promotes a positive environmental and health impact. \n\nThe intellectual
    merit of this SBIR Phase I project is to explore the feasibility of using a biocide/biocide-resistant
    system to prevent and treat microbial contamination during continuous biomanufacturing.
    Microbial contamination in biomanufacturing processes is a major concern, as it
    results in loss of productivity, time, and money.  In addition, it restricts the
    production mode to slow batch fermentation, and prohibits the implementation of
    continuous fermentation. The proposed technology solves the contamination problem,
    as a biocide will inhibit the invading microbial and viral contaminants and a
    biocide-resistant enzyme will protect the processing hosts. The proposed Phase
    I research will address the technical challenges by using classical molecular
    biology and synthetic biology techniques. The first objective is to demonstrate
    that the proposed technology will provide biocide resistance to bioplastics-producing
    organisms while inhibiting the outgrowth of contaminants. The second objective
    is to show that the proposed technology can be used to prevent and treat contamination
    in continuous fermenters. The final objective is to fine-tune the biocide/biocide-resistant
    system to demonstrate the technology will not adversely affect the production
    yield and product quality in continuous fermenters. If successful, future Phase
    II development will be conducted in pilot and industrial-scale reactors to further
    optimize the technology.\n\nThis award reflects NSF's statutory mission and has
    been deemed worthy of support through evaluation using the Foundation's intellectual
    merit and broader impacts review criteria."
  awardeeAddress: 2151 BERKELEY WAY RM 420
  awardeeCity: BERKELEY
  awardeeCountryCode: US
  awardeeName: POW GENETIC SOLUTIONS, INC.
  awardeeStateCode: CA
  awardeeZipCode: '947041011'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843365'
  piEmail: wangouwei@gmail.com
  piFirstName: Ouwei
  piLastName: Wang
  piPhone: '4152781693'
  poName: Ruth Shuman
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  A Biocide/Biocide-Resistant System for Microbial Contamination
    Control in Biomanufacturing'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project will address a critical bottleneck to widespread
    advanced material use in commercial markets.  Carbon nanotubes are advanced supermaterials
    that have been at the forefront of technological innovation since their discovery
    in the early 1990s, but limited commercial success has ensued due to their high
    cost of production.  Current use of carbon nanotube materials is limited to a
    few industries capable of absorbing the high cost of research-scale quantities
    of carbon nanotubes (defense applications, aerospace manufacturers, and research
    institutions). Achieving scalable, lower-cost carbon nanotube manufacturing processes
    will enable widespread applications such as: advanced batteries with lower cost,
    weight, and improved longevity, tires with longer lifetimes and increased fuel
    efficiency, and coatings enabling enhanced functionality such as in the case of
    de-icing for aircrafts, spacecraft vehicles, and drones.  The societal impact
    of this advancement includes better performing and more energy efficient devices
    for consumers without added cost.  The commercial impact of this technology will
    enable the significant effort carried out in many market sectors to evaluate and
    understand the benefit of carbon nanotubes to products, to be economically realized.
    \   \n\n\nThis Small Business Innovation Research (SBIR) Phase I project will
    develop a novel electrochemical liquid-phase growth method for carbon nanotube
    production, which significantly lowers the cost of production for carbon nanotubes
    and enables widespread commercial use of the materials.  The largest bottleneck
    to carbon nanotube utilization today is the high production cost that arises due
    to numerous factors including low efficiency of chemical processes, high overhead
    cost for scaling, and formation of toxic by-products that require additional costs.
    \ These limitations have led to high prices for the materials that prohibit their
    use in cost-sensitive markets, which rely on low-cost additives such as carbon
    black.  The research objectives of this SBIR project will demonstrate feasibility
    of using a scalable catalyst preparation and deposition technique for the production
    of carbon nanotubes through low-cost, environmentally-beneficial electrochemical
    routes.  To achieve this, we will utilize ambient processing for catalyst preparation
    and a scalable electrochemical reaction chamber that harnesses the precision of
    electrochemistry, sources the carbon feedstock directly from air, and operates
    at extremely high energy efficiencies (>90%).  The anticipated technical results
    include a rapid and scalable growth technique with minimized added cost from catalyst
    deposition without compromising carbon nanotube quality.\n\nThis award reflects
    NSF's statutory mission and has been deemed worthy of support through evaluation
    using the Foundation's intellectual merit and broader impacts review criteria."
  awardeeAddress: 2630 Oleander Way
  awardeeCity: Knoxville
  awardeeCountryCode: US
  awardeeName: SkyNano LLC
  awardeeStateCode: TN
  awardeeZipCode: '379313073'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843794'
  piEmail: anna.douglas@skynanotechnologies.com
  piFirstName: Anna
  piLastName: Douglas
  piMiddeInitial: E
  piPhone: '3302853299'
  poName: Linda Molnar
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Scalable Electrochemical Production Of Carbon Nanotubes From
    Carbon Dioxide'
- abstractText: "This SBIR Phase I project will build technology to reduce the time
    needed to identify effective antibiotics for urinary tract infections (UTIs) from
    2 days to 2 hours. Every year in the US, 13 million UTIs are treated with a physician's
    best guess antibiotic, because antimicrobial susceptibility testing (AST) is too
    slow. Up to half of first guesses are wrong, opening up the possibility for infections
    to worsen into life-threatening sepsis and allowing antimicrobial resistance to
    evolve. One quarter of 1.5 million sepsis cases and at least 250,000 deaths every
    year begin as UTIs. Rapid AST using biophysical sensing can take guesswork out
    of UTI treatment, save lives, and avoid billions in unnecessary healthcare costs.
    By sensing bacterial cell fluctuations associated with the mechanically active
    processes of metabolism, motility, and growth, this novel and fundamentally different
    measurement concept for AST enables almost an order of magnitude increase in speed.
    This project will establish technical and commercial feasibility of developing
    the underlying sensor technology for point-of-care diagnostics that demand push-button
    technology operable in a hectic clinical environment. Translating innovative federally-funded
    technologies like this out of the laboratory and into medical clinics will build
    taxpayers' return on basic research investments. \n\nThis project tackles a key
    technical hurdle for clinical implementation of rapid biophysical AST at a meaningful
    scale: demonstration that the demanding performance characteristics of the underlying
    resonating quartz sensor technology can be reproduced using low cost materials
    for a disposable resonator housing providing fluidic, thermal, and electrical
    control.  The rapid biophysical AST method takes the pulse of bacterial cells.
    Changes in mechanical fluctuations of cells occur after exposure to an effective
    antibiotic, and can be sensed in real time by detecting phase noise generated
    by cells on a resonating crystal substrate. Key to the commercial success of this
    technology are multichannel resonators that can be manufactured in large quantities
    to perform with very low noise resonance characteristics. Best practices from
    low cost microfluidics studies will dovetail with those from high-tech resonator
    development to deliver the phase noise performance needed to pick up the biological
    signal. Rapid prototyping tools including 3D printing will be used for quick design
    iterations. If satisfactory, Phase II will optimize fabrication methodologies
    for both resonators and housing modules interfacing with a fully integrated clinical
    prototype instrument ready to support clinical trials of the technology.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 721 1ST ST
  awardeeCity: GOLDEN
  awardeeCountryCode: US
  awardeeName: MICROBIAL PULSE DIAGNOSTICS, LLC
  awardeeStateCode: CO
  awardeeZipCode: '804031380'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1845581'
  piEmail: danielle@microbialpulse.com
  piFirstName: Danielle
  piLastName: France
  piPhone: '7204313423'
  poName: Henry Ahn
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Multichannel Resonators Enabling A Phenotypic Point Of Care
    Infectious Disease Diagnostic'
- abstractText: "The broader impact/commercial potential of this Small Business Technology
    Transfer (STTR) project is the reduction of significant disease flare-ups in patients
    with Chronic Obstructive Pulmonary Disease (COPD), increase in patient quality-of-life,
    and a reduction of expensive and unnecessary healthcare utilization. Current at-home
    care support for COPD patients is often completely missing or consists of action
    plans that fail to provide effective, individualized care. The alternative solution
    under development in this project is an easy-to use, personalized mobile application
    that catches disease degeneration early, tracks patient health history, and provides
    decision support to guide patients to the right medical care at the right time.
    COPD is one of the leading chronic conditions driving potentially avoidable hospital
    admissions. Pairing a mobile health management app with a smart triage system
    that provides instant healthcare guidance has the potential to dramatically reduce
    unnecessary COPD hospitalization and provide long-term maintenance treatment of
    COPD symptoms. Moreover, an easily accessible, highly accurate, convenient solution
    can empower patients to make better health decisions early. \n\nThis STTR Phase
    I project proposes to demonstrate positive impact and adoption of a mobile triage
    application for COPD patients. To date, a set of triage algorithms has been built
    and validated on simulated patient cases. The algorithms exhibited performance
    that is comparable to or better than a panel of board-certified pulmonologists.
    The next vital step is to establish the technical feasibility of a packaged, stand-alone
    mobile application. This research will focus on developing a fully featured prototype
    that is optimized for adoption, retention, and efficacy. A mix of user feedback
    and rigorous usage analysis collected through human testing will provide necessary
    insights on barriers to use, missing functionality, and consumer value. Standardized
    markers of health safety, symptom escalations, and patient quality-of-life will
    be used as metrics of product performance. Moreover, all data and conclusions
    will be subjected to peer review through publication and public presentations.
    As an additional objective, the accuracy of the algorithmic triage recommendations
    will be tested on real patient cases to further validate their accuracy and effectiveness.
    The anticipated result of the phase I procedure is demonstration that the app
    is safe (objective 1), operationally sound and optimal (phase 2), and valuable
    to consumers (objective 3).\n\nThis award reflects NSF's statutory mission and
    has been deemed worthy of support through evaluation using the Foundation's intellectual
    merit and broader impacts review criteria."
  awardeeAddress: 6400 Westwind Way
  awardeeCity: Crestwood
  awardeeCountryCode: US
  awardeeName: Revon Systems Inc
  awardeeStateCode: KY
  awardeeZipCode: '400146773'
  fundsObligatedAmt: '224999'
  fundProgramName: STTR PHASE I
  id: '1820049'
  piEmail: sswami2750@gmail.com
  piFirstName: Sumanth
  piLastName: Swaminathan
  piPhone: '2676349997'
  poName: Henry Ahn
  date: 07/09/2018
  startDate: 07/15/2018
  expDate: 06/30/2019
  title: 'STTR Phase I:  A Mobile Triage Application for Reducing the Risk of COPD
    Exacerbations'
- abstractText: "The broader impact/commercial potential of this STTR Phase I project
    is a sustainable fruit and vegetable processing technology utilizing a new, low
    temperature technique that can extend the shelf life of pre-cut fruits and vegetables
    by months without using preservatives, chemicals, freezing, or refrigeration.
    \ The technology would enable: all-natural, shelf stable fruit and vegetable products
    that retain maximum nutritional value, texture, and taste.  With significant percentages
    of the total US national energy budget used for food-related energy, and high
    fresh produce loss in the developed countries due to insufficient refrigeration,
    achieving shelf life extension without cold storage or preservatives could drastically
    reduce energy costs, increase efficiency, and expand access to nutrition globally.
    \n\nThis STTR Phase I project proposes to develop, validate, and build-upon initial
    research to evaluate the feasibility and scope of a novel food processing technology.
    Traditional processing methodologies have fundamental drawbacks.  High temperature
    treatments degrade nutritional quality while altering texture and taste of end-products.
    Freezing negatively affects the reconstitution properties of fruits and vegetables,
    and requires high energy consumption throughout the food system to maintain the
    cold chain.  HPP (high pressure processing) has limitations on the enzymes it
    can inactivate, and chemical alterations from high pressure treatment negatively
    affects texture and taste.  This research proposal will use validation studies
    to evaluate the feasibility and applicability of the novel processing technique
    to a variety of fruits and vegetables.  Successful experimentation will prove
    that the application of dense phase gas at low temperatures can overcome the aforementioned
    drawbacks, achieving enzymatic inactivation, destruction of the spores, improved
    reconstitution properties, lower energy requirements, and minimal deterioration
    of taste, texture, and nutritional quality.  Such a result would actuate follow-on
    development work to validate that, at commercial scale, the new process technology
    improves upon the operational costs of traditional methodologies.\n\nThis award
    reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 409 College Avenue
  awardeeCity: Ithaca
  awardeeCountryCode: US
  awardeeName: Natural Cuts, Inc.
  awardeeStateCode: NY
  awardeeZipCode: '148504694'
  fundsObligatedAmt: '224387'
  fundProgramName: STTR PHASE I
  id: '1819600'
  piEmail: vipul@fartherfarms.com
  piFirstName: Vipul
  piLastName: Saran
  piPhone: '5083400777'
  poName: Anna Brady-Estevez
  date: 06/26/2018
  startDate: 07/01/2018
  expDate: 11/30/2019
  title: 'STTR Phase I:  Development of a Process to Extend the Shelf Life of Fruits
    and Vegetables at Ambient Temperature'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is the reduction of the cost of wind energy through a
    robust, inexpensive, and efficient vertical-axis wind turbine (VAWT). This project
    has the potential to increase global wind power production through technological
    advancements that lower installation, operations, and maintenance costs via an
    innovative design which addresses reliability and efficiency concerns that have
    previously limited the penetration of VAWTs into the wind energy market. Compared
    to the common horizontal-axis wind turbine (HAWT), the proposed technology requires
    an order of magnitude fewer components. Additionally, heavy and maintenance intensive
    components are located at ground level for ease of access. One initial market
    for this technology will be stand-alone, small-scale generation, where this technology
    will provide long-lasting, low-maintenance power for remote locations. Another
    initial market is the repowering and augmentation of existing wind turbine arrays.
    Here, this technology will be a cost effective method of revitalizing underperforming
    or aging HAWT farms. The long-term objective is large-scale, VAWT-only arrays.
    Recent scientific advances indicate that, unlike HAWTs, interactions between VAWTs
    can be beneficial, resulting in cost-effective, high-output wind farms. \n\nThis
    SBIR Phase I project proposes to address the reliability and efficiency concerns
    that have previously limited the penetration of VAWTs into the wind energy market.
    XFlow Energy's novel design utilizes a robust, stationary central shaft extending
    the length of the rotor, reducing harmful loading to the rotor structure. This
    design requires a larger central shaft than VAWTs tested to date, and the impact
    of a large central shaft on VAWT power output has not been previously investigated.
    Laboratory-scale tests will be performed on a range of geometries to analyze the
    fluid-dynamic impact of larger central shafts and the resulting changes in turbine
    performance and loading. This information will inform the design and structural
    simulation of a 500 W turbine.  This design will be prototyped and will undergo
    thorough performance measurements. Ultimately destructive testing will be performed
    to identify structural deficiencies, and the design updated appropriately. The
    objective of SBIR Phase I is to produce a 500 W turbine that is thoroughly characterized,
    can survive up to 100 mph winds, and is ready for commercialization. This design
    will inform development of a utility-scale turbine (>50 kW) which will be the
    focus of SBIR Phase II.\n\nThis award reflects NSF's statutory mission and has
    been deemed worthy of support through evaluation using the Foundation's intellectual
    merit and broader impacts review criteria."
  awardeeAddress: 8009 7th Ave S
  awardeeCity: Seattle
  awardeeCountryCode: US
  awardeeName: XFlow Energy Company
  awardeeStateCode: WA
  awardeeZipCode: '981084365'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819785'
  piEmail: ben@xflowenergy.com
  piFirstName: Benjamin
  piLastName: Strom
  piPhone: '4019323544'
  poName: Anna Brady-Estevez
  date: 06/21/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Lowering Wind Power Costs Through Robust Vertical-Axis Turbines'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will result from the development of a scalable, enterprise-ready conversational AI platform that enables businesses to automate customer support requests, optimize call routing efforts to get customers to the right human support agent, generate customer self-service resources like smart FAQs, augment human staff with bot capabilities, and enable personalized recommendations to support sales and purchasing decisions for customers. Such technology is beneficial to any enterprise organization, B2C (business-to-consumer) and B2B (business-to-business), who needs to communicate to customers, employees, and the public. With rising customer service and communication costs, automation is critical for businesses to maintain profitability and competitive advantages. On a societal level, conversational interfaces democratize access to information and resources worldwide. A significant portion of the world's population lives in regions where internet access is poor and device ownership is rare. Many also suffer from physical limitations, such as impaired vision or limited motor control. Accelerating technology access through conversational interfaces such as SMS and voice has already been shown to transform quality of life for disadvantaged groups through applications in telemedicine, personal finance, and education.

    This Small Business Innovation Research (SBIR) Phase I project aims to enable human-level conversational ability in machines. Teaching computers to communicate like humans is a critical step to achieving human-level machine intelligence (HLMI), also called artificial general intelligence (AGI). Current state-of-the-art approaches to automated dialog systems use a combination of supervised learning and reinforcement learning implemented with deep neural network architectures. These approaches have shown promise on toy problems in academic research, but have mixed performance in enterprise settings. This Phase 1 project extends current deep learning approaches by developing a repeatable methodology for annotating and preparing enterprise data for use in dialog systems and a scalable, grounded neural network architecture that can reference external knowledge sources with minimal manual engineering.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 106 B Warwick Place
  awardeeCity: Ithaca
  awardeeCountryCode: US
  awardeeName: TOPBOTS Inc
  awardeeStateCode: NY
  awardeeZipCode: '148501731'
  fundsObligatedAmt: '224479'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819808'
  piEmail: mariya@topbots.com
  piFirstName: Yanjia
  piLastName: Yao
  piPhone: '6366751088'
  poName: Peter Atherton
  date: 06/19/2018
  startDate: 07/01/2018
  expDate: 12/31/2019
  title: 'SBIR Phase I: Automating Conversational Systems For Enterprise Customer
    Support'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be to transform 2-way, mobile satellite communications from a niche service (affordable to less than 0.1% of the world?s people), to a broadly accessible mass market product (at costs well under $1/month).  Communications devices (that could be as small as vehicle key fobs) will communicate modest volumes of data to and from virtually anywhere on Earth.   The number of potential applications is large, with the following being a few examples:  every lifejacket on every commercial aircraft and cruise ship could transmit its location and status (in the event of a mishap); children and the elderly could be tracked globally; and drivers could be assured of assistance wherever they travel.   Secondary impacts would include an increase in average fuel efficiency when, for example, more vehicles are sold without spare tires (as drivers have more peace-of-mind regarding the possibility of being stranded).   The United States will benefit in terms of improved safety, conserved resources, stimulus to the satellite and related industries, and increased export revenues.

    The proposed project centers around a combination of innovations that exploit inherent (but previously unutilized) capabilities of existing satellites.  Currently operational Mobile Satellite Systems have communications architectures that do not lend themselves to low-cost transmission of small volumes of data.  By starting with a blank sheet of paper and rethinking the architecture, costs can be reduced by orders of magnitude (for both the communications devices and the data service).  The cost reduction of the terminal devices is primarily driven by lower data rates (with associated lower power and size).  While most technical aspects of communications links improve with lower data rates, one characteristic emerges as a constraint on the extent to which data rate can be reduced.  The purpose of this research is to study this characteristic, called phase noise, and its impact on the communications performance at low data rates when using real satellite links.  The results of this research will be quantitative conclusions regarding the trades between data rates, the cost impact of lowering phase noise in the communication elements, transmission performance, and the modem architectural options.  This study will enable optimization of this trade when developing the follow-on commercial products.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1460 Santa Luisa
  awardeeCity: Solana Beach
  awardeeCountryCode: US
  awardeeName: eSAT Global, Inc.
  awardeeStateCode: CA
  awardeeZipCode: '920751619'
  fundsObligatedAmt: '158852'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820435'
  piEmail: michael.parr@esatglobal.com
  piFirstName: Michael
  piLastName: Parr
  piMiddeInitial: I
  piPhone: '8584807204'
  poName: Rick Schwerdtfeger
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 07/31/2019
  title: 'SBIR Phase I: Efficient Narrow-Band Communication via Geosynchronous Satellites'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project will be the development of a detection assay to reduce the incidence of Vibrio-related infections. Infections from Vibrio parahaemolyticus and Vibrio vulnificus are the leading causes of seafood-borne infections and fatalities, respectively, and stem primarily from raw oysters. Development and implementation of rapid, accurate, inexpensive and easy-to-use testing methods would expand Vibrio data collection and enhance preventive measures by state shellfish labs (monitor harvest areas), and oyster processors and post-harvest processors (quality control at facilities). The assays will be available to users in simple, ready-to-prepare kits. These kits will make it easy for non-specialized personnel to test oyster lots still under refrigeration without disrupting logistics, and help U.S. oyster processors and post-harvest processors improve risk management tools and access export markets with restrictions on Vibrio levels. The tests also will improve environmental risk evaluations for harvest areas by state shellfish labs, FDA, National Oceanic and Atmospheric Administration, and other members of the National Shellfish Sanitation Program. The tests will be marketed in the U.S., and other large oyster producing nations.

    This STTR Phase I project proposes to develop two-phase, thermostable test tube media formulations for the detection and enumeration of pathogenic V. parahaemolyticus, total V. parahaemolyticus, and V. vulnificus in oysters. The goal is to demonstrate a) > 95% sensitivity and specificity of each test with pure cultures and oyster samples; b) 24-hr detection time; c) ease-of-use of the ready-to-prepare kits, based on time, steps, equipment, materials and feedback from industry; and d) low cost. The main technical hurdles are: 1) Increasing formulation volumes for test tube assays since linear increases of agar layer volumes in test tube media formulations could impact Vibrio organism motility, and consequently detection speed and accuracy; and 2) replacing a non-heat stable antibiotic component, Polymixin B of the V. vulnificus test, with a heat stable alternative, like ampicillin or lincomycin, to improve ease-of-use.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 206 White Street
  awardeeCity: Martin
  awardeeCountryCode: US
  awardeeName: Secure Food Solutions
  awardeeStateCode: TN
  awardeeZipCode: '382373222'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1819545'
  piEmail: chris.ramezanpour@gmail.com
  piFirstName: Chris
  piLastName: Ramezanpour
  piPhone: '9014963254'
  poName: Ruth Shuman
  date: 05/24/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'STTR Phase I:  Feasibility of a two-phase test tube assay for rapid detection
    and enumeration of Vibrio vulnificus and Vibrio parahaemolyticus in oysters'
- abstractText: "This Small Business Innovation Research Phase I project will develop
    a novel process and platform for the aerosol synthesis of metal-oxide nanoparticles.
    When coupled with an existing aerosol deposition technology, this aerosol synthesis
    source will enable the production of the next generation of functional coatings.
    These include antireflective and self-cleaning coatings for solar modules, novel
    electrical contacts that reduce silver usage in solar cells, and thermal barrier
    coatings for windows that increase thermal efficiency. Each of these represents
    a large addressable market in need of coatings innovation: For example, the coated
    flat glass market is expected to reach $43.2B in 2025 and the metal-oxide nanoparticle
    coatings from this project are anticipated to capture at least 10% of that market.
    Beyond the commercial and related societal impacts of the project, this project
    will increase the scientific understanding of the nucleation of nanomaterials
    in the gas phase and the subsequent manipulation of nanoparticles in low-pressure
    flows. \n\nThe intellectual merit of this project lies in its development of a
    new method to synthesize metal-oxide materials in the gas phase, resulting in
    an aerosol that can be manipulated and deposited on a substrate with gas flows.
    Prior art for the synthesis of metal-oxide nanoparticles and the subsequent formation
    of films suffers from three challenges: (1) synthesis methods that utilize high-pressure
    gas-phase processes tend to create large light-scattering agglomerates that produce
    hazy films, (2) \"wet\" synthesis coating techniques can suffer from stability
    challenges, optical non-uniformities, and processes that are not easily scaled
    and (3) all methods have limited control of the optical properties of the film,
    specifically the refractive index. Synthesis of metal-oxide nanoparticles using
    the approach in this project is a promising, but under-examined and under-utilized,
    technique. It will generate unagglomerated nanoparticles of controllable size,
    overcoming the first challenge, and, with suitable aerosol deposition techniques,
    enable large-area uniform films with controllable refractive index, overcoming
    the second and third challenges.\n\nThis award reflects NSF's statutory mission
    and has been deemed worthy of support through evaluation using the Foundation's
    intellectual merit and broader impacts review criteria."
  awardeeAddress: 8501 W. Foothill Dr
  awardeeCity: Peoria
  awardeeCountryCode: US
  awardeeName: Swift Coat
  awardeeStateCode: AZ
  awardeeZipCode: '853832052'
  fundsObligatedAmt: '223837'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820364'
  piEmail: peter@SwiftCoat.com
  piFirstName: Peter
  piLastName: Firth
  piPhone: '6233632687'
  poName: Steven Konsek
  date: 05/22/2018
  startDate: 06/01/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Non-Thermal Plasma Source for Functional Metal-Oxide Nanoparticle
    Coatings'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to establish faster, less expensive, more accurate ways of determining the contents of biological samples leading to novel medical diagnostics, new drugs, and other new products beyond the reach of the current scientific methods that employ mass spectrometry. The project will develop technology that enables better software for mass spectrometry, and will make mass spectrometry-based sample analysis more accessible to a broader segment of academic and industrial scientists, disrupting a $100M market. Advanced software is required to transform raw experimental data into the lists of molecules and quantities needed to create new drugs, discover diseases and increase food production. The successful completion of the aims of this proposal will enable the development of software built for the next generation of mass spectrometry, providing user-friendly, fast cloud software built on advanced, high-information algorithms.

    This SBIR Phase I project proposes to develop novel, high-information software technology for mass spectrometry data processing. The proposed work in Phase I will provide proof-of-concept for prototype development and testing in Phase II. The research will address three critical technical hurdles that are prerequisites to prototype development: 1) A mass spectrometry data storage and retrieval architecture sufficient to handle significantly more information from the hundreds of files in a typical study, 2) cloud-optimized versions of mass spectrometry information extraction algorithms, and 3) a cloud-based model-view controller framework that overcomes web-specific challenges for mass spectrometry data processing. The goal is to allow more experiments in the same amount of time without increasing costs, identifying more molecules than existing methods from the same experiment, and detecting molecules that are less abundant and go undetected by current methods.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 15637 S Sperry Grade Rd
  awardeeCity: Greenough
  awardeeCountryCode: US
  awardeeName: Prime Labs Inc
  awardeeStateCode: MT
  awardeeZipCode: '598239624'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819290'
  piEmail: 2robsmith@gmail.com
  piFirstName: Robert
  piLastName: Smith
  piPhone: '4068800062'
  poName: Ruth Shuman
  date: 05/22/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Technical R&D for cloud-based high-information mass spectrometry
    data extraction commercialization'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project will serve two complementary unmet market needs
    by: (1) accelerating the evaporation rate of brine ponds and enhancing salt production
    efficiency by 2-3 times; (2) condensing the moisture evaporated from contaminated/salty
    water so that one can obtain clean drinking water with n consumption of electricity.
    We will develop an enhanced solar vapor generation strategy based on a patent-pending
    electricity-free solar thermal technology. Specifically, we will develop/optimize
    functional materials to enhance the solar-driven vapor generation rate. The target
    is to double or even triple the salt production of mining companies relying on
    evaporation of brine ponds exposed to natural sun and wind. We will work with
    selected industrial partners to perform the field test in lithium brine ponds,
    which is the key source material for future Lithium battery industry. In addition,
    by condensing the evaporated moisture, we will aim to produce clean water using
    low cost materials and systems, which is a promising and sustainable solution
    to address the global drinking water scarcity using affordable electricity-free
    products in coastal and resource-limited areas. \n\nThe proposed project will
    aim to commercialize a patent-pending technology to realize an enhanced solar-driven
    water evaporator, which is highly desired for both solar mining production and
    clean water generation. Due to the superior solar energy absorption, heat conversion,
    and thermal insulating properties of our disclosed structure, most of the absorbed
    energy can be used to evaporate surface water with significantly reduced thermal
    dissipation. Remarkably, our pilot system has realized a record solar thermal
    conversion efficiency of >88% under illumination of 1 kW/m2 with no solar concentration.
    The corresponding vapor generation rate is ~1.28 kg/m2/h - a full 3X higher than
    the natural evaporation of bare water surfaces in the same environment. This Phase
    I SBIR effort will aim to overcome the remaining technical barriers for material
    and system optimization and scaling up strategies for manufacturing. By comparing
    the roll-to-roll coating and direct dying processes in this proposed research,
    we will select the best overall technology to complete our supply chain for the
    production in Phase II. In particular, we will perform field tests by working
    with solar mining industrial partners as well as Non-Government Organizations
    (NGO's) to get their feedback on how to improve the product in relevant environment."
  awardeeAddress: 419 Wood Acres Drive
  awardeeCity: East Amherst
  awardeeCountryCode: US
  awardeeName: SUNNY CLEAN WATER LLC
  awardeeStateCode: NY
  awardeeZipCode: '140511669'
  fundsObligatedAmt: '224934'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1745846'
  piEmail: zongminbei@gmail.com
  piFirstName: Haomin
  piLastName: Song
  piPhone: '7165331342'
  poName: Rick Schwerdtfeger
  date: 01/05/2018
  startDate: 01/01/2018
  expDate: 04/30/2019
  title: 'SBIR Phase I:  Enhanced solar-thermal vapor generation for salt mining and
    stilled clean water'
- abstractText: |-
    This SBIR Phase I project will examine a new ultra-rapid 3D printing technology designed to break down important barriers to the future of Additive Manufacturing. The subject is a machine and materials set that can provide exponentially faster object generation at high resolution. This system leverages several familiar technologies in a new way to provide a path for 3D printing, generally considered reserved for the high-tech sectors, to become accessible to everyone. Because the new method is so rapid, detailed, and the materials are so diverse, it is poised to enhance plastics manufacturing profit margins by eliminating mold costs in many cases. In this way, many American business forced to outsource overseas will be able to maintain domestic production and increase the return of manufacturing jobs to the US. In addition, the manufacturing of the consumables will also enhance job creation. When this new method is fully adopted, its use in the medical field will make lifesaving and life enhancing prosthetic, implantable, and pharmaceutical testing applications much more cost effective, fundable by Medicare, benefiting all our citizens. By servicing a higher percentage of the general plastics manufacturing $600B industry, as well as professional designers, engineers, technical professionals, and the medical and scientific community, the new system in its many forms will eventually be of benefit to nearly every industry in the US, increasing the growth and practical value of the 3D market sector.


    The subject invention is unique in its use of multiple disciplines simultaneously. As a solid-state system, pressure-biased build material presses up against a glass screen, which is micro-porous, and is laced with the same kind of electronics as are found in flat screen displays. The discrete addressing normally reserved for video images, known as row-and-column refresh rates, is instead used to activate resistive material generating micro-heat spots in this open weave configuration. The heat stimulates the build material to transit the glass and solidify topside, at 1000 dpi resolution, or 1 million droplets per square inch. These high-resolution droplets conjoin and cool, as an entire layer is created at once at 30-120 times a second with no mechanical heads tracking back and forth. The objects should seem to simply appear on the glass at about one to seven vertical inches per minute, depending on the refresh rate, at virtually any planar size, and can be used right away, since no post-curing treatment is needed. Integrating an activated video matrix to build entire cross sections at once, increases speed exponentially. The pores in the glass rely on the known science of Microfluidics, a highly refined means of moving an entire 2D matrix of liquid, to eliminate costly and slow mechanization, and will be studied in this application. Robust and diverse materials have been developed for many embodiments and will be tested. Optimizing first in Multiphysics simulation, and then fabricating a simplified Proof of Concept in Phase I, should provide compelling evidence for continued work on this novel method in Phase II.
  awardeeAddress: 43126 Lancashire Common
  awardeeCity: Temecula
  awardeeCountryCode: US
  awardeeName: Meisner Consulting Inc.
  awardeeStateCode: CA
  awardeeZipCode: '925929227'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1747210'
  piEmail: robin@voxel-llc.com
  piFirstName: Milton
  piLastName: Meisner
  piMiddeInitial: D
  piPhone: '8584873000'
  poName: Linda Molnar
  date: 12/19/2017
  startDate: 01/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Novel Ultra-Rapid, High Definition, Additive Manufacturing
    System'
- abstractText: |-
    The broader impact/commercial potential of this project is to improve law enforcement (LE) effectiveness in battling the illegal drug epidemic in the U.S. Death rates related to drug use have been increasing yearly and exceeded 72,000 Americans in 2017. To control this epidemic, the President?s 2019 Budget Request called for $30B in federal funding to combat illegal drug use, presenting a commercial opportunity to disrupt the existing market for conventional color test kits and Raman-based testing systems. Numerous interviews conducted with LE and forensic supply resellers demonstrate a readiness to adopt a new technology to replace drug test kits currently in use. This novel drug test system will improve the accuracy, reliability, ease of use, safety, and affordability of field drug identification and permit field use data analysis, which will help remove dangerous drugs from the streets. This innovation will also enhance the understanding of the chemical and photoluminescent properties of narcotic drugs reacting with various drug-indicator materials such as copper(I) iodide and validate the use of such information to identify suspected drugs. This is a wireless technology for the LE market sector, with the potential to eventually expand into the medical diagnostics and environmental analysis markets.

    This Small Business Innovation Research (SBIR) Phase I project will develop a novel system for on-site field drug testing for LE. Conventional chemical-based color tests are outdated and highly flawed, causing issues for end users and the rest of the drug enforcement ecosystem. These issues include false positive drug tests and the lack of ability to identify new drugs that are introduced into U.S. communities each year. Superior testing methods such as handheld Raman devices are too expensive for LE agencies to widely adopt, thus a low-cost technologically-innovative solution is necessary. This innovation leverages photoluminescence spectroscopy in four main components: a handheld spectrometer, a drug-sampling device, a mobile app with a matching algorithm and access to a cloud database of reference drug standards. The goal of this phase I project is to achieve a high-fidelity Minimum Viable Product drug testing system. The investigation of alternative fluorescent drug-indicators is anticipated to result in novel methods for drug identification with high selectivity and sensitivity. These methods will be implemented into a drug-sampling device. As a part of software and hardware optimization, beta testers within LE will help identify system shortcomings and provide input to develop enhancements for usability and ergonomics.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 311 6th Ave.
  awardeeCity: Indialantic
  awardeeCountryCode: US
  awardeeName: IDEM, LLC
  awardeeStateCode: FL
  awardeeZipCode: '329034301'
  fundsObligatedAmt: '224722'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843595'
  piEmail: dnash2005@gmail.com
  piFirstName: David
  piLastName: Nash
  piPhone: '3218484506'
  poName: Muralidharan Nair
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Novel Field Drug Test System for Law Enforcement'
- abstractText: |-
    This SBIR Phase I project supports development of an innovative device for use in laparoscopy (minimally invasive surgery of the abdomen). Laparoscopic injuries most often occur during primary port entry, before visualization into the abdominal cavity is possible. Injuries are primarily to the bowel or vasculature and are very serious, with mortality rates up to 5% for bowel injuries and up to 15% for vascular injuries. To minimize this risk, surgeons lift the abdominal wall away from the vital organs that could be inadvertently punctured during primary port entry. Two lifting techniques are commonly utilized, but one is unreliable and the other invasive. The product in development utilizes suction instead of mechanical force to grasp the abdominal wall and is more reliable and less invasive than the current techniques. Projected benefits include better surgical outcomes, increased surgeon and patient satisfaction, and decreased patient post-op pain. Successful development of this product is forecasted to create 40 new jobs by 2023 with an annual payroll exceeding $2.5M. As a direct result of this Phase I grant, this innovative product can reach the U.S. market in 2019 and become the gold standard for abdominal wall lifting devices in the next five years.

    The technical innovation in this proposed project is a novel abdominal lifting device for use in laparoscopic surgery that is more reliable and less invasive than current lifting techniques. The novelty of the innovation is affirmed with one issued patent and an additional pending patent application. The device takes advantage of existing suction available in every operating room.  This suction allows for the non-invasive attachment of the lifting device to the abdominal wall.  Current lifting techniques include manually grasping the abdominal wall and using perforating towel clips. Manual grasp does not always provide a secure grip and perforating towel clips invasively perforate abdominal wall tissue to provide a handle by which to lift and elevate. The technical goals of this project focus on creating a minimum viable product produced with biocompatible materials using standard good manufacturing practices for FDA Class I medical devices. Production quality samples will be produced with five different materials to determine which performs best in terms of strength, reliability, and flexibility. These samples will also be used to determine if any further design changes are needed prior to commercialization.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2746 N Hidden Springs Drive
  awardeeCity: Fayetteville
  awardeeCountryCode: US
  awardeeName: Lapovations, LLC
  awardeeStateCode: AR
  awardeeZipCode: '727039203'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843314'
  piEmail: nhiem@lapovations.com
  piFirstName: Nhiem
  piLastName: Cao
  piPhone: '4792839634'
  poName: Henry Ahn
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'SBIR Phase I:  AbGrab Laparoscopic Lifting Device'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to address the global challenge of pollution abatement and air purification which have a profound impact on the environment, health, and economy. Hundreds of billions of dollars are spent each year on emission control activities, yet air pollution costs the global economy over five trillion of dollars annually in welfare costs and is attributed to one in every eight deaths. The design and performance of current industrial catalytic air purification technologies is insufficient to treat the growing number of airborne pollutants. Finding sustainable, cost-effective solutions to this problem, and is becoming increasingly important in view of tightening regulations. The technology we propose has a high commercialization potential due to the fact that it is cost-effective, shows excellent long-term performance and potential for scalable fabrication within an existing manufacturing framework within the United States.  Further, the founders of the company are inventors of the technology and have exclusive licensing of the core IP. Significantly, our demonstration of operating temperature reductions has been well-received by industry as evidenced by findings from our customer discovery effort through programs such as NSF I-Corps.

    This Small Business Innovation Research (SBIR) Phase I project addresses outstanding challenges in catalytic converters, notably technical challenges associated with cold start, durability, and high cost, which can be attributed to the use of substantial amounts of platinum group metals, and reliance on the limited reserves of these metals. Through highly controlled composition and nano-, micro-, and macro- structuration, we have previously demonstrated dramatically reduced precious metal content in a catalytic decomposition of known pollutants. The research objectives of this SBIR project are to develop a scalable deposition method of these advanced catalytic materials onto industrially relevant substrates, to promote and accelerate their integration into commercial products to tackle the growing problem of air pollution and greenhouse gas emissions. The technical work will involve the synthesis of these materials and modifications to the synthetic schemes in a way that will be compatible with such large-scale deposition processes, as well as longevity, robustness, and catalytic testing. It will require building equipment for the deposition. Overcoming the technological challenges that are the subject of this SBIR Project will facilitate translation of the nanostructured materials to a broad range of catalytic applications related to pollution abatement and air purification.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 127 Western Ave.
  awardeeCity: Boston
  awardeeCountryCode: US
  awardeeName: AirCrew Technologies, Inc.
  awardeeStateCode: MA
  awardeeZipCode: 021341008
  fundsObligatedAmt: '224990'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843534'
  piEmail: e.shirman@gmail.com
  piFirstName: Elijah
  piLastName: Shirman
  piPhone: '6179490017'
  poName: Linda Molnar
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  NANOSTRUCTURED 3D CATALYTIC COATINGS FOR HIGH-EFFICIENCY
    POLLUTION CONTROL AND AIR PURIFICATION'
- abstractText: "This SBIR Phase I project focuses on developing chemically cross-linked
    synthetic nanomaterials to address the unmet clinical need in promoting infection
    free tissue regeneration in surgical, traumatic, ocular, burn, and chronic wounds.
    While small wounds heal naturally, larger chronic wounds demonstrate delayed wound
    healing with infections, and affect over 6.5 million patients costing over US
    $25 billion annually in treatments. In addition, annually, 2 million Americans
    suffer from serious infections due to drug resistant bacteria resulting in severe
    morbidity, serious complications, huge economic losses with an estimated 23,000
    deaths. As conventional antibiotics are failing, our ability to fight drug resistant
    pathogens is diminishing and the pipeline of new potential antibiotic drugs is
    very skim. Thus, there is an urgent need to develop a product that can fight multiple
    pathogens through a mechanism against which bacteria are less likely to develop
    further resistance. Hence, the current project evaluates the feasibility of developing
    a novel, easily handleable dry film with potential to eliminate a variety of infectious
    pathogens while improving wound healing in a single application. This product
    is pliable, easily rehydratable, has intrinsic tissue scaffolding properties and
    is inherently antimicrobial against a broad range of pathogens without the use
    of any additional agents.  \n \nThis SBIR Phase I project will demonstrate the
    feasibility of developing a shape retaining, pliable, easily handleable antimicrobial
    cell-scaffolding gel matrix into a product that is simultaneously toxic to antibiotic-resistant
    bacterial strains, while remaining conducive to tissue regeneration. This current
    product has a nano-porous gel matrix that promotes cellular infiltration and attachment
    along with utilizing a charge-based mechanism to lyse bacterial membranes upon
    contact. Although there is on-going research on such self-assembled hydrogels,
    the formation of films using these nanofibers has never been assessed before and
    stands to be the key technological advancement. Thus, this current proposal explores
    two methods for making films such as i) solvent casting methods relying on non-covalent
    crosslinking - where the hydrogel is applied to a surface and then allowed to
    dry into a film overnight, and ii) Covalent crosslinking by - incorporating cysteines
    by oxidizing using H2O2 or crosslinking using Schiff base formation followed by
    reductive deamination. The films so formed will be structurally and functionally
    evaluated for their ability to eliminate infections and biocompatibility.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 15 Waverly St
  awardeeCity: Brighton
  awardeeCountryCode: US
  awardeeName: Gel4Med
  awardeeStateCode: MA
  awardeeZipCode: '021351200'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843682'
  piEmail: mmehta@gelformed.com
  piFirstName: Manav
  piLastName: Mehta
  piPhone: '6179030678'
  poName: Henry Ahn
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Tunable Mechanical and Functional Properties of Peptide Films'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project lies in the increase in efficiency and reduction in cost of gathering information in surface water environments using unmanned surface vehicles (USVs). USVs have the potential to increase accessibility to bodies of water, enhance coverage, and make data collection safer by removing humans from the task. However, to fully realize the potential of USVs for gathering information, a level of autonomy with minimal need for human supervision and intervention is required. The development of this technology will open the door to the pervasive use of USVs for environmental data collection, and ultimately benefit society through: i) more information upon which to base decisions about resource management and environmental policy; ii) higher frequency of data collection activities through reduced cost; and iii) increased safety by keeping human personnel out of harsh environments.

    This Small Business Innovation Research (SBIR) Phase I project will lay the foundation for a transformative approach to environmental data collection in surface waters. The intellectual merit of this project lies in addressing technical challenges that will enable unmanned surface vehicles (USVs) to effectively navigate autonomously in complex surface waters that may contain a range of diverse obstacles, which would otherwise be inaccessible or at best require a high degree of human supervision. This will be achieved by advancing the state-of-the-art in computer vision and machine learning toward intelligent obstacle characterization. The proposed framework interprets images or video of obstacles to extract salient features, such as flexibility or rigidity, through the innovative use of machine learning, dimensionality reduction, and tools borrowed from the analysis of collective behavior. This extra layer of information provided through the proposed framework represents a significant advancement in computer vision, which offers direct benefits to environmental monitoring and data collection by empowering USVs with new unmanned capabilities.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 195 Adams St  Apt 14D
  awardeeCity: Brooklyn
  awardeeCountryCode: US
  awardeeName: Manifold Robotics Inc.
  awardeeStateCode: NY
  awardeeZipCode: '112011853'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843049'
  piEmail: jeffreylaut@gmail.com
  piFirstName: Jeffrey
  piLastName: Laut
  piPhone: '7186145807'
  poName: Peter Atherton
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Robust autonomy for robotics-based data collection in surface
    water environments'
- abstractText: "This SBIR Phase I project builds a new query engine for K12 that
    addresses four major shortcomings in existing automated question-answering systems.
    The shortcomings prevent both students and teachers from fully leveraging the
    power of such systems. Existing systems 1) cannot handle raw student queries like
    - Ten Ford Fiestas cost $146,000. How much does each Ford Fiesta cost?, 2) do
    not take into account students' skill-levels to return results that is within
    the scope of their understanding, 3) do not have a community vetting and feedback
    mechanism that allows systems to learn the quality of their automated answers,
    and 4) discard valuable insights obtainable from students' queries that can be
    used to inform future classroom instruction. The query engine, which is free to
    use, addresses all four shortcomings, improves classroom instruction and closes
    the achievement gap. It empowers students of all abilities and from all communities
    to obtain automated answers from the AI technology and regular answers from the
    community of users. The community of users on the platform range from students
    to teachers to experts from the industry fulfilling their corporate social responsibilities.
    The platform is compliant with federal and state privacy regulations and is projected
    to earn significant Annual Recurring Revenue from corporations and EdTech companies
    seeking to build their brand among the K12 community. \n\n\nThis project develops
    new skill-aware AI technology that automatically maps student's raw queries into
    topics, sub-topics and intent. The technology considers the user skill-levels
    and automatically constructs an answer extracted from the most relevant educational
    resources, with highest preference given to teachers' own resources. The technology
    does something more if the detected topic falls under Algebra and the intent of
    the query is 'How do I solve this?' It generates, on-the-fly, additional scaffolding
    instructions for solving the problem. This approach extends to disciplines beyond
    Algebra. In addition, Phase I research leverages the latest advancements in Machine
    Learning, Natural Language Processing and Topic Detection to extract and track
    skill-levels, as well as strengths and weaknesses of students for teacher's benefit.
    Finally, the project will also demonstrate the efficacy of the technology in terms
    of queries made, relevant responses generated and its impact in terms of Algebra
    math outcomes.\n\nThis award reflects NSF's statutory mission and has been deemed
    worthy of support through evaluation using the Foundation's intellectual merit
    and broader impacts review criteria."
  awardeeAddress: '20488 Stevens Creek Blvd #1501'
  awardeeCity: Cupertino
  awardeeCountryCode: US
  awardeeName: A Carrot, Inc
  awardeeStateCode: CA
  awardeeZipCode: '950142293'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843326'
  piEmail: m@acarrot.com
  piFirstName: Mahesh
  piLastName: Godavarti
  piPhone: '6502240377'
  poName: Rajesh Mehta
  date: 12/21/2018
  startDate: 01/01/2019
  expDate: 12/31/2019
  title: 'SBIR Phase I:  Qalaxia: skill-aware query engine for K12 Classrooms'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop a protein sample preparation kit that eliminates variability and provides researchers with the information they need to find important protein drug targets and biomarkers.  The high throughput protein analysis methods of proteomics are having a significant impact on the biotechnology and pharmaceutical industries, from the development of new protein-based drugs to quality control monitoring and biomarker discovery to clinical diagnostics. All proteomics applications require robust, repeatable and automatable sample preparation methods. Currently, however, these methods are not standardized. The lack of the standardization often leads to experimental failure and unreliable results, which may require many rounds of experimental repeats, costing time and money. Standardized protein sample preparation kits will provide significant workflow savings, improve time to market, and accelerate biomarker discovery and drug development.

    The intellectual merit of this SBIR Phase I project is to develop a universal peptide isolation kit to serve the diverse needs of the proteomics community.  Currently, methods for sample preparation typically have more than a dozen steps, are prone to peptide loss and bias, and require more than a day to complete.  Through the NSF I-Corps program, it was discovered that more than 70% of researchers in academia and industry are unhappy with current protein sample preparation methods.  To address this need, a sample preparation kit that increases the speed and efficiency of peptide sample preparation was developed. The approach differs from current methods in three fundamental ways.  First, all manipulations will be done in solution in a single tube with half the number of steps compared to existing protocols. Second, a fast, universal, and reversible chemical tag is employed rather than relying on physical separation, preventing sample loss or bias. Third, a stabilized derivative of trypsin will allow for complete digestion of protein samples followed by efficient removal of intact and fragmented trypsin, preventing contamination.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1406 BROWNING RD
  awardeeCity: PITTSBURGH
  awardeeCountryCode: US
  awardeeName: IMPACT PROTEOMICS, LLC
  awardeeStateCode: PA
  awardeeZipCode: '152061738'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843332'
  piEmail: amber.lucas@impactproteomics.com
  piFirstName: Amber
  piLastName: Lucas
  piPhone: '4129532008'
  poName: Ruth Shuman
  date: 12/17/2018
  startDate: 01/01/2019
  expDate: 12/31/2019
  title: 'SBIR Phase I:  Universal Proteome Sample Preparation Kit Development'
- abstractText: |-
    This SBIR Phase I project addresses the problem of assessing blood clotting and associated bleeding and thrombosis risks in neonatal and pediatric patients. Existing coagulation analyzers put these patients at further risk because they cannot operate with low volumes of blood, and because they are less reliable owing to the requirement for test sample contact. This project will develop Acoustic Tweezing Thomboelastometry (ATT) for these patients.  Using only a single acoustically-levitated drop of blood, this non-contact technology platform enables safe and reliable assessment of blood clotting in small children and provides an opportunity for development of newborn screening tests for coagulation abnormalities. This technology is the outcome of NSF funding which has supported the training of several PhD students in biomedical and mechanical engineering.  ATT can reduce side effects for neonatal and pediatric patients by using 1/100th the sample volume required by technologies developed for adult healthcare and improve diagnostic response time for critical care providers by up to 350%. This technology could decrease the cost of blood coagulation analysis by over 30%, thus allowing for patients in the United States to save $2.0 billion annually.

    This SBIR Phase I project develops an innovative technology for non-contact blood coagulation analysis that integrates photo-optical and viscoelastic measurements in a single drop of blood (<6uL in volume).  The essence of the ATT technology is to levitate a small sample in a host fluid (e.g., air) by the acoustic radiation force and measure its physical properties under deformation during levitation.  ATT addresses the issue of high variability and poor standardization of existing coagulation analyzers caused by blood sample contact with artificial surfaces. Due to its noncontact feature and low sample volume requirement, ATT can rapidly (<10 minutes) and reliably assess bleeding/thrombotic risks and is sensitive to temporal changes in shear viscosity and elasticity during blood clotting and fibrinolysis.  In addition, ATT can measure platelet function and assess the functional levels of fibrinogen and other coagulation factors. The goal of this project is to develop a user-friendly minimal marketable product for the market of pediatric coagulation analyzers. This goal will be achieved by meeting the following three objectives: 1) build the user-friendly prototype; 2) develop integrated software for device control, data acquisition, and data analysis; and 3) calibrate the prototype and standardize it for coagulation measurements.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1126 Webster St
  awardeeCity: New Orleans
  awardeeCountryCode: US
  awardeeName: Levisonics Inc.
  awardeeStateCode: LA
  awardeeZipCode: '701180000'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1843479'
  piEmail: kevinluo006@gmail.com
  piFirstName: Daishen
  piLastName: Luo
  piPhone: '4803990213'
  poName: Henry Ahn
  date: 02/12/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'STTR Phase I:  Innovative Platform for Low Volume Blood Coagulation Analysis'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to accelerate the implementation of digital pathology by giving pathologists computational guides to help them achieve higher accuracy and efficiency in making their "calls". Currently biopsy diagnosis is a labor-intensive process that relies upon 19th century microscope technology; pathologists are doctors who use microscopes to make diagnoses. Pathologists examine slides from breast biopsies as part of breast cancer screening programs for more than a million women each year in the US.  This is a highly subjective process and there is evidence that even pathologists may disagree with one another, especially with difficult cases. This is potentially large patient safety issue, as some patients may not be optimally triaged.  It is currently possible to digitize the slides as whole slide images (WSIs), but there are very limited options for computer assisted pathologist review and this is a major reason that the digital pathology market has not developed as rapidly as most experts predicted. This project is a major advance as it addresses a large clinical need ? augmenting pathologists in their ability to make efficient and accurate diagnoses; and it also has great commercial potential as a disruptive, must-have application in the early digital pathology marketplace.

    This Small Business Innovation Research (SBIR) Phase I project will address the issue of accuracy and efficiency of pathologist diagnosis in breast core biopsies, and this should validate our approach as an unmet need in the current digital pathology marketplace. There are other groups applying machine learning to pathology, but this project is a unique approach that addresses practical issues related to expert training of the machine, rapidly displaying targeted images to pathologists, and providing a guiding support while keeping the doctors in control. The project will ask pathologists to label WSIs with their diagnoses; this data will be used to train an AI system; and the AI system performance will be studied. Preliminary studies seem to support that a human and AI system working together will be both more efficient and more accurate than a human working alone. If this expanded project validates this, then there is a tremendous commercial opportunity that can also have a positive impact on patients. Not only access to better diagnoses for patients, but also the possibility for any pathologist to perform at a higher level.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2425 Sidney Street
  awardeeCity: Pittsburgh
  awardeeCountryCode: US
  awardeeName: SpIntellx, Inc.
  awardeeStateCode: PA
  awardeeZipCode: '152032116'
  fundsObligatedAmt: '224999'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843825'
  piEmail: akifburak@gmail.com
  piFirstName: Akif
  piLastName: Tosun
  piMiddeInitial: B
  piPhone: '4123781816'
  poName: Peter Atherton
  date: 02/08/2019
  startDate: 02/15/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  HistoMapr-Breast: Computational diagnostic guides for breast
    pathologies'
- abstractText: "This Small Technology Transfer Phase I project will realize a sensorized
    soft robotic hand exoskeleton coupled with an interactive 3D virtual reality (VR)
    gaming environment that provides fine motor training for stroke patients' hands.
    There is a currently a lack of available devices that provide fine sensory and
    motor training of the hand. The potential benefit is to fill this niche market
    opportunity, especially when considering the high incidence of hand disability
    due to stroke and other neuromusculoskeletal injuries. This system can provide
    structured therapy sessions which requires minimal therapist supervision while
    improving patient engagement which enhances the broader participation. As a complimentary
    technology for current rehabilitation practice, it has a potential to lower health
    care and labor costs associated with neurological rehabilitation. The outpatient
    physical rehabilitation market is a $30 billion industry growing at a rate of
    7% in the US, mainly due to the growing elderly population. The robot-assisted
    rehabilitation market is expected to grow dramatically, reaching $2 billion by
    2020. As robot-assisted treatment becomes widely available, the customer base
    will grow from acute care clinics to long-term rehabilitation centers and finally
    to home-based care. \n\nThe intellectual merit of this project results from the
    combination of a soft robotic system with fine motor control synced to VR games
    for both sensory and motor stimuli. The robotic exoskeleton provides individual
    joint control to practice complex grasping while the VR environment provides targeted
    rehabilitation games. This system addresses the fine motor control needs that
    have not been met by current hand rehabilitation devices, which only offer gross
    motions. Adaptive algorithms will adjust to the patient's level of ability to
    accomplish the assigned tasks in virtual game scenarios, providing accessibility
    for a wide range of population with different levels of severity. There are three
    main goals for the project. First, we will develop a VR environment simulating
    real-world hand motion via interaction with objects in an immersive game. Second,
    we will develop adaptive control algorithms for the soft robotic exoskeleton to
    provide active assistive motion in performing rehabilitation-oriented tasks in
    the VR environment. Third, a pilot study will be conducted with both healthy individuals
    and hand-impaired stroke patients. The Phase I project will produce a system with
    assistive hand motion in a targeted rehabilitation virtual game environment, which
    can be tested for efficacy in a larger clinical population of stroke survivors.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 6913 CAMP BOWIE BLVD STE 173
  awardeeCity: FORT WORTH
  awardeeCountryCode: US
  awardeeName: NEUROLOGICAL REHABILITATION VIRTUAL REALITY, L.L.C.
  awardeeStateCode: TX
  awardeeZipCode: '761167169'
  fundsObligatedAmt: '224893'
  fundProgramName: STTR PHASE I
  id: '1843880'
  piEmail: veenasomareddy@neurorehabvr.com
  piFirstName: Veena
  piLastName: Somareddy
  piPhone: '9404358774'
  poName: Benaiah Schrag
  date: 02/06/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'STTR Phase I:  Motion Assisted Hand Exoskeleton with Virtual Reality (MAVHEXO)
    for Post Stroke Rehabilitation'
- abstractText: |-
    The broader impact/commercial potential of this Small Technology Transfer Research (STTR) Phase I project lays in its ability to enable reconfigurable hardware acceleration in the Internet-of-Things (IoT). Users under constrained power at the edge will be able to choose a new solution that can bring acceleration, and enable datacenter like capabilities, and benefit from the IoT's long-sought promise.  Using Resistive Random-Access Memory (RRAM) to develop a next-generation Field Programmable Gate Array (FPGA), increasing performance while reducing energy consumption at the sensor node level, is possible. As already experienced in our data driven world, it is critical that we improve our computing capabilities at the edge in order to gain in responsiveness and increase our energy efficiency. With evermore data and performance requirements to deliver on the consumer demands, innovative uses of emerging memories are showing great promise and providing capabilities that will help fulfill the IoT's potential. If fulfilled, this technology has the potential to enable a whole set of data driven applications at the edge, such as low-energy image recognition and learning in drones to operate longer and more effectively or long-lasting medical implants with leading data aggregation and reactiveness.

    This Small Technology Transfer Research (STTR) Phase I project will aim to commercialize a patented technology to realize a ultra-low-power Field Programmable Gate Array (FPGA) based on Resistive Random-Access Memory (RRAM). To handle the data explosion in Internet of Things (IoT) network, the industry is moving towards increasing intelligent analysis capability for single IoT devices. Tight power budget has become a critical road block: high-end solutions, such as multicore CPUs, GPUs, can provide enough computing capability but fail to meet the power budget, while low-power commercial products, such as micro-controllers and low-power FPGAs, can satisfy power constraints but hardly follow the increasing complexity in data analysis algorithms. This project aims to develop a ultra-low-power FPGA that can offer high-performance data analysis capability under IoT-level power limits. This project will prototype a FPGA chip built around an innovative RRAM-based routing multiplexer design. We will also release an associated software tool suite to support the implementation of customer's applications on the technology. Compared to existing commercial solutions, the proposed FPGA product is expected to demonstrate similar computing capability as high-end FPGA solutions while satisfying an IoT power budget (<1W).

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 4803 S Oak Terrace Drive
  awardeeCity: Salt Lake City
  awardeeCountryCode: US
  awardeeName: ReRouting, LLC
  awardeeStateCode: UT
  awardeeZipCode: '841245644'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1843216'
  piEmail: contact@reroutingllc.com
  piFirstName: Nathan
  piLastName: Chetrit
  piPhone: '8019889896'
  poName: Rick Schwerdtfeger
  date: 02/05/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'STTR Phase I:  Enhancing IoT''s Connected Device Capabilities using High-Performance
    Low-Power RRAM-based FPGAs'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to enable the development of monolithic 3D integration of carbon nanotube (CNT) computing in conjunction with silicon nanoelectronics. The value of nanoelectronics utilizing silicon integrated with CNT has been shown to have immense potential through various academic studies. However, the transition of this technology from academia to industry has been stymied by lack of CNT material that meets the manufacturing requirements particularly in terms of alignment, purity, and compatibility to be properly explored. Monolithic 3D integration will enable game-changing levels of improvement to computing speed and power efficiency, creating better computing for all. Providing a material which accelerates research and development for improved computing will create a game changing impact on the $500B integrated circuit market and potentially create billions of dollars in revenue. This project is focused on the needs of the nanoelectronics industry because of the impact possible in that market, but other markets such as biosensing or flexible electronics would benefit from the same materials and often at relaxed specifications.

    This Small Business Innovation Research Phase I project will greatly expand the utilization of carbon nanotubes (CNTs) in nanoelectronics by making industrially relevant material available. This will allow application oriented nanoelectronics teams to move forward with R&D projects. Further, the project's work on the fundamentals of aligned CNT growth and purification will benefit the CNT materials community by the extension of the material into commercial manufacturing. The research objectives are on two fronts: 1) growth of CMOS compatible aligned CNTs and 2) purification of aligned CNTs. Growth of highly aligned CNT populations has typically utilized catalysts which are not compatible with front end of line CMOS fabrication, hindering the use of material in conjunction with Si integrated circuits. Current methods of CNT purification to remove metallic CNTs suffer from either destroying the critical CNT alignment, utilization of non-CMOS compatible materials, or the need of extensive post-processing. This project will develop a growth process and a purification process that preserves alignment while maintaining CMOS compatibility and utilizes wafer scale batch processes that allow high throughput manufacturing. The purification scheme is a proprietary method which must be characterized and refined to meet the exacting purification standards of 99.99% semiconducting CNTs or better.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2517 SEDLAK CT
  awardeeCity: SAN JOSE
  awardeeCountryCode: US
  awardeeName: ALIGNED CARBON INC.
  awardeeStateCode: CA
  awardeeZipCode: '951482514'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1844111'
  piEmail: jprovine@alignedcarbon.com
  piFirstName: John
  piLastName: Provine
  piPhone: '6506449403'
  poName: Linda Molnar
  date: 02/01/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Manufacturable Growth And Purification Of Aligned, Semiconducting
    Carbon Nanotubes'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is the development of advanced X-ray imaging,
    high-energy X-ray grating-based interferometry, systems for nondestructive evaluation
    of additive manufacturing components. The image quality of the high-energy, X-ray
    grating-based interferometry imaging system will be advantageous for detecting
    critical size flaws \non flight critical aerospace components, such as turbine
    components, and medical devices such as customized hip cups. Interferometry radiography
    is capable of detection of sub-micron to micron voids at a rate faster than conventional
    industrial X-ray CT scanning. Imaging speed and quality is important; some flight
    critical components face a reject rate of 10% based on the current X-ray CT scans.
    \ The goal of better image quality is feedback into the additive manufacturing
    print parameters so as to increase part yield and reliability. \n\nThis Small
    Business Innovation Research (SBIR) Phase I project will be the first to commercialize
    high-energy, X-ray grating interferometry in the US.  The interferometry concepts
    for this proposal are novel and have been partly derived from the NSF-supported
    gravity wave detection facility, the Laser Interferometry Gravitational-wave Observatory
    (LIGO), which led to a hardware/software patent for high-energy X-ray grating
    optics and software. The microfabricated gold and/or nickel structures on silicon
    or graphite wafers have exceedingly high aspect ratios, requiring the use of support
    structures for physical stability of the microfabricated features.  The support
    structures introduce image noise and diminished interferometry performance.  The
    LIGO-derived procedure accommodates the support structures, restoring image quality
    and instrument performance.  The support structures are especially important for
    optics used with high-energy X-rays, such as systems designed for inspection of
    additive manufacturing metal components\n\nThis award reflects NSF's statutory
    mission and has been deemed worthy of support through evaluation using the Foundation's
    intellectual merit and broader impacts review criteria."
  awardeeAddress: 17901 INVERNESS AVE
  awardeeCity: BATON ROUGE
  awardeeCountryCode: US
  awardeeName: REFINED IMAGING, LLC
  awardeeStateCode: LA
  awardeeZipCode: '708105978'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843347'
  piEmail: mvincent@refinedimagingllc.com
  piFirstName: Michael
  piLastName: Vincent
  piMiddeInitial: D
  piPhone: '3378498349'
  poName: Linda Molnar
  date: 02/01/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  High-Energy X-ray Gratings for Nondestructive Evaluation'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will result from the development of quantum computers that will impact many technologies by enabling, for example, molecular simulations for drug design and catalyst development for energy applications, quantum machine learning, and solving optimization problems such as scheduling. Scalable, universal quantum computing promises to be one of the most transformative technologies of the modern era. The range of applications are broad and will only expand with the development of new quantum algorithms, with one of the biggest opportunities being molecular simulations for the chemical and pharmaceutical industries. For example, despite being a multi-billion dollar industry, computational drug discovery is limited by the approximations necessary to make calculations tractable for classical computers. In order to perform these simulations at a scale useful for commercial applications, qubit numbers must be increased several orders of magnitude beyond the state of the art. The proposed innovation of trapping and individual control of neutral atoms will, if successful, enable quantum computers to scale to the thousands of qubits needed for error-corrected, universal quantum computing.

    This Small Business Innovation Research Phase I project will develop technology for scalable trapping and addressing of neutral atom qubits through dynamic, parallelized optical trapping and individual addressing of alkaline earth qubits. Neutral atoms are an emerging platform for quantum computing and the majority of work thus far has been directed towards alkali atoms (i.e., those with a single valence electron). Alkaline earth atoms have two valence electrons and correspondingly a richer energy level structure, which has demonstrated very long trapped coherence times.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 11250 SUN VALLEY DR
  awardeeCity: OAKLAND
  awardeeCountryCode: US
  awardeeName: ATOM COMPUTING INC.
  awardeeStateCode: CA
  awardeeZipCode: '946055736'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843926'
  piEmail: jonathan@atom-computing.com
  piFirstName: Jonathan
  piLastName: King
  piPhone: '7857700088'
  poName: Peter Atherton
  date: 02/01/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Spatially Modulated Light For Trapping And Addressing Of
    Alkaline-Earth Neutral Atom Qubits'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be to make organizations more productive by helping them organize operational data in a structured yet accessible way. Today, organizations tend to accumulate such data in spreadsheets, scattered across users and folders, with new copies and revisions being made every time data must be presented, summarized, or integrated in a new way. This leads to tedious cut-and-paste workflows, costly errors, and a lack of reliable information for decision support. This project proposes a general-purpose software solution, based on a recently developed method for interactive database visualization. The system's novelty is in the ease and flexibility with which data can be queried and laid out on the screen, covering a large range of use cases that would previously require custom programming. Applications can be found in all manner of organizations: corporations, non-profits, higher education, science, healthcare, journalism, disaster response, the military, public administration, and so on.

    This Small Business Innovation Research (SBIR) Phase I project will develop a general-purpose, user-friendly software product that individuals within an organization can use to store and share structured data along with the various data displays through which said data is viewed, queried, and edited. Such data displays could include arbitrary database queries, visualizations such as crosstabs, calendars, and bar charts, as well as non-tabular multi-query visualizations such as forms, dashboards, and hierarchical reports. Using the proposed software, organizations can decrease time spent on administrative and managerial tasks, improve the use of data in decision-making, and, in many cases, eliminate yearlong internal software development projects.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 4540 MACARTHUR BLVD NW APT 309
  awardeeCity: WASHINGTON
  awardeeCountryCode: US
  awardeeName: ULTORG LLC
  awardeeStateCode: DC
  awardeeZipCode: '200074230'
  fundsObligatedAmt: '224995'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843774'
  piEmail: ebakke@ultorg.com
  piFirstName: Eirik
  piLastName: Bakke
  piPhone: '6172187740'
  poName: Peter Atherton
  date: 02/01/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  General-Purpose Software for Collaborative End-User Database
    Management'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to enable emergency managers, first responders, and elected officials across the country to increase community resilience in disaster to save countless lives, save key critical infrastructure, and save the environment from otherwise catastrophic outcomes during disasters, some of which continue to increase in frequency and severity.  It will allow for significant advances in protecting our society's most vulnerable populations in disaster.

    This Small Business Innovation Research (SBIR) Phase I project develop a platform to integrate, interpret, and organize a multitude of relevant data sources in order to deliver actionable insights to those responsible for intervention before, during, and after disaster. This project will enable a fully integrated, dynamic web-based tool capable of generating estimated and real-time results for a broad set of hazards across the nation down to the neighborhood level granularity. As a real-time, dynamic tool, it will operationalize population vulnerability data and provide forward-leaning decision support and actionable intelligence to first responders, emergency managers, and elected officials that will save lives by identifying those populations with the greatest needs and highest risk during a disaster.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 9668 E 28TH AVE
  awardeeCity: DENVER
  awardeeCountryCode: US
  awardeeName: GEOSPIZA, INC.
  awardeeStateCode: CO
  awardeeZipCode: '802382990'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843098'
  piEmail: sarah@geospiza.us
  piFirstName: Sarah
  piLastName: Tuneberg
  piPhone: '6462752726'
  poName: Muralidharan Nair
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I: Increasing community resilience through actionable data and
    analytics'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Technology Transfer Phase I project are its two intended contributions: it will advance computer vision for navigation and it will create unprecedented opportunity and independence for individuals with visual impairment. 253 million people with blindness or visual impairment around the world experience difficulty to independently navigate in new spaces. The lack of independence directly leads to disadvantages in getting education and joining the workforce. This project, NavigAid,  is aimed at creating a breakthrough spatial intelligence aid offered as a mobile application which will solve spatial tasks from locating objects to identifying paths of navigation, and to generating rich descriptions of the surroundings. Solving this problem will unlock an estimated direct economic benefit of $26B  annually for people with visual impairment around the world, by decreasing the need for human assistance. The main technological innovation of this project, Ally Networks, is a novel neural network architecture that can learn more robust representations than existing models are able to. The robust representations prevent the networks from making mistakes and make them more operable and useful in situations that need high reliability. Ally Networks thus represent a potential breakthrough to the field of computer-vision navigation.


    This Small Business Technology Transfer Phase I project will introduce a novel spatial intelligence system, NavigAid, to assist individuals with visual impairment in crucial navigation tasks. NavigAid will generate contextually relevant, task-oriented spatial information from smartphone cameras. With NavigAid, users will be able to navigate independently in unfamiliar, complex environments, thus achieving unprecedented mobility. NavigAid will advance assistive technologies by providing unprecedented services, such as locating objects and generating functionally relevant natural language descriptions of complex environments. The core innovation in this project is Ally Networks, a novel neural network architecture that learns robust spatial semantics rather than 2-dimensional representations. This unique multimodal learning strategy is a high-risk endeavour, with broad impact if successful. Large-scale multimodal learning is difficult, and our technique?s success will revolutionize the state of the art: neural network vision will transform from systems that fail in inscrutable ways, to systems that never fail under circumstances in which human vision would not also fail. Key objectives of this project are to 1) develop and validate Ally Networks on benchmarks, 2) develop spatial problem solvers that address the most pressing needs of users with visual impairment, and 3) develop a test suite to evaluate the spatial problem solvers.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 16A IVALOO ST
  awardeeCity: SOMERVILLE
  awardeeCountryCode: US
  awardeeName: VIRTUAL COLLABORATION RESEARCH INC.
  awardeeStateCode: MA
  awardeeZipCode: 021433608
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1843464'
  piEmail: zaman@mit.edu
  piFirstName: Cagri
  piLastName: Zaman
  piMiddeInitial: H
  piPhone: '6178407145'
  poName: Peter Atherton
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 09/30/2019
  title: 'STTR Phase I:  Spatial Artificial Intelligence System for the Visually Impaired
    (NavigAid)'
- abstractText: "This SBIR Phase I project seeks to address the lack of approved device
    therapies available for the almost 4 million patients in the U.S. who suffer from
    diastolic heart failure (DHF) - a disease for which the potential market is estimated
    to be approximately $5B worldwide. In DHF, the chambers of the heart become stiff
    and cannot relax completely, reducing the amount with which they fill with blood
    and thus reducing the amount of blood pumped by the heart during each cardiac
    cycle. The only evidence-based therapy to treat DHF is to manage blood pressure
    pharmacologically, and treat associated complications. DHF is a major cause of
    hospital admissions and has poor patient outcomes, without any discernable improvement
    over the last two decades. Thus, there is a strong need for an effective device
    solution that can alleviate the symptoms associated with DHF while improving patient
    outcomes, as well as further fundamental understanding of the key factors and
    mechanisms that lead to DHF. \n\nThis project is focused on the development of
    a non-blood contacting biventricular diastolic recoil device for the treatment
    of patients with heart failure with preserved ejection fraction (HFpEF), also
    referred to as diastolic heart failure (DHF). The proposed device will provide
    a patented minimally invasive, non-blood contacting approach to mitigate the symptoms
    associated with HFpEF, addressing a large unmet need in a market which currently
    lacks any approved device therapies. Primary goals of this Phase I project include
    investigating variations in device design, functionality, and mechanical properties
    in pilot animal studies in order to optimize augmentation of cardiac function
    and hemodynamics, as well as the development of an accelerated fatigue test apparatus
    to test the durability of the device components. The commercialization effort
    in bringing this novel device to market will address the largely unmet need for
    the millions of Americans who suffer from DHF by alleviating symptoms, significantly
    increasing quality of life, and reducing morbidity and mortality.\n\nThis award
    reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 2450 Holcombe Blvd., Suite J
  awardeeCity: Houston
  awardeeCountryCode: US
  awardeeName: CorInnova Incorporated
  awardeeStateCode: TX
  awardeeZipCode: '770212041'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843901'
  piEmail: christina.bolch@corinnova.com
  piFirstName: Christina
  piLastName: Bolch
  piMiddeInitial: M
  piPhone: '2814336791'
  poName: Henry Ahn
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Non-blood contacting, less invasive device for restoration
    of ventricular diastolic recoil'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to improve the productivity and environmental sustainability of soybean cultivation. Soybean is the most widely grown crop in the United States with nearly 90 million acres under cultivation. Soybean is a key part of the food system and generates $22 billion in export revenue each year. One of the greatest threats to soybean production is the fungal pathogen known as Asian Soybean Rust. Current commercial soybean varieties have no resistance to this pathogen and over $2 billion is spent annually on fungicides to control this disease. While soybean is highly susceptible to this disease, many wild plant species have natural resistance to this pathogen. This project seeks to identify the naturally occurring mechanisms of disease resistance in wild plant species that can be used to develop disease-resistant soybean varieties. Adoption of these varieties is expected to bring more than $4 billion in value to the soybean industry while improving productivity and reducing fungicide use.

    The intellectual merit of this SBIR Phase I project is to identify plant immune receptor proteins that confer disease resistance to Asian Soybean Rust, which is caused by the fungal pathogen Phakopsora pachyrhizi. A key determinant of whether or not a plant is resistant to a particular pathogen is whether the plant has an appropriate immune receptor protein capable of recognizing the presence of the invading pathogen. Once activated, plant immune receptors trigger plant defense responses that typically result in immunity. This project will use reverse genetic and biochemical approaches to identify plant immune receptor proteins that confer resistance to Asian Soybean Rust. Preliminary work identified several molecules from Phakopsora that elicit an immune response in non-host plant species. The goal is to identify the cognate immune receptors and test them for sufficiency to enable immune activation in response to Asian Soybean Rust elicitor molecules. This research will enable future work to the development soybean varieties with resistance to Asian Soybean Rust.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 663 Colusa Ave
  awardeeCity: Berkeley
  awardeeCountryCode: US
  awardeeName: Fortiphyte, Inc.
  awardeeStateCode: CA
  awardeeZipCode: '947071517'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1844088'
  piEmail: alex.schultink@gmail.com
  piFirstName: Alex
  piLastName: Schultink
  piPhone: '5174202955'
  poName: Ruth Shuman
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Identification of disease resistance traits to improve the
    productivity and sustainability of soybean cultivation'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the creation of new fluorescent materials that will provide new color technologies to the paint, polymer, and ink industries. These new materials will overcome the undesirable properties of commercial fluorescent pigments, like a tendency to rapidly fade, give weak color strength, and degrade during processing. Besides giving fabrics, packaging, and toys bright, attractive colors, improvements to fluorescent pigments could change several parts of daily life: Brighter paints and signs could improve road and airport safety. Product designers for next-generation consumer electronics will have a new color palette for their newest gadget. Agricultural scientists would have a new tool to study crop treatments. As a result, success in this research project has the potential to claim a share of the multi-billion dollar colorant market, disrupt expectations around fluorescent pigments, bring new products to consumers, and create high-tech jobs. In addition, this project leverages collaboration with academic partners, supporting science and entrepreneurship education of university students and postdoctoral fellows.

    This Small Business Innovation Research (SBIR) Phase I project provides a revolutionary solution to a problem that has haunted chemistry for more than 150 years. Existing fluorescent materials are formulated with pigments that have thinly dispersed colorants, which dilutes their color and makes them susceptible to degradation. This is done by necessity, because fluorescent dyes have a tendency to aggregate, causing unwanted color changes and loss of the fluorescence effect. This solution utilizes a bottom-up "self-assembly" strategy to eliminate aggregation and create stable fluorescent solids that maximize the longevity and boldness of the color. This research will study this novel class of fluorescent pigment to gauge its resistance to fading, improved chromaticity, and material performance in realistic conditions. This will be done by measuring changes to fluorescence intensity and color appearance under natural and laboratory-accelerated weathering conditions, and creating test "products" in the form of paints and polymers. These test materials are expected to have stronger color for longer periods of time while still being amenable to commercial processing techniques. In addition, this project is an opportunity to study the behavior of self-assembling materials inside polymer formulations, which is a new research area with broad scientific and commercial potential.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3519 E MORNINGSIDE DR
  awardeeCity: BLOOMINGTON
  awardeeCountryCode: US
  awardeeName: STAR VOLTAIC LLC
  awardeeStateCode: IN
  awardeeZipCode: '474084333'
  fundsObligatedAmt: '224933'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843202'
  piEmail: crbenson6@gmail.com
  piFirstName: Christoper
  piLastName: Benson
  piMiddeInitial: R
  piPhone: '8122724023'
  poName: Linda Molnar
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Bright and Lightfast Fluorescent Pigments for Paints, Polymers
    and Inks'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will enable Fortify to provide U.S. manufacturers with a disruptive manufacturing technology to create low-volume tooling parts with order of magnitude reductions in lead times and part price. U.S. manufacturers rely on prototype and low-volume production parts that are currently produced using aluminum soft tooling that need to be precision machined. Prices for these small run parts can reach USD $10,000 or more per tool, depending on complexity, with lead times extending weeks or months. This results in high unit costs when parts are produced in low volumes. Industry data suggests the market for outsourced prototype and low volume injection molded parts with physical dimensions serviceable by Fortify technology may be as large as USD $2.7 Billion.

    This Small Business Innovation Research Phase I project will enable Fortify to create a thermal competitive advantage to enable customer discovery in the field of low-volume injection molding tooling. Despite the noise in the field of 3D printing, disrupting the injection molding tooling industry has remained elusive due to the lasting need for high strength, thermal stability, fatigue resistance, and smooth mold finish in 3D printed molds. Fortify is uniquely positioned to address these technical challenges by leveraging novel materials, patented manufacturing hardware, and proprietary manufacturing software. Fortify prints ceramic-filled, high-temperature resins that are locally textured by magnetic fields in customized magnetic printers to produce optimum ceramic microstructures designed by Fortify's INFORM software to maximize the thermomechanical performance of the printed parts.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 21 Drydock Ave
  awardeeCity: Boston
  awardeeCountryCode: US
  awardeeName: 3DFortify Inc.
  awardeeStateCode: MA
  awardeeZipCode: '022104501'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843035'
  piEmail: josh@3dfortify.com
  piFirstName: Joshua
  piLastName: Martin
  piPhone: '7322454321'
  poName: Linda Molnar
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  3D Printing of Thermally Stable Composites for Injection
    Molding Tooling'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is the development of a new generation of machine learning/artificial intelligence tools for improving the efficiency and effectiveness of wastewater treatment systems. Over $160 billion is spent on sewer fees in the U.S., with year-to-year costs increasing by over 5% for many users. Even with the significant resources spent on wastewater treatment, 3 to 10 billion gallons of untreated sewage are still released from US wastewater treatment plants each year. Development of technologies leveraging machine learning and artificial intelligence to better manage complex biological and chemical processes will not only have a major impact on the $91 billion wastewater treatment system control market, but on other biochemical-dependent industries as well. In addition to reducing the societal financial burden associated with wastewater treatment, this technology will improve the sustainability of the infrastructure and will limit the environmental impact of human activities. Wastewater operators will be able to utilize this technology's real-time decision-making software to significantly reduce their municipal facility operating costs and decrease environmental pollution caused by non-compliance and overflows.


    This SBIR Phase I project proposes to develop real-time software for assisting wastewater treatment operators with decision-making for improved efficiency and effectiveness. Existing commercial simulation solutions for control and monitoring do not accurately reflect actual treatment plant behavior, do not model biological processes, do not require extensive configuration to be used, and do not respond rapidly to changes in plant performance. This project improves upon current approaches by linking biological components of the wastewater treatment plant with historical data using machine learning techniques. Phase I research will focus on development of: 1) an influent flow/composition model allowing accurate model inputs; 2) a full-scale hybrid model combining physical process and machine-learning bioprocess modules able to accurately predict plant effluent flow and quality, and; 3) a software platform to manage the model processes. The technical approach will focus on balancing the complexity of incorporating large-scale genomic data as part of a non-linear treatment process while ensuring high accuracy and maintaining model stability. Anticipated technical results will provide waste operators a software product that develops full-scale treatment plant models in real-time, using historical and current plant data, enabling significantly improved operational decision-making.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3830 NW BOXWOOD DR
  awardeeCity: CORVALLIS
  awardeeCountryCode: US
  awardeeName: MAIA ANALYTICA LLC
  awardeeStateCode: OR
  awardeeZipCode: '973303350'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843020'
  piEmail: lesnikk@oregonstate.edu
  piFirstName: Keaton
  piLastName: Lesnik
  piMiddeInitial: L
  piPhone: '6198959992'
  poName: Anna Brady-Estevez
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 09/30/2019
  title: 'SBIR Phase I:  Real-Time Decision Making Software for Wastewater Treatment
    Operators'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project pertains to the novel production of short-fiber reinforced thermoplastic material applicable to a range of processes, with the added benefit of utilizing  high quality, low cost recycled or recovered fibers. The beachhead application is in a powder-based additive manufacturing system capable of mid-scale manufacturing that can bridge between prototype-stage and capital-intensive injection molded economy-of-scale manufacturing. Such systems can be located in regional production hubs to accelerate new or highly-customizable products to market. The inclusion of the proposed additives in these systems will expand the range of end-product material properties available, and thereby expand the potential client pool for the same platform. Anticipated flow properties of the material will position it as an accessible additive option for other 3D printing technologies as well as the much larger-market of injection molding processing.

    This Small Business Innovation Research (SBIR) Phase I project adapts a processing technology that is yet untapped for this application, to produce a composite thermoplastic additive for polymeric powder feedstock 3D printing. This additive is expected to increase stiffness, strength, and thermal stability of the end product, while reducing weight and providing superior handling characteristics during production relative to existing alternatives. The project is focused on identifying process conditions required to produce a nominally conforming product, followed by testing that characterizes the material and handling properties. Results of these tests will be compared against acceptance standards published by the beachhead additive manufacturing system supplier in preparation for inclusion into 3D printed test components.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 751 Pine Ridge Road
  awardeeCity: Golden
  awardeeCountryCode: US
  awardeeName: Vartega Inc.
  awardeeStateCode: CO
  awardeeZipCode: '804038052'
  fundsObligatedAmt: '224998'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843430'
  piEmail: alice.havill@vartega.com
  piFirstName: Alice
  piLastName: Havill
  piPhone: '6302174966'
  poName: Linda Molnar
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Carbon Fiber Encapsulated Polymer Powder for Additive Manufacturing
    Advancements'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be the development of a coating product with superior durability and antifouling performance in the targeted environmental-friendly marine coating market. This innovative solution requires a less frequent application and reduces the amount of subaquatic growth on the hull of ships and static objects in bodies of water. Potential economic benefits include improving fuel efficiency and saving the maintenance cost of ships and static marine structures. At the same time, this product provides enormous environmental benefits by reducing the greenhouse gas emission from cargo ships and avoiding the potential species invasion caused by current marine coatings. In particular, this product is the first non-biocide environmentally friendly product of its kind. It addresses the current and future needs highlighted by global regulations to replace the existing harmful biocide-leaching coatings with an eco-friendly solution.

    This Small Business Innovation Research (SBIR) Phase I project aims to develop and commercialize a novel marine coating product to deliver a high-performing eco-friendly antifouling solution that is currently lacking in the marketplace. Current self-polishing coating products were subject to increasing regulatory restriction, while alternative environmental-friendly option such as fouling-release coating suffered low antifouling performance. This novel coating technology potentially achieves the durability and high antifouling performance for targeted marine applications, and the eco-friendly feature without leaching biocide into the aqueous environment. The objective of this project is to explore the key fabrication factors in coating formulation and identify their impacts on the coating stability and antifouling performance. Critical knowledge will be obtained enables the development of prototype product showing year-long reliability and top marine antifouling function.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2222 W Grand River Ave Ste A
  awardeeCity: Okemos
  awardeeCountryCode: US
  awardeeName: Repela Tech, LLC
  awardeeStateCode: MI
  awardeeZipCode: '488641604'
  fundsObligatedAmt: '224998'
  fundProgramName: STTR PHASE I
  id: '1843790'
  piEmail: schaefer.evan@gmail.com
  piFirstName: Evan
  piLastName: Schaefer
  piPhone: '9896002169'
  poName: Linda Molnar
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'STTR Phase I:  Next Generation Of Environmental-Friendly Marine Coating
    With Superior Durability And Antifouling Performance'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is to develop a novel web application for faster and more
    accurate estimation of important physical and chemical properties of materials
    used by engineers and scientists from various academic and industrial disciplines.
    Oil and gas, mining, nuclear waste management, and environmental consulting companies
    can use this tool to acquire critical information which are esential to: estimate
    the oil and gas production rates under different hydraulic fracturing and enhanced
    oil recovery strategies, minimize the risk of groundwater contamination by acid
    mine drainage, asses the safety of cement-based engineered barrier systems in
    nuclear waste repositories, and design the efficient treatment and remediation
    strategies for contaminated sites. It can also provide necessary parameters for
    analyzing the long-term effects of geothermal energy usage, evaluating nutrient
    cycling and pesticide contamination in soil systems in agriculture and food production
    industry, and quantifying the uncertainties associated with carbon dioxide geological
    sequestration and storage. \n\nThis SBIR Phase I project proposes to develop a
    cloud-based application which will use novel machine learning algorithms and deep
    learning image processing techniques to turn large volumes of data into valuable
    parameters used by various industries in their decision-making process.  Built
    on artificial neural network models, minimum viable product version of the new
    application will target the oil and gas market. It will offer a state-of-the-art
    data-driven module for early adopters including special core analysis (SCAL) service
    providers, exploration and production companies, and chemical product suppliers.
    The customized application will introduce a more computationally-efficient alternative
    to SCAL and digital rock technology field (i.e. combined physics-based and imaging
    paradigm) and will accelerate the forecasting process of rock properties. Initially,
    users will be able to calculate one of the most critical properties of the reservoir
    rock, i.e. permeability. Customizing machine learning algorithms developed in
    Phase I for rock permeability estimation to other industries will facilitate entering
    into other markets. Built on Amazon?s AWS cloud service, it will offer a flexible,
    computationally-scalable, on-demand and cost-effective solution to the customers
    by decreasing the upfront and maintenance costs of hardware and software.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 1625 MAIN ST APT 1310
  awardeeCity: HOUSTON
  awardeeCountryCode: US
  awardeeName: AquaNRG Consulting Inc.
  awardeeStateCode: TX
  awardeeZipCode: '770027545'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1841740'
  piEmail: babak.shafei@AquaNRGconsulting.com
  piFirstName: Babak
  piLastName: Shafei
  piPhone: '4045795238'
  poName: Anna Brady-Estevez
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 08/31/2019
  title: 'SBIR Phase I: Data-Driven Module for Prediction of Materials Physical-Chemical
    Properties Using Machine Learning'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will lead to broader adoption of newer medical technologies and increased revenue for medical device companies, decreased training costs, and decreased liability from misuse or lack of appropriate training on medical devices. Research has shown that surgical skill is directly related to a variety of patient outcomes, yet there are few tools that can reliably and affordably measure surgical proficiency. Providing objective measurements of surgical proficiency is not enough; the assessment method must also identify areas of difficulty during a task to improve the surgeon's future performance. The proposed innovation is an objective and scalable way to measure procedural competency using head and hand motion-tracking data collected in a surgical simulation and applying novel, deep-learning algorithms to the analysis. By providing surgeons with real-time feedback during training, this project will allow surgeons to rapidly improve training on specialized devices, thus leading to wider adoption of new technology. Adoption of this surgical assessment platform in medical schools and operating rooms across the country will enable an objective assessment of surgical proficiency, thus reducing training time and costs and lowering risk of medical error due to underdeveloped skills.

    This Small Business Innovation Research (SBIR) Phase I project seeks to develop an innovative, deep-learning Surgical Training and Assessment Platform to increase the commercial viability of a Virtual Reality (VR) surgical training program. VR surgical training technology holds enormous potential in improving the efficiency of learning by allowing for unlimited practice and rehearsal of surgical procedures; however, without the ability to reliably assess performance, such platforms cannot be used to their full potential. This application will translate the simulation environment into a vehicle for technical skills assessment to prevent trainees from graduating to independent practice without first proving competency in critical areas. The novel, proprietary software algorithms developed in this proposal will allow for the above applications and broad improvements to training efficiency and patient safety through the tracking and analysis of hand and head motion as a surrogate measure for surgical expertise. The Surgeon Assessment Platform will be developed by determining the most vital head and hand motion data to collect and validating the resulting assessment dataset in a small proof-of-concept study, while meeting the challenge of collecting, storing, and analyzing such a large, high-fidelity dataset.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2806 SAN ARDO WAY
  awardeeCity: BELMONT
  awardeeCountryCode: US
  awardeeName: OSSO VR INC
  awardeeStateCode: CA
  awardeeZipCode: '940021342'
  fundsObligatedAmt: '222596'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843983'
  piEmail: jhbarad@ossovr.com
  piFirstName: Justin
  piLastName: Barad
  piPhone: '3107098289'
  poName: Muralidharan Nair
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Proposal For The Assessment Of The Feasibility Of An Objective
    Surgeon Assessment Platform.'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to offers a way for semiconductor chip fabricators to extend Moore's Law and simultaneously allowing them to reduce costs in consumables and scrap wafers that have been damaged during polishing. Currently chip fabricators are challenged to continue Moore's Law due to the complexity and scale down sizes of semiconductor device structures. Improved computer chip performance is critical to countless applications as computers,mobile phones, tablets, and Internet of Thing have become ubiquitous in everyday life.

    This Small Business Innovation Research Phase I project will address the challenges which the semiconductor industry faces trying to move beyond 14 nm technologies by using Chemical Mechanical Planarization. Polishing pads are used to planarize wafer surface for multilayer stack integration. Conventional polishing pad technology has randomly distributed micro pores that lead to non-uniform polishing and scratched due to stress concentration on asperities with less than 1% real contact area. Additionally, conventional pads require a pad conditioning process to re-generate pad surface. This project proposes engineering micro features on the pad surface using micro fabrication technologies. In addition, the real contact area between the pad and wafer will be controllable increasing to 5-10 percent of the total pad-wafer contact. This will make the polishing performance more precise and consistent. The micro features are designed to retain polishing slurry longer so to increase the number of active slurry abrasives for polishing. The contact area and feature design will be tunable to specific polishing performance requirements per customer applications. The independent multi-body structure of a hard top-pad with a soft sub-pad will increase the conformity of the pad and distribute the pressure from polishing evenly across the pad surface. This will significantly improve the chip-level planarization and wafer-level uniformity, as well as reducing the pad wear during polishing.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 14 MALLARD DR
  awardeeCity: REXFORD
  awardeeCountryCode: US
  awardeeName: SMART PAD LLC
  awardeeStateCode: NY
  awardeeZipCode: '121481516'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843578'
  piEmail: gooyoun10@hotmail.com
  piFirstName: Goo Youn
  piLastName: Kim
  piPhone: '3023338025'
  poName: Rick Schwerdtfeger
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Chemical Mechanical Planarization pad with controlled micro
    features for sub 7nm semiconductor technology'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the reinvention of community wellness programming from a typically qualitative process into an evidence-based procedure. Treating wellness as a science will allow for more efficacious use of wellness budgets (an annual expenditure exceeding $100 Billion), will create a positive social impact within organizations, and by extension, society as a whole. Organizations with effective wellness initiatives have higher employee engagement, improved productivity, and increased profitability. Hence, there is significant opportunity for societal and commercial impact through evidence-based wellness technologies.

    This Small Business Innovation Research (SBIR) Phase I project involves the theoretical development, and practical deployment, of recommendation algorithms that arrange meetings between groups of people with divergent interests and incentives. Our research objectives are (1) the development of a theoretically grounded recommendation algorithm that accounts for the effects of social dynamics and incentives on behavior, (2) the development of an application to facilitate community wellness through in-person meetings.  We anticipate the successful deployment of the platform, the collection of multi-center data for semi-supervised training and prospective evaluation of the developed algorithms.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 540 MEMORIAL DR APT 603
  awardeeCity: CAMBRIDGE
  awardeeCountryCode: US
  awardeeName: GHAMUT CORPORATION
  awardeeStateCode: MA
  awardeeZipCode: 021394907
  fundsObligatedAmt: '224995'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1845752'
  piEmail: deskool@gmail.com
  piFirstName: Mohammad
  piLastName: Ghassemi
  piMiddeInitial: M
  piPhone: '6175996010'
  poName: Muralidharan Nair
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  A Community-Building Platform That Uses Machine Learning
    To Facilitate In-Person Interactions'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to make talent search faster and much more effective. More specifically, it will aim to make it easier to connect open jobs with the talents of job seekers. The innovation proposed here will redefine job search in a time when the labor market is in major flux, and the technology developed in this project will enable job searching to move far beyond a one-page resume and focus more on the skills needed to succeed in a job. In so doing, the innovation will enable job seekers to find new opportunities that are aligned with their career interests and enable employers to find skilled talent matched to their project needs. Employers using this technology will be able to search for talent according to what they need performed, without necessarily knowing how the task will be performed. Similarly, job seekers will be able to search for jobs that they may not have known existed but are still strongly aligned with their career goals.

    This Small Business Innovation Research (SBIR) Phase I project will develop a skills-to-tasks matching system that serves as a basis for which worker skills are employed to perform which tasks on the job. Currently, available data on the skill content of occupations does not capture variation across industries, geographies, or over time. Nor does it capture the applicability of a worker's current skills to new workplace tasks, an important consideration for up-skilling and re-training programs. This limitation has left a major source of information asymmetry intact in the 21st century job market, where the most effective talent search strategy remains peer-referrals. This same lack of granularity in available data has limited the effectiveness of policymakers to measure the skills-gap, identify career pathways, and design training programs most needed in their local economies. The research proposed in this project will produce an up-to-date compendium of the skills and work activities that are evolving in the labor market and map the relationships between them. This technology will provide a dynamic and granular view of the labor market and improve the quality of information available to decision-makers in industry, education, workforce development, as well as for the study of the future of work.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1968 WINTERPORT CLUSTER
  awardeeCity: RESTON
  awardeeCountryCode: US
  awardeeName: XOPOLIS LLC
  awardeeStateCode: VA
  awardeeZipCode: '201913600'
  fundsObligatedAmt: '214218'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1846420'
  piEmail: lokeshdani@xopol.is
  piFirstName: Lokesh
  piLastName: Dani
  piPhone: '5714217979'
  poName: Muralidharan Nair
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  A Big Data Skills-To-Tasks Ontology For Career Mapping, Job
    Matching, And Talent Acquisition.'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to, through development of a Real-time Artificial Intelligence algorithm, bring expertise in endoscopic imaging interpretation to physicians taking care of patients at risk for esophageal cancer, to detect precancer earlier, and lower the cost of healthcare.  Esophageal cancer is one of the fastest growing cancers in the US with a 6 fold increase in incidence in the last 4 decades. Most endoscopists are not trained well to detect pre-cancer in the esophagus as <5% have received dedicated advanced imaging training to identify dysplasia (advanced precancer) within Barrett's Esophagus. There are well-proven minimally invasive endoscopic treatments for dysplasia and early esophageal cancer that are >95% effective in providing cure to the patient. On the other hand, when cancer is caught at a later stage the only option is removal of the esophagus with surgery in combination with expensive chemotherapy and radiation. Creating this real-time Artificial Intelligence system will assist endoscopists to detect precancer earlier, prevent this deadly cancer and expand access to esophageal cancer screening to the community at large and also to the underserved community, who typically have fewer well-trained physicians.

    This Small Business Innovation Research (SBIR) Phase I project will develop the first system that can detect dysplasia in Barrett's Esophagus in real-time during endoscopy. This proposed research will expand on the company's preliminary work in detecting dysplastic lesions in colonoscopy and applying transfer learning methods to develop the first ever dysplasia-detection algorithm for upper endoscopy. It will initially be trained using static, annotated images, and will expand on the company's software platform to be able to eventually process video feeds, in real-time, from device makers without frame-drop or lag. The company has begun engaging with endoscopy OEMs to define metrics for success in running real-time algorithms.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 16533 Sequoia Street
  awardeeCity: Fountain Valley
  awardeeCountryCode: US
  awardeeName: DOCBOT, INC.
  awardeeStateCode: CA
  awardeeZipCode: '927087725'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843975'
  piEmail: andrew.q.ninh@gmail.com
  piFirstName: Andrew
  piLastName: Ninh
  piMiddeInitial: Q
  piPhone: '7147166674'
  poName: Peter Atherton
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 09/30/2019
  title: 'SBIR Phase I:  A Real-time Artificial Intelligence Dysplasia Detection (AIDD)
    system for Barrett''s Esophagus and Early Esophageal Cancer'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is to enable researchers to recruit participants
    for clinical trials more quickly and reliably. A major problem in medical research
    is that a majority of clinical trials are delayed or canceled because of insufficient
    recruitment of eligible participants. By developing an independent (third-party)
    data aggregation platform for detailed electronic patient data through this project,
    researchers will be able to efficiently reach a large pool of potential participants
    for trials, and increase the likelihood of trial success. The resulting platform
    will create a much more efficient recruitment system, as the data is shared among
    the broader research community rather than managed by any individual research
    organization. With subscriptions and fees per enrolled patient, the platform will
    be able sustain itself while at the same time lowering recruitment costs for researchers.
    More broadly, the greater ability to design and execute successful clinical trials
    will be a huge benefit to the medical community and accelerate the pace of research
    and new product development. \n\nThis Small Business Innovation Research (SBIR)
    Phase I project seeks to improve the speed, accuracy, and reliability of clinical
    trial design and recruitment. Research organizations like pharmaceutical companies
    and hospitals typically maintain isolated databases with limited, static patient
    data. This project focuses on building a third-party data platform that elegantly
    stores and organizes electronic patient data. The design of the platform enables
    ontological queries, allowing researchers to consult data when designing trials
    and quickly ?testing? specific inclusion/exclusion criteria to determine feasibility.
    When proceeding to execute the trial, the platform will rank individuals by likelihood
    to enroll, and facilitate contact with potential patients that have previously
    provide consent to be contacted. Initial objectives of the project include the
    development of a methodology to abstract patient data from medical records, and
    programming of the database structure. Later the work will focus on quality assurance
    software, and algorithms to translate free-text trial requirements into filters
    compatible with said database. The expected outcome is a platform storing accurate
    data of 200 patients, with filtering and ranking algorithms that match patients
    to trials with nearly the same accuracy of an experienced recruitment team.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 15335 MORRISON ST STE 202
  awardeeCity: SHERMAN OAKS
  awardeeCountryCode: US
  awardeeName: SANGUINE BIOSCIENCES, INC.
  awardeeStateCode: CA
  awardeeZipCode: '914031595'
  fundsObligatedAmt: '224981'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843917'
  piEmail: glee@sanguinebio.com
  piFirstName: Gerald
  piLastName: Lee
  piPhone: '4082052974'
  poName: Benaiah Schrag
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Advanced Direct-To-Patient Data Aggregation Platform For
    Clinical Trial Recruitment.'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be a novel wearable device for unobtrusively detecting changes in the lung health of patients with chronic respiratory disease. This Passive Unobtrusive Lung function Monitor (PULMO) will be the only device that can automatically measure a patient's lung health information without requiring any active engagement from the clinician, and without imposing any obtrusive changes to the patient's daily routine. The PULMO is useful in a broad range of respiratory disease applications, such as lung transplant post-operative care, asthma management and respiratory therapy research, that require continuous, objective and unobtrusive monitoring of lung function change. Since PULMO technology is compatible with low-cost microcontrollers, it has the potential to dominate the spirometry market and respiratory clinical trials space with high-volume production. The spirometry market has an expected CAGR of 9.4 % from 2018 to 2025, reaching a $1.4 billion market value by 2025, while clinical trials expenditures on new respiratory therapy drugs is forecast to reach $1.7 billion in 2025.

    This Small Business Innovation Research (SBIR) Phase I project addresses the major drawback of the state-of-the-art in continuous monitoring of respiratory disease, which is that it demands daily discipline, effort and proper technique of the patient, resulting in missing, invalid or fabricated data. In this project, a manufactured PULMO test device will be implemented with an intelligent event detection unit combined with a low power microcontroller, and the total average power consumption will be less than 300 microWatts. The measurement error of the PULMO will be within +/- 5 %, which is necessary for detecting changes in lung impairment. The intelligent event detection unit will be implemented as a nonlinear dynamical system in a custom integrated circuit. A gated recurrent neural network that is optimized for embedded low resource systems will be implemented in the low power microcontroller and will be used to detect respiratory disease symptoms. Controlled tests will be performed with a silicone phantom chest to evaluate the measurement accuracy of the PULMO device.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1 South St
  awardeeCity: Hanover
  awardeeCountryCode: US
  awardeeName: Clairways LLC
  awardeeStateCode: NH
  awardeeZipCode: 037552186
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843658'
  piEmail: justiceamoh@gmail.com
  piFirstName: Justice
  piLastName: Amoh
  piPhone: '6035138411'
  poName: Benaiah Schrag
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Medical Device for Monitoring Respiratory Disease'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to drive hypertension awareness and control rates around the world, through the availability of low-cost, portable blood pressure monitoring. High blood pressure (BP) is a major cardiovascular risk factor that affects up to 1 billion people worldwide. It is treatable, yet hypertension awareness and control rates are low. Ubiquitous BP monitoring technology could improve hypertension management, but existing devices require an inflatable cuff and therefore do not afford anytime, anywhere measurement of BP. The market for a portable, cuff-less blood pressure monitor is estimated in the tens of billions of dollars. Successful completion of this project via demonstration of measurement accuracy across a broad range of blood pressures will provide the company with a strong position in this large market. Ultimately, the success of this project could translate to much greater awareness and control of hypertension, helping reduce the incidence and burden of cardiovascular disease around the world.

    This Small Business Technology Transfer (STTR) Phase I project aims to develop a technology for cuff-less and calibration-free measurement of blood pressure via a button on a smartphone. Existing automated cuff-based monitors are bulky and do not enable anytime, anywhere measurement of BP. The 'oscillometric finger pressing method'is an emerging approach that uses the same measurement principle that is employed by most automatic cuff devices, but instead of inflating a cuff, the user presses his or her finger (and the underlying artery) against a combination of optical and pressure sensors to determine the blood pressure. The objectives of this program are to shrink the current prototype design and validate its accuracy. The proposed R&D plan includes miniaturization of the circuit components to mount them on a single board and optimization of the sensing technology and algorithm to work in a broad range of normotensive and hypertensive individuals. This work will be followed up by a clinical test of the monitor. The resulting device is expected to be small and thin enough to mount to the back of a smartphone and demonstrate clinical-grade accuracy for the measurement of blood pressure.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 7 DANA RD STE 111
  awardeeCity: VALHALLA
  awardeeCountryCode: US
  awardeeName: DIGITOUCH HEALTH LLC
  awardeeStateCode: NY
  awardeeZipCode: '105951554'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1843514'
  piEmail: mzemel@mkmventuresllc.com
  piFirstName: Marc
  piLastName: Zemel
  piPhone: '9145941986'
  poName: Benaiah Schrag
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'STTR Phase I:  Smartphone-based blood pressure monitoring via the oscillometric
    finger pressing method'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will result from enabling efficient repeatable computing using commodity technology. While computers should, in principle, operate the same way each time, we have all seen how a program that ran fine yesterday somehow crashes today. Our current computing infrastructure betrays its fundamentally unrepeatable nature in a thousand careless ways, by letting processor and operating system details affect how programs run. Popular computing abstractions like containers and virtual machines improve repeatability, but do not provide any guarantees. This project conducts R&D on a new repeatable container, which provides repeatability for arbitrary programs running inside it. Repeatable containers will allow for reproducible software builds, software testing that runs the same on all machines, and faster software debugging with "one click" reproduction of failures. Repeatable containers reduce software development and QA costs. Repeatable containers can also facilitate archiving software and scientific research, and trustless grid computing.

    This Small Business Innovation Research (SBIR) Phase I project involves the development of new container runtime systems that can enforce repeatability with low performance overhead. This project will focus on technical improvements that yield a robust container runtime which can handle a wide range of legacy software that collectively exercises the full range of processor and operating system behaviors. The container will integrate smoothly with both existing container technologies and existing container users, to facilitate easy adoption by software developers. Key technical results will include developing a "fingerprinting" technology to uniquely identify container executions, and a stress-testing methodology to increase confidence that the repeatability guarantee holds.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3814 E DEVONSHIRE CT
  awardeeCity: BLOOMINGTON
  awardeeCountryCode: US
  awardeeName: CLOUDSEAL INC
  awardeeStateCode: IN
  awardeeZipCode: '474089698'
  fundsObligatedAmt: '224444'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843634'
  piEmail: rn@cloudseal.io
  piFirstName: Ryan
  piLastName: Newton
  piMiddeInitial: R
  piPhone: '6176428059'
  poName: Peter Atherton
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 09/30/2019
  title: 'SBIR Phase I:  Cloudseal: Software Testing with Deterministic Containers'
- abstractText: |-
    The broader impact of this Small Business Innovation Research (SBIR) Phase I project is in improving crop yields, while reducing the amount of pesticides used. By significantly improving the accuracy and timeliness of insect surveillance, we will allow more effective pest management, allowing the applications of insect interventions to be targeted in space and time. For example, rather than a blanket spraying of harsh pesticides across the entire field, our system could suggest spraying of a milder (and cheaper) pesticide in just a few "hot spots", at the optimal time of day. Reducing the volume of pesticides has further positive benefits to society at large, it will reduce pollution, and the use of pesticides has been implicated as a contributor to climate change and to colony collapse disorder. The hardware/algorithms/representations/data-models created in this project have an obvious application to mosquito surveillance, which has implications for control of insect vectored diseases of both humans and livestock. The commercial potential of this SBIR Phase I project is obvious. Insects damage or destroy about 150 billion dollars' worth of crops each year. If we prevent reduce this by just one percent, we have a billion-dollar market.

    The proposed project will investigate techniques to improve the state-of-the-art in flying insect classification, with the goal of producing a platform that allows insect surveillance for precision agriculture. In particular, we will take the current algorithms and representations (many of which were invented by the current PIs) and make them invariant to the wide range of conditions (temperature, pressure, humidity) encountered in the field. The company's research has shown that without creating such invariances, the variability induced by changing environment conditions will swamp the regularities in the features that are currently exploited by classification algorithms, and reduce the accuracy to random guessing. It is well understood how temperature, pressure, humidity effect air density, and how air density effects insect flight. However, the current models treat the insects as idealized objects using aerospace equations for density vs. lift and completely ignore the effects of the environment on insect physiology. The company plans to achieve this by creating a model that compensates for environmental conditions. To achieve these ambitious goals, they plan to use machine learning to learn the appropriate invariances and model corrections.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 786 NAVAJO DR
  awardeeCity: RIVERSIDE
  awardeeCountryCode: US
  awardeeName: FARMSENSE INC.
  awardeeStateCode: CA
  awardeeZipCode: '925076018'
  fundsObligatedAmt: '224968'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843998'
  piEmail: shail@farmsense.io
  piFirstName: shailendra
  piLastName: singh
  piPhone: '6077275603'
  poName: Rick Schwerdtfeger
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 11/30/2019
  title: 'SBIR Phase I:  Inexpensive Automatic Classification And Counting Of Insects
    To Enable Precision Agriculture'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project will be to develop an enzyme immobilization platform
    to be used in the production of biopharmaceuticals and other biomanufacturing
    processes to reduce the timeline and cost associated with discovering and manufacturing
    biotherapeutics.  Biopharmaceutical sales have soared in recent years and healthcare
    authorities have increased pressure on pharmaceutical manufacturers to reduce
    the cost of biologics leaving pharmaceutical engineers to focus on reducing bioproduction
    costs.  To accomplish this goal, pharmaceutical companies are aggressively investigating
    continuous processing technologies to reduce the capital and other costs associated
    with biopharmaceutical manufacture. The immobilization platform described in this
    proposal will provide a technology that is compatible with continuous processing
    strategies to reduce the timeline and cost associated with discovering and manufacturing
    biotherapeutics.  In addition, this platform has the potential to reduce the cost
    and increase the efficiency of biomanufacturing processes across several other
    industries including food, leather, and textiles. \n\nThe intellectual merit of
    this SBIR Phase I project is to develop pH responsive immobilized enzymes for
    the production of biopharmaceuticals. There are three key technical challenges
    associated with this project: The immobilized-enzyme must demonstrate pH responsive
    behavior compatible with biologics manufacture (pH 6-7); mass transfer of protein
    substrates must be comparable to the native enzyme; and extended shelf-life of
    the immobilized-enzyme is required for long-term storage. To mitigate these challenges,
    this project aims to covalently bind an enzyme to a pH responsive polymer that
    is formulated to have reversible solubility near neutral pH. The solubility of
    the immobilized-biocatalyst can be tightly controlled within a specified pH range
    allowing for continuous processing and facile purification of the biotherapeutic
    product. Poor mass transfer often results from immobilizing biocatalysts on solid
    supports. These challenges are further exaggerated in bioconjugation reactions
    because the coupling partner, a protein, is generally more affected by sterics
    than small molecules. Therefore, fabrication of the solid support will be explored
    to produce resins of varied size, morphologies, and dissolution properties that
    are compatible with macromolecule functionalization. Additionally, the immobilized
    enzyme generated in this project can be utilized under soluble conditions, which
    combines the positive attributes of both immobilization and soluble enzyme catalysis.
    The final challenge of developing a commercially viable shelf-life of the catalyst
    will be addressed through development of novel drying protocols. Shelf-stable
    immobilized enzymes will be developed so that inventory can be maintained without
    requiring long lead times for catalyst production.\n\nThis award reflects NSF's
    statutory mission and has been deemed worthy of support through evaluation using
    the Foundation's intellectual merit and broader impacts review criteria."
  awardeeAddress: '64 Thompson St. #19'
  awardeeCity: New York
  awardeeCountryCode: US
  awardeeName: Curie Co. Inc.
  awardeeStateCode: NY
  awardeeZipCode: '100124317'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843690'
  piEmail: emm@curieco.com
  piFirstName: Erika
  piLastName: Milczek
  piMiddeInitial: M
  piPhone: '6467700263'
  poName: Ruth Shuman
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Reducing the cost of biomanufacturing and biopharmaceutical
    production with smart biocatalysts that can be incorporated into continuous processing
    technologies'
- abstractText: |-
    The broader impact/commercial potential of this project is to transform the culture of photosynthetic aquatic microorganisms. Although microalgae and cyanobacteria have high volumetric productivities, the cultures cannot be too deep, due to restrictions of light penetration.  This proposed technology removes the light penetration limit inherent in current technologies. The results of this project will allow the production of medical and food grade biomass in controlled conditions, as the light source will not be connected to the exterior of the culture reactors. This approach will provide the advantages of a fermentation production using phototrophic species, without the need to supply organic carbon. The photosynthetic biomass production makes use of carbon dioxide and light for growth. This project will result in a microalgal/cyanobacterial biomass production in areas where it is not currently feasible and with higher productivity. The increase of the depth of the cultures two, five or more times of what is currently possible, practically reduces the area required for biomass production. A reduction of cost will improve the economic outlook for microalgal-based commodity products, including feed, food, fuels, nutraceuticals and pharmaceuticals and lower the environmental impact.

    This Small Business Technology Transfer (STTR) Phase I project addresses one of the most significant problems found in achieving the promise of microalgae and cyanobacteria as source of food, fuels and other products is the limitation of light penetration. Most outdoor cultures are limited to less than 60 cm depth. In reactors with artificial light, besides the light penetration high electrical costs limit their use to high value products.  This project will result in a light system that takes advantage of the water movement in cultures to generate electricity for LED lights in untethered units that move with the culture. The proposed generator uses methods more efficient and lighter that traditional electromagnetic and piezoelectric generators. The developed energy harvester can be used in other applications such as power for water quality monitoring and other sensing equipment. In this phase, a unit with a miniaturized energy harvester coupled with passive switching, charging, discharging and rectifying modules in the same substrate, in a waterproof casing will be developed. Data proof of the suitability of these units to support photosynthetic microorganisms? biomass production will be obtained. The results will inform further development of the units in a future phase.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 8000 INNOVATION PARK DR BLDG 310
  awardeeCity: BATON ROUGE
  awardeeCountryCode: US
  awardeeName: ENVIROTRONICS, LLC
  awardeeStateCode: LA
  awardeeZipCode: '708207400'
  fundsObligatedAmt: '211834'
  fundProgramName: STTR PHASE I
  id: '1843399'
  piEmail: maria.teresa@gutierrez-wing.com
  piFirstName: MARIA
  piLastName: GUTIERREZ-WING
  piMiddeInitial: T
  piPhone: '2252350895'
  poName: Muralidharan Nair
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'STTR Phase I:  Self-powered underwater light system for photosynthetic cultures'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will result from developing technology to enable enterprise, cloud, academic, and government network operators to cost-effectively scale computer clusters to support the growing demands on these systems. Computer clusters underpin an increasingly broad range of services that businesses, researchers, and society have come to rely on, from machine learning systems to online social media platforms. Companies increasingly use computer clusters to gain a competitive advantage and accelerate product development. Today's networking technologies improve in performance by a factor of two every two years, but the demand placed on cluster computing systems is growing more than twice that fast in some market segments. The technology developed through this project is well-positioned to exceed the cost and performance scaling limitations of current networking technology, enabling business and scientific end-users to find solutions to more complex problems more quickly.

    This Small Business Innovation Research (SBIR) Phase I project demonstrates the feasibility of a network interconnect for computer clusters that routes traffic through transparent optical switches. Optical switches remove communication bottlenecks in the network fabric but require fundamental changes in how distributed applications communicate information across the network compared to present-day technologies. The commercial success of the technology depends on its ability to accelerate the execution of common distributed applications while providing the interoperability, reliability, and manageability expected by network operators. This project aims to demonstrate a 2x improvement in the execution speed of network-bound applications compared to today's technologies. The proposed research to reach this goal includes developing and optimizing the software stack necessary to interface commodity applications with the fabric, quantifying the performance of those applications subject to the constraints imposed by optical switching, and optimizing the optical switch design to maximize application performance at a system level.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3957 30TH ST UNIT 406
  awardeeCity: SAN DIEGO
  awardeeCountryCode: US
  awardeeName: INFOCUS NETWORKS
  awardeeStateCode: CA
  awardeeZipCode: '921043080'
  fundsObligatedAmt: '224993'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842768'
  piEmail: max@infocusnetworks.com
  piFirstName: William
  piLastName: Mellette
  piMiddeInitial: M
  piPhone: '7604015929'
  poName: Peter Atherton
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Scaling Cluster Computing Fabrics with Optical Networking'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be to develop an alternative source of pharmaceutical heparin using engineered cultured mammalian cells. Heparin is a widely prescribed anticoagulant (blood thinner), critical for surgical operations and for patients that otherwise have risks of blood clotting. Over 300,000 doses are administered per year in the US alone. Currently, heparin is prepared from animal tissues, primarily pig intestines in China, which has regulatory agencies in the US and other countries concerned. For one reason, heparin manufacturing is difficult to regulate in China as evidenced by the heparin adulteration crisis in 2008 that led to allergic reactions and over 250 deaths worldwide. In addition, there is concern that the Chinese pig population will not be able to keep up with the increasing demand. The FDA is considering reintroducing heparin produced from beef cattle as an alternative source, however, bovine heparin is still subject to complications involving animal tissues and it has different anticoagulant properties, which complicates dosing. The current proposal develops cell-based production in which the entire supply chain can be under GMP control and scalable as needed with no dependence on the number and health of an animal population.

    The intellectual merit of this SBIR Phase I project is to genetically engineer cells to produce a heparin product that can be manufactured for pharmaceutical use. Cellular production can be entirely under GMP control, and cell engineering provides opportunities to produce heparin with improved properties. A survey of clinicians that use heparin overwhelmingly identified heparin induced thrombocytopenia (HIT) as a serious detrimental side effect. HIT can lead to blood clots, stroke, heart attack and loss of life and limb. Treatment is complicated and expensive. HIT is an allergic reaction caused when heparin binds to a specific protein in the blood called platelet factor 4 (PF4). PF4 binding depends on elements of heparin structure that are not involved in heparin's anticoagulant activities. Through cell engineering, heparin molecules with an altered structure will be produced that have reduced affinities for PF4, while maintaining potent anticoagulant properties. In addition, heparin has demonstrated efficacy in other areas such as inflammation and cancer that are not involved in blood clotting. Through cell engineering, heparin structures also could be tailored for these additional applications.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 9500 Gilman Drive, MC 0713
  awardeeCity: La Jolla
  awardeeCountryCode: US
  awardeeName: TEGA Therapeutics Inc
  awardeeStateCode: CA
  awardeeZipCode: '920935004'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842736'
  piEmail: cglass@tegatherapeutics.com
  piFirstName: Charles
  piLastName: Glass
  piMiddeInitial: A
  piPhone: '8582463240'
  poName: Ruth Shuman
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Bioengineered Recombinant Anticoagulant Heparin'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project will be on any industry or product category that
    suffers from product counterfeiting; that is to say on nearly every industry imaginable.
    It is estimated that the global counterfeit market will grow from $1.2 Trillion
    in 2017 to more than $1.8 Trillion by 2020. In an attempt to combat this trend,
    spending on anticounterfeit packaging will grow from $122 Billion in 2017 to $264
    Billion by 2023. Of most dire concern, the counterfeit pharmaceutical industry
    is estimated at approximately $200 Billion, resulting in about 1 million deaths
    annually. Existing anti-counterfeit packaging techniques have proven largely ineffective
    in combating this counterfeiting problem. This project will result, for the first
    time, in packaging or seals that, without ambiguity, inform users of the authenticity,
    integrity, and provenance of any product outfitted with the project?s resultant
    technology. All stakeholders in a supply chain will be enabled to detect fake
    goods before they can be used or consumed. This increased visibility into the
    supply chain will also broaden enforcement opportunities for relevant entities
    and/or authorities and provide special benefit to those industries most urgently
    impacted: pharmaceuticals, military/defense products and high-priced goods. \n\nThe
    proposed innovation is a novel enhancement to Radio Frequency Identification (RFID)
    that seals any package or container to which it is attached and, when queried
    by a reader/interrogator (e.g. any modern smartphone), provides the status (i.e.
    tampered/un-tampered) and identity to the user or system. The project will produce
    the designs and manufacturing techniques required to create RFID-based seals that
    provide assurance of authenticity, integrity, and provenance for products to which
    these seals are applied. Research will be conducted on several specific hardware
    components required by this innovation and will produce the requisite software
    and cryptographic systems for the testing, design, and commercialization of this
    proposed solution to product counterfeiting. Developed software will provide the
    testing and development framework for commercial applications of the proposed
    anti-counterfeiting solution. Advances in hardware design, especially concerning
    the minimization of power requirements for the RFID-based seals and the manufacturing
    techniques for specific required hardware components (i.e. the components that
    detect tampering events) will be accomplished during this research project. Research
    and development activities will employ varied techniques including iterative design,
    3D printing, and advanced electronics prototyping. This SBIR Phase I project will
    ultimately result in the design and validation of production-ready seals.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 951 W ORANGE GROVE RD APT 77104
  awardeeCity: TUCSON
  awardeeCountryCode: US
  awardeeName: SGNT LLC
  awardeeStateCode: AZ
  awardeeZipCode: '857044075'
  fundsObligatedAmt: '224470'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1844217'
  piEmail: emil@sgnt.io
  piFirstName: Emil
  piLastName: Tremblay
  piMiddeInitial: C
  piPhone: '4802256500'
  poName: Rick Schwerdtfeger
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Radio-Frequency-Identification Based Seal & Packaging Methods
    To Eliminate Counterfeiting And Tampering Of Physical Goods'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be the development of a new class of high affinity compounds that would be small enough to be delivered into challenging environments such as living cells. Inhibitors of disease-related proteins are central to modern therapeutics across the spectrum of diseases, from cancer to autoimmune diseases, to viral infections, and even to certain hereditary disorders.  Many of these drivers of disease are transcription factors or signal-transduction molecules, yet these proteins are commonly thought of as "undruggable," due to a lack of small pockets for drug binding or due to large protein-protein interaction interfaces. This proposal is aimed at developing an easily screenable library, consisting of DNA-encoded peptidomimetics, whose members have the necessary properties to inhibit these "yet-to-be-drugged" proteins.  Of highest commercial importance, these compounds could address many of the currently "undruggable" molecular drivers of diseases such as cancer and autoimmune disorders.

    The intellectual merit of this SBIR Phase I project is to create a DNA-encoded library of constrained peptidomimetic compounds. Current DNA-encoded libraries are primarily limited to small molecules (DNA-encoded chemical libraries; DECLs) or to natural amino acids in the context of translated-protein display (e.g., phage display or mRNA display). In contrast, member molecules of this library will have a much larger binding surface than current small molecules from DECLs, and will be both protease resistant and have a wide range of chemical side chains, unlike the natural peptides from phage display. The goal of this project is to demonstrate the ability to synthesize compounds with conformational rigidity along with parallel DNA encoding.  A library of these compounds could be screened to discover new therapeutic candidates (human and veterinary), life sciences research tools, and heat-resistant diagnostic reagents.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2723 MONSERAT AVE
  awardeeCity: BELMONT
  awardeeCountryCode: US
  awardeeName: TRILO THERAPEUTICS, INC.
  awardeeStateCode: CA
  awardeeZipCode: '940021447'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843405'
  piEmail: kurt@trilotx.com
  piFirstName: Kurt
  piLastName: Gish
  piPhone: '4158064662'
  poName: Ruth Shuman
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'SBIR Phase I:  Development of DNA-Encoded Peptidomimetic Library for High-Affinity
    Binders Against Disease-Related Proteins'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR)
    project is to make unique properties of Distributed Ledger Technology (DLT) widely available to
    developers. In doing so, the company will empower developers to create novel distributed services with
    trustworthy and consistent shared state operations that will lead to more transparent business
    and governance practices. In the Phase I tools will lead to new innovative meat
    distribution businesses in Bozeman, MT. In the long term, we aim to build the fundamental tools
    for the growing ranks of blockchain developers, who need powerful and easy-to-integrate tools
    that access and manipulate DLT state. Ultimately, our suite of services will provide a unified
    interface to multiple DLT implementations and facilitate the trustworthy exchange of shared
    state among different applications to create a wide and consistent view of world state.

    This SBIR Phase I project proposes to create an ecosystem of tools to operate on shared
    application state stored on DLTs and to roll out these tools as they mature. The ultimate goal is
    to provide a unified API much like that of leading cloud service providers, which consists of
    several incrementally introduced services.
    Specifically, the services planned to provide are:
    1. Blocky Valve - A JavaScript API that simplifies DLT read and write access.
    2. Blocky Pipes - A DLT data delivery microservice based on message queues connected
    to Blocky Valve.
    3. Blocky Loading Ramp - A continuous integration and continuous delivery (CI/CD) service
    of smart contracts.
    4. Blocky Cement - An oracle service for exchanging data across DLTs using
    consensus-based provenance. Cement will also enable interaction between smart
    contracts across different DLTs.
    5. Blocky Crates - A database-like query interface to data stored on DLTs. Crates will also
    enable smart contracts to interact with up-to-date shared application state stored on
    DLTs.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2708 HARRIS ST
  awardeeCity: BOZEMAN
  awardeeCountryCode: US
  awardeeName: BLOCKY MCCHAINERSON LLC
  awardeeStateCode: MT
  awardeeZipCode: '597186046'
  fundsObligatedAmt: '224989'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843991'
  piEmail: jon.heinecke@gmail.com
  piFirstName: Jonathan
  piLastName: Heinecke
  piPhone: '4062617307'
  poName: Anna Brady-Estevez
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  A Microservices Approach To Low-Latency Process Interaction
    Through Distributed Ledgers'
- abstractText: |-
    The broader impact/commercial potential of this project is to develop the first low-cost and integrated onboard charger and auxiliary power module for electric vehicles, facilitating deployment of next-generation electrified transportation systems. It is noteworthy that there are more than 250 million registered passenger vehicles in the U.S. Over 40% of greenhouse gases and 70% of emissions come from the transportation sector, and transportation is 99% dependent on one source of fuel: petroleum. Mainstream adoption of electric vehicles is essential if the U.S. is to gain energy security and substantially reduce carbon emissions. The electric car industry has passed its tipping point; however, electric vehicles are still in the very early stages of development. Like early computers, the pieces that make up an electric car are large, heavy, costly and unable to efficiently communicate amongst themselves. The proposed technology not only reduces the volume, cost, and weight of onboard chargers for electric vehicles, but also enhances their efficiencies, and enables bidirectional operation to support future Smart Grid functionalities. This project will lead to creating jobs once the technology matures toward commercialization.

    This Small Business Innovation Research (SBIR) Phase I project will lead to design and development of an innovative integrated and bidirectional onboard charger for electric vehicles. Currently, all the upcoming and commercially available electric vehicles are equipped with an individual onboard charger to charge traction batteries and an additional auxiliary power module to power auxiliary loads. These converters are heavy, bulky, costly and need to communicate over a variety of controller area networks. The intellectual merit of this project is in the innovative topology, design, control, development, packaging, and validation of the first charger which integrates an onboard charger and an auxiliary power module. This SBIR Phase I project involves the design of the converter, investigation and design of the controller, design and implementation of the electromagnetic interference filter stage, creating the schematics and layout, thermal management, reliability analyses, enclosure design, and final alpha prototype assembly and verification. This important work will (1) lead to theoretical advancements in the design, control, and integration of power electronic converters, (2) involve interdisciplinary research in power electronics, control, packaging, and thermal management, and (3) lead to commercialization of the first integrated onboard charger and auxiliary power module for electric vehicles.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 387 Technology Advmnt Bldg
  awardeeCity: College Park
  awardeeCountryCode: US
  awardeeName: AmpX Technologies, Inc.
  awardeeStateCode: MD
  awardeeZipCode: '207423371'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842929'
  piEmail: kgpayan@gmail.com
  piFirstName: AYAN
  piLastName: MALLIK
  piPhone: '2404959173'
  poName: Muralidharan Nair
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Integrated Onboard Charger and Auxiliary Power Module for
    Electric Vehicles'
- abstractText: "The broader impact/commercial potential of this project is to enable
    broad market adoption of rooftop and other methods for local wind energy generation
    through reduction in costs. This is achieved through development of technology
    designed to lower the cost of wind turbine drive trains and associated power electronics,
    high cost items which are often left without innovation in new wind turbine designs.
    Prohibitively high costs are currently the biggest barrier to widespread adoption
    of distributed wind turbines, and power electronics can be as much as 50% of these
    costs. Significant cost reduction has the potential to increase worldwide distributed
    wind power adoption. The innovative power train technology developed in this project
    is specifically designed to couple with a proprietary technology for wind capture
    at rooftop edges. When combined with this technology, costs estimates are competitive
    with rooftop solar energy, enabling wind energy to become a common addition to
    rooftop solar installations. Successful deployment of this technology will contribute
    to society by decreasing the carbon footprint of energy production, increasing
    energy resiliency, and creating new jobs associated with manufacturing and deployment.
    Significant manufacturing efforts are likely to remain in the US, creating local
    job opportunities and economic growth. \n\n\nThis Small Business Technology Transfer
    (STTR) Phase I project proposes to use a novel drive train architecture to reduce
    small wind turbine power train costs. In this architecture, costs are lowered
    by temporarily storing the energy coming out of the wind turbine rotor in a flywheel
    before passing it on to the generator. This allows for the power train to include
    a generator and inverter that are sized for average rather than peak power outputs,
    enables removal of diversion load, and allows for the use of a faster spinning,
    and therefore lower cost generator. The Phase I project seeks to prove the feasibility
    of developing a low-cost flywheel which meets the needs of the overall drive train
    (including efficiency and reliability), a powertrain control system which maintains
    high efficiency, and a powertrain system configuration which maintains the reduced
    cost projections required for market traction. Research efforts include development
    of a bench-scale drive train to test the controls of the flywheel, powertrain
    simulation to test alternative generator and converter topologies, and benchmarking
    of generator candidates to determine efficiency and power density.\n\nThis award
    reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 911 Washington Ave, Suite 501
  awardeeCity: St. Louis
  awardeeCountryCode: US
  awardeeName: Accelerate Wind LLC
  awardeeStateCode: MO
  awardeeZipCode: '631011272'
  fundsObligatedAmt: '224999'
  fundProgramName: STTR PHASE I
  id: '1843944'
  piEmail: eboeing@acceleratewind.com
  piFirstName: Erika
  piLastName: Boeing
  piPhone: '3143268180'
  poName: Muralidharan Nair
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'STTR Phase I:  Integrated Solution for Low Cost Distributed Wind Energy
    Generation'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to create a cost-effective, high-performance anticorrosive coating for protecting metal structures, particularly in marine environments. High value assets that are essential parts of the US energy infrastructure, such as offshore oil and gas platforms, marine ships and wind turbines, are exposed to one of the most corrosive environments with direct exposure to salt water via immersion and seawater spray. Corrosion of these metal structures is estimated to cost the world economy around $2.3 trillion in maintenance and replacement capital every year. This project's superhydrophobic coating has the potential to significantly reduce both cost and waste by improving structural safety, reducing maintenance frequency and lengthening the operating lifetime of such vital assets. It will also reduce the environmental impact of corrosion protection systems by using less harmful materials, negating coating repainting needs and extending metal lifetime.

    This Small Business Innovation Research (SBIR) Phase I project seeks to make a durable, superhydrophobic, high-performance anticorrosive coating through creation of dual-function coating additives. Coatings and corrosion inhibitors are generally the first line of defense in this fight against corrosion. Highly-water repellent superhydrophobic coatings are leading contenders for delivering a step change in corrosion protection performance. However, current solutions suffer from two notable issues: high cost and low durability in highly corrosive marine environments. Existing superhydrophobic coatings require complex and expensive equipment and materials. In addition, these coatings are easily damaged during use, resulting in the loss of their water repellency and corrosion protection ability. The key innovation of this project is a novel dual-function additive that can impart coatings with both superhydrophobicity (passive corrosion protection) and on-demand corrosion inhibitors release (active corrosion protection). This additive based approach results in a durable coating that retains its protective abilities even through significant use and abrasion and enables adaptation to many other coating applications, even ones outside of corrosion.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 16914 Deer Oak Lane
  awardeeCity: Orlando
  awardeeCountryCode: US
  awardeeName: SynMatter, LLC
  awardeeStateCode: FL
  awardeeZipCode: '328286979'
  fundsObligatedAmt: '224993'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843436'
  piEmail: Jun@SynMatter.co
  piFirstName: Xuejun
  piLastName: Zhang
  piPhone: '3219476478'
  poName: Linda Molnar
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Durable Superhydrophobic Smart Coating with Active Corrosion
    Protection'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is in contributing towards the global effort in minimizing food spoilage and combating world hunger. The worldwide cold-chain freight and logistics industry deals with the storage and transportation of more than 100 million metric tons of fresh produce annually. In this industry, there is currently an urgent need to continuously monitor the air quality in shipping containers where large volumes of perishable food items (fresh fruits and vegetables) are stored. Poor environmental conditions in these containers such as unregulated or high temperatures and low humidity can trigger early ripening of fruits and vegetables, leading to the efflux of specific volatile organic compounds; predominantly ethylene. Due to large volume of produce stored in these containers, if gone unchecked, the environment inside can quickly accumulate high levels of ethylene leading to accelerated ageing and subsequently spoilage. As one can imagine, an appropriate gas sensing technology to continuously monitor ethylene levels would allow adaptive climate control inside the containers, thereby ensuring produce freshness on arrival and preventing billions of dollars in loss and reducing food waste.

    This SBIR phase I project proposes to develop a low-cost ethylene sensing technology using bulk silicon transistor technology (also called CS-FET or chemical sensitive field effect transistor), for mass-deployment in refrigerated containers transporting fresh produce to different parts of the world. This innovation will address an unmet need in the cold-chain logistics industry where continuous monitoring of fruits and vegetables is required to ensure quality and freshness on-arrival. Existing technologies are either too expensive or have poor sensitivity for deployment in large-scale sensing operations. Specifically, Phase I seeks to identify and engineer a sensitive nanoscale catalyst/sensing-layer that will respond to ethylene. To develop the ethylene sensing layers, this effort will pursue the screening of various nanomaterial systems such as ultra-thin layers of noble and transition metals, their composites, sub-oxides, as well as polymeric films using the silicon CS-FET as the backbone technology platform. Additionally, the proposal will also seek to develop a scientific understanding of the interaction mechanism between ethylene and the target sensing layer at both standard ambient conditions as well as conditions prevalent in reefer containers, i.e. low temperature and high humidity.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2150 SHATTUCK AVE PH
  awardeeCity: BERKELEY
  awardeeCountryCode: US
  awardeeName: Serinus Labs, Inc.
  awardeeStateCode: CA
  awardeeZipCode: '947041370'
  fundsObligatedAmt: '224996'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1844045'
  piEmail: serinuslabs.inc@gmail.com
  piFirstName: HOSSAIN
  piLastName: FAHAD
  piMiddeInitial: M
  piPhone: '5123516068'
  poName: Anna Brady-Estevez
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Low-cost ethylene CS-FET gas sensors for applications in
    the cold-chain logistics industry'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will benefit manufacturers of residual gas analyzers, mass spectrometers, ion-mobility spectrometers, time-of-flight spectrometers and related instruments. Implementation of these sensors will increase the revenue, revenue streams and market share of commercial manufacturers of mass spectrometers by significantly lowering production cost, and by enabling penetration into new markets that require increased sensitivity, lowered size, weight, power consumption, and instrument complexity. The product, if successful, will lead to analytical tools that can substantially benefit the needs of education/research, space, bio/health, agricultural, defense and security markets.

    This Small Business Innovation Research (SBIR) Phase I project will develop nanotechnology-based chip-scale ion sensors with ultra-high intrinsic charge-to-current amplification factors. This patent-pending technology allows semiconductor-processable miniaturization and scalability, sub-microwatt intrinsic power draw, and robust ambient-pressure-agnostic operation. With reduced size, weight, and power requirements, increased sensitivity and dynamic range, these sensors can potentially replace expensive, bulky, and/or high-power-consuming charged particle detectors such as microchannel plates, Daly detectors, electron-multiplier tubes and Faraday cups. The ability to operate under any ambient pressure and distinguish charge polarity can significantly enhance field-portability, turnkey operations, and enhance analytical reach of ion-sensing-based applications. Specifically, the proposed research will seek to overcome the challenges related to generation of high signal responses (by enhancing the electronic transport parameters), high ion-sensor interaction (by optimizing sensor design), and lower readout noise (by optimizing materials and design).

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 21 DRYDOCK AVE, SUITE 610E
  awardeeCity: BOSTON
  awardeeCountryCode: US
  awardeeName: GUARDION, INC.
  awardeeStateCode: MA
  awardeeZipCode: '022104501'
  fundsObligatedAmt: '223660'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843742'
  piEmail: dan@guardiontech.com
  piFirstName: Dan
  piLastName: Esposito
  piPhone: '6037697265'
  poName: Rick Schwerdtfeger
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Ultrasensitive chip-scale ion-sensors for mass spectrometry'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to accelerate the adoption of AI features in Internet of Things and mobile devices.  The proposed multi-bit non-volatile memory (NVM) based Deep Neural Networks (DNN) IP is based on the standard CMOS logic processes. Existing solution for the DNN hardware typically requires off-chip access to retrieve neural network parameters from external memories, incurring additional communication latency and power consumption. Additionally, when critical neural network parameters are transmitted off-chip, security or privacy concern may arise, which is unacceptable especially for the applications such as personalized AI devices. Alternative approach integrating the DNN engine in a special NVM process requires as much as 10 additional masks beyond the conventional logic CMOS process which is not cost-effective for medium density DNN engine in cost-sensitive edge devices. With this proposed IP, any existing or new system on chip requiring persistent AI functionality can be built quickly and cost effectively.

    This Small Business Innovation Research (SBIR) Phase I project seeks to develop a cost-effective non-volatile neural network accelerator IP for edge devices. To solve the security, latency, power consumption, and cost issues associated with the traditional approaches, a single-poly based low cost, non-volatile, multi-bit eFlash cell is proposed. Multi-bit cell operation however presents significant challenges due to inherent reduction in signal-to-noise ratio. Key technical hurdles include solving disturbances of unselected cells, improving sensing margin, and overcoming reliability issues associated with high voltage operation in readout circuits as well as developing robust neural network cell arrays. To address these challenges, several new ideas related to multi-bit cell, high-voltage circuits, and cell programming methods have been proposed. Once verified successfully in this project, the multi-bit cell IP can then be integrated as logic compatible non-volatile memory to store neural network parameters on-chip, or as logic compatible non-volatile neural network IP to execute entire neural network operation.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3003 N 1ST ST STE 221
  awardeeCity: San Jose
  awardeeCountryCode: US
  awardeeName: ANAFLASH
  awardeeStateCode: CA
  awardeeZipCode: '951342004'
  fundsObligatedAmt: '224931'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843483'
  piEmail: ssong@anaflash.com
  piFirstName: Seung-Hwan
  piLastName: Song
  piPhone: '6122374629'
  poName: Rick Schwerdtfeger
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Energy Efficient Neural Network Accelerator Featuring a Logic
    Compatible Non-Volatile Synapse Array'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is that enabling processing thin glass substrates for next generation communications and packaging needs will mean faster communications with improved power efficiency.  Society has an ever-expanding need for data, due to technologies such as mobile communications, cloud computing, the Internet of Things (IoT), and the shift of communication to higher frequencies (1s-10s of GHz).  As the frequency increases, traditional material choices, such as silicon, can experience very high losses and therefore there is increasing interest in using insulating materials, such as glass, to improve power efficiency.  Similarly, as device size is also important, ability to process thin materials is also critical.  Successful completion of this work will enable cost-effective processing of thin glass substrates and enable next generation communication initiatives impacting commercial, military and industrial markets.

    This Small Business Innovation Research (SBIR) Phase I project is proposed to enable processing thin glass substrates in high volume environments.  There has been substantial interest in using glass for next generation RF and packaging solutions for many years due to its advantageous material properties, and scalability.  Of particular interest is the dielectric properties, which provide low electrical loss solutions relative to incumbent materials such as silicon.  Furthermore, the smoothness, hermetic properties and scalability of glass provides additional advantages over materials such as ceramics and organic laminates.  There has been a lot of progress in establishing processes to form thin glass and make precision through glass vias (TGV), as well as demonstrating advantaged functional performance in a lab environment.  There has been a challenge to establish the ability to scale to high volume for thin glass solutions due to gaps in the supply chain.  This SBIR project will establish a process that enables a carrier solution using a silicon carrier that will allow processing of glass in existing infrastructure making thin glass solutions available to the current well established and capable supply chain.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 500 LEE RD STE 200
  awardeeCity: ROCHESTER
  awardeeCountryCode: US
  awardeeName: MOSAIC MICROSYSTEMS LLC
  awardeeStateCode: NY
  awardeeZipCode: '146064261'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843230'
  piEmail: shelby.nelson@mosaicmicro.com
  piFirstName: Shelby
  piLastName: Nelson
  piMiddeInitial: F
  piPhone: '5853147441'
  poName: Rick Schwerdtfeger
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Manufacturable Implementation of Thin Glass for Next Generation
    Electronics Packaging'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is to improve high-risk pregnancy care and preterm
    labor detection by developing a noninvasive, low-cost, point-of-care wearable
    electronic patch for pregnancy monitoring in both clinical and home environments.
    Each year, 4 million women give birth in the US. More than one in ten of pregnancies
    is considered high-risk, where the mother, fetus, or newborn has elevated risk
    of experiencing an adverse health condition. The proposed platform will allow
    doctors to remotely monitor and manage high-risk pregnancies and intervene, as
    needed, upon detection of labor or other potential complications. By enhancing
    early detection of fetal well-being and increasing access to care, the device
    will allow for improved healthcare delivery, thus increasing mother and infant
    safety, preventing maternal and neonatal morbidities, and lowering healthcare
    costs. By applying machine learning to what could become the largest and most
    comprehensive dataset on maternal and fetal health, the proposed platform could
    become a valuable resource to researchers to identify underlying causes and biomarkers
    of preterm birth. Primary end users are women with high-risk pregnancies, and
    elevated risk of preterm birth. Target customers are hospitals, health care providers
    and insurance companies. \n\nThis Small Business Innovation Research (SBIR) Phase
    I project seeks to develop an unprecedented means to support advances in maternal
    and fetal health: a state-of-the-art miniaturized mobile monitor that discretely
    sticks onto the mother's abdomen and uses sensors to noninvasively monitor fetal
    heart rate (FHR) and other physiological parameters in home and clinical environments.
    The device communicates to a smartphone, which acts as gateway to send data to
    a cloud-based platform, where the data is collected, stored and analyzed, with
    doctors able to set notification thresholds. For this project, patch technology,
    proven to effectively measure uterine activity and fetal movement will be leveraged
    to develop a disruptive product capable of detecting FHR as early as 25 weeks
    gestation. Miniaturization, power consumption and cost levels necessary for deployment
    in remote settings will be achieved. A usability study of the prototype monitor
    will then be conducted in expectant women in hospital settings, followed by an
    equivalency study to validate accuracy of the prototype compared to cardiotocogram,
    the current clinical gold standard. This solution will increase specificity of
    FHR testing, and improve interpretation of monitoring data, as well as aggregate
    data to train AI models to predict adverse events such as preterm birth.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 1931 MCALLISTER ST Unit D
  awardeeCity: San Francisco
  awardeeCountryCode: US
  awardeeName: Bloomlife, Inc.
  awardeeStateCode: CA
  awardeeZipCode: '941154330'
  fundsObligatedAmt: '224890'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843361'
  piEmail: eric@bloomlife.com
  piFirstName: Eric
  piLastName: Dy
  piPhone: '4152154251'
  poName: Benaiah Schrag
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  A noninvasive, low-cost, point-of-care wearable electronic
    patch for continuous pregnancy monitoring'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be to improve security of cloud computing without sacrificing performance and cost efficiency. Cloud computing has proven to be a disruptive technology in the Information Technology (IT) sector, and the application container market is a rapidly growing segment of this sector. Although containers provide a simpler and more efficient apparatus to host applications in the cloud, there are important problems to address, such as weak security isolation, low kernel compatibility, and poor kernel customization. Security is the most common concern because one infected kernel can affect a multitude of containers. So far, each organization that has adopted container applications has been required to independently ensure their own security. One study found that a majority (54% of participants) ran containers on top of virtual machines (VMs) for security isolation, which sacrifices performance and cost efficiency. Thus, there is a significant need to provide a container architecture that supports greater security without sacrificing performance and cost efficiency. This project addresses this urgent need, and the resulting technology can be applied broadly to domains such as cloud computing, Information Technology (IT) infrastructures, Network Function Virtualization (NFV), etc.

    This Small Business Innovation Research (SBIR) Phase I project will further improve usability, security, and efficiency of a novel software application container architecture, so that it can be easily deployed and evaluated by customers. While the current platform can run Docker containers without modifications, it is incompatible with the Docker and Kubernetes orchestration platforms, which is a probable obstacle to adoption for many container users and developers. The novel containers can run unmodified iterations of existing applications and automatically optimize performance of many applications by patching the binary during runtime. However, it is challenging to handle complicated scenarios in the application binary, and a more sophisticated technique is required to further improve the coverage of the automatic binary optimization module. Due to the licensing requirements of some of the software the novel container platform is based on, the research prototype is run open-source. The goal of this project is to address these limitations and challenges through five major objectives: support Docker and Kubernetes ecosystem compatibility; improve automatic binary optimization coverage; re-design the platform to avoid open-source license violations; further improve security; develop an automatic installation tool and a product demonstration.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 154 LEXINGTON DR
  awardeeCity: ITHACA
  awardeeCountryCode: US
  awardeeName: EXOTANIUM, INC.
  awardeeStateCode: NY
  awardeeZipCode: '148501719'
  fundsObligatedAmt: '224967'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842846'
  piEmail: zhiming.shim@gmail.com
  piFirstName: Zhiming
  piLastName: Shen
  piPhone: '6072293395'
  poName: Peter Atherton
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  X-Containers: Fast, Secure Containers for a Cloud-Native
    World'
- abstractText: |-
    This SBIR Phase I project will help to address a critical need for patients who have suffered an infection in a total knee replacement joint.  Unfortunately, doctors have few good options for effectively treating this type of infection to avoid the potential for limb amputation or even death should the infection persist and spread.  Today, treatment requires surgical replacement of part or all of the existing implant while using oral or intravenous antibiotics.  Due to the capsule around the joint (isolated from blood vessels) these methods deliver marginal amounts of antibiotic within the knee where the bacteria reside.  Patients suffer elongated treatment, many times without the use of their knee, waiting for the bacterial infection to slowly resolve.   ForCast Orthopedics' Antibiotic Dispensing Knee Spacer provides a refillable reservoir within the artificial knee that can distribute antibiotic directly into the knee capsule for effective infection treatment.  Physicians can prescribe the antibiotic most appropriate for the bacteria diagnosed.  The patient returns to the doctor's office once per week for a checkup and antibiotic refill injection until the infection is cured.  No follow up surgery is required. Duplicating the antibiotic delivery of previous successful clinical studies (using representative but intolerable daily injections) should result in similar highly successful patient outcomes, reduced patient suffering and reduced healthcare costs.

    This SBIR Phase I project addresses an underserved clinical need for improved treatment of Periprosthetic Joint Infection (PJI).  Today, doctors have few good options for treatment to avoid the potential for limb amputation or even death should PJI persist and spread.  All methods require surgical debridement and replacement of part or all of the existing implant (to reduce bacterial load) while using oral or intravenous antibiotics that cannot reach the remaining bacteria within the knee capsule (blood/synovial fluid barrier). Temporary eluting antibiotic spacers and beads are too short lived. Patients suffer elongated treatment, many times without a load-bearing knee.  ForCast Orthopedics is developing an Antibiotic Dispensing Spacer (AD Spacer) to replace the standard spacer in a total knee implant.  The AD Spacer provides a refillable reservoir to hold the antibiotic of choice for the bacteria identified and a delivery system to maintain a therapeutic concentration within the knee for the entire therapy duration, typically a minimum of 6 weeks. As a permanent spacer, no further surgery is required after treatment.  Emulating the delivery characteristics of previously successful clinical studies (using intolerable daily injections) should result in similar highly successful patient outcomes, reduced morbidity and reduced total cost of care.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 6224 TREVARTON DR
  awardeeCity: LONGMONT
  awardeeCountryCode: US
  awardeeName: FORCAST ORTHOPEDICS INC
  awardeeStateCode: CO
  awardeeZipCode: '805039095'
  fundsObligatedAmt: '224872'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842958'
  piEmail: JCASTLEBERRY@FORCASTORTHO.COM
  piFirstName: Jeff
  piLastName: Castleberry
  piPhone: '3035034818'
  poName: Henry Ahn
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'SBIR Phase I:  Antibiotic Dispensing Spacer for improved treatment of PJI
    in TKA'
- abstractText: |-
    The broader impact/commercial potential of this project affects one of the most critical problems facing the United States agricultural industry, a shortage of available labor.   This shortage has had a particularly pronounced effect on the fruit and vegetable industry, where even a brief loss of labor can result in a total loss of harvestable products.  More recently, U.S. produce suppliers have been forced to rely heavily on imported produce sourced from greater distances and of lower quality.  Advancements in agricultural technology have already dramatically improved the efficiency of produce farms in terms of land utilization and water consumption by enabling produce to be grown indoors using highly sophisticated commercial greenhouses, automated nutrient delivery, and light control.  However, to date, these commercial greenhouses still lack a comprehensive solution for automating routine harvesting, pruning, and crop care labor tasks.  Thus, newly developed agricultural technologies which can automate these tasks have the potential for substantial commercial impact by making domestic farming operations more profitable and efficient.  Commercial adoption of automated harvesting technology will also benefit consumers by enabling higher quality produce grown closer to market and position the U.S. agricultural sector as a new area of growth for highly skilled technical jobs.

    This Small Business Innovation Research (SBIR) Phase I project will focus on the development of new deep learning techniques used to identify harvestable fruits (initially tomatoes) using computer vision cameras and to accurately estimate their orientation and connectivity (bunches of fruits that are connected by the same stem or vine).  Successful development of a method capable of running in real-time would resolve substantial technical risks which inhibit the ability to commercialize robotic automated harvesting solutions.  Such advancements would also contribute newfound insights to the broader computer vision and robotic manipulation communities into the unique challenges that sparse and deformable ?vine? like structures present to traditional methods of object pose estimation and grasping.  In the later portion of this Phase I project, Root AI will incorporate these new methods of sensing tomato fruit orientation into an improved motion and task planning system which uses the additional information to intelligently plan a complex movement path to harvest individual fruits in congested and heavily occluded natural growing environments.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 444 SOMERVILLE AVE
  awardeeCity: SOMERVILLE
  awardeeCountryCode: US
  awardeeName: ROOT AI, INC.
  awardeeStateCode: MA
  awardeeZipCode: '021433260'
  fundsObligatedAmt: '220982'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843379'
  piEmail: jlessing@root-ai.com
  piFirstName: Joshua
  piLastName: Lessing
  piPhone: '9178553989'
  poName: Muralidharan Nair
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Real-Time Pose and Grasping Affordance Estimation for Vine
    Crops'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the development of a single beam ion source that enables the manufacturing of high-quality thin film materials and related products. Thin films have a significant impact on quality of life as they are used widely in semiconductor devices, displays, solar panels, tribological coatings, cell phones, optical filters, and micro-electro-mechanical systems. The annual market of these industry segments exceeds $600 billion and has been steadily increasing. Common methods to produce thin films include physical and chemical vapor depositions, which today have tradeoffs between film quality and manufacturability. A high deposition rate results in loosely packed atoms and subsequently unstable materials properties. Producing high-quality dense films today requires slow deposition at elevated temperatures leading to high manufacturing cost and other limitations, such as inability to use flexible substrates. Ion sources are plasma generation devices that enable ion beams to interact with materials at the atomic level and efficiently produce dense films. The single beam ion sources bring in multiple benefits for thin film fabrication, including superior stability, improved adhesion, low electrical resistivity, high optical transmittance, and smooth surfaces.

    This Small Business Innovation Research (SBIR) Phase I project will validate the technical and commercial feasibilities of the single beam ion sources particularly suitable for fabricating high-quality thin films and devices. In ion beam assisted thin-film deposition, ions simultaneously interact with the atoms as they are deposited from another source. The ions transfer kinetic energies to the surface atoms so that they can move around to form densely packed films. The single beam ion sources proposed in this project can produce a highly focused beam of ions with tunable energy for optimal processing of the growing films. These unique features are enabled by an innovative design of the electromagnetic fields, which efficiently generate plasmas and extract the ions in a narrow beam. Unlike the conventional racetrack type ion sources, the single beam ion sources can accurately control the ion incident angle, which has strong effects on the surface morphology of the deposited film.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2697 Elderberry Dr
  awardeeCity: Okemos
  awardeeCountryCode: US
  awardeeName: Scion Plasma LLC
  awardeeStateCode: MI
  awardeeZipCode: '488644602'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842740'
  piEmail: mshrestha@scionplasma.com
  piFirstName: Maheshwar
  piLastName: Shrestha
  piPhone: '6056514676'
  poName: Rick Schwerdtfeger
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Single Beam Ion Sources for Advanced Materials Processing'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project technology has potential to be transformative in power
    generation.  The ultimate goal of this project is to produce aneutronic fusion
    energy in a system that is small, simple and inexpensive.  This system will produce
    power that is as clean as renewable energy while simultaneously removing the need
    for energy storage that is required for intermittent sources like wind and solar
    power.  It utilizes new, innovative physics which has not been incorporated in
    fusion devices before.\n\n \tThis SBIR Phase I project proposes to study a plasma-based
    fusion device which has two rings that oscillate in the axial and radial directions.
    \ The rings will be confined in an axial harmonic oscillator potential.  The two
    rings collide with one another axially when both rings have their maximum axial
    velocities. Fusion occurs primarily from the relative velocities of the rings,
    not from the thermal energy in the plasma.  This will allow for the use of advanced
    aneutronic fuels.  The primary goal of the phase I is to evaluate the theoretical
    feasibility of this system.\n\nThis award reflects NSF's statutory mission and
    has been deemed worthy of support through evaluation using the Foundation's intellectual
    merit and broader impacts review criteria."
  awardeeAddress: 274 DP RD
  awardeeCity: Los Alamos
  awardeeCountryCode: US
  awardeeName: TIBBAR PLASMA TECHNOLOGIES INC.
  awardeeStateCode: NM
  awardeeZipCode: '875443231'
  fundsObligatedAmt: '224780'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1841031'
  piEmail: r_nebel@hotmail.com
  piFirstName: Richard
  piLastName: Nebel
  piPhone: '5056620867'
  poName: Anna Brady-Estevez
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  A  Plasma Heat Engine for Efficient Production of Fusion
    Energy'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to develop a widely applicable, innovative pipeline for drug discovery against rare genetic disorders. While each orphan disease affects a small fraction of individuals, thousands exist, affecting 400 million people world-wide. The challenge to bring therapies to the clinics for diseases that currently have no cure, which is coupled with an expanding market.  Orphan drug sales are expected to reach $262 billion in 2024.  Over the last few years, organoids made from human embryonic stem cells have raised the possibility of understanding the mechanisms leading to a genetic disorder by reconstituting, in vitro, a similar arrangement of the specific cell populations that are implicated in a certain disease. By comparing organoids made from healthy cells to those carrying the associated genetic mutation, drug testing may be performed in vitro to discover new therapeutics. However, this potential has not been harnessed due to technical limitations. In this proposal, as a necessary step towards this goal, the plan is to develop the analytical tools based on machine learning algorithms that will allow the analysis of drug therapeutic potential and toxicity when applied to organoid cultures.

    The intellectual merit of this STTR Phase I project is to develop and validate an unbiased analytical scheme to quantify the results of high-throughput phenotypic screens performed on micropattern organoids. Organoids have the potential to revolutionize the pre-clinical part of the drug discovery pipeline as they provide unbiased endpoints, they are disease relevant, and sensitive to toxicity. However, the use of multi-cellular organization in a high-throughput platform requires analysis of large amounts of information-rich microscopy images. The tools developed in this proposal will allow turning the biological complexity of tissue scale phenotypes into information predictive of the clinical potential of a compound. In the first aim, the goal is to demonstrate that the proposed method allows quantifying compound toxicity. The plan is to calibrate the toolbox against known methods quantifying cell viability, applying known toxic agents and withdrawn drugs. This will constitute a stringent test for the efficiency of the proposed method at quantifying deleterious effects of a compound. Second, the goal is to optimize the algorithm to measure therapeutic potential, using positive controls on micropattern-based organoids modeling Huntington's Disease (HD). The objective is to demonstrate the ability to analyze results of a screening campaign aimed at phenotypic reversal on the HD organoids, and detect hit molecules from a small library of FDA-approved drugs.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 953 INDIANA ST
  awardeeCity: SAN FRANCISCO
  awardeeCountryCode: US
  awardeeName: RUMI SCIENTIFIC, INC.
  awardeeStateCode: CA
  awardeeZipCode: '941073007'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1843570'
  piEmail: arjun@rumiscientific.com
  piFirstName: Arjun
  piLastName: Adhikari
  piMiddeInitial: S
  piPhone: '7183163160'
  poName: Ruth Shuman
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'STTR Phase I:  A Machine Learning Toolbox to Identify Therapeutics for Rare
    Genetic Disorders from Phenotypic Screens on Micropattern-Based Organoids'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be to create an abuse-free and ad-free social network based on principles of affirmative consent using a novel hybrid human-machine moderation technology. Harassment and abuse plague current social platforms. This abuse is particularly directed towards women, people of color, and the LGBTQ community, who are most vulnerable to these types of attacks. These demographics around the world need a harassment-free social network platform to communicate and share content and would be willing to pay a subscription fee. In addition, independent "new media" content creators also need an advertising-free and harassment-free platform to build an audience, interact with followers or fans, control access to paid content, and receive payment for their work. Users who have fled other platforms due to harassment, data mining, or personal privacy concerns may also want friendly and safe spaces to interact and share content. In addition to subscription fees, this novel moderation technology has the potential to be offered as a service to other social network businesses.

    This Small Business Innovation Research SBIR Phase I project takes a novel consent-based approach to social network moderation. The project combines data from multiple sources, including machine learning models, in order to give users more control over the content they wish to see and prevent harassment and abuse. By supplementing automated approaches with human ones, and putting users in control of which sources of moderation content and metadata to trust, this innovation will reduce the labor required for human moderation and the accuracy of machine approaches, all while making relatively strong guarantees that the most vulnerable users will not be exposed to abuse or harassment.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 220 Collingwood St Ste 140
  awardeeCity: Ann Arbor
  awardeeCountryCode: US
  awardeeName: Sassafras Tech Collective
  awardeeStateCode: MI
  awardeeZipCode: '481036226'
  fundsObligatedAmt: '224821'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842949'
  piEmail: jill@sassafras.coop
  piFirstName: Jill
  piLastName: Dimond
  piPhone: '2067991190'
  poName: Muralidharan Nair
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Social Platform with Machine Learning Moderation'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be to develop a microfluidic device for cell therapy manufacturing. Advantages in terms of cost and quality of the cell products produced by the proposed technology should benefit clinical researchers and cell therapeutics. Further, by providing an efficient, standardized, and scalable approach to the manufacturing process, the translation of lab-scale discoveries to curative therapies that are widely-available should be significantly accelerated.  On a fundamental level, this project will enhance technological understanding of how to apply microfluidic technology concepts to clinically-relevant applications (requiring macroscopic flowrates) in a practical manner, while also establishing a new medical device sector centered on a suite of easily implemented cell separation devices for use in cellular therapies and related fields.

    The intellectual merit of this SBIR Phase I project is to employ a cell separation approach to create a high-throughput proof-of-concept prototype to help simplify and streamline the manufacture of cellular therapies.  To accomplish this objective, a two-stage microfluidic module will be designed to achieve isolation of separate lymphocyte- and monocyte-rich subpopulations from blood samples, while removing undesirable red blood cells and platelets, at levels sufficient for successful culture growth.  In addition, the plan is to fabricate a full-scale prototype system of parallelized lymphocyte/monocyte isolation modules to achieve a volumetric throughput capable of processing 200mL of peripheral blood-, buffy coat-, or mononuclear cell (MNC) leukapheresis-derived product within ~30 minutes.  Once developed, this technology will overcome many drawbacks that plague current cell isolation approaches including high per unit cost, laborious/time-consuming workflow, and potential to compromise sterility. This device will require no expensive or complex equipment on-site to drive the separation/concentration of the cells of interest.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2319 BRIGHTON PARK LN
  awardeeCity: FRIENDSWOOD
  awardeeCountryCode: US
  awardeeName: HALCYON BIOMEDICAL, INCORPORATED
  awardeeStateCode: TX
  awardeeZipCode: '775463357'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843623'
  piEmail: scgifford@halcyonbiomedical.com
  piFirstName: Sean
  piLastName: Gifford
  piPhone: '6174593915'
  poName: Ruth Shuman
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'SBIR Phase I:  A New Approach for Isolating Leukocyte Sub-populations to
    Enable Efficient Manufacturing of Cellular Therapies'
- abstractText: |-
    This SBIR Phase I project examines the feasibility of using magnetic sensors based on Acoustically Driven Ferromagnetic Resonance (ADFMR) for neurological imaging. Information about brain activity is critical to the diagnosis and treatment of a variety of disorders including epilepsy, traumatic brain injury, and Alzheimer's disease. The most powerful non-invasive technique for measuring brain activity, magnetoencephalography (MEG), uses magnetometers that require liquid helium cooling and magnetic shielding to operate. Due to these requirements, current MEG systems are large and expensive, limiting their adoption and accessibility. ADFMR sensors could allow for the measurement of biomagnetic fields without the need for cryogenics and magnetic shielding, dramatically reducing the size, cost, and power consumption of such systems. The portability of this improved technology would allow for functional neuroimaging outside of the carefully controlled imaging suites where it is possible today. This could allow for diagnosis of previously unreachable patients (ie. in the ICU, operating room, or ambulance) as well as the development of new uses for this technology (ie. long-term monitoring, scanning during movement). This improved, portable MEG could also enable the first practical, portable brain-computer interface ? applicable across a wide variety of applications in both defense and consumer sectors.

    This SBIR Phase I project investigates the ability for ADFMR sensors to measure extremely small magnetic fields, such as those generated by the human brain. The ADFMR phenomenon has been shown to be a much more power and size efficient alternative to traditional methods of exciting ferromagnetic resonance, allowing for its use as a sensing mechanism for chip-scale magnetometers. In the proposed program, a number of methods to improve the performance of current ADFMR devices will be investigated. First, a compact model will be developed to allow for fast modeling of ADFMR devices and their associated detection circuitry. Using the results of this model, devices will be fabricated in order to experimentally validate various mechanisms for the reduction of 1/f noise in the detector circuitry and for the optimization of the ADFMR absorption profile for maximum sensitivity to applied magnetic fields. These sensor elements will initially be tested using standard benchtop characterization equipment. Following a benchtop demonstration, challenges in miniaturizing the full sensor system will be addressed by developing fully integrated magnetometer prototypes.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1832 FRANCISCO ST
  awardeeCity: BERKELEY
  awardeeCountryCode: US
  awardeeName: SONERA MAGNETICS, INC
  awardeeStateCode: CA
  awardeeZipCode: '947031313'
  fundsObligatedAmt: '224996'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843519'
  piEmail: dom@soneramagnetics.com
  piFirstName: Dominic
  piLastName: Labanowski
  piPhone: '6143271618'
  poName: Henry Ahn
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Evaluating ADFMR magnetometers for portable, non-invasive
    functional bioimaging'
- abstractText: |-
    The broader impact/commercial potential of this project is that it addresses the injection molding industry which generates over $100 billion in revenue in the US alone. The proposed multivariate shrinkage sensor promises a leap forward from the current use of in-mold pressure/temperature sensors for indirect estimation of molded part dimensions and quality. Direct measurement of the shrinkage along with pressure and temperature in situ from the proposed sensor will enable improved process and quality control methods for injection molding which will eliminate the burden of frequent post-molding inspections and allow fully automated manufacturing. As a result, over 30 % of manufacturing cost and time will be saved while achieving 100% quality assurance even for the parts with tighter specifications. The proposed sensor will help heavily regulated industries such as medical devices and automobile manufacturing in achieving significant time reduction for process set-up and stabilization, and improvement in parts quality while meeting stringent regulatory requirements. Each percentage point improvement in productivity due to cycle time reductions, yield improvements, and related automation corresponds to cost savings of more than $1 billion per year in the United States alone while reducing the energy consumption and environmental waste related to molding, discarding, and recycling of defective plastic parts.

    This Small Business Innovation Research Phase I project provides a creative and original concept: a multivariate design for measuring shrinkage along with pressure and temperatures via a conventionally packaged device. Furthermore, knowledge and understanding are expected to be advanced in the development and validation of improved on-line models for estimating molded part shrinkage in real-time. Previous research did not have access to in-mold shrinkage data and so propagated faulty initial conditions throughout the shrinkage analysis. Due to the lack of direct observability and controllability of the molded part dimensions, most molders rely on the use of cavity pressure traces or part weight measurements as estimators of the part dimensions. However, there still is no technology or research available to monitor and predict the shrinkage on-line during production to improve, to optimize and to control parts quality and processing parameters without using expensive instrumentation. The outcome of this Phase I project will fill this gap and develop a fully functional multivariate shrinkage sensor which will enable measurement of molded product dimensions in situ prior to ejection from the mold.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 8120 Penn Ave S Ste 100-D
  awardeeCity: Bloomington
  awardeeCountryCode: US
  awardeeName: LEONINE TECHNOLOGIES INC.
  awardeeStateCode: MN
  awardeeZipCode: '554313114'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843921'
  piEmail: rahul.panchal@leoninetech.com
  piFirstName: Rahul
  piLastName: Panchal
  piMiddeInitial: R
  piPhone: '9789960440'
  poName: Muralidharan Nair
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Multivariate Shrinkage Sensor For Injection Molding'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop technology for single-cell RNA sequencing (scRNA-seq).  Single-cell RNA-sequencing has emerged as one of the best tools to catalogue cell types and understand their function.  The key advantage of scRNA-seq is that it provides transcriptome-wide information about individual cells in heterogeneous samples while alternative methods either provide information about only a limited set of genes (e.g., flow cytometry, qPCR) or cannot provide single-cell resolution (bulk RNA-seq, microarrays).  However, current scRNA-seq approaches remain expensive, enable only limited sample multiplexing, and are not compatible with common sample storage conditions. This project will focus on the key technical challenges that are required to develop universally applicable scRNA-seq kits that meet customer needs. If successful, the end product will be a scRNA-seq kit that is ready for pilot testing with academic and pharmaceutical company customers. By reducing the cost and increasing sample size and sample multiplexing of scRNA-seq, the technology will improve the ability to understand multicellular systems and enhance workflows used in the pharmaceutical industry, such as drug screening and patient stratification.

    The intellectual merit of this SBIR  Phase I project is to develop a single-cell RNA sequencing (scRNA-seq) method by using a combinatorial barcoding scheme that labels transcripts within fixed cells.  The proposed technology makes it possible to measure the transcriptional profiles of hundreds of thousands of individual cells in parallel. Unlike previous scRNA-seq technologies, the technology also enables high sample multiplexing (up to 96 samples/experiment), is compatible with stored samples, and fixes cells before dissociation, reducing the risk of perturbations to gene expression during cell handling. Most importantly, the method requires no complex instruments, which contributes to making the technology an order of magnitude less expensive than existing technologies. The objectives of this project are to dramatically improve the number of molecules detected per cell and to simplify the workflow for users. Modifications to assay chemistry will be tested to increase molecular detection, and time-consuming steps in the workflow will be altered to shorten the overall experimental time and reduce the probability of user error.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 10719 EXETER AVE NE
  awardeeCity: SEATTLE
  awardeeCountryCode: US
  awardeeName: SPLIT BIOSCIENCES, INC.
  awardeeStateCode: WA
  awardeeZipCode: '981256941'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1854072'
  piEmail: alex@splitbio.com
  piFirstName: Alexander
  piLastName: Rosenberg
  piMiddeInitial: B
  piPhone: '7732944109'
  poName: Ruth Shuman
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Development of a stand-alone kit for high-throughput and
    low-cost single-cell RNA sequencing'
- abstractText: |-
    This SBIR Phase I project is dedicated to building a scalable project-based learning education technology platform. The technology in this project is based on a chatbot that sustains ongoing, interdisciplinary conversations with each student. The platform is designed to provide middle school students with curriculum materials that expose them to authentic and engaging real-world problems that, over the course of weeks or months, come together to form a cohesive response to a project prompt. The goal of this project is to build and refine this new form of eLearning platform that has the potential to greatly improve engagement and learning outcomes, especially for low-income and minority students. This goal will be achieved by making the standards-aligned educational content meaningful and relevant to the interests of students and by catering the instructional materials to each individual student's skill level so they can move through the materials at their own pace towards mastery. To measure the impact of this technology on student outcomes, this project will involve state-of-the-art efficacy research in accordance with guidelines in the Every Student Succeeds Act (ESSA).


    This SBIR Phase I project is concerned with developing a forward-looking education platform built around a chatbot that sustains long term, goals-oriented conversations powered by artificial intelligence (AI) and based on a decision tree architecture. The highly-customized chatbot is designed to make project-based learning scalable by empowering students to choose and customize their own project theme from a set of options, and then providing conversational explanations and practice questions that illustrate how Common Core standards apply to the student?s project. This research undertaking will involve developing and training custom neural networks to interpret student responses and questions. It will also involve developing algorithms that correctly identify each student's level of reading comprehension and, independently, conceptual understanding. With an understanding of the student's level, another algorithm will be developed that selects the appropriate materials and resources at the student?s reading comprehension level. These algorithms will be refined through user testing and a preliminary study of the efficacy of this education intervention will be tested in a correlational study with statistical controls.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 74 Middlefield Rd
  awardeeCity: Atherton
  awardeeCountryCode: US
  awardeeName: Engaging Education Inc
  awardeeStateCode: CA
  awardeeZipCode: '940273020'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843358'
  piEmail: ninalhooper@gmail.com
  piFirstName: Nina
  piLastName: Hooper
  piMiddeInitial: L
  piPhone: '6179998734'
  poName: Rajesh Mehta
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Increasing Student Engagement with Scalable Project-based
    Learning'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is to develop technology using engineered bacteria
    to improve protein stability in two large markets: therapeutic proteins and industrial
    enzymes. Proteins used as therapeutics frequently have insufficient half-lives
    in human blood plasma, so that patients with chronic disease need to receive frequent
    dosings, often by painful injections. These burdensome dosing schedules result
    in high rates of patient noncompliance, with attendant poor responses and negative
    health outcomes. Therapeutic proteins with improved half-lives in blood plasma
    would permit relaxed dosing schedules, lowering costs of administration and improving
    outcomes by reducing noncompliance. This proposed technology focuses on improving
    the plasma half-life of a therapeutic for a chronic disease primarily affecting
    children that currently comprises a $4B global market. Similarly, industrial enzymes
    are frequently deployed in harsh environments that impair enzyme stability and
    activity. Endowing enzymes with improved resistance to destabilizing chemicals
    would enable their deployment in high-value environments that are currently prohibitive.
    The proposed technology will be used to stabilize an enzyme for application in
    a $730M segment of the personalized medicine market. If successful, this work
    would provide a platform for developing next-generation enzymes deployable in
    currently prohibitive environments. \n\nThe intellectual merit of this SBIR Phase
    I project is to utilize a synthetic biology platform to create proteins with new
    amino acid building blocks that dramatically improve half-life and stability.
    Many proteins used as therapeutics or used as industrial enzymes are stabilized
    by disulfide bonds. These bonds break in the presence of chemicals called reducing
    agents that are found both in human blood plasma (destabilizing to therapeutics)
    and in solvents and buffers (destabilizing to industrial enzymes). Using a strain
    of engineered E. coli that can incorporate amino acids beyond the 20 standard
    amino acids into proteins, the goal is to replace disulfide-forming cysteine amino
    acids with selenocysteine amino acids that form bonds called diselenides. Diselenide-stabilized
    proteins maintain stability and activity in environments with reducing agents
    incompatible with disulfide-stabilized proteins. This project will produce a diselenide-stabilized
    protein therapeutic for a major disease class. Improvements to disulfide-stabilized
    therapeutics will be demonstrated by ELISA assays showing improved binding activity,
    and by cell-based assays showing improved therapeutic activity, after prolonged
    exposure to blood plasma. This project also will produce a diselenide-stabilized
    industrial enzyme to catalyze a critical reaction for personalized medicine. Performance
    improvements over disulfide-stabilized enzymes will be demonstrated by in vitro
    stability and activity assays in reducing conditions.\n\nThis award reflects NSF's
    statutory mission and has been deemed worthy of support through evaluation using
    the Foundation's intellectual merit and broader impacts review criteria."
  awardeeAddress: 131 FULLER ST UNIT 3
  awardeeCity: BROOKLINE
  awardeeCountryCode: US
  awardeeName: GRO BIOSCIENCES INC
  awardeeStateCode: MA
  awardeeZipCode: '024465711'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842697'
  piEmail: dan.mandell@grobio.com
  piFirstName: Daniel
  piLastName: Mandell
  piMiddeInitial: J
  piPhone: '6179038359'
  poName: Ruth Shuman
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Synthetic biology platform for production of stabilized high-value
    proteins'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to bring curative gene editing therapies using CRISPR to patients with genetic diseases. CRISPR-based therapeutics have the potential to be next generation therapeutics, particularly for genetic diseases due to their ability to cut DNA with sequence specificity. However, this type of targeted genome editing has not yet been successfully demonstrated for human therapeutics with existing methods.  The translation of CRISPR-based gene editing to the clinic remains a significant unmet need and the most difficult aspect of translating CRISPR-based gene editing into therapeutics is the lack of safe and effective delivery methods to the target the tissues. Existing viral-based delivery systems have limitations that include immunogenicity, pre-existing antibodies against them, broad tropism, off-target effects, restricted DNA cargo packaging capacity, and manufacturing challenges. As a result, non-viral methods that employ synthetic materials are being widely investigated as potential alternatives. Developing non-viral delivery vehicles that can effectively deliver CRISPR components to target tissues will improve the ability to broadly use CRISPR-based therapeutics for many genetic diseases.

    The intellectual merit of this SBIR Phase I project is to develop a non-viral delivery system for the CRISPR enzyme Cas 12a (Cpf1) for delivery to target muscle tissue, and, potentially, enable the development of a novel gene editing treatment for Duchenne muscular dystrophy (DMD). The approach involves proprietary CRISPR-nanoparticles that are composed of peptide PEG-PAsp(DET) complexed to Cpf1 RNP, which possess good biocompatibility and high gene editing efficiency with the potential to manufacture and scale up under GMP for use in clinical trials. Preliminary data demonstrate that PEG-PAsp(DET) complexed to Cpf1 RNP can efficiently deliver Cpf1 RNP to the muscle tissue and can induce the expression of the dystrophin protein by deleting exon23 with a mutation. Under this proposal, the specific experiments will focus on improving the biocompatibility, stability, and muscle-targeting ability of the CRISPR-nanoparticles. The experimental plan is to synthesize various Peptide-PEG-PAsp(DET), followed by screening in primary myoblasts and reporter mouse system. This technology using CRISPR-nanoparticles will be the first example of a delivery vehicle that can simultaneously deliver Cpf1 protein and gRNA via intravenous injection and achieve gene editing.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 140 Hearst Mining Bldg
  awardeeCity: Berkeley
  awardeeCountryCode: US
  awardeeName: GenEdit Inc
  awardeeStateCode: CA
  awardeeZipCode: '947201760'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1844019'
  piEmail: lkw0922@gmail.com
  piFirstName: Kunwoo
  piLastName: Lee
  piPhone: '5109992091'
  poName: Ruth Shuman
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'SBIR Phase I:  A block copolymer delivery system for the Cpf1 ribonucleoprotein'
- abstractText: "This SBIR Phase I project will test the feasibility of incorporating
    a novel vaccine technology to diphtheria, tetanus, and acellular pertussis (DTaP)
    vaccine to produce a thermostable and orally administered formulation. Vaccines
    are one of the best investments in global public health and are estimated to save
    2-3 million lives per year and protect more than 100 million lives from illness
    and disability. This project proposes to use a novel vaccine technology platform
    that targets immune cells in the intestine, enducing a broad immune response,
    and retains stability at room temperature. This technology has the potential to
    minimize dependence on the cold-chain and trained medical professionals to administer
    the vaccine, which are barriers to full vaccine coverage. Additionally, it has
    potential to increase uptake of vaccine booster doses for adults, with convenience
    of self-administration and reduced anxiety with no needles. Finally, successful
    formulation of an oral DTaP vaccine would open the doors to other antigens to
    be delivered orally. This technology can significantly improve national health,
    which is one of the missions of NSF. Additionally, switching vaccines to thermostable,
    oral delivery form is very cost-effective and will alleviate the burden and cost
    of cold-chain and professional to administer the vaccines. \n\nThis SBIR Phase
    I project will test the application of a novel delivery technology to the DTaP
    vaccine. The highly innovative delivery platform consists of a novel adjuvant,
    a C-type lectin (CTL) receptor ligand with aluminum hydroxide that targets mucosal
    immune cells for a strong synergistic boosting of broad immune response, and microencapsulation
    of the vaccine to resist the strong acidic environment of the stomach. This technology
    can be incorporated into existing or new vaccines enhancing stability and allowing
    oral delivery. The first goal of this project includes incorporation of CTL receptor
    ligand to the DTaP vaccine and applying enteric microencapsulation to the particles
    to protect the vaccine from low pH. Extensive testing and experiments will be
    conducted to obtain the optimal formulation of the final oral vaccine. The second
    goal will be to test and compare the potency of the newly formulated vaccine with
    a commercially available DTaP vaccine in mice. The final goal will be to test
    and compare the stability of both vaccines at high temperatures. Successful completion
    of all objectives will provide a great base for commercial feasibility of the
    technology. This technology has the potential to be incorporated on any vaccine
    that can benefit from a thermostable and orally delivery platform.\n\nThis award
    reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 2213 EVENING SUN RD
  awardeeCity: NAZARETH
  awardeeCountryCode: US
  awardeeName: VAXFORM, LLC
  awardeeStateCode: PA
  awardeeZipCode: '180641462'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843518'
  piEmail: garry.morefield@vaxform.com
  piFirstName: Garry
  piLastName: Morefield
  piPhone: '6105739620'
  poName: Henry Ahn
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Incorporation of a new adjuvant system to produce a thermally
    stable, orally administered Diphteria-Tetanus-Pertussis vaccine'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is to develop a novel seed treatment technology
    for plants, based on small naturally occurring molecules proven to activate natural
    defenses against a wide range of agriculturally important pathogens. The proposed
    innovation as a plant protectant is active at very low concentrations (nM range),
    can be readily synthesized in large quantities, and is biodegradable and non-toxic.
    To feed a projected world population of over 9 billion people in 2050, innovation
    will be required at all stages of crop production and distribution. Annual application
    of more than 600 different chemical pesticides (500 million Kg) costs $10 billion,
    and yet 37% of all crops are still destroyed by pests (insects 13%, pathogens
    12%, weeds 12%). By providing an alternative, effective method for managing transmissible
    diseases in major crops, dependence on existing agrochemicals such as copper,
    synthetic fungicides and antibiotics will be reduced, as will the rate of resistance
    development. The goal is to improve the economic and environmental sustainability
    of agriculture by reducing the use of potentially harmful pesticides, and significantly
    enhance food security worldwide. \n\nThe intellectual merit of this SBIR project
    is to develop a novel control for plant pathogens by leveraging a class of small,
    naturally occurring molecules that elicit specific immune responses in plants.
    These small molecules are recognized by plants at extremely low concentrations,
    and their perception has been demonstrated to result in defense responses and
    enhanced resistance to viral, bacterial, oomycete, and fungal pathogens, in Arabidopsis,
    tomato, potato, barley, and wheat. In order to bring the innovation to market
    in the form of a commercial seed treatment, the following must be demonstrated:
    a seed-coating formulation capable of long-term stability and efficacy, without
    adverse effect on seed germination or natural microbe/insect populations. The
    focus of the proposed Phase I project will be to optimize synthesis of the compound
    of interest and develop a stable, commercially viable formulation that is effective
    across a breadth of crops. Following initial validation, product testing will
    advance to in vivo efficacy testing in greenhouse and field trials. The seed treatment
    product developed will establish the technical and economic feasibility of using
    small-molecule signals to activate plant immune responses, and demonstrate their
    utility to improve economic and environmental sustainability of agriculture.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 950 Danby Road, Suite 101
  awardeeCity: Ithaca
  awardeeCountryCode: US
  awardeeName: Ascribe Bioscience Inc.
  awardeeStateCode: NY
  awardeeZipCode: '148505795'
  fundsObligatedAmt: '224923'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843116'
  piEmail: manohar.iitr@gmail.com
  piFirstName: Murli
  piLastName: Manohar
  piPhone: '9794819382'
  poName: Ruth Shuman
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Controlling plant pathogens with novel seed treatments based
    on nematode-produced ascarosides'
- abstractText: |-
    This SBIR Phase I project will produce a digital + physical game for 6-10 year olds that fosters computational thinking practices through collaboration, listening, and tinkering through play with music. It is widely recognized that to be ready for the future, today?s students need to develop the ability to think critically, identify and solve complex problems, communicate clearly about their thinking, and work collaboratively with a team. Computational thinking (CT) is the core of Science, Technology, Engineering and Mathematics (STEM) disciplines, and is about developing a set of problem-solving heuristics, approaches and habits of mind. Collaboration and creativity, now seen as cross-cutting 21st Century skills, are also viewed as CT practices. Not all learners are motivated to learn CT through traditional programming contexts, even those designed for young learners. Moreover, there are a lack of learning environments to engage children in tinkering--trying things out and debugging--finding out why things didn?t happen as expected. And, the vast majority of existing CT learning environments for young children do not explicitly support the development of positive attitudes towards problem solving, confidence in dealing with complexity, and communicating and collaborating with others to achieve a goal. This product will enhance students? grasp of collaborative problem solving and ultimately computational thinking by engaging them in fundamental concepts that unite computing and music.


    The core technical innovation of this project is the design and development methodology that will lead to the creation of a transformative learning platform in its approach to learning outcomes, collaborative problem solving, and engaging game play. This multi-user, multi-device experience relies on a new approach to collaborative problem solving, leveraging multiple user inputs responsive to group tinkering and debugging. Players must employ critical listening, tinkering, debugging, and communication to identify pieces of music that are off, and work collaboratively to adjust controllers to get the music back to its original state. This game not only requires problem solving across scales (debugging smaller parts of the puzzle to get to an overall solution) but also requires collaboration and communication, something largely missing in educational games for children. This phase will focus on the build of the digital component of the game as well as conduct research and development around physical controllers. Additionally, this phase of development will research the balance of visual, audio and haptic feedback mechanisms to help players through frustrating moments, foster player communication and collaboration, and test visual design for the most effective feedback.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 6320 Brookside Plaza
  awardeeCity: Kansas City
  awardeeCountryCode: US
  awardeeName: MAKEFULLY, LLC
  awardeeStateCode: MO
  awardeeZipCode: '641131709'
  fundsObligatedAmt: '224649'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843894'
  piEmail: anna@makefullystudios.com
  piFirstName: Anna
  piLastName: Jordan-Douglass
  piPhone: '8164906458'
  poName: Rajesh Mehta
  date: 01/28/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Collaboration, Creativity and Computational Thinking - A
    Cooperative Music Tinkering Game'
- abstractText: |-
    This SBIR Phase I project will develop educational technologies to better train university students to innovate. To become innovators, students must gain practice solving real-world problems, such as reducing hospital acquired infections, narrowing education achievement gaps or reducing poverty. However, universities struggle to provide the labor intensive, face-to-face coaching necessary for student innovators to tackle real-world problems. This project develops a novel online project-based learning platform that helps instructors more effectively coach innovation project teams. The platform allows instructors to (a) create libraries of project goals to help students plan, (b) collaboratively author and remix design guides to help students develop technical skills, and (c) crowdsource large group, face-to-face critique to provide feedback on in-progress innovation work. The research and development in this project focus on overcoming the technical risks associated with creating the software libraries necessary to create new project-based learning platforms and supporting the complex computer-supported collaborative learning interactions necessary to achieve desired learning outcomes. By developing the technologies necessary to enable more effective project-based learning, this project will improve university education and create a more capable innovation workforce better able to tackle societal challenges.


    This SBIR Phase I project will conduct research and development of the Loft platform, which combines a novel project-based learning environment, social media platform, and software components to transform how universities train social innovators. Technical risks in this project stem from software engineering, learning sciences, and computer-supported cooperative work obstacles associated with creating novel software platforms to enable new pedagogical strategies that achieve more effective learning outcomes in project-based learning environments. Software libraries will include a more powerful and flexible set of components for creating complex object hierarchies and social media interfaces required for rapid development of the crowdsourcing and real-time collaborative editing features needed for online project-based learning platforms. The platform will introduce new computer-supported collaborative learning strategies, such as collaborative remixing of instructional content, technology-supported tailoring of instructional goals to individual project teams, and crowd critique to provide feedback as good or better than individual instructors. Research and development will test the impact of the platform on learning outcomes for innovation teams.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2040 Sherman Ave
  awardeeCity: Evanston
  awardeeCountryCode: US
  awardeeName: ForgeWorks, LLC
  awardeeStateCode: IL
  awardeeZipCode: '602013245'
  fundsObligatedAmt: '224982'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843776'
  piEmail: my@forge.works
  piFirstName: My
  piLastName: Nguyen
  piPhone: '7078493539'
  poName: Rajesh Mehta
  date: 01/28/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Digital Loft--An online platform for innovation education'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be to drive economic growth and innovation by increasing a knowledge worker's ease of access to the digital information that is relevant to his/her work. Businesses today are enormously dependent on the archives of files, communication, and other information contained within the systems and services they rely on (networked drives, cloud storage, messaging tools, email, etc.). As these archives grow, they are increasingly hard to standardize and organize so that individuals know where to look for and how to find the information they need to do their jobs. The result is that individual employees waste enormous amounts of time trying to locate files and information fragmented across complex directories and many communication channels. Centralizing access to files and communication within an easily searchable and flexible workspace can unlock several hours of lost productivity and duplicate efforts per knowledge worker per week. Furthermore, presenting all of the relevant context around each file and message, including other file-versions, related files, discussions, activity events, etc., can help knowledge workers today with better version control, an understanding of how projects/ideas unfold, transferring of best practices, and preventing institutional knowledge-loss.

    This Small Business Innovation Research (SBIR) Phase I project seeks to further develop a novel method for users to contextually and unobtrusively access all relevant files and information associated with their work. This project focuses on developing software that can automatically map the relationships between digital workflow components (email messages, chat messages, tasks, contacts, files, etc.), and store them in discrete private databases controlled by the users. This project's key technical challenges include: improving the proprietary algorithms that automatically interconnect user information (while the information remains hosted on third party systems/services); improving the scalability of data ingress, processing, indexing, and syncing; and establishing a system capable of hosting and processing a multitude of discrete and disconnected databases of user information. The anticipated outcome of this project is a new type of software platform that can be hosted in private instances and that improves the productivity of its users by: consolidating user information stored on third-party systems/services; making it all easily searchable and manageable; and augmenting every file with additional history and context from all other connected third party systems/services.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 20 10th St NW Unit 2501
  awardeeCity: Atlanta
  awardeeCountryCode: US
  awardeeName: Comake, Inc
  awardeeStateCode: GA
  awardeeZipCode: '303093871'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843818'
  piEmail: andres@comake.io
  piFirstName: Andres
  piLastName: Gutierrez
  piPhone: '7703098717'
  poName: Peter Atherton
  date: 12/21/2018
  startDate: 01/01/2019
  expDate: 12/31/2019
  title: 'SBIR Phase I:  The Comake Graph'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will result from enabling businesses to process and extract insights from large unlabeled datasets, using machine learning with minimal human supervision, in application areas such as cyber security, precision medicine and predictive maintenance.  Current deep learning approaches require large amounts of labeled data.  Creation of labeled data is expensive, error prone and time consuming. The proposed software will provide fully automated capabilities for semi-supervised learning for anomaly detection in cyber security applications. All businesses ranging from large scale enterprises to boutique data science consulting firms will benefit from this project. The expected impact can range in the billions of dollars in the areas of cyber security and predictive maintenance, to name just two. More broadly the proposed technologies will enable both corporations and public institutions to harvest large datasets at minimal cost.

    This Small Business Innovation Research (SBIR) Phase I project will design, develop, and deploy high-performance computing (HPC) software for unsupervised learning and anomaly detection. In the last decades tremendous successes in machine learning have been achieved in the area of supervised learning that requires compilation of large datasets with labels (for example, grouping of pictures based on the individual depicted on the image). In contrast, unsupervised learning algorithms do not require labels and thus require minimal human participation. However, due to significant technical difficulties they have not been as successful as supervised learning algorithms. This software package circumvents these difficulties and opens the way to scaling unsupervised learning algorithms to large and complex datasets.  The main research and development challenges that will be addressed in this project are the ability to integrate this new technology with real world complex datasets through the choice of the correct comparison function between the objects of the dataset and the fully automatic algorithm and algorithm parameter selection.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 13026 sierra vista drive
  awardeeCity: lake oswego
  awardeeCountryCode: US
  awardeeName: RocketML Inc
  awardeeStateCode: OR
  awardeeZipCode: '970356780'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843988'
  piEmail: vinay@rocketml.net
  piFirstName: vinay
  piLastName: rao
  piPhone: '5039278954'
  poName: Peter Atherton
  date: 12/21/2018
  startDate: 01/01/2019
  expDate: 09/30/2019
  title: 'SBIR Phase I:  Large Scale And Automated Unsupervised Machine Learning For
    Anomaly Detection'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is that it will provide a concrete implementation
    with practical commercial applications in renewable energy and climate-related
    risk of a hybrid, ultrafast physics-informed machine learning technology that
    emulates complex numerical physics-based climate/weather models. Physics-based
    (hydro)climate/weather simulation models are used across trillion-dollar industries
    of utmost societal interest, from agriculture to insurance to energy to logistics.
    Faster (by 3-5 orders of magnitude), hyperlocal, large-scale estimates of physical
    climate/environmental parameters that are difficult/expensive or even impossible
    to measure empirically (such as snow-water equivalent), integrating best-available
    real-time observational remote-sensing data, can both streamline existing applications
    (faster hydropower scenario forecasting), as well as enable new capabilities and
    products (e.g., real-time storm risk response or automated parametric insurance
    contracts). The proposed R&D effort will illustrate how scientific modeling, including
    of climate, can leverage both the body of knowledge embedded in numerical simulation
    models, which the scientific community has spent more than seven decades building,
    as well as the high speed and natural capability of novel AI and machine learning
    models to process novel sources of observational data (particularly remote-sensing)
    on the natural environment. \n\nThis Small Business Innovation Research (SBIR)
    Phase I project addresses the need in the renewable energy and insurance industries
    for fast, high-resolution (in space and time) estimates of the hazard profiles
    of environmental and climate/weather parameters informed by real-time observational
    data. The project aims to provide a first proof-of-concept that a commercial-grade
    hybrid physics-informed AI technology can be developed for estimating relevant
    climate and weather parameters, starting with hydroclimate modeling. The R&D effort
    proposed will focus on 1) developing and validating a generative deep learning
    model trained on numerical hydroclimate simulation data as well as observational
    meteorological data; 2) identifying and benchmarking best-practices for ensuring
    stable training and updating of the model, observational/simulation data requirements,
    and computational resources needed; and 3) designing and developing streamlined
    model access patterns and web-based API functionality for use cases relevant to
    renewable energy and insurance/risk modeling use-cases. The envisioned proof-of-concept
    is a modular computational system running natively on GPU hardware that will allow
    creating gridded datasets of physical parameters such as snow water equivalent,
    precipitation, or water level, as well as their associated probability curves
    for geographical locations and time horizons of interest.\n\nThis award reflects
    NSF's statutory mission and has been deemed worthy of support through evaluation
    using the Foundation's intellectual merit and broader impacts review criteria."
  awardeeAddress: 301 CARL ST APT 5
  awardeeCity: SAN FRANCISCO
  awardeeCountryCode: US
  awardeeName: TERRAFUSE, INC.
  awardeeStateCode: CA
  awardeeZipCode: '941173748'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843103'
  piEmail: toni@terrafuse.ai
  piFirstName: Adrian
  piLastName: Albert
  piPhone: '5102131220'
  poName: Peter Atherton
  date: 12/21/2018
  startDate: 01/01/2019
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Machine learning emulators of weather and hydroclimate models
    for operational and financial risk assessment'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be to disrupt the 1000 hours per child per year where American children have no school and no parents and deserve access to the best enrichment activities. The company plans to build a much-needed technical infrastructure for schools, enrichment providers, and parents. By automating and simplifying the process of providers supplying, parents consuming and schools hosting enrichment activities, the proposed system will remove significant friction and create an efficient market. A key invention is the company's Automatic Schedule Recommendation System which recommends a schedule of classes for a family of one or more children and satisfies constraints such as ages and driving distance, maximizes desirable attributes such as minimal driving and diversity in classes across time, and leverages historical data like classes taken in the past and social data such as classes enjoyed by friends and classmates, to make effective recommendations. The proposed technology removes the most significant friction during parents' purchases of enrichment classes, namely, piecing together a class schedule from classes across different providers. This project is the first interdisciplinary research that strategically combines algorithms from the fields of optimizations and recommender systems to solve the problem and achieve scalability and efficiency.

    This Small Business Innovation Research (SBIR) Phase I project will design, implement and evaluate an Automatic Schedule Recommendation System. Existing recommender systems are insufficient because they largely recommend a single item to a single user; this application requires that a sequence of items (namely, a sequence of classes that fit in a coherent schedule) be recommended and coordinated among a group of users (i.e. children in the same family or set of friends). Existing class scheduling algorithms are insufficient because they find optimal schedules using known preferences; in this problem there is a need to predict preferences. The company will design a fully-automatic schedule recommendation system that predicts the suitability of each session to each user using machine learning techniques and aggregates these predictions over time to propose full schedules that are most appropriate for a parent and satisfy multi-dimensional constraints. The resulting system will be deployed to the company's users along with extensive evaluation of its efficacy.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 17444 NE 97th Way
  awardeeCity: Redmond
  awardeeCountryCode: US
  awardeeName: Goodwintercrop Inc.
  awardeeStateCode: WA
  awardeeZipCode: '980526959'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842790'
  piEmail: helen@6crickets.com
  piFirstName: Helen
  piLastName: Wang
  piMiddeInitial: J
  piPhone: '4256106035'
  poName: Peter Atherton
  date: 12/21/2018
  startDate: 01/01/2019
  expDate: 09/30/2019
  title: 'SBIR Phase I:  6crickets Automatic Schedule Recommendation'
- abstractText: |-
    This SBIR Phase I project proposes the creation of a unique, art-centric e-learning platform aimed at sparking the interest of young learners in science, technology, engineering, and math (STEM). This extensible software platform implements a new category of e-learning based on the ample body of research in educational psychology and technology that advocates the use of art and guided play to teach STEM. This project will test the hypothesis that an e-learning system based on scientific illustration sparks engagement and enhances learning in young students. With students disengaging from STEM at an increasing rate, it is critical to make more tools available to teachers that connect student with STEM. STEM-related fields will drive innovation in our economy for decades to come; opening new pathways to vastly broaden participation in STEM is critical to our economic future. This project also proposes the creation of an online community and marketplace supporting STEM education through this platform. This will connect teacher-to-teacher for sharing best practices in teaching science using art and can make a deep and broad impact on the way STEM is taught.


    Built on scientific illustration and coupled with a set of tangible user interface (TUI) devices that mimic scientific instruments, this e-learning platform brings student hand-drawn art to life, creating interactive lessons that correlate to Next Generation Science Standards. As this system will be extensible and customizable, a major part of the R&D effort will be to create an easy-to-use templating toolkit that any teacher can leverage to develop custom lessons in STEM. The Phase I goal will be to create a fully functioning product and assess this system in elementary school classrooms. This toolkit will be developed in collaboration with Curio Interactive?s educational partners, as well as the Pacific Science Center, where Curio Interactive is a startup in residence, to rapidly develop this system, continuously iterating the software with real testers, following agile development methods. One of this project?s objectives is to appeal to groups historically underrepresented in STEM. Because this platform will be visual and kinetic, highly affordable, and universally available via the web, the proposed platform will improve the equity and accessibility of learning science.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2101 N 35TH ST
  awardeeCity: SEATTLE
  awardeeCountryCode: US
  awardeeName: CURIO INTERACTIVE LLC
  awardeeStateCode: WA
  awardeeZipCode: '981039103'
  fundsObligatedAmt: '224934'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843530'
  piEmail: barry@curiointeractive.com
  piFirstName: Barry
  piLastName: Boone
  piPhone: '2062274951'
  poName: Rajesh Mehta
  date: 12/21/2018
  startDate: 01/01/2019
  expDate: 12/31/2019
  title: 'SBIR Phase I:  The Curio Classroom: A Software Toolkit to Spark Engagement
    in STEM Through Hand-drawn Art and Tangible User Interfaces'
- abstractText: |-
    This SBIR Phase I project will develop a mobile technology that can train healthcare professionals in science-based skills to break the habit of unconscious bias. Unconscious biases result from learned sets of mostly false and negative associations between a trait and a social group, i.e. stereotypes, that distort how people perceive, reason, and make decisions about other people. In healthcare, these biases often begin a chain of discriminatory interactions that lead to misdiagnoses, increased hospitalization, and unnecessary repeat visits that sustain health disparities and cause tremendous suffering to millions of Americans. Furthermore, these disparities cost the American economy multibillion dollars annually. This project aims to address both these challenges through a scalable mobile technology that will create learning experiences for providers to adopt skills that break the habit of unconscious bias. The project will further NSF's mission by advancing health, prosperity, and welfare of all Americans so they can receive the highest quality of care untainted by unconscious bias. The project's success would contribute to creating a healthier and productive American population, workforce, and economy. A successful outcome of this effort could spur its extension to other sectors, including education, law enforcement, and business.

    The intellectual merit of this project lies in demonstrating that the company's proprietary methodology enables healthcare providers to develop greater self-awareness about their unconscious biases and thus reduce health disparities. The project will create novel employment of technological, discursive, and experiential learning using a mobile application that offers and incentivizes the practice of bias breaking tools to fully and sustainably break the habit of unconscious bias. The mobile platform will be intentionally designed with the end user's experience and interactions in mind to incentivize them every day to learn and practice activities that transform unconscious biases in themselves. The goal in Phase I is threefold: to determine user preferences in design and experience for adopting new skills and building new habits; develop a high-fidelity beta-test for a limited number of experiences that teach breaking bias skills over a mobile platform; and test its usability and desirability with a representative number of healthcare providers.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: '7 Gates Avenue #7E'
  awardeeCity: Brooklyn
  awardeeCountryCode: US
  awardeeName: Be More, Inc.
  awardeeStateCode: NY
  awardeeZipCode: '112381531'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843286'
  piEmail: anurag@bemoreamerica.org
  piFirstName: Anurag
  piLastName: Gupta
  piPhone: '3473300311'
  poName: Rajesh Mehta
  date: 12/21/2018
  startDate: 01/01/2019
  expDate: 06/30/2019
  title: 'SBIR Phase I:  A Mobile Learning System to Reduce Unconscious Bias Among
    Healthcare Providers'
- abstractText: |-
    This SBIR Phase I project will develop and test a computer-based expert system that will guide development of beginning literacy curricula in any phonics-based language. The system will produce beginning literacy curricula mobile apps for phones and tablets and will include beginning reading, writing, vocabulary-building, and assessment activities. The expert system will (a) minimize cost, time and expertise required to develop early literacy curricula, (b) produce curricula that could increase early reading fluency and bilingualism, which is related to children's improved ability to manage their thoughts, behaviors and emotions, (c) provide effective curricula to learn languages other than English at home or school, (d) revitalize endangered or underserved languages while increasing connections to culture and heritage, which will improve long-term academic, health and economic outcomes for indigenous children or children who speak a language other than English at home, and increase their participation in STEM careers, and (e) contribute to research on bilingualism's impacts on academic, social, emotional, and cultural outcomes. The system will be licensed by underserved language communities, tribes, individuals, and organizations interested in improving literacy, with revenue produced by the mobile app products developed using the expert system shared between curriculum developers and the expert system developer.


    This SBIR Phase I project will develop and test a knowledge-based expert system that integrates early literacy research; language analysis to provide evidence-based recommendations for developing decodable text for phonics-based early literacy curricula; evidence-based teaching and formative assessment strategies; curriculum development knowledge; user interface/user experience best-practices; natural language processing for pronunciation feedback; and database and technology skills to guide users who may not have the knowledge and skills in developing a beginning literacy curricula in any language. The best practices and methods based on the research will be incorporated by analyzing text to create lists of sounds/letters and words, their frequencies, and sounds and words that come before and after each sound/word. From these lists, the system will generate language-specific recommendations based on the rules for optimal sequencing of sounds and words for learning to decode in another language. While some evidence-based guidelines needed for decoding in English, which is less phonetically regular than many underserved languages, may not apply in a language that is more phonetically regular, most are expected to. These rules will guide recommendations from which users of the knowledge-based expert system can select sequences sounds, words, and phrases to write decodable, connected text, culturally relevant stories for beginning literacy curricula.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 6575 SNOWVIEW DR
  awardeeCity: PARK CITY
  awardeeCountryCode: US
  awardeeName: BETTERMENT LABS, L.L.C.
  awardeeStateCode: UT
  awardeeZipCode: '840986167'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842833'
  piEmail: ccallowheusser@bettermentlabs.com
  piFirstName: Catherine
  piLastName: Callow-Heusser
  piMiddeInitial: A
  piPhone: '4357572724'
  poName: Rajesh Mehta
  date: 12/21/2018
  startDate: 01/01/2019
  expDate: 06/30/2019
  title: 'SBIR Phase I:  READ! Toolkit, A Knowledge-Based Expert System to Develop
    Beginning Literacy Curricula in Endangered or Underserved Languages'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is the development of a cost-effective, environmental and economically sound Limulus amebocyte lysate (LAL) production facility based on a finite number of horseshoe crabs (HSC) using minimally impactful and novel bleeding procedures.  The goal is to address the demands of an estimated $114 million LAL market and finished kit market in excess of $1 billion per annum. Success of this project also anticipates exceeding current standards by ensuring biomedical and pharmaceutical manufacturing compliance with fewer total horseshoe crabs than the number that die annually from current practices. New approaches to HSC bleeding developed in this project would also enable repeated, controlled bleeding while maintaining optimal conditions for animal vitality and for the adjacent communities. Assuming optimized, scalable HSC bleeding operations could eventually expand current supplies, innovative applications could be developed. For example, early detection of sepsis could help avert some $30 billion in direct care every year in the US, notwithstanding the potential to save countless lives with development of gram-negative screening tools for hospital acquired septicemia.

    This SBIR Phase I project proposes to develop an alternative method of bleeding horseshoe crabs (HSCs) for Limulus amebocyte lysate (LAL) harvest. The overarching objective to demonstrate the proof-of-concept of an implantable, and surgical-grade device engineered to facilitate routine bleeding, without compromising the integrity and well-being of the HSC. This will be achieved via a systematic study of HSC bleeding outcomes to investigate whether such a device can meet the sterility and quality standards of traditional approaches, while obviating the need for extraneous transport to expensive, inland bleeding facilities. Furthermore, the commercial opportunity and feasibility of the device paired with a habitat-based, enclosed system to systematically monitor HSC wellbeing will be investigated. This SBIR Phase I project would be the first to investigate an alternative approach to bleeding HSCs, a technique that has not changed significantly since the late 1800's. At scale, the proposed approach would also be expected to improve product quality and traceability, and ultimately the bottom line of companies producing LAL kits, given a surplus of LAL in the supply chain.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2901 E Lee St
  awardeeCity: Greensboro
  awardeeCountryCode: US
  awardeeName: Kepley Biosystems Incorporated
  awardeeStateCode: NC
  awardeeZipCode: '274014904'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819562'
  piEmail: kristen.bowey@gmail.com
  piFirstName: Kristen
  piLastName: Dellinger
  poName: Ruth Shuman
  date: 09/06/2018
  startDate: 09/01/2018
  expDate: 08/31/2019
  title: 'SBIR Phase I:  A Novel Horseshoe Crab Device and Approach for a Sustainable
    Endotoxin Testing Resource'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to make non-pharmacological treatment of depression accessible to all patients. According to the World Health Organization, 350 million individuals are affected by depression. In the United States, depression affects 16 million people and it costs $210 billion a year in lost productivity and care for the illnesses related to the disease. Antidepressant drugs are coupled with negative side effects and they are ineffective in 30% of the cases. Repetitive Transcranial Magnetic Stimulation (rTMS) is an FDA approved non-invasive method for depression therapy that consists in the administration of short electromagnetic pulses on patient?s scalp to stimulate regions of the brain involved in mood control. This SBIR Phase I project will help the generation of a new rTMS system that will improve outcomes of depression treatment by stimulating deeper brain cells and reducing the incidence of pain and discomfort associated with current rTMS therapy. The new device will allow broad distribution of rTMS based therapy for both professional clinicians and, in the future, home-care settings. It will avoid reliance on drugs to people affected by depression and it will reduce the impact of depression on society.

    The SBIR Phase I project proposes to develop and demonstrate the efficacy a new wearable rTMS stimulator device. Although rTMS has a 75% success ratio on depressed patients, 40% of subjects report pain, headaches and discomfort during therapy with current rTMS systems, resulting in a high dropout rate. This is mainly due to poor localization of electromagnetic pulses with commercially available rTMS devices. The new system will combine a new technology that stimulates the brain?s deepest regions involved in depression with unprecedented precision and a new protective shield designed to ward off unwanted heat away from the head, reducing scalp pain and discomfort. The project will develop and validate the efficacy of these components and their integration into a wearable helmet. The project will also demonstrate the superiority of the new device over current gold standard rTMS solutions. The company expects that this research will lead to the generation of a new device capable of treating depression patients through precise stimulation reducing over 40% the unwanted heat, thereby preventing headache and scalp discomfort.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2040 Martin Ave
  awardeeCity: Santa Clara
  awardeeCountryCode: US
  awardeeName: NeuroPrex Inc.
  awardeeStateCode: CA
  awardeeZipCode: '950502702'
  fundsObligatedAmt: '224925'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820005'
  piEmail: janice@neuroprexinc.com
  piFirstName: Hsiu
  piLastName: Huang
  piMiddeInitial: W
  piPhone: '4086881707'
  poName: Henry Ahn
  date: 07/09/2018
  startDate: 07/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  A Novel, Protective Shield to Increase Safety and Efficacy
    of rTMS Depression Treatment'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project include development of a commercial proof-of-concept percutaneous directional microwave ablation (MWA) applicator which may provide medical practitioners a new approach for treating cancer. In clinical use, a directional MWA applicator will facilitate both procedural and technical simplification of MWA treatments, saving time and critical resources in hospitals, and ultimately improve quality of, and access to, cancer treatment for a broad range of patients. The research and development proposed in this project will enhance scientific and technological understanding of miniaturized MWA antennas capable of radiating with directional patterns. Specifically, special materials to reduce required antenna dimension and increase efficiency, and advanced antenna designs to maximize the size of directional ablation zones will be studied during this project. Commercial development of the proposed technical advances could expand their use for the treatment of other medical conditions or for applications in other industries such as wireless communications. This STTR Phase I project will contribute to the creation of technology jobs in Kansas, a region where there are few medical or technology companies.

    This STTR Phase I project proposes to develop a commercial proof-of-concept directional microwave ablation (MWA) applicator. MWA procedures offer cost-effective, minimally-invasive treatment options for localized tumors and other disease. These treatments are especially important to the large population of cancer patients who are poor candidates for surgery or other physically demanding therapies. However, currently available MWA systems employ applicators with omni-directional radiation patterns, which if not placed precisely may damage critical healthy tissues or result in disease recurrence. A directional MWA applicator can facilitate technical and procedural simplifications which to alleviate these current challenges. We will investigate: (1) alternative materials to shrink antenna cross-section and (2) novel antenna geometries to maximize the size of directional microwave ablation zones. We will employ an approach integrating multiphysics computational models, benchtop experimentation in ex vivo tissue, and experiments in animal models in vivo to design, optimize, and validate our device. Our anticipated technical results are the development of a MWA applicator that provides directional control of radiation pattern that can ablate to depths of greater than 30 mm, creating an ablation volume comparable to current clinical non-directional devices.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3809 Buckeye Cir
  awardeeCity: Manhattan
  awardeeCountryCode: US
  awardeeName: Precision Microwave Inc.
  awardeeStateCode: KS
  awardeeZipCode: '665033145'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1819177'
  piEmail: austin.pfannenstiel@gmail.com
  piFirstName: Austin
  piLastName: Pfannenstiel
  piPhone: '6208027113'
  poName: Henry Ahn
  date: 07/09/2018
  startDate: 07/15/2018
  expDate: 06/30/2019
  title: 'STTR Phase I:  Directional minimally invasive microwave antenna for precise
    spatial control of thermal ablation'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is an inexpensive handheld smartphone device for rapid detection of the toxigenic cholera pathogen in environmental water sources. Contaminated water sources place populations at risk for contracting cholera. Once contracting the disease, patients with cholera exhibit symptoms of diarrhea, vomiting, and dehydration and, if left untreated, ultimately death. Wide-scale cholera outbreaks devastated Haiti in 2010 and Yemen in 2017, affecting over one million total individuals. Currently, methods used to detect the cholera pathogen in water involves a 3 to 5-day water collection and cell culture procedure. This project proposes a portable smartphone platform used to detect the cholera pathogen, Vibrio cholerae, in under 30 minutes at the water source. Smartphone connectivity, will also enable geomapped and time-stamped detection results. This novel and proactive approach for detection can enable organizations to remediate water sources prior to communities contracting and spreading cholera. Downstream, this technology will save the time and costs currently associated with cholera outbreaks and can be expanded to other infectious diseases.

    This SBIR Phase I project proposes to develop a rapid, cost-effective, and robust smartphone platform to detect Vibrio cholerae and automate the detection result at an environmental water source. The device performs isothermal DNA amplification assay combined with the novel sensing approach, particle diffusometry. This project proposes to characterize the specificity, sensitivity, and lower limit of detection of Vibrio cholerae detection on the smartphone platform. The detection results will be compared against current gold-standard quantitative DNA amplification methods. Further, a reagent storage method involving freeze drying will be used to eliminate the need for cold-chain storage. We will assess the long-term stability of our assay reagents through accelerated aging studies. Lastly, a low powered integrated heating unit will be designed to perform the isothermal DNA amplification assays in the handheld device. At the completion of this Phase I project, an integrated smartphone platform will be ready for field testing.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2042 Malibu Drive
  awardeeCity: West Lafayette
  awardeeCountryCode: US
  awardeeName: OmnniVis LLC
  awardeeStateCode: IN
  awardeeZipCode: '479065306'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819970'
  piEmail: kclayton@omnivistech.com
  piFirstName: Katherine
  piLastName: Clayton
  piMiddeInitial: N
  piPhone: '4153099524'
  poName: Anna Brady-Estevez
  date: 06/25/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  A Rapid Portable Biosensor for Field Detection of Vibrio
    Cholerae in Environmental Water Sources'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project will be to allow new hardware platforms to be
    more quickly deployed and useful software products to be more readily made available
    on a wide variety of hardware to satisfy the needs of their users.  Additionally,
    researchers in science and engineering can reduce the runtime of their applications
    by hours or days on the machines inside high performance computing or data centers,
    enabling more scientific modeling and simulations to be completed within these
    centers, while allowing each individual scientist to concentrate more on his/her
    research, which in turn may more quickly benefit society.  For example, in the
    defense industry, many contracting companies develop Monte Carlo simulation software
    to predict outcomes from disasters. Increasing the throughput of these simulations
    would allow for more simulation results to be analyzed and tested, thereby resulting
    in better predictions and handling of disastrous situations. \n\nThis Small Business
    Innovation Research Phase I project is unique in its automated connection between
    existing performance modeling and prediction tools, and pattern-driven compiler
    optimization. Novel runtime monitoring and modeling techniques will be developed
    to automatically map performance bottlenecks discovered by existing performance
    analysis tools to potential opportunities of source code optimizations. Such opportunities
    again will be used to guide pattern-driven compiler optimizations, particularly
    to enhance the performance of finite element methods on both GPGPUs and multi-core/many-core
    CPUs. Deep learning neural networks will be used to automate the runtime behavior
    classification of computations. The new pattern-driven specialization of compiler
    optimizations will enable general-purpose compiler techniques to be aware of the
    higher-level semantics of library abstractions (e.g., data structures and algorithm
    abstractions) and allow them to be collectively customized and coordinated to
    attain the best performance.\n\nThis award reflects NSF's statutory mission and
    has been deemed worthy of support through evaluation using the Foundation's intellectual
    merit and broader impacts review criteria."
  awardeeAddress: 19415 Lincoln Green Ln
  awardeeCity: Monument
  awardeeCountryCode: US
  awardeeName: Crestone Computing LLC
  awardeeStateCode: CO
  awardeeZipCode: '801328738'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820076'
  piEmail: bnesterenko09@gmail.com
  piFirstName: Brandon
  piLastName: Nesterenko
  piMiddeInitial: M
  piPhone: '7192387076'
  poName: Peter Atherton
  date: 06/19/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Enhancing the Performance of Scientific Applications Through
    Intelligent Advice'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project can be summarized as follows. (1) Businesses will benefit from the proposed product because companies are increasingly using data-driven predictive models to improve their bottom line. In many areas where structured data are readily available, such as credit scoring, these models have produced impressive returns on investment. One of the main obstacles hindering the application of these models in other areas is the lack of structured data. By extracting information from sources such as web pages, blogs and social media messages, and storing it as structured data, companies will be able to take advantage of the vast amount of unstructured data that are generated daily and thereby improve their bottom line. (2) As the Chinese economy expands and becomes more deeply intertwined with the US economy, many US businesses will need high-quality and timely information about Chinese markets. However, information extraction from Chinese text is an underserved area. The proposed product can fill this void and thereby meet a significant commercial demand.

    This Small Business Innovation Research (SBIR) Phase I project will develop a new information extraction (IE) method. Currently IE focuses on information extraction from short text snippets consisting of a few words in order to derive structured factual information from unstructured text. But its performance is often deteriorated by the shortage of features - the sparse feature problem. A major benefit of the approach developed in this project is that it takes advantage of the important role of specific linguistic units even when the number of words in a sentence is limited. These linguistic units give a sentence its structure. Depending on structural characteristics or functional principles of sentences, the features around them are grouped. The grouped features satisfy certain properties and can be used to capture structural and semantic information, which is helpful for minimizing the sparse feature problem.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 22 Stonybrook Ln
  awardeeCity: Shrewsbury
  awardeeCountryCode: US
  awardeeName: AI STRIKE, LLC
  awardeeStateCode: MA
  awardeeZipCode: '015455477'
  fundsObligatedAmt: '224991'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820118'
  piEmail: jzhou@businessdataminers.com
  piFirstName: Jiang
  piLastName: Zhou
  piPhone: '9787263182'
  poName: Peter Atherton
  date: 06/15/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Semantic Information Extraction From Text'
- abstractText: "This Small Business Innovation Research Phase I project is for the
    development of an automated manufacturing process for polymeric, ultra-lightweight,
    bicycle spokes composed of an ultra high molecular weight polyethylene (UHMWPE)
    and stainless steel hybrid structure. The use of an innovative polymer-to-metal
    connection allows for the creation of a bicycle spoke that out-performs modern
    stainless steel spokes. In comparison, steel spokes are heavier, do not effectively
    damp road vibrations, and are more prone to fatigue related failure. The target
    market for this innovation is the high-end bicycle spoke market, which is valued
    at over $100M. The research of new polymeric materials at universities is at an
    all-time high. Despite this, there exists a gap in the commercialization of new
    materials because of the difficulty in interfacing these materials to other common
    construction materials, such as stainless steel. This work will contribute fundamental
    knowledge to and catalyze the development of processes for new advanced polymer
    products. It will enable the use of UHMWPE and other materials in new applications.
    \n\nThe intellectual merit of this project is the development of an advanced manufacturing
    process capable of the complex manipulation necessary for the production of novel
    polymer-to-metal connections and integral eye splices. These types of connections
    are not practiced in high-volume textile manufacturing today due to the novelty
    of the polymer-to-metal connection and the complexity of the eye splice operation.
    The research objectives include validating the key steps for process automation
    and optimization of the UHMWPE-metal connection. The anticipated outcome of this
    Phase I project is a prototype automated spoke manufacturing process.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 1995 Beacon St
  awardeeCity: Roseville
  awardeeCountryCode: US
  awardeeName: BERD LLC
  awardeeStateCode: MN
  awardeeZipCode: '551135602'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819577'
  piEmail: brad.guertin@berdspokes.com
  piFirstName: Brad
  piLastName: Guertin
  piPhone: '7636397060'
  poName: Linda Molnar
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Advanced Manufacturing of Ultra High Molecular Weight Polyethylene
    and Metal Hybrid Structures for Bicycle Spokes'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to enable more efficient access to information, goods, and services from organizations and businesses through conversational interfaces. With an estimated 33 million voice-activated devices installed in the U.S. by the end of 2017, consumers are beginning to see the benefits of the rise in business services on these devices. Interacting with computers in natural language is more efficient than ever before, and business are urgently seeking to include their services on this new modality. Yet, while advances in machine learning have increased the speed and accuracy with which conversational interfaces are built, today's solutions still result in major bottlenecks in the development process. Addressing these bottlenecks would result in significant savings of time and resources for businesses, in addition to increased convenience for end users.

    This Small Business Innovation Research (SBIR) Phase I project advances the development of machine learning and natural language processing technologies that will enable rapid creation of conversational interfaces and increase the efficiency with which individuals interact with computers. Despite major recent advances in conversational interface tooling, current bottlenecks in building robust conversational interfaces still exist, as portions of the development process go from highly-automated to manually-programmed. Instead, the proposed approach will achieve end-to-end automation using an innovative LSTM sequence-to-sequence machine learning model to learn and simulate human behavior on a web page, as well as a new system for open-domain question answering.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2562 Amethyst Dr
  awardeeCity: Santa Clara
  awardeeCountryCode: US
  awardeeName: PLASTICITY INC.
  awardeeStateCode: CA
  awardeeZipCode: '950511155'
  fundsObligatedAmt: '224679'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820240'
  piEmail: ajay@plasticityai.com
  piFirstName: Ajay
  piLastName: Patel
  poName: Peter Atherton
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 04/30/2019
  title: 'SBIR Phase I:  A System for Automating End-to-End Creation of Natural Language
    Interfaces'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to accelerate the most common computations in processing Big Data and performing real-time analyses on data streaming-in to enterprise data centers. For the same total cost, the technology advanced by the proposed project is expected to increase performance by a factor of 12. As part of this improvement, it is expected to reduce the energy per instruction by a factor of 25 times or greater. This frees businesses to apply more advanced analytics techniques and react more quickly to changing business conditions.

    This Small Business Innovation Research (SBIR) Phase I project addresses the ever-growing need to process more data, but on a fixed budget. The objective is to provide accelerator technology for an increasingly critical set of applications that are currently underserved by generic CPU technology. The project aims eventually to deliver a PCIe accelerator card populated by silicon chips based on a new type of accelerator micro-architecture.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: '40087 Mission Blvd., Suite #274'
  awardeeCity: Fremont
  awardeeCountryCode: US
  awardeeName: Intensivate Incorporated
  awardeeStateCode: CA
  awardeeZipCode: '945393680'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820507'
  piEmail: seanhalle@intensivate.com
  piFirstName: Sean
  piLastName: Halle
  piMiddeInitial: S
  piPhone: '5103459027'
  poName: Peter Atherton
  date: 06/15/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I: High Performance Low Power Dense Server for Cloud'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be to enable smaller businesses to participate to the chatbot revolution, by making it easier to design and deploy chatbots. The initial focus of this project is healthcare, where there is great opportunity to improve the quality and availability of patient services. The key technological innovation is the facilitation of an ecosystem of chatbot designers and agents, through the creation of novel chatbot design, collaboration and deployment tools.

    This Small Business Innovation Research (SBIR) Phase I project will create the technology to allow chatbot designers to incorporate human agents into the logical flow of chatbots. Currently, chatbots are designed in an ad-hoc trial-and-error manner, which is infeasible for small businesses who do not have the resources to constantly refine and evaluate their chatbots. The project will also create techniques to allow human agents to be productive when taking over chatbot sessions, and allow designers to improve the logical flow of chatbots based on usage data.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3499 10th St
  awardeeCity: Riverside
  awardeeCountryCode: US
  awardeeName: SmartDocFinder LLC
  awardeeStateCode: CA
  awardeeZipCode: '925013617'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819362'
  piEmail: pgior001@ucr.edu
  piFirstName: Preston
  piLastName: Giorgianni
  piMiddeInitial: R
  piPhone: '9516344615'
  poName: Peter Atherton
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  SmartBot360: A Platform to Enable an Effective Chatbot Ecosystem'
- abstractText: |-
    This SBIR Phase I project will create a novel educational product by pairing VR/360 video with impact measurement software and interactive social engagement tools to simulate true-to-life experiences that enable users to gain personal insight into pressing social issues and then take action to solve them. Installed either as a multisensory 'empathy exhibition' or used in a classroom setting, participants embark on a transformative learning journey which builds empathy and critical understanding about a social issue and those affected by it, then connects them to concrete opportunities to make social change. Users begin as uniformed participants, and through the proposed process emerge as changemakers engaged in solving social problems. Experiential learning has long been an empathy building discipline outside the mediated experience, yet it is encumbered by barriers of cost, safety, distance, time and access that limit participation. Transformation360 will use technology to render experiential learning programs virtually anywhere. The result will be a revolutionary new way to move the public from apathy to action on a limitless number of social issues. Transformation360 will provide nonprofits, governments, and institutions working to solve social problems with a powerful social engagement tool that creates actively engaged citizens, consumers, volunteers, supporters, and social entrepreneurs to address the world's most pressing social problems.


    This SBIR Phase I project will develop a VR/360 video hybridization that will allow users interactive choices within a conventional three-degree-of-freedom 360 Video experience. Currently only VR's computer-generated imaging can provide a significant choice landscape for users. By using 360/3D photography, unique game engine software and multi-scenario video capture in the field the project will give users a new level of choice options for a photo documentary experiences. The efficacy of this technology for building empathy will be quantified through audience testing. Also, cinematic techniques such as mise-en-cine and montage, not currently used in most 360 video projects, will also be tested against audience reactions. These video production and consumption technologies and techniques will also be cross-tested against experience learning processes such as the breaking down assumptions, peer learning, debriefing, uncertainty, and risk. Potential adverse side effects to VR/360 video will also be addressed. The project will rely heavily on the engagement measurement and data visualization tool Harvis to test and analyze audience reactions to these experiments.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1201 N Orange street
  awardeeCity: Wilmington
  awardeeCountryCode: US
  awardeeName: Virtue Ventures, LLC
  awardeeStateCode: DE
  awardeeZipCode: '198011155'
  fundsObligatedAmt: '224753'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819650'
  piEmail: kalter@virtueventures.com
  piFirstName: Sutia
  piLastName: Alter
  piMiddeInitial: K
  piPhone: '2026894403'
  poName: Rajesh Mehta
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Transformation360'
- abstractText: |-
    The broader impact/commercial potential of this project focused on a novel seat design that reduces vehicle-based whole-body vibration and shock will 1) better protect human health while 2) addressing major transportation markets including trucking, agriculture, construction, military vehicles, and mass transit, as well as automobiles and water-/land-based recreational vehicles.  The envisioned socio-economic impact is significant:  Continual exposure to whole-body vibration and shocks can cause discomfort, reduction in work performance, and chronic low-back pain for vehicle operators and passengers.  Low-back pain is the largest component of disability among all occupational-related injuries. Though so-called "active" seats can help reduce these vibrations/shocks, their high cost is a major barrier. The low-cost seats being pursued here could benefit millions of vehicle operators. The work will also result in a greater scientific and technological understanding of the sources/effects of and potential remedies for whole-body vibration and shock. The suspension system market is projected to grow at a CAGR of 5.11%, by value, from 2016 to 2021. The market is expected to grow from USD 52.38 Billion in 2015 to USD 67.22 Billion by 2021.  The market for bus seats alone is expected to be at $10.03 Billion by the year 2022.

    This Small Business Innovation Research (SBIR) Phase I project is focused on the feasibility of a quasi-semi-active seat (QSAS) technology.  Seating design for heavy equipment and vehicle operators has faced a trade-off between performance and cost. The most-complex 'active seats' reduce vibration but are cost-prohibitive at $3,500. Semi-active seats are simplified active seats and perform better than passive seats, but still magnify input vibration and cost several thousand dollars. Passive seats are the least expensive, but they magnify input vibration at low frequencies.  Recent design/material advances and strong preliminary data set the stage for developing an innovative passive seat at a fraction of the cost of semi-active seats that will reduce input vibration at low frequencies. Phase I feasibility will be shown using sliding friction to mitigate vibration at low frequency.  A QSAS prototype will be built and used to show potential in laboratory and field settings.  Technical challenges will involve material selection that will show maximum vibration mitigation and dissipation, as well as integration of the cushion with a suspension system that can handle the weight of a seated person. The research will determine effective performance parameters under different magnitudes and frequencies of vibration that simulate realistic operational conditions.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2261 Crosspark Rd Ste 202
  awardeeCity: Coralville
  awardeeCountryCode: US
  awardeeName: ACTIBIOMOTION, LLC
  awardeeStateCode: IA
  awardeeZipCode: '522414716'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819917'
  piEmail: jonathan@actibiomotion.com
  piFirstName: Jonathan
  piLastName: DeShaw
  piPhone: '5635438505'
  poName: Muralidharan Nair
  date: 06/14/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Quasi- Semi-Active Seats (QSAS) for Heavy Machinery'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is reduced levelized cost of electricity (LCOE)
    of offshore wind from current levels that are about twice that of onshore wind.
    Given the proximity of offshore wind resources to load centers along the coast,
    it is an attractive renewable energy source for the nation, but high costs are
    an impediment to widespread adoption. One way to address this is with larger turbines
    that can lead to lower ?balance of plant? costs, which can be as high as 65% of
    the total project costs of offshore wind. However, turbine rating is currently
    limited due to the large size and weight of the generator and the rotor, as well
    as infrastructure obstacles like manufacturing, transport, and assembly. The lightweight
    superconducting (SC) generators being developed within this project, coupled with
    advanced rotors already being developed by the OEM?s, could open the door to significantly
    larger turbine ratings and lower costs. The underlying high specific power machine
    technology can also help transform a number of other weight-sensitive electrical
    systems like hybrid electric airplanes and ship propulsion.\n \nThis Small Business
    Innovation Research (SBIR) Phase I project seeks to disrupt the traditional risk
    versus benefit trade of the low Technology Readiness Level (TRL) SC technology
    by significantly increasing the benefits with a novel ?active magnetic shielding?
    concept. This design concept enables a very high operating magnetic field within
    the machine while eliminating the need for a yoke made of ferromagnetic steel
    to contain the field. The higher internal fields increase the electromagnetic
    torque significantly over other solutions, leading to very high power density.
    Additionally, the elimination of heavy iron from the magnetic circuit leads to
    further reduction in weight. The proposed generator design can be about half the
    size of currently available wind direct-drives. Efficiency is also expected to
    improve with the elimination of about a third of copper coils while maintaining
    the same current density. Available cryogenic cooling technology from the commercially
    successful magnetic resonance imaging (MRI) industry will be adapted and utilized
    in the machine to reduce many of the cryogenics related risks while maintaining
    high specific power.\n\nThis award reflects NSF's statutory mission and has been
    deemed worthy of support through evaluation using the Foundation's intellectual
    merit and broader impacts review criteria."
  awardeeAddress: 1804 Vale St
  awardeeCity: Champaign
  awardeeCountryCode: US
  awardeeName: HINETICS LLC
  awardeeStateCode: IL
  awardeeZipCode: '618223563'
  fundsObligatedAmt: '219444'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819321'
  piEmail: ayoon@hinetics.com
  piFirstName: Andy
  piLastName: Yoon
  piPhone: '6304429517'
  poName: Muralidharan Nair
  date: 06/13/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Actively Shielded Superconducting Generators for Large Wind
    Turbines'
- abstractText: "This SBIR Phase I project develops a bacterial platform for intracellular
    drug delivery to solid tumors, with a primary focus on liver cancer. Every year,
    30,000 men and women are diagnosed with unresectable hepatocellular carcinoma
    (HCC), which has a 5-year survival rate of 17.6 %. The prognosis for these patients
    is poor. Currently, there are no curative treatments for these patients. The current
    standard-of-care only increases overall survival by months and has toxic side
    effects, with a cost to the US healthcare system of $1.5B per year. This technology
    is based on the inherent feature of bacteria to colonize solid tumors throughout
    the body in ratios of 100,000 to 1 compared to healthy tissue. Due to this specificity,
    the developed bacterial platform has the potential to increase dosage specifically
    in tumors, while reducing toxic side effects in healthy tissues. This platform
    will be a toolbox that can target intracellular pathways that are currently considered
    undruggable and deliver potent doses of biologicals directly into tumor cells.
    The affinity of bacteria for solid tumors, independent of organ localization,
    enables the extension of this delivery method to other hard-to-treat tumor types,
    such as pancreas, ovarian and gastric cancer. \n\nSystemic cancer therapies have
    many obstacles, such as stability in the blood, traversing the cellular membrane,
    internalization and endosomal release. These processes impede the use of RNAi
    and peptides in humans and hamper the targeting of intracellular pathways with
    monoclonal antibodies. The development of a bacterial drug delivery platform can
    optimize drug potency in tumors and reduce side effects in healthy tissue. In
    this SBIR phase I, efficacy of this platform will be measured in HCC by targeting
    intracellular pathways essential for cell survival, for which no systemic therapy
    exists. A bacterial strain will be created according to FDA guidelines that can
    be manufactured reliably without loss of activity. An optimized preservation protocol
    will be developed to ensure maximal bacterial fitness and maximal delivery efficacy
    after administration. This bacterial delivery system has the potential to accelerate
    the translation of fundamental cancer research into clinical therapies. Discoveries
    could be genetically translated directly into protein, antibody or shRNA therapies
    that regulate mammalian gene expression and function.\n\nThis award reflects NSF's
    statutory mission and has been deemed worthy of support through evaluation using
    the Foundation's intellectual merit and broader impacts review criteria."
  awardeeAddress: 2 Ladyslipper Ln.
  awardeeCity: Hadley
  awardeeCountryCode: US
  awardeeName: Ernest Pharmaceuticals
  awardeeStateCode: MA
  awardeeZipCode: '010353512'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819794'
  piEmail: vandessel@ernestpharma.com
  piFirstName: Nele
  piLastName: Van Dessel
  piPhone: '4135616043'
  poName: Henry Ahn
  date: 05/21/2018
  startDate: 06/01/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I: A bacterial intracellular delivery platform for liver cancer'
- abstractText: |-
    This SBIR Phase I project aims to develop and demonstrate the feasibility of a system that can identify a broad range of bacteria in < 1 hour directly from blood. Existing diagnostic systems require 2-6 days to identify the bacteria, which delays treatment using appropriate antibiotics. Sepsis, which is often caused by a bacterial infection, contributes to up to half of all hospital deaths in the US largely due to complications arising from delays or inappropriate treatment (which is mainly because of lack of information regarding the infection-causing bacteria). It is the most expensive hospital-treated condition in the United States ? representing $20.3 billion in healthcare costs. The proposed system aims to sharply reduce the time to provide information needed by physicians, enabling them to initiate treatment using the appropriate antibiotic rapidly. This is expected to lead to significant reductions in costs, complications, and mortality. Further, by eliminating the need for culturing, new insights into bacterial behavior can be acquired contributing to additional fundamental knowledge of bacteria. This knowledge will aid antibiotic discovery efforts, improve understanding of mechanisms of drug resistance, support new biomanufacturing processes through faster detection of bacterial contamination of pharmaceutical products and foods, and characterization of the microbiome.

    The challenges of rapid bacterial identification are primarily in two areas ? sample preparation, that eliminates the need for culturing, and multiplex identification, to cover the diverse range of bacterial species capable of causing infection. The proposed work is based on leveraging the differential response between bacteria and the cells in a sample matrix to selectively break down the sample matrix, but not bacteria, such that the largest lysis debris is smaller than intact bacteria. The debris is subsequently separated from intact bacteria using a size-based technique enabling rapid isolation of a broad range of bacteria directly from the sample. A novel Fourier-transform infrared microspectroscopy system is then used to identify the isolated bacteria at clinically relevant concentrations. No bacteria-specific reagents are employed. The proposed Phase I work addresses the highest risk technical hurdles in the process. Isolating and detecting low concentration of bacteria directly from blood is accomplished through the three objectives of this project that optimize the purification and bacterial recovery from the sample, identification accuracy, and performance of the integrated system relative to the traditional culturing-based method.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 20271 Goldenrod Lane
  awardeeCity: Germantown
  awardeeCountryCode: US
  awardeeName: 3I Diagnostics, Inc.
  awardeeStateCode: MD
  awardeeZipCode: '208764064'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819613'
  piEmail: rk@3idx.com
  piFirstName: Rajesh
  piLastName: Krishnamurthy
  piPhone: '3015156380'
  poName: Henry Ahn
  date: 05/21/2018
  startDate: 06/01/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Culture-independent Rapid Bacterial Isolation and Identification'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project encompasses the development of a continuous fabrication
    process to enable production of larger volumes of the next generation of agrochemical
    compounds. Although the first focus is on utilization for efficient delivery of
    antimicrobial and antifungal crop protection chemicals, this platform can be applied
    for actives and biologicals with other functionalities. The broader significance
    of this research and development effort entails the following aspects: First,
    in addition to agricultural crop protection products, the delivery system developed
    here is expected to find commercial applications in many products targeted to
    the consumer, construction markets, and healthcare. Second, the formulation of
    benign small structures that have the potential to replace a wide range of persistent
    and harmful nanoparticles in various industrial settings will enhance scientific
    and technological understanding of scalable processes on the nanoscale. Third,
    the sustainable solutions developed in this project could strengthen existing
    natural resources, enhance biosecurity of the U.S. food supply, and improve public
    health. \n\nThis SBIR Phase I project proposes to engineer an innovative system
    for efficient delivery of agricultural actives. To increase productivity, current
    agricultural practices utilize large amounts of crop protection chemicals. However,
    the intensive use of agrochemicals creates environmental threats damaging natural
    resources and potentially causing climate change. To address these challenges
    we are developing innovative, breakthrough platform technology with potential
    to increase efficiency of farming with the same or fewer inputs, while protecting
    the environment. The goal of this work is to create a new class of scalable, functionally
    active, sustainable and eco-friendly materials based on the widely available,
    biodegradable and bio-renewable resource lignin. The first objective of the project
    is to build a continuous flow process for preparation of lignin particles functionalized
    with small amounts of active biocides. This research will establish feasibility
    for continuous formulation of these preparations. The second objective of the
    study includes characterization of the new formulations using a series of antimicrobial
    and antifungal assays. As a result of the Phase 1 effort, technical risk will
    be reduced by identifying the most promising formulations for field studies to
    be conducted in Phase 2."
  awardeeAddress: '840 Main Campus Dr. #3550'
  awardeeCity: Raleigh
  awardeeCountryCode: US
  awardeeName: BENANOVA Inc
  awardeeStateCode: NC
  awardeeZipCode: '276065221'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746692'
  piEmail: anka.veleva@benanova.com
  piFirstName: Anka
  piLastName: Veleva
  piPhone: '9196071074'
  poName: Anna Brady-Estevez
  date: 01/05/2018
  startDate: 01/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Lignin-Based Formulations for Efficient and Sustainable Control
    of Plant Pathogens'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project, if successful, will be the implementation of
    an effective point-of-care (POC) test that will not only impact the lives of patients,
    but can reduce the costs to hospitals, health insurances companies, and government
    agencies. According to the National Institutes of Health, cancer cost the U.S.
    an estimated $219 billion in 2007, including $130 billion for lost productivity
    and $89 billion in direct medical costs. The proposed screening technology is
    expected to help gynecologists in hospitals or in private practice to provide
    a complete diagnosis in less time, reducing the number of visits and the endometrial
    cancer incidence through an early detection, especially in women over 50 years
    old. This would benefit the medical insurance by lowering the cost per patient
    with this type of cancer. If successful, the proposed non-label/real-time cancer
    diagnostic device will contribute to new scientific findings and engineering aspects
    in bio-sensing technology. The resulting device will also provide a non-invasive,
    fast, and accurate method to detect cancer for preclinical diagnosis. In addition,
    the research based on this technology will improve a range of equivalent studies
    that use similar systems and biological indicators. \n\n\nThe proposed project
    is aimed to develop a POC technology for the sensitive detection of telomerase
    as a cancer measurable indicator in real-time. Telomerase is a distinctive enzyme
    whose presence in cells or tissues is used for screening, early cancer detection,
    prognosis and/or monitoring a residual cancer disease. The proposed technology
    is based on the detection of telomerase in cancer cells through the measuring
    of an in-situ elongation process of an immobilized label-free single strand DNA
    probe by means of sensitive electrochemical events occurring at the conductive
    gold microchip surface. For the development of this new sensing microchip device
    the team will use commercially available products. Silicon wafers have been used
    as substrate with gold as electrodes due to their reliability but these materials
    are expensive and the fabrication is labor intensive. Therefore, important diagnostic
    device parameters will be studied after incorporation of bare bio-sensing strips.
    Phase I of this project, is aimed at demonstrating the feasibility of the proposed
    technology as well as testing the reliability and robustness of the microchip
    biosensor using uterine cancer samples."
  awardeeAddress: P.O. Box 20276
  awardeeCity: San Juan
  awardeeCountryCode: US
  awardeeName: Bidea
  awardeeStateCode: PR
  awardeeZipCode: 009280276
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746384'
  piEmail: r.diazayala@bideallc.org
  piFirstName: Ramonita
  piLastName: Diaz-Ayala
  piPhone: '7873424538'
  poName: Henry Ahn
  date: 12/29/2017
  startDate: 01/01/2018
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Development of a Device for Early Detection of Uterine Cancer
    Cells at the Point-of-Care'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is to deliver state of the art cryptography and
    cybersecurity solutions to Internet of Things (IoTs) and embedded device designers,
    enterprise hardware and software vendors, and government contractors against the
    attack of classical and quantum computers. It has been widely accepted that quantum
    computer attacks on today's security are expected to become a reality within the
    next decade. Some progress towards constructing quantum computers has been made,
    although no quantum computers with serious computing power have yet been built.
    Nevertheless, we believe it is prudent to plan ahead for future needs as it normally
    takes many years to change cryptosystem deployments due to network effects. This
    project plans to implement quantum-safe solutions which will require the integration
    of quantum-safe software and/or hardware cryptographic solutions on resource-constrained
    devices used in embedded systems.  \n\nThis Small Business Innovation Research
    (SBIR) Phase I project will design, develop, and implement cryptographic algorithms
    that are suitable for small and resource-constrained devices employing hard and
    complex mathematical assumptions known to be classical- and quantum-safe. All
    post-quantum cryptography candidates need to be evaluated in terms of performance
    while the target applications are resource-constrained devices. Long-term and
    lightweight security are two main parameters that need to be considered while
    deploying quantum-safe cryptographic algorithms in these devices. We plan to employ
    a special class of quantum-safe algorithms based on maps on elliptic curves to
    achieve the required performance and security. Cryptosystems based on these maps
    on the elliptic curves are known to provide the smallest possible key sizes and
    their security level is determined by a simple choice of a single parameter in
    comparison to the other quantum-safe candidates. The hardware designs are taken
    through VLSI design flow to realize the integrated circuits that are evaluated
    for energy/power, area/performance, and security. The project will generate new
    insights and results about how to be safe and secure in the quantum era. This
    project will also contribute to the ongoing standardization effort by the US government
    and other international organizations."
  awardeeAddress: 901 NW 35th Street
  awardeeCity: Boca Raton
  awardeeCountryCode: US
  awardeeName: PQSecure Technologies, LLC
  awardeeStateCode: FL
  awardeeZipCode: '334316410'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1745882'
  piEmail: brandon.langenberg@pqsecurity.com
  piFirstName: Brandon
  piLastName: Langenberg
  piPhone: '2018445743'
  poName: Peter Atherton
  date: 12/27/2017
  startDate: 01/01/2018
  expDate: 04/30/2019
  title: 'SBIR Phase I:  Post-Quantum Cryptography in Resource-Constrained Devices'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to provide spoof-free biometric fingerprint sensors. Consumer confidence in adopting many technologies such as IoT devices, and reach a cash-less society is limited by our confidence in transactions being fraud-free. Around the world, there are varying degrees of fraud and it is well known that poorer countries have higher levels of fraud then more advanced countries. By providing a trustable biometric device, the proposed commercialization plan will allow lower levels of fraud and allow greater degree of economic activity bringing up standards of living. The technology of GHz ultrasonics for sensing also has the potential for to be used for applications in being able to image baby fingerprints, enable fingerprint readers in fire-arms for authenticated use at very fast speeds, and allow integration with credit and debit cards. The success of the commercial activities will create a new paradigm for trusting the electronic economy.

    This Small Business Innovation Research (SBIR) Phase I project will develop revolutionary new biometric sensors. Biometric technologies range from sensing the unique patterns of the eyes, to voice, and fingerprints amongst other markers. Capacitive fingerprint sensors, and optical fingerprint sensors are very commonly found in smartphones and desktop applications. These technologies produce images that are often limited in resolution and are not spoof-proof. For example, optical fingerprint readers can be spoofed by fingerprint images and capacitive fingerprint sensors can be spoofed by skin-like dielectric polymer fingerprint molds. Ultrasonic images offer the potential for detecting tissue material properties that can help identify fake fingerprints. Although many low-frequency technologies for ultrasonic fingerprint sensing are available, very few have made it into the market in large quantities owing to cost, packaging, and insufficient SNR and resolution. In this project the company will extend the frequency of operation to the GHz range to achieve four to eight times the standard industry standard of 500 dpi resolution. Coupled with integrated circuits operating at low voltages, the company aims for integration of the sensors in very thin platforms such as credit cards.
  awardeeAddress: 610 The Parkway
  awardeeCity: Ithaca
  awardeeCountryCode: US
  awardeeName: Geegah llc
  awardeeStateCode: NY
  awardeeZipCode: '148502273'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746710'
  piEmail: justin@geegah.com
  piFirstName: Justin
  piLastName: Kuo
  piPhone: '7324911940'
  poName: Peter Atherton
  date: 12/27/2017
  startDate: 01/01/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  GIGAHERTZ ULTRASONIC FINGERPRINT IMAGERS'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to spark more cybersecurity innovations, by reducing the R&D expenditures via providing fundamental security analytics tools as a service. Global cybersecurity spending is increasing significantly year over year. Enormous R&D resources have been invested in the development of a range of security products to meet this market. However, different security product providers repeatedly build the fundamental security analytics tools and use them to further develop different innovative security solutions. That is a huge waste of R&D resources.  The proposed solution reduces the R&D expenditure of customers and lowers the entry bar for the growing cybersecurity market. With the lowered entry bar, the company anticipates that more innovations will be put into practice. As a result, with the increased competition and reduced R&D expenditure, the company expects a reduction in cybersecurity spending by companies and the government.

    This Small Business Innovation Research (SBIR) Phase I project focuses on malware intelligence, which has been a long-standing as well as increasingly complex cybersecurity problem. Traditional signature based detection and manual reverse engineering approaches can no longer keep up with the pace of increasingly sophisticated obfuscation and attack techniques. The objective of this project is to develop a security analysis tool for malware intelligence by combining the following two unique techniques: "whole-system emulation based dynamic binary analysis" and "deep-learning based binary code similarity detection". The first technique provides a fine-grained monitor capability to observe the behaviors of malware. The second technique provides the capability of learning and characterizing complex features. By combining these two techniques, the proposed technology will be able to better understand malware and generate actionable intelligence.
  awardeeAddress: 20871 Westbury Rd.
  awardeeCity: Riverside
  awardeeCountryCode: US
  awardeeName: DEEPBITS TECHNOLOGY LLC
  awardeeStateCode: CA
  awardeeZipCode: '925082974'
  fundsObligatedAmt: '224987'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746819'
  piEmail: xchu@deepbitstech.com
  piFirstName: Xunchao
  piLastName: Hu
  piPhone: '9518276437'
  poName: Peter Atherton
  date: 12/27/2017
  startDate: 01/01/2018
  expDate: 08/31/2019
  title: 'SBIR Phase I:  Building Extensible and Customizable Binary Code Analytics
    Engine for Malware Intelligence as a Service'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the restoration of trust in computing systems.  Successful cyberattacks, including mass privacy breaches and the discovery of device backdoors, have shaken trust in computing, put users at risk, hurt the economy, and even threatened our national security.  The usual set of ad-hoc, incomplete, and costly approaches simply have not addressed the problem.  This research effort will advance a viable, practical, and holistic solution that gives users much stronger guarantees of security while lowering the costs of keeping systems secure.

    This Small Business Innovation Research (SBIR) Phase I project will develop TigerGuard, a computer system security architecture that contains the effects of cyberattacks on existing computer infrastructure.  TrustGuard is based on a small, separately manufactured, and easy-to-verify hardware element, called the Sentry, that serves as the root of trust.  The Sentry is a general-purpose hardware trust component that, when combined with an application-specific Dynamic Specification Check (DSC) software component, provides flexible containment capabilities.  The containment guarantees of TigerGuard hold despite design and manufacturing flaws (known and not-yet-known, malicious and unintentional) in the operating system, firmware, hardware, and software, including those in the application software itself. Formal verification of both the Sentry and DSC, a practical effort given their total size of only a few thousand lines of code, becomes equivalent in security guarantees to proving hundreds of millions of existing lines of code correct (including the processor design, memory implementation, hard drive firmware, the operating system, shared libraries, and the application code).
  awardeeAddress: 119 Jefferson Road
  awardeeCity: Princeton
  awardeeCountryCode: US
  awardeeName: Tigerstone Inc
  awardeeStateCode: NJ
  awardeeZipCode: 085404602
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746947'
  piEmail: stephen@tigerstonelabs.com
  piFirstName: Stephen
  piLastName: Beard
  piMiddeInitial: R
  piPhone: '5303014162'
  poName: Peter Atherton
  date: 12/27/2017
  startDate: 01/01/2018
  expDate: 09/30/2019
  title: 'SBIR Phase I:  Secure Computing using Pluggable Trust Technology'
- abstractText: "The broader impact/commercial potential of this Small Business Technology
    Transfer (STTR) Phase I project will result from a direct benefit to the energy
    sector of the U.S. economy, since seismic exploration will play an increasingly
    important role in meeting increasing energy demands and maintaining healthy oil
    and gas output. The goal of this project is to develop a software package for
    automated pattern recognition that can be used by seismic processing companies
    to automatically pick geological features from seismic data. Seismic data volumes
    have grown exponentially over the last three decades as the seismic exploration
    industry increases its survey coverage. Manual picking and geological pattern
    identification jobs, which depend on visual inspection, are labor intensive and
    cannot keep up with the growth in data generated by seismic surveys. In this project,
    the company will develop a machine vision enabled picking and identification tool
    trained by a deep learning network. Lessons learned in training an efficient deep
    learning network for pattern recognition have wide applications in other areas
    such as medical image analysis. This project will support the training of both
    graduate and undergraduate students in the areas of seismic exploration, machine
    learning and high-performance computing. \n\nThis Small Business Technology Transfer
    (STTR) Phase I project aims to develop a deep learning network model to recognize
    unique patterns embedded in seismic data, which patterns are characteristic of
    the associated geological structures. Specifically, the project will demonstrate
    the feasibility of delivering a machine vision enabled inspection tool to relieve
    domain experts from labor-intensive visual examination activities. Various automatic
    picking approaches currently exist, with differing degrees of success. Nonetheless,
    the uncertainty involved in these tools is still too high for them to be widely
    adopted by the industry. Recent advances in the area of deep learning make it
    possible to surpass human-level visual recognition performance in some applications.
    High performance deep learning network models, however, require a large amount
    of high quality training data. In this project, the company proposes to use a
    novel self-taught deep transfer learning approach to overcome the data shortage
    problem resulting from proprietary rights associated with the data. The new training
    workflow is adaptive to the domain of seismic data processing. It will also minimize
    the training effort and deliver a robust system with guaranteed performance for
    new and unseen datasets."
  awardeeAddress: 14100 Southwest Freeway
  awardeeCity: Sugar Land
  awardeeCountryCode: US
  awardeeName: Advanced Geophysical Technology Inc.
  awardeeStateCode: TX
  awardeeZipCode: '774784566'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1746824'
  piEmail: wenyi.hu@agtgeo.com
  piFirstName: Wenyi
  piLastName: Hu
  piPhone: '2818886789'
  poName: Peter Atherton
  date: 12/27/2017
  startDate: 01/01/2018
  expDate: 06/30/2019
  title: 'STTR Phase I:  Deep Transfer Learning Enabled Machine Vision Inspection
    and Its Applications in Exploration Geophysics'
- abstractText: |-
    This Small Business Technology Transfer Phase I Project will develop a metal-free route to the production of high performance plastics and composites. Specifically, this project focuses on a unique class of materials based upon a thermoset that displays high strength-to-weight ratio and exceptional fracture toughness. A challenge to broader adoption of these materials stems from the current reliance on metal-based reagents and catalysts for their production. The metals impose a significant recurring cost of production, show sensitivity to air, and remain as contaminants in the final products. This innovation provides the first metal-free access to such materials. Additionally, the unique metal-free catalyst system is capable of producing resin and polymer feedstocks that are not available from metal-based reagents, and may offer advantages in processing and performance. The projected commercial impacts of the innovation will be enhanced material performance, lower cost products, and broadened (new) fields of use. The existing market is estimated to be $578M with 4.9% annual growth through 2023.

    The intellectual merit of this project is the invention and development of the first metal-free route to olefin metathesis polymers and oligomers. Prior art has demonstrated on small scale the ability to use a unique organocatalyst to produce polymer and resin feedstocks that are easily processable into high performance thermosets and composites. The organocatalyst approach is a divergence from all previous methods of producing materials via olefin metathesis and therefore warrants validation and optimization toward commercial scale-up. The Phase I research aims will include (1) scale-up through the design and implementation of flow reactor technologies, (2) mechanical analyses and product specification sheets for thermoset prototypes, and (3) evaluation of new resins and polymers for use in fiber reinforced composite materials.  The results should be useful commercially and academically.
  awardeeAddress: 7725 31st Ave NE
  awardeeCity: Seattle
  awardeeCountryCode: US
  awardeeName: Boydston Chemical Innovations, Incorportated
  awardeeStateCode: WA
  awardeeZipCode: '981154727'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1747201'
  piEmail: john.goldstone@live.com
  piFirstName: John
  piLastName: Goldstone
  piPhone: '2537321876'
  poName: Benaiah Schrag
  date: 12/23/2017
  startDate: 01/01/2018
  expDate: 04/30/2019
  title: 'STTR Phase I:  Metal-Free Production of Olefin Metathesis Polymers and Resins'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop a universal design kit for silicon photonics that will include, for the first time, the ability to design and produce, in a fabless model, a cost-effective, silicon-controlled, tunable laser.

    The proposed project goals will include the analysis, design, and fabrication of silicon photonic integrated circuits for back-reflection suppression. A key research objective will be to enable the design of a customized, silicon-controlled, tunable laser capable of insertion into a high-speed data communication link based on hybrid III-V/Si integration. A key development objective will be to enable the assembly and manufacture of the silicon photonic integrated circuits using industry-accepted back-end-of-line integration methods.
  awardeeAddress: 16132 Cayenne Creek Rd.
  awardeeCity: San Diego
  awardeeCountryCode: US
  awardeeName: Axalume Inc.
  awardeeStateCode: CA
  awardeeZipCode: '921273708'
  fundsObligatedAmt: '224997'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746684'
  piEmail: ashok@axalume.com
  piFirstName: Ashok
  piLastName: Krishnamoorthy
  piPhone: '7326875535'
  poName: Rick Schwerdtfeger
  date: 12/21/2017
  startDate: 01/01/2018
  expDate: 04/30/2019
  title: 'SBIR Phase I:  PIC:  Hitless III-V/Si Widely Tunable Laser with Back Reflection
    Suppression'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project will be the development of a fermentation-based technology that enables the renewable and sustainable production of medium-chain fatty acids - an important class of widely used industrial chemicals - using glycerol-rich waste streams as feedstocks. These chemical products constitute a growing multi-billion dollar market with applications in the flavoring, fragrances, personal care, plastics, textile, and pharmaceutical industries. This technology also will create new high-value uses for existing glycerol-rich waste streams generated within the bio-diesel industry, which can greatly improve the economic competitiveness of bio-diesel with fossil diesel, especially in an era of low oil prices. Thus, commercialization of this fermentation-based technology will serve as a foundation for developing additional eco-friendly technologies for the production of other industrial chemicals that contribute to the ~$800 billion/year petrochemical industry, in turn creating new jobs for helping the environment, benefiting society, and building a sustainable future. In addition, this SBIR project will establish a carbon conservation technology as the basis for developing the next-generation of fermentation-based chemical production technologies.

    This SBIR Phase I project proposes to develop a unique carbon conserving (C2) platform technology to enable the cost-competitive and sustainable production of a variety of fatty chemicals from renewable feedstocks such as crude glycerol. The C2 platform technology comprises a series of non-natural biosynthetic pathways that minimize/eliminate carbon loss as CO2 during production, thereby improving theoretical yields over the state of the art by as much as 50%. The improved achievable yields along with the anaerobic production processes enabled by the C2 technology are two crucial features for establishing bioprocesses with cost-competitive economics relative to incumbent technologies, which is critical for commercial success. One goal of this Phase I project will be to demonstrate the production of a high-value fatty acid, hexanoic acid, from crude glycerol and using the C2 technology. For the second goal, enzyme screening, strain development, and metabolic engineering approaches will be implemented for improving hexanoic acid production metrics (i.e., higher titers, rates, and yields) from crude glycerol. Accomplishing these goals will substantially de-risk the C2 technology and establish its commercial potential for the cost-advantaged production of hexanoic acid at the commercial level.
  awardeeAddress: 473 & 473D TAN HALL
  awardeeCity: BERKELEY
  awardeeCountryCode: US
  awardeeName: ZYMOCHEM INC
  awardeeStateCode: CA
  awardeeZipCode: '947200001'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1747279'
  piEmail: jon@zymochem.com
  piFirstName: Jonathan
  piLastName: Kuchenreuther
  piPhone: '5302200541'
  poName: Ruth Shuman
  date: 12/19/2017
  startDate: 01/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  A carbon conserving platform technology for the microbial
    production of medium chain fatty acids from crude glycerol'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is that it makes high-dimensional data visualization
    more accessible to mainstream users. An interactive multivariate visualization
    framework will assist users in the understanding of complex phenomena and help
    with decision making in the presence of multiple factors. It uses a map-like layout
    of factors and data that naturally appeals to a mainstream user's innate visual
    literacy, making it easy to learn and use. Through a variety of interaction facilities,
    users can define areas in this layout that indicate parameter values of their
    interest. This then enables them to make informed decisions within a single visual
    interface and balance among the diverse impacts the various factors have on the
    decisions. Given the massive growth in the availability of multivariate data,
    the unique capabilities that the proposed framework provides are expected to have
    a strong impact on society, in many application domains and at many different
    levels - personal, business, finance, scientific, medicine, and so on. In short,
    this project will have a significant societal impact by allowing users to make
    better decisions in less time. \n\nThis Small Business Innovation Research (SBIR)
    Phase I project makes several intellectual and scientific contributions. A core
    contribution is the ability to embed high dimensional points and factors into
    a 2D plane or map, such that the distance between points has contextual meaning.
    This allows a single visualization to convey what currently takes a dashboard
    of several bivariate plots to show. The inherent mechanisms that create the combined
    map-like layout of data and factors are novel and open new opportunities to understand
    multivariate data. The same is true for the interactions defined on the layout,
    in particular those that allow users to derive the areas of influence of the various
    factors. Another intellectual contribution is the interface that allows users
    to focus their attention on specific attributes and deals with the mental and
    cognitive overload that may arise in users in the presence of too many factors
    and attributes. The proposed system constructs a meaningful hierarchical representation
    of the attributes that can be navigated within a novel space efficient visual
    interface. Using our design tools, anyone with an internet connection and a modern
    web browser will be able to create these layouts from multivariate data."
  awardeeAddress: 302 E 88th Str.
  awardeeCity: New York
  awardeeCountryCode: US
  awardeeName: Akai Kaeru, LLC
  awardeeStateCode: NY
  awardeeZipCode: '101284931'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1721664'
  piEmail: epapenha@akaikaeru.com
  piFirstName: Eric
  piLastName: Papenhausen
  piPhone: '5185861451'
  poName: Peter Atherton
  date: 07/14/2017
  startDate: 07/15/2017
  expDate: 06/30/2019
  title: 'SBIR Phase I:  The Data Context Map'
- abstractText: "This SBIR Phase I project will provide prototype products to satisfy
    customer needs in prioritized wearable sensor market segments for the endurance
    sports market. One advantage of the proposed sensor is its similar feel to cloth
    fabric, a benefit in comfort and convenience to the user.  This is in contrast
    to current hydration monitors made of thick plastic materials requiring the use
    of an additional wristband or adhesive patch.  This value proposition was developed
    and tested based on the findings of 374 customer interviews during a spring 2017
    NSF I-Corps workshop.  That study determined the commercial and product potential
    of a fabric sensor to monitor hydration.  In 2015 alone more than 17.1 million
    people finished endurance events.  According to interview data, 50% of respondents
    are interested in a hydration solution due to past dehydration and cramping issues.
    Additionally, 40% of respondents indicated interest in a technology-based solution.
    This group equates a target market of $342 million for a hydration monitor priced
    at $100 per unit, a good estimation of the total available market based on I-Corps
    interviews. In general, the data collected from the developed sensor could lead
    to better understanding of health and disease processes, including the analysis
    of common diabetic neurological complications, the diagnosis of cystic fibrosis
    (CF), and sweat monitoring for advanced prosthetic limb applications, bedridden
    patients, or athlete performance tracking leading to better treatments and health
    outcomes for all patients.  \n\nA monitor that analyzes the sodium concentration
    of a person's sweat would be able to notify them before they begin suffering from
    exercise-induced illnesses such as hypernatremia or hyponatermia. This early notification
    system would allow people to be on top of their hydration, and be able to replenish
    their electrolytes as needed, without overhydrating. The team has developed flexible,
    lightweight fabric materials that can selectively determine physiological information
    from sweat forming on the surface of the skin.  The technology is the first lightweight
    fabric sensor to provide real-time information regarding hydration levels during
    exercise or training. These dehydration patterns are unique and vary based on
    diet, weather conditions, and human physiological cycles. The ability to monitor
    an individual's hydration parameters is unique to the proposed sensor and gives
    it a competitive advantage over sweat monitors that monitor water lost or water
    timers that remind the athlete to drink water every 20 minutes.  Specifically,
    the proposed work will focus on the large-scale development of a hydration monitor,
    validation of the monitor during material testing and on the body in an exercise
    physiology laboratory, and leveraging partnerships with potential strategic partners.
    As athletes strive for peak performance, improper hydration can undermine their
    progress in both training and competitive settings.\n\nThis award reflects NSF's
    statutory mission and has been deemed worthy of support through evaluation using
    the Foundation's intellectual merit and broader impacts review criteria."
  awardeeAddress: 440 Stonehurst Drive
  awardeeCity: Copley
  awardeeCountryCode: US
  awardeeName: RooSense LLC
  awardeeStateCode: OH
  awardeeZipCode: '443213105'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1843539'
  piEmail: hanieh.usm@gmail.com
  piFirstName: Hanieh
  piLastName: Ghadimi
  piPhone: '2342819164'
  poName: Henry Ahn
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'STTR Phase I:  Wearable Fabric Sensor for Hydration Monitoring'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is  the development of an improved methane sensor module
    that can enables new drone sensing and sensor network applications in the energy,
    agricultural, and waste management sectors. Methane, the third largest energy
    source after petroleum and coal in the U.S., is relatively difficult and expensive
    to measure compared to other gasses. It is a major atmospheric pollutant, both
    as a component of smog and as a greenhouse gas. This technology can provide societal
    environmental benefits by helping reduce methane release into the environment
    through the ubiquitous sensing of small natural gas leaks, allowing companies
    to rapidly respond. This sensor system has the sensitivity of laser-based spectrometers
    but is smaller, lighter, and has lower power requirements at a price three orders
    of magnitude less than existing high-end spectrometers. Designed to reduce power,
    weight and cost to a minimum while not compromising sensitivity, this technology
    is ideal for UAV-based measurements. It can also give station mounted and handheld
    monitoring units high sensitivity at a lower price point, enabling multiple monitor
    sampling strategies and a multi-station networked array to track intermittent
    sources of methane leaks. This technology can provide novel capabilities to cost-conscious
    customers in the energy sector while opening up additional markets for agricultural,
    waste management, and safety products. A first prototype of this methane sensor
    successfully measured methane in nitrogen down to 10 ppm. The long-term objective
    is the creation of a commercially available low-cost, high precision methane sensor
    product line. SBIR project funding is enabling the transition of this promising
    sensor technology from a small business research and development project into
    the early commercialization stages of a valuable new product. \n\n\nThis SBIR
    Phase 1 project proposes to create a self-contained methane sensor system, smaller
    in size than a quarter, with the sensitivity of advanced laser spectrometers.
    Current methods of detection do not meet the needs of industry. They are either
    cheap, high power and low sensitivity, such as catalyst-based systems, or they
    are large, expensive, high power optical systems. There is a market need for methane
    sensors that improve upon size, weight and power, while still maintaining useful
    sensitivity and selectivity. The system consists of 3 primary modules: the replaceable
    or consumable sensor package, the sense electronics, and the data storage and
    communication system. Due to the extremely low power requirements of the sensor,
    clever design of the data and communications system is critical if the low power
    benefits of the sensor are to be realized in a product. Ultimately, the system
    will include wireless connectivity (Bluetooth, WiFi, 5G, Zigbee) for cloud and
    IoT data management. This design will be prototyped and will undergo performance
    measurements. Materials for methane sensing will be identified  The objective
    of SBIR Phase 1 is to produce an initial prototype sensor for methane-sensing
    that will be the focus of SBIR Phase II.\n\nThis award reflects NSF's statutory
    mission and has been deemed worthy of support through evaluation using the Foundation's
    intellectual merit and broader impacts review criteria."
  awardeeAddress: 2325 3rd St
  awardeeCity: San Francico
  awardeeCountryCode: US
  awardeeName: AdvancedMEMS
  awardeeStateCode: CA
  awardeeZipCode: '941074301'
  fundsObligatedAmt: '223890'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1844067'
  piEmail: dmcc@advancedmems.com
  piFirstName: Daniel
  piLastName: McCormick
  piMiddeInitial: T
  piPhone: '5308670905'
  poName: Anna Brady-Estevez
  date: 02/01/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Low Cost, High Precision Methane Sensor System'
- abstractText: |-
    This SBIR Phase I project will advance novel techniques for developing high-resolution noninvasive brain imaging systems, capable of recording unprecedented spatiotemporal resolution inferences of the brain activity for a portable system.  These systems leverage novel fundamental analysis and results, and experimental demonstrations, that show that spatial resolution of Electroencephalography (EEG) is not saturated at densities of a few hundred electrodes, unlike what has been widely believed in clinical and neuroscience community.  They also build on recent work by the PIs that enables faster and reliable acquisition of EEG signals. The success of the proposed work will help diagnose worsening brain injuries before the injury occurs. Brain injuries affect 1.7 million Americans every year. Commercially, it will enable higher resolution brain-machine interfaces for applications such as virtual reality interfacing and neuroprostheses, generating novel avenues for jobs and revenue through creation of an entirely new industry.  This transdisciplinary effort brings together neuroscientists and engineers and the concepts developed in this effort will inform material for basic neuroscience and neuroengineering courses.  The team will continue to publish and publicize their work at clinical conferences.  One of the core employees will be a minority female who has contributed to the research, guided several other minority (and non-minority) female students, and now wants to lead the development end of this project.

    This effort builds a systematic platform that challenges the widely held belief that increasing electrode-densities of EEG to beyond a few hundred electrodes does not improve spatial resolution. There are several problems with the traditional EEG that the platform overcomes: (i) typically only 9-32 electrodes are used for clinical diagnoses and these are fundamentally limited to only providing poor spatial resolution; (ii) because traditional EEGs have low resolution, surgical treatments often require invasive procedures. E.g., for diagnosing severity or worsening of Traumatic Brain Injuries (TBI) by measuring parameters of cortical spreading depolarizations (CSDs), which are mediators of worsening brain injuries; (iii) long-term EEG measurements are cumbersome, and high-density systems can take hours of manual labor to install. The PIs' preliminary work provides strong evidence supporting the claim that ultra-high-density EEG will provide the first non-invasive and portable modality for high spatial and temporal resolution brain imaging.  Novel brain-imaging algorithms will be developed and benchmarked against existing techniques and assessed using novel fundamental limits.  Novel techniques will be deployed in the design of conductive sponges and in lowering power, enabling the platform to be portable and usable over long term.  These improvements will be rigorously tested through simulations, experiments, and real data analysis.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 4620 Henry St
  awardeeCity: Pittsburgh
  awardeeCountryCode: US
  awardeeName: Precision Neuroscopics
  awardeeStateCode: PA
  awardeeZipCode: '152133715'
  fundsObligatedAmt: '224999'
  fundProgramName: STTR PHASE I
  id: '1843859'
  piEmail: shawnkkelly@gmail.com
  piFirstName: Shawn
  piLastName: Kelly
  piMiddeInitial: K
  piPhone: '4126136652'
  poName: Henry Ahn
  date: 02/19/2019
  startDate: 02/15/2019
  expDate: 01/31/2020
  title: 'STTR Phase I:  Portable Ultra-Resolution EEG for Improved Diagnosis and
    Treatment of Brain Disorders: Instrumentation and Algorithms'
- abstractText: |-
    The broader impact/commercial potential of this project is to provide a low cost Lidar+Thermal camera to the autonomous car market that will eventually enable level 4 and level 5 autonomy. The proposed innovation incorporates both a Lidar and a thermal detector to locate objects but also classify them, as this is the most crucial aspect of autonomous vehicles. The dual polarity Lidar+Thermal photodetector solves a few major issues in the current Lidar industry. First, current Lidars have to use advanced algorithms to classify the objects, whereas a Lidar+Thermal detector can easily distinguish between animate and inanimate objects, while continuing to establish their location. This is done due to the drastic heat signature of animate objects. Second, the dual polarity detector is able to detect and locate hazards on the road such as snow or puddles, which is vital if autonomous vehicles are used in northern regions. In addition, the frame rate of the Flash Lidar+Thermal is up to 200 Frames per second, which will drastically reduce smearing effects and allow for driving at speeds of 70+ MPH. Lastly, the high thermal resolution of the camera will ensure operation in bad weather conditions including fog and rain.

    This Small Business Innovation Research (SBIR) Phase I project will provide a proof-of-concept of the dual polarity Lidar+Thermal detector. An array of 32x32 pixels will demonstrate that in one polarity, a thermal hot-mid-wave image and in the other polarity the pixels will operate in a time-of-flight mode for Flash Lidar operation. The pixel?s spectral response will range from 500nm up to 3.5?m in the Lidar mode. Characterization of the detector array will use the eye-safe 1550nm laser. The goal is to show a 200m Lidar operation with a high resolution of a few centimeters and thermal imaging with a thermal sensitivity of 4mK. The transition to Phase II will include an array size of 1000x500 with 10?m pixel pitch. The detector will be evaluated outdoors to demonstrate the detection of animate objects, snow and puddles and will be tested under fog conditions.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 136 WILSHIRE RD
  awardeeCity: Rochester
  awardeeCountryCode: US
  awardeeName: NBN TECHNOLOGIES, LLC
  awardeeStateCode: NY
  awardeeZipCode: '146181221'
  fundsObligatedAmt: '222500'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843757'
  piEmail: shimonmaimon@yahoo.com
  piFirstName: Shimon
  piLastName: Maimon
  piPhone: '5853555556'
  poName: Muralidharan Nair
  date: 02/06/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Affordable Multi-Wavelength Lidar and Thermal Imager for
    Autonomous Vehicles'
- abstractText: |-
    The broader impact of this Small Business Technology Transfer (STTR) Phase I project is to enable a much wider adoption of various photomedical treatments.  Broadly speaking, photomedical treatments use light to cure diseases and promote healing.  Specifically, photodynamic therapy uses light to activate a photosensitizing chemical agent to kill cancer cells or bacterial with minimal side effects.  Moreover, photobiomodulation is the application of light to impaired or dysfunctional tissue to reduce pain and inflammation to speed healing and to promote or inhibit various cellular processes.  The light source is a critical part of any photomedical treatment system.  Existing sources such as lasers and LED arrays are bulky and expensive, generally require additional optics to deliver the light to the target treatment areas.  The current project aims to develop a photomedical treatment system based on a novel light source - quantum dot light emitting devices (QLEDs).  Flexible and large area QLEDs can be placed immediately adjacent to target treatment areas without additional optics.  Their simple driver requirements will result in much lower system costs and facilitate at-home use.  These QLED-based systems will enable the wider adoption of photomedical treatment methodologies, including in currently underserved areas and patient populations.

    The proposed project will leverage the recent invention of ultra-bright quantum dot light emitting devices (QLEDs) into a low-cost and convenient-to-use photomedical treatment system that will enable wider adoption of photomedical treatment methodologies for a variety of pathologies and use cases.  Project tasks include developing QLEDs with emitting spectra precisely tuned to match the absorption spectra of photosensitizers at 630 nanometers (nm), 635 nm and 660 nm; fabricating QLEDs on flexible substrates with device structures guided by microcavity simulations; developing a low DC voltage, current-controlled driver able to deliver a precise light dosage; and demonstrating the photomedical efficacy of thus developed QLEDs in a) ALA-PplX photodynamic therapy and associated dosimetry of oral malignancies using in-vitro 3D co-culture models of oral cancers; b) determining and optimizing parameters for photobiomodulation for wound healing applications including incisional and pressure ulcer wounds, in-vitro using multiple cell lines and models of cellular metabolism, cellular proliferation and scratch wound healing.  Successful completion of these tasks will result in a functional preliminary photomedical treatment system that lays the foundation for in-vivo animal studies of oral cancer or diabetic wound healing treatment paradigms in Phase II of the project.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3251 Progress Drive, Suite 128,
  awardeeCity: Orlando
  awardeeCountryCode: US
  awardeeName: QLEDCures LLC
  awardeeStateCode: FL
  awardeeZipCode: '328262931'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1843101'
  piEmail: ppalomaki@gmail.com
  piFirstName: Peter
  piLastName: Palomaki
  piPhone: '5183664410'
  poName: Rick Schwerdtfeger
  date: 02/05/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'STTR Phase I:  Flexible Quantum Dot Light Emitting Devices for Photodynamic
    Therapy and Photobiomodulation'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to make walking both safer and easier for transfemoral amputees. Falling and fear of falling are pervasive in this population. Transfemoral amputees fall at a rate approximately 200 times that of healthy age-matched individuals, and they seek medical attention from falls at the same rate as the institution-living elderly. Such falls result most commonly from a lack of full knee extension in late swing, combined with a lack of knee proprioception, in which case the user enters a non-recoverable knee buckling state shortly after loading. This project proposes a knee prosthesis that provides a powered, motion-controlled knee swing which guarantees full knee extension prior to heel strike, and it therefore substantially reduces the likelihood of a fall. Further, powered knee movement lessens the need for compensatory movements, and therefore the effort required for walking is lessened. As a result, the proposed knee will provide safer and easier walking, enabling users to walk with greater confidence. The prosthesis will be reimbursable under current reimbursement codes and will result in improved mobility, health, and quality of life for end users.

    This Small Business Innovation Research (SBIR) project proposes a novel knee prosthesis that incorporates a hybrid approach to providing the two major functions of a knee prosthesis: stance and swing control. In this device, stance control is provided by a polycentric joint, while swing control utilizes a small motor for assistance. Consequently, the proposed device is called a polycentric swing-assist (PSA) knee. Unlike a passive extension aid employed in a typical polycentric knee, the swing-assist motor is able to aid both flexion in mid swing and extension in late swing. The PSA prosthesis is intended to inject small amounts of power during the swing phase of gait in order to guide the knee through the swing trajectory. Since the assistance is associated with low-torque and low-power movements, the motor, transmission, and battery can be small, lightweight, and quiet relative to a fully-powered knee prosthesis. The goal of this work is to design, construct, and test a PSA knee prototype. The efficacy of the prosthesis prototype will be compared to a commercial knee. The investigators will test whether or not the prosthesis better emulates healthy kinematics through outcome measures such as toe clearance and peak knee flexion across walking speeds.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3030 OLD HILLSBORO RD
  awardeeCity: FRANKLIN
  awardeeCountryCode: US
  awardeeName: SYNCHRO MOTION LLC
  awardeeStateCode: TN
  awardeeZipCode: '370649543'
  fundsObligatedAmt: '223589'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843764'
  piEmail: brianedwardlawson@gmail.com
  piFirstName: Brian
  piLastName: Lawson
  piMiddeInitial: E
  piPhone: '3176911604'
  poName: Linda Molnar
  date: 02/04/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  A SWING-ASSIST KNEE PROSTHESIS FOR INCREASING MOBILITY IN
    TRANSFEMORAL AMPUTEES'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is to help wastewater treatment plants become compliant
    with emerging environmental regulations, while saving energy and without adding
    cost.  It has potential to reduce the amount of biosolids that need to be shipped
    off-site and landfilled by up to 85% as well as completely destroy odors and pathogens.
    \ As a result, the project may also enhance social justice throughout the country.
    \ Currently, low-income and disadvantaged communities inherit waste from other
    communities, sometimes very far away from where the waste originated.  They inherit
    the stench, the vectors (rats, flies, birds) and toxins.  For example, 7% of the
    biosolids produced by New York City end up in Alabama, via trains and trucks.
    \ People living near the landfills and along transportation routes no longer use
    their porch because of the stench.  By improving the economics of a technology
    that destroys organics much better than state-of-the-art technologies, wastewater
    treatment plants will become cleaner, less malodorous and use less energy.  Other
    markets could open as well including clean power and chemical manufacturing. Finally,
    the project may lead to increased hiring of employees over the next three years.
    \n\nThis SBIR Phase I project proposes to create an affordable and reliable process
    to cleanly and completely destroy organic waste, extract more resources and energy
    from sludge and biosolids at wastewater treatment plants while considerably reducing
    the amount of biosolids that need to be shipped off-site for disposal.  This objective
    will be achieved by improving a process that uses water contained within the waste
    to create a hyper oxidative environment.  Similar processes use costly and hazardous
    pure oxygen, are extremely energy intensive, and are plagued with high maintenance
    cost.  By making innovations in energy recovery, the use of air as an oxidant
    instead of oxygen is possible without the large cost associated with having to
    heat and compress an entire air stream- oxygen plus inert nitrogen. Once optimal
    technical conditions for energy recovery are identified, the project will enter
    the design and fabrication phases. The resulting new energy recovery module will
    be added to an existing system. The prototype will be tested for continuous operation.
    New insights into energy recovery will be gained, which will benefit the scientific
    community as a whole.\n\nThis award reflects NSF's statutory mission and has been
    deemed worthy of support through evaluation using the Foundation's intellectual
    merit and broader impacts review criteria."
  awardeeAddress: 1192 CLINTON STREET
  awardeeCity: REDWOOD CITY
  awardeeCountryCode: US
  awardeeName: BEYOND THE DOME INC
  awardeeStateCode: CA
  awardeeZipCode: '940612237'
  fundsObligatedAmt: '223882'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843662'
  piEmail: sophie@beyondthedome.com
  piFirstName: Sophie
  piLastName: Mancuso
  piPhone: '6508080288'
  poName: Anna Brady-Estevez
  date: 02/01/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'SBIR Phase I:  Energy Efficient Supercritical Water Oxidation'
- abstractText: "This Small Business Innovation Research Phase I project enables key
    proof points behind the novel concept of a hand-held medical robot, i.e. use of
    a medical robot to autonomously perform a task during which neither the robot
    not the patient is fixed in space. The potential outcome of this project is a
    comprehensive line of robotic ultrasound transducers that enable a variety of
    interventional point-of-care robotic applications by enhancing the skills of a
    multitude of clinicians.  As a result, many technically challenging critical procedures
    will no longer be restricted to solely highly trained experts. Applications include
    central vascular access (pediatric and adult), biopsy, regional anesthesiology,
    precision extraction (e.g. thoracentesis), and precision injections (e.g. orthopedic
    biologics), creating an addressable market exceeding $2 billion. Benefits of man-machine
    teaming using hand-held medical robots include faster, simpler procedures that
    can be performed by a much broader group of clinicians, reduced medical complications
    and patient discomfort, and improved hospital infrastructure utilization, ultimately
    benefitting both clinical outcomes and total costs of care. Significant insights
    and implications for other man-machine teaming applications may also result from
    this project, with potential for robotic applications well outside of the medical
    realm. \n\nThe intellectual merit of this project centers on demonstrating the
    feasibility of first-of-kind hand-held robotic capabilities for autonomous needle
    placement. This project builds on two existing layers of innovation. First is
    the ability to use real-time ultrasound data to send a needle precisely to a point
    in the body. This differs significantly from other imaging modalities that require
    multiple images from different orientations integrated \"off line.\" Next, this
    is an autonomous and powered system. Once a user selects a target, the needle
    path is calculated and the needle is advanced automatically. This project builds
    the third level of innovation through its research objectives - creating the real-time
    ability to i) recognize and track the target as an object, and ii) make automatic
    robotic corrections to maintain that target during user or patient movement or
    changes in target characteristics. The research involves novel image recognition
    and tracking technology and very precise novel sensing and control loop technology
    that interact in real time to maintain targeting accuracy in a dynamic environment.
    The anticipated technical result is to enable a non-expert clinician to reliably
    enter a clinically challenging \"small\" central blood vessel in a pediatric patient
    model with an introducer needle.\n\nThis award reflects NSF's statutory mission
    and has been deemed worthy of support through evaluation using the Foundation's
    intellectual merit and broader impacts review criteria."
  awardeeAddress: 1311 VINE ST STE 300
  awardeeCity: CINCINNATI
  awardeeCountryCode: US
  awardeeName: XACT MEDICAL, LLC
  awardeeStateCode: OH
  awardeeZipCode: '452027118'
  fundsObligatedAmt: '224993'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842423'
  piEmail: rdunki_jacobs@xactmedical.com
  piFirstName: Robert
  piLastName: Dunki-Jacobs
  piMiddeInitial: J
  piPhone: '5133685654'
  poName: Benaiah Schrag
  date: 02/01/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Optimizing an autonomous point of care medical robot to improve
    central vascular access'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project centers on the possibility opened by plasma-activated water in dairy sanitation. Plasma activated water has several advantages: it is reusable and reduces the need to buy, store, and dispose of chemicals, it will not face antimicrobial resistance, unlike chemicals, and could be a faster disinfectant. In addition to replacing chemical disinfectants, plasma activated water could prove to be fast enough to allow for disinfecting the milking unit in-between individual cows, which should reduce the spread of mastitis within a herd, reducing the farmer's costs in terms of medicine, increased labor, and culling. By using plasma activated water as part of a milking system, cleaning could be automated as well as target spores in farm environments. The resulting reduction in costs, infection rate, manual labor & strain, and increase in milk quality, could revolutionize the dairy industry.

    This SBIR Phase 1 project proposes to research a method whereby plasma activated water replaces chemical disinfectants used in dairy milking machines. The dairy industry is facing two major problems relating to milking machines: first, a manual labor shortage, and secondly an ever-present threat of mastitis, an infection estimated to cost the industry $1B annually. These two problems come to a head at the milking machine, as current methods require cows to be manually cleaned before milking. The goal of this project is to explore whether plasma activated water could be an effective replacement for teat dips, aiming to design a self-cleaning milking attachment for existing machines, and clean the cows with PAW prior to milking. In Phase I, the focus will be on building a basic prototype to check sanitation capabilities, and compatibility with a farm environment. Future research would include a longer-term study of animals and track infection rates before and after.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 45 A Manor Parkway
  awardeeCity: Rochester
  awardeeCountryCode: US
  awardeeName: Ozonovation Corp
  awardeeStateCode: NY
  awardeeZipCode: '146202625'
  fundsObligatedAmt: '224828'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843833'
  piEmail: christi.durham@gmail.com
  piFirstName: Christianne
  piLastName: Durham
  piPhone: '2084731333'
  poName: Anna Brady-Estevez
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Exploration of Plasma Activated Water Systems in the Dairy
    Industry'
- abstractText: |-
    The broader impact and commercial potential of this Small Business Innovation Research (SBIR) Phase 1 project will be the research and development of a new class of extremely portable deployable structures that allows easier transportation and simplifies the deployment of bulky structure. This fundamental technology covers a wide variety of potential commercial products including large easily transported rescue equipment and large tents for earthquake and other widespread humanitarian disaster scenarios; large space satellite structures such as antennas and optical arrays; large deployable UAV wings; large volumes for habitation or material storage; piping for water, sewage, oil or gas. This technology can help save lives during disasters, ease the transportation of potable water, sewer and energy with lower construction and deployment costs.

    This Small Business Innovation Research (SBIR) phase I project will entail the systematic analysis and development of a novel highly compact, rapidly deployable composite tube technology. The challenge is to harness and combine the extremely energy dense properties of chemical combustion with a photocuring high-performance structural composite material to create an easily transported structure that can be rapidly deployed.  The project will entail experiments to better understand the polymer material properties and tailor them to the electromagnetic spectrum emitted by the combustion. Customization of an adhesive that will combine the necessary viscosity, structural and curing properties. A multiphysics simulation, validated with laboratory experiments, will be used to predict the technology's limitations.  The qualifying components will be utilized in a refined design and evaluated by manufacturers for large scale production. These efforts will culminate in scale prototype construction and testing.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1 Westinghouse plz, Ste D157
  awardeeCity: Hyde Park
  awardeeCountryCode: US
  awardeeName: Helios Applied Science Inc
  awardeeStateCode: MA
  awardeeZipCode: 021362196
  fundsObligatedAmt: '224973'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843840'
  piEmail: avbright@gmail.com
  piFirstName: Alfram
  piLastName: Bright
  piPhone: '7819748841'
  poName: Linda Molnar
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Utilization of a Combustion Process to Rapidly Solidify a
    Photocuring Composite Structure'
- abstractText: |-
    This STTR Phase I project will develop a transformative platform for inexpensive screening for pancreatic cancer detection, based on profiling of cancer-related proteins from a small blood draw.  Pancreatic cancer is one of the deadliest types of cancer, killing over 50,000 each year in the US, and with a five-year survival rate below 7%.  However, currently there are no reliable diagnostic tests for pancreatic cancer, and the great majority of cases are detected at a late stage, with bleak mortality rates as a result.  As cancer is driven fundamentally by a dysregulation of key protein networks, directly measuring the activity of key proteins provides a robust bio-signature for cancer detection. The project will develop a scientifically novel diagnostic technology based on broad protein profiling for the accurate and low cost detection of pancreatic cancer, and thereby shift the therapeutic field of battle to an earlier stage of the disease, where the current treatments can be more effectively harnessed to improve patient outcomes and save lives, avoid unnecessary and ineffective procedures, and generate health system cost savings across the US and elsewhere. Commercialization of this diagnostic platform is expected to drive creation of a substantial enterprise, and related employment and tax-revenues.

    The major innovation of this project is the breakthrough technology for monitoring the state of dozens of cancer-related proteins in biological samples and its application for diagnosing pancreatic cancer from a minute sample of a patient?s blood. The innovative platform has superior levels of sensitivity and accuracy compared to existing technologies, and also offers substantially lower costs, which are critical advantages for the diagnostic application. A further innovation in this project is the development of the analytic engine and the bio-signature knowledge base, that will be used for analysis of the patient?s protein profile.  In this project, the Company will focus on several key technical challenges to develop and validate a 1.0 version of its diagnostic platform for pancreatic cancer detection:  i. identifying a robust, differentiated multi-target, bio-signature for pancreatic cancer; and ii. doing so with an accuracy and at a sufficiently early stage in the cancer emergence and progression to be medically useful. This project will extensively profile biobank samples from various stages of pancreatic cancer and normal patients to generate the differentiated bio-signatures, develop a diagnosis prediction engine to match the bio-signatures and inform diagnoses, and validate those results using additional samples. This award reflects NSF's statutory mission and has been deemed worth of support through evaluations using the Foundation?s intellectual merit and broader impacts review criteria.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 142 Marsh St.
  awardeeCity: Belmont
  awardeeCountryCode: US
  awardeeName: ActivSignal, LLC
  awardeeStateCode: MA
  awardeeZipCode: 024782133
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1843738'
  piEmail: ialexandrov@activsignal.com
  piFirstName: Ilya
  piLastName: Alexandrov
  piPhone: '6173193077'
  poName: Henry Ahn
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'STTR Phase I:  ActivSignal Protein Profiling from Serum Exosomes for the
    Early Detection of Pancreatic Cancer'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to develop disease resistant soybean varieties that will reduce the substantial losses in agricultural production caused by plant diseases.  Loss to disease can be as high as 40% globally and cost billions of dollars annually. In soybean alone, an estimated $3 billion dollars of production value is lost from plant diseases annually.  In addition, the destruction of crops by plant diseases threatens global food security and has a significant negative impact on the environment due to the use of pesticides. Application of a tunable, broad-spectrum disease resistance strategy in agriculturally important crops will have a major societal impact by protecting crops from devastating diseases for which alternative solutions are not currently available, securing agricultural production, and reducing environmental pollution from agricultural chemicals.  In the future, the goal is to apply the proposed technology to other agriculturally important crops such as corn, rice, and tomato.

    The intellectual merit of this SBIR Phase I project is to engineer tunable, broad-spectrum disease resistant soybean varieties. In this project, a soybean immune regulatory cassette will be constructed through sequence homology, and then functionally validated by demonstrating pathogen-inducible resistance against various diseases with minimal yield penalty. The methods that will be used in this project include bioinformatic analysis of soybean sequences to identify homologous defense genes and corresponding regulatory elements, molecular cloning, transformation of both Arabidopsis and Soybean plants, and testing the resulting transformant plants to determine levels of resistance to different types of pathogens. Results from this project will be essential for moving forward with larger field trials, which to be accomplished in the Phase II of the project.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3619 DOVER RD
  awardeeCity: DURHAM
  awardeeCountryCode: US
  awardeeName: UPSTREAM BIOTECHNOLOGY, INC.
  awardeeStateCode: NC
  awardeeZipCode: '277075103'
  fundsObligatedAmt: '224912'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842620'
  piEmail: peter.alexander@upstreambiotech.com
  piFirstName: Peter
  piLastName: Alexander
  piPhone: '9194917112'
  poName: Ruth Shuman
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Engineering broad-spectrum disease resistance in soybean
    without fitness cost'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to significantly lower the cost and expand the number of addressable markets for ice thermal energy storage. Cost effectively storing energy is imperative to a sustainable future. Storage can provide reliable access to power from intermittent renewable sources, increase the resiliency of the grid to weather events or terrorist attacks, and increase the utilization efficiency of existing assets, deferring costly upgrades. Today, ice thermal storage systems help building owners shift cooling loads from costly peak hours to when electricity is less expensive. Unfortunately the upfront cost of these systems, driven by the large cost of the cooling coil used to generate ice, prevents adoption from many users and has unduly restricted the number of addressable markets for ice thermal storage. Elimination of ice buildup on the cooling coil would reduce the size of the coil, and more importantly significantly lower the cost of these systems. Low-cost ice thermal energy storage could greatly improve the economics for long-duration energy storage technologies such as pumped thermal energy storage.

    This SBIR Phase I project proposes to translate the discovery of surfaces with zero ice adhesion into a cooling coil that can be integrated into a functioning ice thermal energy storage system. In order to repel ice, these surfaces require complete submersion in an immiscible oil phase, making coil geometry and overall system development challenging. At the beginning of this project, various plate and tube based cooling coil geometries will be systematically prototyped and refined, measuring the freezing and melting heat transfer efficiencies. Different formulations of the surface coating will be tested as well. The most promising candidate geometries will be charged and discharged over multiple cycles as part of an ice thermal energy storage system. The results from cycling will be compared to conventional ice-on-coil technology using metrics such as energy density and heat transfer efficiency. An ice shedding cooling coil, at less than a third of the size of an ice-on-coil system, is expected to deliver improved cooling performance. Demonstration of an ice shedding cooling coil in a functioning ice thermal energy storage system will prove the technology?s readiness to scale.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1011 Hamilton Ridge Ln
  awardeeCity: Knoxville
  awardeeCountryCode: US
  awardeeName: Active Energy Systems, Inc.
  awardeeStateCode: TN
  awardeeZipCode: '379223672'
  fundsObligatedAmt: '224901'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843112'
  piEmail: levon@activeenergysystems.com
  piFirstName: Levon
  piLastName: Atoyan
  piPhone: '6073792856'
  poName: Anna Brady-Estevez
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Grid-scale electricity storage from waste heat'
- abstractText: |-
    This SBIR Phase I project will develop an innovative imaging device that applies tactile sensing to the surface detection of vertebrae to help clinicians place needles for the nearly 13 million diagnostic and therapeutic spinal punctures performed in the United States each year. The standard of care involves manual palpation of the back to estimate a vertebral gap for needle insertion. This technique is highly inaccurate, often requiring multiple attempts, which lead to pain and complications, unpredictable procedure times, poor throughput, and high rates of referrals to radiology for fluoroscopic guidance. By offering an accurate means of localizing bony landmarks, this project will enable successful insertion in fewer attempts, thereby improving clinical outcomes and reducing costs across the $3.2 million market, including emergency medicine, neurology, anesthesiology, and pain medicine. The device can also be introduced for training and to reduce errors in clinical testing of intrathecal drugs; and can increase procedure access by offering an alternative, bedside solution for challenging cases. To date, tactile imaging has only been applied clinically to soft-tissue evaluations. This project will pave the way for expanded use of this low-cost, non-radiative modality; to possibly replace palpation for other procedures, such as joint injections and thoracenteses.

    The innovation is the first standalone, clinical tactile imager. Its imaging subsystem comprises a sensitive, high-resolution pressure-sensing array, which detects vertebral landmarks when pressed against the back, and communicates them as a 2D pressure map to an integrated display. The device also includes a novel needle guide, which allows for flexible and reliable insertion. Positive gap localization has been verified in early development. This project will first confirm accurate insertion relative to imaging output by characterizing the relationship between guide and visualized-landmark locations, and by developing a mechanism to stabilize the device over unpredictable lumbar curvatures. Next, 2D pressure information will be evolved into an optimally robust and intuitive image. Advanced algorithms will be developed to detect, track, and highlight features of interest; and to understand and predict device use across cases. At each stage, the device will be tested on phantoms and through IRB testing on anesthesiology patients. Performance will be evaluated across anatomical variations, and compared with the standard of care. The resulting device will have demonstrated feasibility as a comprehensive spinal-puncture localization and insertion solution, rendering it suitable for further development and testing toward a regulatory submission, and providing compelling evidence for continued optimization in Phase II.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2450 HOLCOMBE BLVD STE X
  awardeeCity: HOUSTON
  awardeeCountryCode: US
  awardeeName: INTUITAP MEDICAL, INC.
  awardeeStateCode: TX
  awardeeZipCode: '770212039'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843381'
  piEmail: yganjeh@intuitapmedical.com
  piFirstName: Yashar
  piLastName: Ganjeh
  piPhone: '6304848862'
  poName: Henry Ahn
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Tactile sensing for spinal-needle placements'
- abstractText: |-
    This STTR Phase 1 project seeks to develop an automated system that would significantly increase the speed and accuracy of biopsy assessments at the point of care. The proposed technology eliminates extensive manual tissue processing steps and generates digital images of fresh biopsies that look just like standard pathology slides. The imaging can be performed in seconds, thus improving the efficiency of biopsy assessments at the point of care. Rapid, whole fresh biopsy imaging also improves evaluation accuracy while maximally preserving tissue for further testing and facilitating remote pathology consultation. With over five million patients in the United States undergoing biopsy procedures each year, and one in five of those patients returning for repeat procedures due to inaccuracies in biopsy assessments, an increase in accuracy and procedure speed could have a profound impact. This could lead to decreases in patient procedure time and decreases in repeat procedure rates, preventing unnecessary, painful, and invasive repeat biopsy procedures. With an estimated 1.6 billion USD spend on repeat procedures per year, this would also represent a significant decrease in financial burden on patients. In addition, due to the decrease in time per procedure, this could increase procedure throughput for hospitals, thus increasing hospital revenue potential. Finally, by producing remotely viewable images, this system could be utilized in a remote pathology setting at underserved communities within the US.

    This STTR Phase I project seeks to develop an automated sample processing and tissue pathology imaging system that delivers biopsy-to-image in a completely automated manner on fully-intact fresh tissues within five minutes of tissue removal.  Through integration with the previously developed Video-Rate Structured Illumination Microscopy (VR-SIM) system as the integrated optical sectioning modality, and using novel fluorescence dye combinations that recapitulate gold-standard histology,  the throughput, efficiency, and accuracy of biopsy evaluation can be improved while maximally preserving tissue for downstream processing and readily facilitating telepathology consultation. Preliminary work in multiple fresh tissue preparations, including core-needle biopsies and whole surgical resections,  indicates that the technology and method can deliver high image quality and diagnostic accuracy in short, clinically-relevant timeframes. A prototype of an automated, disposable cartridge system for biopsy staining and imaging for effortless integration with VR-SIM imaging will be developed. Image quality will be optimized at the highest optical sectioning power to be equivalent to physically-sectioned tissues, using polarization-gated VR-SIM and novel immersion media. ADPL workflow testing, validation of diagnostic image quality, and verification of compatibility with downstream analysis in human biopsy samples will be completed.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 5855 Marcia Ave
  awardeeCity: New Orleans
  awardeeCountryCode: US
  awardeeName: Instapath Inc.
  awardeeStateCode: LA
  awardeeZipCode: '701241121'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1820258'
  piEmail: mwang@instapathbio.com
  piFirstName: Mei
  piLastName: Wang
  piPhone: '5048106152'
  poName: Henry Ahn
  date: 06/29/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'STTR Phase I:  An automated digital pathology lab for rapid on-site processing
    and imaging of tissue biopsies'
- abstractText: "This Small Business Innovation Research (SBIR) Phase I project will
    demonstrate the commercial feasibility of a manufacturing platform for functionalizing
    textile materials with smart functionality such as for wearable smart garments
    developed out of the NSF funded ASSIST Engineering Research Center for Self-powered
    Wearable Nanosystems. Smart garments have been touted as the next sensing platform
    for acquiring biometrics such as electrocardiogram, heart rate, or heart rate
    variability. However, mass adoption has been difficult due to the high production
    cost, leading to a small market segment within the greater wearable technology
    market. As demonstrated by our customer discovery through the NSF I-Corps program
    in Fall 2016, the biggest barrier to adoption is the production cost. This project
    seeks to decrease the cost by 5x and decrease production time by 36x, enabling
    this market segment to grow for applications in health & wellness, healthcare,
    and beyond. By employing high-throughput direct-write printing and deposition
    of functional dielectric and conductive materials from the printed electronics
    space, high-value data generating devices such as smart garments can be manufactured
    in a single step bridging established practices within the textile and electronics
    industry resulting in automated textile electronics. Novel materials will be explored
    to impart functionalities on existing textiles with our manufacturing platform.
    \n\nThe broader impact of this project is to create a single manufacturing platform
    that marginalizes the cost of production for textile electronics such as smart
    garments and demonstrate minimum viable product (MVP) solutions for stakeholders
    within the value chain of smart textiles. The proposed innovation combines developments
    from 3D printing, printed electronics, and textile science to create disruptive
    advancements in the emerging field of smart textiles and textile electronics,
    creating new knowledge and commercial innovations. Lastly, manufacturing within
    the USA has seen a resurgence due to value-added technical textiles manufacturing
    being brought back. An ancillary broader impact of this project is to serve as
    a driver for value-added smart garment manufacturing technologies to be employed
    for USA manufacturing. Success of this project's vision will allow for low-cost
    smart textiles to usher in a paradigm shift for the textiles industry, allowing
    for a multitude of use-cases and innovative business models to proliferate, ultimately
    increasing the well-being of billions of people around the world.\n\nThis award
    reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 3200 Compatible Way
  awardeeCity: Raleigh
  awardeeCountryCode: US
  awardeeName: Funxion Wear
  awardeeStateCode: NC
  awardeeZipCode: '276033397'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1821134'
  piEmail: hshahar@ncsu.edu
  piFirstName: Hasan
  piLastName: Shahariar
  piPhone: '9195326343'
  poName: Linda Molnar
  date: 06/25/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Direct-write Printed Electronics on Textiles'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project lies in helping more amputees walk safely with less effort. There are approximately 800,000 individuals living with a major lower limb amputation, and this number is growing largely due to diabetes. For 50,000 amputees each year who need a new prosthetic knee, two options exist:  learn to use a traditional prosthetic knee or attempt to obtain a high-tech, computer-controlled knee. The former require the amputee learn and execute specific technique(s) to walk safely, while the latter do so automatically but cost $30,000 to $100,000 and require physical qualification, greatly limiting their availability. The novel prosthetic knee developed here offers stability automatically, regardless of amputee technique. It prevents buckling while simultaneously allowing the user to walk safely with whatever leg motions the user is able to generate. Since it requires no electronics or power, it is available to all amputees regardless of ability, and at a fraction of the cost of high-tech knees. Amputees will be able to walk farther with less effort, improving health and quality of life, and easing caregiver burden. Additionally, this design could be adapted for use in orthotic, robotic or exoskeletal systems.

    This SBIR Phase I project proposes to develop and test a novel prosthetic knee. Funding would be used to build prototypes and conduct mechanical, analytical and destructive testing. This testing is necessary to demonstrate that the design is feasible, safe for humans, and deserving of further development with amputees. An independent engineering design review will be obtained, prototypes will then be bench tested for function in a biomechanics lab, and an independent lab will provide destructive testing to prove ultimate strength of the device for comparison against known standards. The anticipated technical results include proof that the device can support the weight of a 300lb person, and quantitative evidence that the device will afford intuitive and universally available stability to amputees through its innovative swing- and stance-phase functionality. This work would advance the knowledge of prosthetics, rehabilitation and bipedal locomotion.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 32701 111th PL SE
  awardeeCity: Auburn
  awardeeCountryCode: US
  awardeeName: Xonotiv LLC
  awardeeStateCode: WA
  awardeeZipCode: '980924739'
  fundsObligatedAmt: '224542'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1818651'
  piEmail: paulgpomeroy@yahoo.com
  piFirstName: Paul
  piLastName: Pomeroy
  piPhone: '4254055260'
  poName: Henry Ahn
  date: 06/25/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  A novel clutch mechanism for a more intuitive, stable prosthetic
    knee'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to reduce the power required to cool the data and telecommunications centers that drive the internet age. Currently nearly 2.0% of the energy consumed in the United States is used to run such data centers and, often, half of this is used for cooling. The corresponding greenhouse gas emissions will also be reduced. Longer term this technology can be adapted to increasing the efficiency of air-conditioning/refrigeration and power generation. Commercially, the computational fluid dynamics software market the product will compete in is projected to grow from $1.3 billion at present to over $2 billion by 2022. It will also stimulate the growth of the manufacture of specialty heat sinks with optimal geometries for efficient thermal management.

    This intellectual merit of this SBIR Phase I project is based on proposing to hybridize three common numerical methods, i.e., computational fluid dynamics (CFD), flow network modeling (FNM) and multi-variable optimization (MVO), a non-trivial objective. The result will be a software platform that can accurately and simultaneously optimize the geometry of an array of heat sinks found in various types of circuit packs, e.g., blade servers in data centers. This is not possible with CFD alone as it is too slow and it is not possible with FNM alone as it is not sufficiently accurate. The method of the hybrid approach to preserve the accuracy of CFD is to embed pre-computed, non-dimensional look-up tables of flow and thermal resistances from CFD simulations in an FNM. The software will accommodate both single-phase flows of air and water and evaporating/boiling flows of water and refrigerant, which requires modeling complex heat, mass and momentum transport phenomena. Experiments will validate its accuracy on thermal mock-ups of circuit packs.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1 IRVING ST
  awardeeCity: MEDFORD
  awardeeCountryCode: US
  awardeeName: TRANSPORT PHENOMENA TECHNOLOGIES
  awardeeStateCode: MA
  awardeeZipCode: '021552200'
  fundsObligatedAmt: '224956'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819580'
  piEmail: georgios.karamanis@transportphenomenatech.com
  piFirstName: Georgios
  piLastName: Karamanis
  piPhone: '7813635528'
  poName: Anna Brady-Estevez
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Rapid and Accurate Multi-Variable Optimization Software for
    Arrays of Heat Sinks'
- abstractText: |-
    This SBIR Phase I project will help advance the health and welfare of individuals with multiple sclerosis (MS) - a debilitating chronic inflammatory disease affecting nearly 1 million people in the United States. A non-invasive, wearable retinal imaging device will be developed for at-home patient use that detects changes in MS disease activity, enabling patients and their physicians to track responses to treatment and detect disease flare-ups between clinical visits. Early detection and proper treatment of MS is crucial to reducing the risk of disease progression and disability. Current practice relies on infrequent neurological and radiological exams to assess changes in disease activity and treatment efficacy. However, there is currently no way to monitor MS in real time between these visits. Research relating retinal pathology to MS processes in the brain demonstrate that retinal imaging can provide early detection of disease events, offering an alternative monitoring pathway. This device will thus help reduce increases in patient healthcare costs associated with increasing disability, and potentially impact the research and care of patients with other brain conditions that manifest in the retina, including traumatic brain injury, epilepsy, and addiction. Following FDA approval, the device will be sold to MS patients, neurologists, and researchers.

    This project will yield a novel retinal imaging device that uses optical coherence tomography (OCT) and fundus autofluorescence (FAF) to assess retinal biomarkers associated with MS progression. While OCT and FAF are widely-used modalities for imaging the retina, the proposed device differentiates itself from current technologies in that it is specifically designed for use by MS patients at home. This will include a ruggedized, ergonomic, and wearable design suited for those who suffer from low mobility and other symptoms that make trips to a clinic difficult. Patients will use the device briefly once a week, during which time retinal images will be automatically acquired, analyzed, and sent to a physician for remote review. As such, it will further increase engagement between patients and physicians by making patients more proactively involved in their disease management. For this project, the following objectives are planned: 1) Develop the OCT component of the device to acquire high-resolution and repeatable images of layers in a healthy tissue-mimicking phantom retina, 2) Develop the FAF component of the device, and 3) Validate the device?s ability to acquire high-resolution and repeatable images of retinal layer thicknesses and autofluorescence in post-mortem retinas from MS patients and healthy individuals.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 155 Gibbs Street
  awardeeCity: Rockville
  awardeeCountryCode: US
  awardeeName: JuneBrain, LLC
  awardeeStateCode: MD
  awardeeZipCode: '208500395'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819326'
  piEmail: samantha.scott@junebrain.com
  piFirstName: Samantha
  piLastName: Scott
  piMiddeInitial: I
  piPhone: '6503807190'
  poName: Henry Ahn
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Development of a Wearable Retinal Imaging Device for Improved
    Monitoring of Multiple Sclerosis at Home'
- abstractText: |-
    This SBIR Phase I project will explore the technical, commercial, and educational potentials of bringing augmented reality binocular kiosks to public locations and their ability to create lasting impact on the public's understanding of a place. The proposed research and development phase will focus on the deployment and field testing of a collection of prototypes with partner locations, and examine their efficacy at engaging and informing visitors of those sites. The broader significance of the project is the development of an information device and ecosystem that gives the public a better understanding of notable places and the greater physical world. Deployments will be able to visualize a variety of site-specific data, from environmental conditions, to geological formations and landmark navigation. Potential revenue can be generated in partnership with locations, allowing for sustainable long-term engagements between the project and a site. Direct economic impact is brought to a location and its surroundings through increased foot traffic and the encouragement of additional exploration of a space.


    The innovation being proposed is stereoscopic wide-field-of-view see-through augmented reality viewers in the form of landscape binocular kiosks designed to give public spaces a way to engage visitors with the natural, scientific, and historic features of that location. In addition to displaying immersive media experiences optically overlaid onto a view of the real world, this project creates a distributed media network on that location to share data and content for remote viewing and analysis. Goals and scope of research include durability testing of the devices in prolonged public exposure, effectiveness of the user interface and software tools, understanding the range and bandwidth of device-to-device communication, and optimization of the optical, electromechanical, and sensor components. Methods and approaches will include the field testing of prototype units with partner locations, and using survey and analysis techniques to evaluate the overall quantitative and qualitative efficacy of the intervention at those sites.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1106 S Stanley Ave
  awardeeCity: Los Angeles
  awardeeCountryCode: US
  awardeeName: Perceptoscope
  awardeeStateCode: CA
  awardeeZipCode: '900196602'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820238'
  piEmail: ben@perceptoscope.com
  piFirstName: Ben
  piLastName: Sax
  piPhone: '5857496656'
  poName: Rajesh Mehta
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Immersive Augmented Reality Landscape Viewer for Public Space
    Deployment'
- abstractText: "This SBIR Phase I project will address a problem of poor oxygen delivery
    to the core of artificial tissues by providing reliable means of three-dimensional
    oxygen mapping in vitro and in vivo. The field of tissue engineering regenerative
    medicine combines the principles of the life sciences, cell biology, and engineering
    to create functional tissues and organs that can be used for replacing damaged
    tissues and organs. The public health benefit of replacing damaged tissues and
    organs is at par with curing cancer. Almost every part of the human body has been
    considered for replacement. Tissue engineering strives to solve arthritis, Type
    I diabetes, stroke, vascular diseases, liver and kidney damages, and many other
    medical problems by replacing or restoring damaged tissues or organs with artificial
    functional tissues. This project will address the problem of poor oxygen transport
    in artificial tissue grafts, which is one of the major causes of tissue failure,
    by developing an oxygen imaging instrument to generate three-dimensional in situ
    oxygen maps. This instrument will allow scientists to assess oxygen environment
    over the time of graft production and upon implantation and develop better artificial
    tissues. The oxygen imager uses cutting-edge radiofrequency and magnet technology
    and will help create high-tech jobs in the Midwest. \n\nThe oxygen imager will
    be based on the innovative noninvasive electron paramagnetic resonance oxygen
    imaging (EPROI) technology. EPROI uses an injectable water-soluble, non-toxic
    contrast agent, trityl that has oxygen-dependent relaxation rates. EPROI provides
    absolute partial oxygen pressure (pO2) maps with high accuracy (~ 1 torr) within
    1-10 minutes. The oxygen imager will be equipped with a 25 mT magnet and ~720
    MHz electronics suitable for in vitro and small animal in vivo oxygen imaging.
    The instrument will have user-friendly software for image acquisition, image registration,
    data processing and analysis. This project will develop the magnet with the top
    loading of samples along with temperature and gas controlled bioreactor sample
    chamber for in vitro oxygen mapping of artificial tissues. The robustness and
    performance of the imager will be tested by acquiring oxygen maps of cell-seeded
    biomaterials. It is expected that the oxygen imager will become an essential tool
    in tissue engineering labs of academic institutions and biotech companies and
    will have a major impact on the successful development of regenerative medicine
    therapies.\n\nThis award reflects NSF's statutory mission and has been deemed
    worthy of support through evaluation using the Foundation's intellectual merit
    and broader impacts review criteria."
  awardeeAddress: 2242 W Harrison St, Ste 201-18
  awardeeCity: Chicago
  awardeeCountryCode: US
  awardeeName: O2M Technologies, LLC
  awardeeStateCode: IL
  awardeeZipCode: '606123738'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819583'
  piEmail: mkotecha@o2map.com
  piFirstName: Mrignayani
  piLastName: Kotecha
  piPhone: '7739108533'
  poName: Henry Ahn
  date: 06/13/2018
  startDate: 06/15/2018
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Robust Bench-Top Oxygen Imager for Tissue Graft Viability
    Assessment'
- abstractText: "The broader impact/commercial potential of this project is an innovative
    new capacitor technology based on kilohertz high-frequency supercapacitor, called
    AC-Supercap, aiming to replace conventional aluminum electrolytic capacitors (AECs)
    for a vast range of electronic and power systems. Capacitors are an essential
    component used in electronic devices, in power supplies driving electrical machines,
    appliances and instruments, as well as in power conversion and conditioning systems
    used for renewable energy generation. In the consumer electronics sector, miniaturization
    and low-profile or even flexible packaging, and higher power efficiency are some
    of the key demands. In the power system and other power-demanding industry sectors,
    large capacitance, large ripple current absorption, and high temperature rating
    are the key requirements. With the emergence of distributed wireless sensors and
    Internet of Things (IoT), pulse energy storage and generation will be necessary
    as well. AC-Supercap, with its much better performance than current solutions,
    is anticipated to better serve the needs of broad range of customers. Upon the
    success of this technology, there will also be tremendous impact on the local
    ecosystem and regional community of West Texas. \n\nThis Small Business Technology
    Transfer (STTR) Phase I project will investigate the feasibility of producing
    AC-Supercap as high-performance alternating current (AC) filtering capacitors
    for power modules, on-board application, or as compact and efficient pulse power
    storage. Conventional AECs, limited by their low capacitance density, bulky size,
    poor lifetime, large equivalent series resistance, and polarity sensitivity cannot
    meet technical needs well. To achieve AC-Supercaps with both large capacitance
    density and high-frequency response, two contradictory requirements, and nanostructured
    electrode engineering will be investigated. To produce a compact capacitor with
    a large voltage rating and capacitance, multicell integration will be optimally
    designed and demonstrated, which is crucial considering the intrinsic low voltage
    rating of a single cell. The proposed innovative solutions to these technical
    challenges will de-risk the AC-Supercap product prototyping in the following project
    phases to make ready the technology for commercialization. These research activities
    will advance the scientific understanding and technological development of nanostructured
    electrode process and property control, multicell integration design, and particularly
    AC-Supercap technology.\n\nThis award reflects NSF's statutory mission and has
    been deemed worthy of support through evaluation using the Foundation's intellectual
    merit and broader impacts review criteria."
  awardeeAddress: 3004 County Road 7520
  awardeeCity: Lubbock
  awardeeCountryCode: US
  awardeeName: BAONANO, LLC
  awardeeStateCode: TX
  awardeeZipCode: '794236373'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1820098'
  piEmail: nzfh.buet@gmail.com
  piFirstName: Nazifah
  piLastName: Islam
  piPhone: '2149077208'
  poName: Muralidharan Nair
  date: 06/12/2018
  startDate: 06/15/2018
  expDate: 08/31/2019
  title: 'STTR Phase I:  AC-Supercapacitors for Power Applications'
- abstractText: |-
    This Small Business Technology Transfer Research (STTR) Phase I project aims at developing a roll-to-roll, solid-state, continuous process for manufacturing nanocellular thermoplastic films with open (interconnected) or closed (not interconnected) cells of the order 10-100 nm and as much as 50% porosity. The initial application of this proposed project is an improved Lithium-ion battery separator comprising a nanoporous polyetherimide (PEI) film of 10-25-micron thickness with uniformly distributed interconnected 10-50 nm size cells. The nanoporous PEI separator, which has significantly higher heat resistance than current polyolefin-based separators, addresses a very urgent safety issue, i.e., batteries exploding and causing fire due to thermal instability of the separator. Moreover, compared to the current multi-step process for fabricating battery separators, this continuous process will have higher productivity thereby increasing the nation's global competitiveness in battery manufacturing. The total addressable global market for separators used in both primary (single-use) and secondary (rechargeable) lithium batteries is projected to be $1.65 billion by 2020 growing at 4.7%. This innovative research project will contribute to new knowledge in the areas of gas diffusion and cell nucleation in thermoplastic polymeric films and enable development, characterization and application of a whole new class of solid-state nanocellular polymer films.

    The intellectual merit of this project resides in the development of a manufacturing process that brings together interdisciplinary knowledge to synthesize and characterize nanostructures under various process conditions. This new knowledge will advance the field of nanomanufacturing and will be used to optimize processes towards commercialization targets. There are two technical challenges: (i) the dynamic seal concept, which has been proven in a 250-micron thick polymer film but not for a film 10-20 times lower in thickness; and (ii) maintaining enough gas concentration during the cell nucleation and growth to create nano-sized cells. The goals of this project are to: (a) establish the feasibility of a roll-to-roll process operating at a minimum speed of 1 meter/minute to produce nanocellular thermoplastic films and (b) develop a 100-mm wide, 10-25 micron thick nanoporous polyetherimide (PEI) film having the desired properties and nanostructure profile for a Li-ion battery separator application. These two goals will be achieved by implementing the dynamic seal technology to process a 100-mm wide film on a continuous basis and immediately heating the film to create nanocells.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 17405 Ne 131st St
  awardeeCity: Redmond
  awardeeCountryCode: US
  awardeeName: Vesicus LLC
  awardeeStateCode: WA
  awardeeZipCode: '980522170'
  fundsObligatedAmt: '224965'
  fundProgramName: STTR PHASE I
  id: '1819873'
  piEmail: krivenk@gmail.com
  piFirstName: VenkataKrishna
  piLastName: Nadella
  piPhone: '2064090313'
  poName: Steven Konsek
  date: 05/22/2018
  startDate: 06/01/2018
  expDate: 05/31/2019
  title: 'STTR Phase I:  A Roll-to-Roll Process for Manufacturing Nanocellular Polymeric
    Thin Films'
- abstractText: |-
    This SBIR Phase 1 project will create an educational technology that accelerates the acquisition of foundational English language skills by children (4 to 10 years old), by melding English and Spanish language instruction, delivered via a personalized digital learning platform. Using state-of-the-art text-to-speech and speech-to-text engines, students that are English Language Learners (ELL) will engage in deliberate literacy practice across the four modalities of language (listening, speaking, reading, writing). Over the last decade, the number of ELL students enrolling in public schools has steadily increased while there remains a shortage of bilingual or certified ELL teachers. Technology can help these teachers to personalize instruction and extend the school day which in turn increases engaged learning time. Achieving college and career readiness is an economic imperative for all students, especially ELL students given the importance of English communication skills to career success. While developing technologies for use in classrooms by young children can be a risky proposition due to the nature of the modern classroom, the reward far outweighs the risk. This project will produce a high-impact technology solution designed for young children that integrates the latest text-to-speech and speech-to-text technologies and is grounded in sound research about language skill acquisition across the four modalities.

    The key innovation of this SBIR Phase 1 project is a plurilinguistic (e.g., Spanish and English) approach to literacy development across the four modalities of language (e.g., reading, writing, speaking, listening) where young students (aged 4-10 years old) are immersed in personalized learning experiences specifically tailored to support and accelerate language development. The first research goal is to test the feasibility for using and adapting proprietary English and Spanish language text-to-speech and speech-to-text engines with young children. The second research goal is to examine the impact of a dual-language personalized learning platform on children?s acquisition of foundational listening, speaking, reading, and writing skills. Participants will be ELL students whose first language is Spanish. The research is based on a plurilinguistic framework for second language acquisition; researchers hypothesize that a dual-language application that leverages students' first language to learn English will score significantly higher on independent measures of foundational literacy skills and self-efficacy for learning compared to students who are using an English-only personalized learning application. A mechanism of growth may be the amount of time students are immersed in deliberate practice of literacy skills. A dual-language personalized learning platform has the potential to extend teacher-led literacy instruction and increase the amount of time students spend engaged in learning English.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 8008 Strawberry Meadows Ct
  awardeeCity: Raleigh
  awardeeCountryCode: US
  awardeeName: High Road Learning Inc
  awardeeStateCode: NC
  awardeeZipCode: '276131043'
  fundsObligatedAmt: '211741'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820041'
  piEmail: carl.swartz@highroadlearning.com
  piFirstName: Carl
  piLastName: Swartz
  piMiddeInitial: W
  piPhone: '9192727145'
  poName: Rajesh Mehta
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Using Technology to Promote a Dual-language Approach to Personalizing
    English-language Learners'' Growth in Literacy Ability'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is a shift towards both accuracy and affordability
    within the world of energy sub-metering.  This metering system will have a dramatic
    impact on the market for submetering commercial real estate. By drastically reducing
    the cost and knowledge hurdles associated with accurate submetering and bringing
    the costs of submetering in line with value, this technology opens the door for
    a mass-market approach to circuit-level energy use data. The market for this commercial
    submetering is expected to reach $2.5 billion annually within six years, but could
    grow substantially larger with the introduction of low-cost, high-accuracy technologies.
    Additionally, it is estimated that access to metering data alone can reduce energy
    consumption within a building between 5% and 15%, meaning a wide deployment of
    these technologies could have wide-reaching environmental and energy security
    benefits.  \n\nThe proposed project will advance the state-of-the-art in true
    power metering by providing revenue quality AC power submetering using an energy-harvesting,
    as opposed to plug-in, design. Doing so requires fundamental improvements in circuit
    design, embedded software architecture and signal analysis. The result is a self-contained
    system that drastically reduces deployment and installation costs. This project
    will simplify the system implementation and reduce the cost of production, and
    the ability for Triumvi meters to share data and, more importantly, energy harvested.
    Specific key technical objectives include creating a daisy-chain framework through
    which individual nodes within a metering system can share energy and data, improving
    accuracy in the myriad of potential field conditions, and creating a system of
    runtime-diagnostics to identify, and fix, human error in real time. Study and
    pursuit of these objectives will take place both in the lab, as well is in the
    field, where installation and accuracy can be benchmarked against conventional
    hardwired metering solutions.\n\nThis award reflects NSF's statutory mission and
    has been deemed worthy of support through evaluation using the Foundation's intellectual
    merit and broader impacts review criteria."
  awardeeAddress: 2315 E JOHN ST
  awardeeCity: SEATTLE
  awardeeCountryCode: US
  awardeeName: ALLUMIA, LLC
  awardeeStateCode: WA
  awardeeZipCode: '981125412'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1845625'
  piEmail: ablock@allumia.com
  piFirstName: Aaron
  piLastName: Block
  piMiddeInitial: A
  piPhone: '4252987834'
  poName: Rick Schwerdtfeger
  date: 02/12/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Triumvi - A Rapidly Deployable, Energy-Harvesting Real-Power
    Meter'
- abstractText: |-
    The broader market impact/commercial potential of this Small Business Innovation Research (SBIR) project is to foster the mainstream use of decentralized database solutions in place of centrally owned and operated data centers and cloud services offered by companies like Amazon, Google and Facebook. Data security breaches involving tens or hundreds of millions of customers are now commonplace, as are high-profile news stories related to questionable uses of customer-supplied data.

    This SBIR Phase I project proposes to solve the key problem of developing a new network protocol that allows for a low-latency, secure, persistent and highly-available, decentralized No-SQL database which may operate at Internet scale. Key objectives include: development of a novel P2P overlay network which combines a zero-hop Distributed Hash Table (DHT) as a base routing layer and any number of traditional Kademlia DHTs as application specific leaf networks, all of which may communicate through a variety of transport protocols; constructing a new proof-of-space for use  both as the consensus layer of a proof-of-space blockchain and as a proof-of-capacity for storage nodes; creating a secure Decentralized Storage Network utilizing a proof of replication based on verifiable delay functions; and implementing and testing the protocol across common host devices and client runtimes. The end goal of the project is to validate the technical feasibility, scalability, and market interest for the subspace protocol.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1259 El Camino Real Ste B
  awardeeCity: Menlo Park
  awardeeCountryCode: US
  awardeeName: Subspace Labs, Inc.
  awardeeStateCode: CA
  awardeeZipCode: '940250000'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1844037'
  piEmail: jeremiah@omnibuilds.com
  piFirstName: Jeremiah
  piLastName: Wagstaff
  piPhone: '5129947799'
  poName: Anna Brady-Estevez
  date: 02/08/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Subspace: A Decentralized Database of End-User Devices'
- abstractText: "The broader impact/commercial potential of this Small Business Technology
    Transfer (STTR) project will be a low-cost, high-performance nanofiltration membrane
    technology for removing oils, pollutants, and organic materials from highly contaminated
    wastewater. Industrial activity in the U.S. produces more than 25 billion gallons
    of wastewater every day, much of contaminated with oils, greases, solvents, and
    other harmful chemical compounds. Existing filtration membranes are easily clogged
    and damaged by these oily materials, suffering a rapid decline in performance.
    Safely processing this wastewater by conventional means costs U.S. industrial
    facilities more than $40B per year. A breakthrough in nanofiltration technology
    will allow industries across the country - such as food processors, landfills,
    power plants, and paper mills - to easily and affordably clean their wastewater.
    \n\nThis STTR Phase I project proposes to develop the technology and processes
    to produce commercial-scale anti-fouling nanofiltration membranes for use with
    highly contaminated industrial wastewater. The project will combine large-scale
    manufacturing techniques such as high-precision spray coating with a novel chemistry
    platform based on zwitterionic copolymers to produce high-performance, low-cost
    membranes. These polymers exhibit extraordinary resistance to organic fouling
    as well as pore self-assembly at the nanometer scale. To achieve the required
    performance, the project will develop the process and materials to achieve a thickness
    of less than one micron in the selective layer of a thin-film composite. Currently,
    layers of this thickness are only achievable using in-situ polymerization of nylon-based
    polymers, which are costly, have low permeability, and are intolerant of oxidizing
    conditions. This project will overcome these limitations by exploiting the unique
    self-assembly behavior of zwitterionic copolymers to achieve ultrathin, uniformly
    porous films in both flat sheet and hollow fiber forms. The project will furthermore
    demonstrate the chemical robustness of these membranes with accelerated lifecycle
    testing relevant to industrial conditions. Commercial-scale production of self-assembling
    polymer membranes will represent a significant breakthrough for materials in this
    class.\n\nThis award reflects NSF's statutory mission and has been deemed worthy
    of support through evaluation using the Foundation's intellectual merit and broader
    impacts review criteria."
  awardeeAddress: 17 UPLAND RD
  awardeeCity: CAMBRIDGE
  awardeeCountryCode: US
  awardeeName: ZWITTERCO, LLC
  awardeeStateCode: MA
  awardeeZipCode: '021402717'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1843847'
  piEmail: cdrover@zwitterco.com
  piFirstName: Christopher
  piLastName: Drover
  piMiddeInitial: J
  piPhone: '6176826846'
  poName: Anna Brady-Estevez
  date: 02/07/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'STTR Phase I:  Extremely fouling-resistant nanofiltration membranes treating
    organic-rich wastewater'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to place the power of genetic identification in the hands of those who need it, at the front lines of conservation. The DNA Barcode Scanner will enable anyone, anywhere, to perform a low-cost, rapid, automated DNA test to validate the identity of a tissue sample, without specialized training, expensive lab-based equipment, reagents, or reliable power, where it is needed most - in the field. This technological advance has the potential to revolutionize species identification to prevent species extinction, to protect consumers and our food supply, and to combat threats to global biodiversity. The innovation's commercial potential includes improving the safety and sustainability of our supply chains, combatting costly environmental fraud, and detecting pests and pathogens that threaten our nation's economy, security, and health. The initial market opportunity is to address unmet demand from seafood suppliers, distributors, and retailers; government regulators and enforcement agents; and conservation and natural resources entities, for increased transparency and integrity of seafood supply chains by ending seafood mislabeling and fraud, which occurs in over 30% the $17.1 billion dollar U.S. seafood market and is worth up to $250,000 per illegal import.

    The proposed project will develop the customizable DNA collection, extraction, and amplification cartridge that enables a user to go from tissue sample to species identification in a single device. This project focuses on the scientific and technical challenge of automating sample preparation. The company's goal is to create an integrated device that will validate seafood products (our first market) from sample collection to DNA extraction, DNA amplification, and, ultimately, species identification. The goals of this project are to 1) determine a reliable and intuitive method for collecting DNA from a seafood product and create a prototype collection tool, 2) prototype an easy-to-use and highly flexible DNA extraction and sample preparation component to provide DNA suitable for analysis, and 3) fully integrate microfluidic processes and molecular chemistry (DNA amplification and analysis) with clear validation of multiple species. They will design and test several prototypes of the collection, extraction, and amplification cartridge and test these with users to identify the most robust and simplest method for delivering confident species identification. Their objective is to deliver a fully functional prototype that is intuitive for users and can perform a seafood species validation test in multiple field environments.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 4406 TENNYSON RD
  awardeeCity: WILMINGTON
  awardeeCountryCode: US
  awardeeName: CONSERVATION X LABS, PBC
  awardeeStateCode: DE
  awardeeZipCode: '198021240'
  fundsObligatedAmt: '224953'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843702'
  piEmail: paul@conservationxlabs.com
  piFirstName: Paul
  piLastName: Bunje
  piPhone: '9196943784'
  poName: Rick Schwerdtfeger
  date: 02/05/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  The DNA Barcode Scanner: Democratizing Genetic Information
    For Conservation'
- abstractText: |-
    This STTR Phase I project aims to pioneer a novel approach for the sustained delivery of peptide therapeutics using nano-composite microparticles. Peptide therapeutics tend to suffer from rapid enzymatic degradation and clearance, with half-lives on the order of minutes, and require frequent injections. The goal of a sustained release formulation is to reduce the frequency of injections by slowly releasing the therapeutic over a period of weeks to months. This will result in improved patient compliance and quality of life. Patient non-compliance is an economic burden that is estimated to cost the healthcare system over $100 billion/year. The lack of commercial success of existing sustained release technologies is due to low loading efficiencies, lack of controlled release at higher loading, and complex manufacturing. These limitations can be overcome with the newly-developed inverse Flash NanoPrecipitation (iFNP) process to produce nano-composite microparticles. This project aims to develop and test a once-monthly injectable formulation of a peptide therapeutic for type 2 diabetes that is currently injected daily. This research will aid in the understanding of the fundamental materials science and engineering principles that control therapeutic release from nano-composite microparticles. The rules for controlling release will apply broadly to other peptides, and this research will help to more rapidly develop future long-acting formulations.

    Current methods to produce peptide-loaded microparticles suffer from low drug loadings and poor encapsulation efficiencies, two of the most important factors for commercial viability. In contrast to existing methods, the iFNP technology allows for the assembly of nanoparticles with peptide loadings greater than 50wt% and encapsulation efficiencies greater than 90% in a fully scalable process. The nanoparticles are then assembled into microparticles to create the final sustained release formulation. Each drug-containing pore inside the microparticle is surrounded by a dense hydrophobic polymer layer which allows for therapeutic loadings 10x higher than competing technologies. The iFNP process has been demonstrated on a number of proof-of-concept molecules. In this project, iFNP will be used to produce a formulation of a peptide for diabetes therapy with a month-long release profile. The first goal of this project is to develop an understanding of the physical parameters that control the peptide stability and release. Supporting this goal, the peptide will be formulated with polymers of varying glass transition temperatures and degradation rates, and the release profiles will be measured in vitro. The efficacy of the optimal in vitro formulation will then be tested in a rat model. These studies are an important step in developing a commercial product that can positively impact patient care.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 174 Nassau St, Suite 334
  awardeeCity: Princeton
  awardeeCountryCode: US
  awardeeName: Optimeos Life Sciences, Inc.
  awardeeStateCode: NJ
  awardeeZipCode: 085427005
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1843551'
  piEmail: rpagels@optimeos.com
  piFirstName: Robert
  piLastName: Pagels
  piPhone: '4436312431'
  poName: Henry Ahn
  date: 02/04/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'STTR Phase I: Sustained Delivery of Peptides with Inverse Flash Nanoprecipitation'
- abstractText: |-
    The?broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is on renewable electricity production by large scale utilities. Today large scale solar generation (the majority of all solar energy) is almost exclusively by large farms of photovoltaic (PV) panels made from silicon cells, as used also for rooftop solar. The research is aimed at enhancing scientific and technological understanding of an alternative approach that exploits a different, much more efficient type of PV cell.? It promises lower cost electricity in sunny climates around the world, from longer lived plants using less land. The potential societal impact is broader adoption of solar electricity both in the US and across the world, and thus reduced global pollution. The commercial impact of the project is also huge. In the targeted global market, $30 billion now is spent annually on new solar installations and an increase to $100 billion is projected. This is an opportunity for the US to re-establish itself as a world leader in solar manufacturing, of both the different PV cells that underlie our approach, and the optical and mechanical systems that are the target of this research and are key to cost reduction.?

    The proposed project will explore a new approach to solar electricity generation, using advanced photovoltaic (PV) cells that convert sunlight into electricity with twice the efficiency of silicon PV panels. The innovation is in the system used to focus sunlight on the cells as needed?for highest efficiency at lowest cost. The advanced PV cells themselves have already been developed for spacecraft, but previous efforts to commercialize them for ground use have failed, because the systems needed to provide concentrated sunlight were too expensive. The research will be directed to developing, building and testing the two innovative elements critical to a complete, low cost system: 1) Small glass lens arrays used at the focus of large dish reflectors to apportion sunlight equally onto individual small cells. Existing commercial glass molding methods do not yield arrays of the size and precision needed; a new molding method tailored specifically for the task will be developed. 2) A novel mechanical structure will be developed to orient the mirrors toward the sun throughout the day with minimal use of steel, by employing an efficient spaceframe structure turning on a ground track, and a sensor-feedback system to eliminate conventional, heavy, rigid bearings.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: '1718 E. Speedway, #221'
  awardeeCity: Tucson
  awardeeCountryCode: US
  awardeeName: REhnu, Inc.
  awardeeStateCode: AZ
  awardeeZipCode: '857194515'
  fundsObligatedAmt: '224769'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1846588'
  piEmail: ndidato@rehnu.com
  piFirstName: Nicholas
  piLastName: Didato
  piMiddeInitial: J
  piPhone: '5202705463'
  poName: Rick Schwerdtfeger
  date: 02/01/2019
  startDate: 02/01/2019
  expDate: 09/30/2019
  title: 'SBIR Phase I:  Advanced Manufacturing To Revolutionize Solar PV Generation'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is to improve the current spraying practices in agriculture.
    Inefficient crop spraying causes drift which can lead to crop damage or unwanted
    pesticide use in neighboring non-target crop areas. It may contaminate nearby
    bodies of water or be an issue for human health.  Our company would solve this
    through the implementation of a closed loop sensor system which would remotely
    determine the efficiency of sprayer machines and the spray pattern of the material
    continuously and in real time. Farmers will benefit through reduced costs of wasted
    materials resulting from over-spraying, while feeling safe against pest and fungus
    infestation resulting from under-spraying. The initial intended customers are
    large orchards, vineyards and tree farms. Those farmers generally use airblast
    sprayers which are highly inefficient and waste about 45% of the material. Those
    chemicals either hit the ground and contaminate it or pollute the air.  An owner
    of a large farm that implements our proposed device will save a significant amount
    on chemical costs and also avoids the consequences due to drift of chemicals onto
    neighboring farms, public roads, or non-agricultural areas. \n\nThis SBIR Phase
    I project proposes to introduce a new technology to the agricultural sector. This
    technology has been previously built for complex and sophisticated applications
    in mostly academia and government sectors. We look to provide a new functionality
    while reducing the size and cost of the technology. It would be used as a new
    and improved method of calibration, replacing a tedious and often ignored current
    process. Furthermore, the sensor would be integrated as a closed loop system for
    autonomous sprayer adjustments. A complete software solution would accompany the
    hardware in order to make it approachable to the non-scientific community. This
    project will prove the potential of our technology as a competitive player in
    the rapidly growing ag-tech field.\n\nThis award reflects NSF's statutory mission
    and has been deemed worthy of support through evaluation using the Foundation's
    intellectual merit and broader impacts review criteria."
  awardeeAddress: 184 MAPLE AVE
  awardeeCity: ROCKVILLE CENTRE
  awardeeCountryCode: US
  awardeeName: ATOLLA TECH LLC
  awardeeStateCode: NY
  awardeeZipCode: '115704373'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842973'
  piEmail: morann.dagan@gmail.com
  piFirstName: Morann
  piLastName: Dagan
  piMiddeInitial: S
  piPhone: '5163161323'
  poName: Anna Brady-Estevez
  date: 02/01/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Smart Sensor for Precision Agriculture'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is increased revenue and processing potential for scrap recyclers in the US. The artificially-intelligent algorithm designed in this project will enable domestic scrap processors to become more competitive within the material supply chain by giving them the ability to adapt, in real-time, to an ever-changing material consumption climate. With unstable international commodity trade, US scrap processors must reduce reliance on exporting low-value scrap to maintain profitable business models. Additionally, US scrap must exercise optimal processing schedules to prevent scrap surplus domestically while providing consumers with recycled products that are functionally equivalent to new products. The latter offers an environmentally-friendly scrap-to-product option that reduces the energy required for production and the amount of harmful CO2 released. Aluminum scrap recycling has been practiced for decades; however, the majority of post-consumer scrap is downcycled leaving revenue and environmental benefits untapped. Non-ferrous auto-shred was, on average, sold for $0.33/lb. less than its actual value in 2017, which equates to nearly $1 billion in opportunity cost. Artificially intelligent sorting systems will enable scrap processors to reach higher profit margins and meet environmental goals.

    The proposed project will completely automate scrap sortation. The advent of multi-sort capability encourages the need for preliminary research to identify how to operate sensor-based sorters optimally. Artificial intelligence can meet this need. The intellectual merit of this project is the development of an artificially-intelligent algorithm that is capable of optimizing scrap sortation in real-time. The research objectives include:&#8239;(1) identify all data sources in the scrap recycling process that &#8239;can &#8239;influence intelligent decision making (2)&#8239;design a database to host identified data sources such as compositional, market, inventory, and sales data and (3) design a customized artificially-intelligent algorithm for the&#8239; scrap &#8239;recycling industry to develop sorting criteria in real-time. To meet these objectives, a dynamic material flow model will be designed to analyze and host all relevant sensor, market, and experimental data streams to minimize data pre-processing requirements. Concurrently, aluminum scrap will be characterized to investigate how frequently and to what degree composition fluctuates. The database that hosts all supportive data streams will be designed to store and integrate all relevant data streams seamlessly. Finally, using an 80/20 training/testing data split with 5-fold cross-validation, the machine learning algorithm will be selected and optimized to provide the lowest error rate for suggested sorting criteria.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 54 Rockdale St
  awardeeCity: WORCESTER
  awardeeCountryCode: US
  awardeeName: SOLVUS GLOBAL LLC
  awardeeStateCode: MA
  awardeeZipCode: '016062761'
  fundsObligatedAmt: '224757'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843858'
  piEmail: Sean.kelly@solvusglobal.com
  piFirstName: Sean
  piLastName: Kelly
  piPhone: '5087331808'
  poName: Rick Schwerdtfeger
  date: 02/01/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'SBIR Phase I:  Artificially Intelligent Solution to Maximize Value Creation
    and Upcycling Potential of Aluminum Scrap'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is that it will reskill those being displaced by the disruption caused by the impending AI and automation that is sweeping every industry. By providing training and fully integrated career services platforms at significantly lower cost than traditional models, Expercoin Republics will make education more accessible to organizations seeking to upskill their employees and professionals looking to reskill. According to Harvard Business School professor Clayton Christensen, 50% of all American colleges are bound for bankruptcy in the next few decades. Due to the rapid pace of technological change and new employment requirements, we are moving away from credentialing to continuous learning. This project will allow organizations of all kinds to use its protocol to create expert networks and content platforms, while leveraging tokens to reward participation among their users.  400 to 800 million people globally need to be reskilled. This is estimated to translate to $8.5 trillion in unrealized revenue due to lack of talent by 2030.

    This SBIR Phase I project proposes to embrace a novel intellectual approach and business model that empowers employees and employers through upskilling, continuous learning, and skill verification. The mission of Expercoin Republics is to instantly allow anyone to create a specialized community with marketplaces for training, assessments, mentorship and work opportunities. Expercoin will use blockchain to create decentralized autonomous organizations that advance learning and facilitate employment through the creation of thousands of specialized learning communities. A notable achievement of Expercoin would be to create the underlying infrastructure that helps businesses and governments launch learning economies that consist of self-regulated decentralized entities with features such as transparent voting, effective governance, fraud adjudication, spam prevention, account verification and rewards. An Expercoin token will provide a wide range of functions necessary to create a decentralized economy that is not governed by any central authority.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 42 GREENWOOD RD
  awardeeCity: HOPKINTON
  awardeeCountryCode: US
  awardeeName: EXPERCOIN LLC
  awardeeStateCode: MA
  awardeeZipCode: 017483111
  fundsObligatedAmt: '224788'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843169'
  piEmail: hsingh@expercoin.com
  piFirstName: Harpreet
  piLastName: Singh
  piPhone: '6174151300'
  poName: Anna Brady-Estevez
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Expercoin Republics: Protocol for AI-Powered Decentralized
    Learning Economies on Blockchain'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project addresses the immediate need to develop advanced air conditioning technology that increases energy efficiency and will have a significant and positive impact on reducing Greenhouse Gas (GHG) Emissions. As Room Air Conditioning (RAC) demand increases by an estimated 5x over the next 30 years, it is crucial that newly established scientific and technological approaches be developed which lessen the requirement of 'peaker' power plants to supply electricity for their operation. Nativus is engineering an energy-efficient 12,000 BTU Room Air Conditioner (RAC) for residential and light-commercial consumers, capable of cooling 500 ft2. Through a complete architectural redesign, our proprietary technology offers customers a solution to their air conditioning needs which is cheaper to operate, quieter, filters the air, and is easier to install than currently available commercial offerings.

    This SBIR Phase I project proposes to develop a novel, rotating air conditioning design which combines the main components of an air conditioner into a single, packaged device to drastically increase air conditioner performance.  The roughly one billion air conditioners in operation globally operate at 5-10% of their theoretical ultimate Carnot efficiency, as industry focuses on "first-cost" and has not demonstrated meaningful, radical improvements since the inception of the air conditioner. The current state-of-the-art technology in the HVAC industry is based upon the 'fan plus finned-tube' (FPFT) Heat Exchanger in which a fan blows air across either hot or cold heat exchanger fins. This architecture results in the formation of an insulative 'boundary layer', severely degrading heat exchanger performance. Through the use of one high-efficiency motor, instead of two or three motors commonly found on state-of-the-art technology, our proprietary design rotationally-shears the boundary layer from the surface of the heat exchanger, thereby increasing efficiency while decreasing power consumption. Our research objectives include air conditioner component and system-level validation, supported by three milestones which include Nationally Recognized Testing Laboratory (NRTL) performance validation, system reliability through prototype testing, and economic analysis.  The tasks involved in our project include design, manufacture, assemble, and testing of a complete system.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 611 Solana Hills Ct
  awardeeCity: Solana Beach
  awardeeCountryCode: US
  awardeeName: Nativus Inc
  awardeeStateCode: CA
  awardeeZipCode: '920751421'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1844015'
  piEmail: dan.p.poirier@gmail.com
  piFirstName: Dan
  piLastName: Poirier
  piPhone: '8583955060'
  poName: Anna Brady-Estevez
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Rotary heat exchanger for energy reduction in residential
    and commercial HVAC applications'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to increase yields and save irrigation water and costs for farmers of perennial crops and high intensity annual crops.  In order to maximize yields while simultaneously minimizing irrigation water usage, farmers need to understand, predict, and manage plant water stress, which is the yield reducing stress plants undergo when they struggle to draw water from the soil.  If successful, this project will demonstrate to farmers that low-cost measurement and forecasting of plant water stress is possible, and that Machine Learning (ML)-based recommendations for irrigation scheduling reduce water and energy usage, eliminate plant water stress, and increase crop yields.  Research and Development activities completed will enhance the understanding of the relationship of plant water stress to microenvironmental conditions and how plant water stress and microenvironmental conditions can be accurately measured and forecast with low cost sensing capabilities.

    This SBIR Phase I project proposes to perform research and development to validate the concept of a low-cost synthetic sensor for plant water stress.  The objective of this project is to field test the low-cost sensor arrays, compare the output to data from high-cost scientific grade sensors, and utilize the data gathered during the field test to train ML models. These ML models will perform sensor fusion on the data from the low-cost sensor arrays and output a plant water stress measurement.  These ML models can then forecast future plant water stress, which will be compared to actual field measurements for accuracy assessment and refinement.  Once refined, the ML models will determine the minimal amount of irrigation water necessary to mitigate the predicted plant water stress.  This optimized amount of irrigation water will be allocated into a recommend irrigation schedule for farmers to review and implement.  The relevance and ease of use of the recommended irrigation schedule will then be assessed by farmers.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1925 Kenyon Street NW
  awardeeCity: Washington
  awardeeCountryCode: US
  awardeeName: Aquasys LLC
  awardeeStateCode: DC
  awardeeZipCode: '200102620'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843254'
  piEmail: adam@aquasys.co
  piFirstName: Adam
  piLastName: Koeppel
  piPhone: '2026641254'
  poName: Anna Brady-Estevez
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 09/30/2019
  title: 'SBIR Phase I:  Machine Learning Driven Synthetic Sensor for Plant Water
    Stress'
- abstractText: |-
    This SBIR Phase I project is developing a breakthrough technology to non-invasively monitor fetal oxygen levels in utero, to enable the more accurately detection of fetuses in distress and facilitate safer births for mothers and babies. Currently, obstetricians struggle with a 50-year old monitoring technology, which reports fetal heart rate and maternal contractions, and that is associated with an 89% false positive rate for detecting babies in distress. This is a major contributor to high cesarean section rates worldwide and up to 40% in some US hospitals. Because of the costs, risks for mothers and negative implications for babies' health, C-section rates are coming under scrutiny from insurers and accreditors, however, clinicians lack the means to accurately identify oxygenation starvation and, to date, no non-invasive means of directly measuring fetal oxygenation has been developed. Raydiant's system builds off traditional pulse oximetry and will employ safe levels of light, through the mother's abdomen, to monitor fetal pulse and report oxygen saturation, the crucial, but missing diagnostic. This technology will be applicable to over 2.9 million births per year in the US as an enhancement to traditional monitoring whenever a heart rate signal of concern is observed. Both the absolute oxygenation value and its trend over time will enable more informed decision making throughout the birth process.

    This project pushes the fundamental boundaries of pulse oximetry and bio-photonics. Unlike traditional finger pulse oximetry, sensing non-invasively through the maternal abdomen presents a body in a body problem, where the fetal pulse signal is orders of magnitude weaker than and intertwined with the maternal. Photons are scattered and absorbed by multiple tissue layers and there are tradeoffs between signal strength, noise and the ratio of fetal to maternal signal. Non-homogeneities from subject to subject makes calibration difficult. Addressing these challenges will require innovation in photonics hardware and signal processing and this proposal has a three specific aims: the development of a specific sensor hardware architecture that will facilitate detection of the fetal signal; development of Raydiant's algorithm to separate fetal from maternal signal, reject noise and report saturation; and validation of the combined system in a pregnant animal model, where fetal oxygenation levels are actively controlled and compared to the device reading. This proposal encompasses developing a second generation prototype system and represents critical technology de-risking aiming towards a commercial system for integration with current monitoring technology and clinical practice.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: c/o Fogarty Institute
  awardeeCity: Mountain View
  awardeeCountryCode: US
  awardeeName: Raydiant Oximetry, Inc
  awardeeStateCode: CA
  awardeeZipCode: '940400000'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843135'
  piEmail: nevanhanumara@raydiantoximetry.com
  piFirstName: Nevan
  piLastName: Hanumara
  piMiddeInitial: C
  piPhone: '4017415929'
  poName: Henry Ahn
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: SBIR Phase I:Design and optimization of non-invasive fetal oxygenation sensing
    hardware and algorithm
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is to boost the power output of solar cells by
    5-6% and reduce manufacturing costs by ~5%. By commercializing the proposed effectively
    transparent contact (ETC) technology the levelized costs of electricity (LCOE)
    of solar energy systems could be dramatically reduced, resulting in accelerated
    adoption of solar energy to address greenhouse gas emission and to become independent
    of fossil fuels. Improving power output of solar cells is one of the most effective
    means to drive down LCOE, and the ETC technology is broadly applicable to improve
    the power output of nearly all types of solar cells. Lower-cost solar cells can
    also be expected to benefit the developing world as well as disadvantaged communities
    that lack access to the power grid. In the near term, the proposed ETC technology
    will unlock higher power output and new applications for III-V photovoltaics,
    which are used predominantly in aerospace, defense, high performance consumer
    electronics and automotive. These rapidly growing markets require higher power
    output solar cells to add functionality (RADAR, LIDAR and surveillance) by increasing
    the payload capacity that is currently limited by the available space to mount
    the solar cells. \n\nThe proposed project will demonstrate the commercial viability
    of the ETC technology by demonstrating a new world record solar cell and scalable
    fabrication on commercial III-V solar cells. Metal contacts are required for charge
    extraction from solar cells, typically covering 5-6% of the front surface and
    blocking sunlight from reaching the photovoltaic material below. These losses
    due to blocking of incoming sunlight by the metal contacts are the largest single
    contribution to the performance loss in most solar cells. The proposed ETC technology
    eliminates these losses and thereby boost the solar cell power output by 5-6%.
    The ETC technology has been demonstrated at lab scale and is world's highest performing
    front contact technology. During the research project, ETCs will be integrated
    with commercial III-V solar cells supplied by prospective initial customers and
    world-leading research partners. The technical viability of ETCs will be established
    by achieving dramatic improvements in cell efficiency for each cell type, whereas
    the commercial viability will be established by successfully integrating the ETCs
    using techniques, materials, and tools suitable for commercial scale-up. Completion
    of these objectives will accelerate the efforts to commercialize the ETC technology,
    which will broadly increase power output and reduce cost of solar energy.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 1047 LAGUNA AVE
  awardeeCity: LOS ANGELES
  awardeeCountryCode: US
  awardeeName: ETC SOLAR LLC
  awardeeStateCode: CA
  awardeeZipCode: '900264220'
  fundsObligatedAmt: '218237'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1844090'
  piEmail: thomas@etc-solar.com
  piFirstName: Thomas
  piLastName: Russell
  piPhone: '6266348885'
  poName: Rick Schwerdtfeger
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 08/31/2019
  title: 'SBIR Phase I:  Development of printing process of effectively transparent
    contacts (ETCs) for III-V, thin-film and silicon solar cells.'
- abstractText: "This SBIR Phase I project involves the creation of particles that
    will allow one to see a map of temperature within a Magnetic Resonance Imaging
    (MRI) measurement.  This is a significant advancement because conventional thermometry
    is usually invasive, allows only single point temperature measurements, and may
    interfere with the therapeutic and imaging instrument. The proposed technology
    is designed to be biocompatible and minimally invasive, leading to fast 3D temperature
    mapping deep in the human body. The proposed materials and techniques can be used
    with MRI-guided thermal procedures which can replace scalpel-based surgery for
    a variety of cancers, improving patient outcomes and reducing surgical time. The
    method can also be used to improve treatments for essential tremor, uterine fibrosis
    and arteriovenous malformation. In these treatments, the temperature in the entire
    affected region must be constantly monitored. Due to the limitations of the currently
    used temperature measurement methods, these minimally invasive MRI-guided procedures
    are not frequently used or take considerably longer time than desired because
    surgeons often must work around failed temperature measurements. The work in this
    proposal could transform current methods of MRI-guided thermometry, significantly
    reducing surgery time and cost as well as improving patient outcomes.  \n\nThis
    proposal develops a novel, minimally-invasive method of creating temperature maps
    superimposed on anatomical MRI images. The technology uses a new type of temperature-sensitive
    sensor, in the form of magnetic nanoparticles, and could ultimately be used within
    human or other tissues.  The key idea is that magnetic particles embedded in tissue
    will create a local dipole magnetic field that will modulate (statically or dynamically)
    the homogeneity of the main static magnetic field of the MRI scanner.  This changes
    the nuclear relaxation times of the tissue and broadens the Nuclear Magnetic Resonance
    (NMR) linewidth, ultimately leading to local changes in the brightness of the
    MRI image.  The magnetization of the particles is engineered to change with temperature,
    and therefore the results are temperature dependent. Different shades of gray
    in the weighted gradient echo MR images, can then be calibrated to obtain a spatial
    map of temperature. This has immediate application in providing real-time temperature
    information to the surgeon during MRI-guided thermal interventional procedures
    to treat cancer, for example. These new contrast sensors can operate in a wide
    temperature range both below and above the human body temperature, producing spatial
    maps of temperature with an accuracy better than 1 degree Celsius.\n\nThis award
    reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 19740 GLEN SHADOWS DR
  awardeeCity: COLORADO SPRINGS
  awardeeCountryCode: US
  awardeeName: MRX ANALYTICS PBC
  awardeeStateCode: CO
  awardeeZipCode: '809082375'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843616'
  piEmail: janusz.hankiewicz@gmail.com
  piFirstName: Janusz
  piLastName: Hankiewicz
  piMiddeInitial: H
  piPhone: '3129619897'
  poName: Henry Ahn
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'SBIR Phase I:  Improving MRI Guided Thermal Therapies by Designed Magnetic
    Nanoparticles'
- abstractText: "This SBIR Phase I project aims to address two conditions that are
    very prevalent in the aging population, presbyopia and cataract, with a single
    intraocular lens. Presbyopia, the age dependent loss in the ability of the eye
    to adjust focus, is expected to affect 1.37 billion people worldwide by 2020.
    Cataract, the irreversible clouding of the lens that results in blurred vision,
    is expected to affect 30.1 million Americans by 2020. Despite these ever-increasing
    numbers, there currently is no single product available that restores both visual
    acuity and a complete range of spectacle-free vision following cataract refractive
    surgery. Such a solution would provide a greatly improved quality of life for
    patients and would inform future scientific developments in human accommodation
    and cataract formation. Alongside improved quality of life, vision correction
    has the added benefit of increased productivity in the workforce. The cataract
    surgical and intraocular lens exchange markets are significant, with 25.5 million
    IOL implants and $3.3 billion in sales in 2016 worldwide. With the growing and
    aging population, these numbers are expected to increase at a rapid rate. This
    device will fill a significant unmet need and has the potential of restoring a
    range of vision unlike any device currently in the market. \n\nThe proposed intraocular
    lens utilizes a highly sensitive refractive system leveraging large differences
    in refractive indices and has a mechanism of action unlike any currently in the
    market. It has the potential of levels of accommodation that are on par with accommodative
    abilities in a healthy, natural human lens. Forces in the eye are minimal, so
    this level of sensitivity is critical to any effective accommodating intraocular
    lens solution. Current devices and those in development do not exhibit the required
    level of sensitivity and subsequent accommodative amplitude to warrant significant
    adoption in the industry. Additionally, the proposed device shape mimics the natural
    lens, which allows for maximum utilization of the minute forces in the eye and
    prevents posterior capsular opacification. The first goal of this research will
    be the design and optimization of the lens utilizing a combination of mechanical
    and optical modeling. Lens prototypes will then be molded in a biocompatible,
    medical grade silicone. These prototypes will then be assessed for accommodative
    ability - first in an established opto-mechanical model eye experiment, then in
    an established human cadaver eye experiment. Finally, the prototypes will be assessed
    for injectability, to assure smooth integration with standard cataract surgical
    procedures.\n\nThis award reflects NSF's statutory mission and has been deemed
    worthy of support through evaluation using the Foundation's intellectual merit
    and broader impacts review criteria."
  awardeeAddress: 12635 E MONTVIEW BLVD STE 155
  awardeeCity: AURORA
  awardeeCountryCode: US
  awardeeName: CLEARSIGHT, LLC
  awardeeStateCode: CO
  awardeeZipCode: '800457336'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1841895'
  piEmail: kharris@clearsightiol.com
  piFirstName: Kevin
  piLastName: Harris
  piPhone: '7208594125'
  poName: Henry Ahn
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Presbyopia Correcting Intraocular Lens with a Novel Refractive
    System for Restoration of a Complete Range of Vision and Spectacle Independence'
- abstractText: |-
    This SBIR Phase I project will further the development of an orally administered gene delivery vehicle called the Crypt-Reaching Particle (CRP) that is able to overcome the physical barriers of the mucus to deliver DNA-based drugs to the cells of the gastrointestinal tract. The therapeutic agent will then be expressed as a protein locally in the gastrointestinal tract or be secreted into the bloodstream to treat the full body. Development of this vehicle will lead to novel scientific insights on DNA delivery that will benefit and educate the field of fundamental science and engineering. Successful commercialization would benefit pharmaceutical companies by providing an oral drug delivery platform for approved and novel drugs, U.S. patients by reducing the need for injectable drugs and thereby increasing compliance and quality of life, and payers by reducing costs associated with injectable drugs and improving outcomes by increasing patient compliance via oral administration. The drug-agnostic feature provides broad and diverse market opportunities within the rapidly expanding market for biologics, among other therapeutic agents leading to substantial job creation. As an example, a potential addressable market in four areas (i.e., delivering TNF inhibitors, protein replacement, peptide hormones, and blood factors) exceeds $90 billion per year.

    This project is designed to prepare a stable oral formulation of the Crypt-Reaching Particle (CRP), a novel drug-agnostic drug delivery vehicle, and demonstrate that it can deliver a functional DNA cargo for expression and secretion in intestinal epithelial cells in vitro and in vivo. This project focuses on the technical challenges associated with preserving the functionality of a DNA cargo as an example of a challenging drug delivery scenario that is difficult to replicate. The innovation is the design of the vehicle to penetrate through the mucus and transfect underlying epithelial cells by mimicking the enteric poliovirus. This will lay the foundation for the first oral gene therapy. Briefly, the project will address three objectives. First, preparation of a formulation for the CRP for oral administration via lyophilization with analyses to assess formulation and DNA stability as a function of time, temperature, and pH. Second, testing the ability of the orally formulated CRP to deliver a functional DNA plasmid encoding Gaussia luciferase to Caco-2 intestinal epithelial cells in vitro by measuring both cellular and secreted expression. Finally, testing the ability of the orally formulated and administered CRP to deliver a functional Gaussia luciferase plasmid to intestinal epithelial cells in vivo in Fischer 344 rats to assess expression and secretion.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 455 Mission Bay BLVD South
  awardeeCity: San Francisco
  awardeeCountryCode: US
  awardeeName: DNALITE THERAPEUTICS, INC.
  awardeeStateCode: CA
  awardeeZipCode: '941582158'
  fundsObligatedAmt: '224684'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1846078'
  piEmail: timday@dnalite.com
  piFirstName: Timothy
  piLastName: Day
  piMiddeInitial: P
  piPhone: '9134066710'
  poName: Henry Ahn
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'SBIR Phase I:  Development Of An Orally Administered Gene Delivery Platform
    For Induced Protein Secretion Via The Gastrointestinal Tract'
- abstractText: "This SBIR Phase I project addresses the unacceptable incidence of
    orthopedic device-related infections, as well as the dangerous rise of antibiotic
    resistant bacteria. More than 100,000 implanted orthopedic fixation devices (pins,
    plates, and screws) acquire bacterial infections each year in the US, accounting
    for approximately $1.5 trillion in associated medical and surgical treatment costs.
    Furthermore, the overuse and misuse of antibiotics to treat these infections has
    led to a dramatic rise in antibiotic resistance, which poses a severe risk to
    human health. This project aims to develop and optimize a commercially viable
    process to impart orthopedic fixation devices with a unique surface nanotexture
    designed to inhibit bacterial attachment and disrupt the biofilm cycle while simultaneously
    stimulating robust implant integration with adjacent bone. Importantly, this treatment
    acts via topography alone and does not incorporate antimicrobial agents or pharmaceuticals.
    Due to the ubiquity and gravity of the infection epidemic, this first-of-its-kind
    antibacterial surface technology is expected to rapidly infiltrate the orthopedic
    device market and drive a dramatic market shift towards the development of products
    with enhanced biological activity. Ultimately, this project has the potential
    to alleviate significant clinical and economic burdens while stimulating technological
    advances in a competitive market. \n\nThe proposed work aims to create an antibacterial
    surface nanotexture by utilizing a proprietary modified atomic deposition technique.
    The fabrication parameters used during this deposition process are closely linked
    to the resulting surface characteristics (and thus its antimicrobial efficacy).
    However, the link between fabrication parameters and antimicrobial efficacy is
    inadequately understood currently. Therefore, the proposed work employs a systematic
    strategy to elucidate the relationships involved and establish control over the
    fabrication process and resulting surface properties. The project is separated
    into four stages, each designed to explore the effect of a specific fabrication
    parameter on performance outcomes, including bacterial colonization, bone cell
    functions, and trends in certain surface properties that often correlate with
    cell-substrate interactions (e.g. surface energy, roughness, skewness, etc.).
    The relationships revealed through testing will be used to build a set of equations
    that describe how the properties of the nanotextured surface vary as a function
    of the fabrication parameters. This set of equations will then be used to optimize
    the system, enabling consistent and controllable operation of the deposition process
    as manufacturing specifications evolve. In addition to advancing the development
    of a market-changing product, the proposed research will contribute to the growing
    understanding of cell and bacteria responses on nanostructured surfaces in an
    ongoing effort to mitigate infection associated with orthopedic implants.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 89 Headquarters Plz N
  awardeeCity: Morristown
  awardeeCountryCode: US
  awardeeName: Tyber Medical, LLC
  awardeeStateCode: NJ
  awardeeZipCode: 079606834
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842823'
  piEmail: dhickey@tybermed.com
  piFirstName: Daniel
  piLastName: Hickey
  piMiddeInitial: J
  piPhone: '8052848656'
  poName: Henry Ahn
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Antibacterial Nanotopography for Orthopedic Fixation Devices'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to provide high-performance light filtering at a level that potentially affects all people in the world. Inexpensive high-performance light filters allow for early detection of cancer and infection by bringing the highest-precision technologies such as fluorescence microscopy and sensing to portable, consumer diagnostic devices. They also make sensors in self-driving cars and other intelligent devices of the future to detect objects in the surroundings more accurately by eliminating the undesired light noise from the ambient and focusing on the target frequencies of light only. Batteries of future mobile devices may also last up to 20% longer due to more efficient light energy management in display units that become possible with low-cost, large-scale optical filters.?Finally,?the anticipated lower manufacturing cost at high volume will allow for more high-tech manufacturing jobs to remain in the US.

    The proposed project will establish the technical feasibility of using a novel multi-material, micro- and nano-layered film production process in order to produce visible and near-infrared thin-film optical filters. The time and cost requirements of conventional, deposition-based production techniques of such filters are a significant barrier to market growth and commercial acceptance of their broad range of uses. In order to address this market gap, this project will investigate the elements necessary for consistent production of filters made of hybrid organic/inorganic materials using the novel process of thermal drawing. This investigation will cover methods of integration and handling of hybrid organic-inorganic materials in the thermal drawing process as well as understanding and controlling fluidic instabilities at interfaces to obtain filter uniformity and integrity. The results of the proposed research will determine whether the novel thermal drawing process, in conjunction with developed materials and handling techniques, can reliably generate high-performance visible and near infrared filters at scale.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2372 N. Forsyth Rd.
  awardeeCity: Orlando
  awardeeCountryCode: US
  awardeeName: Everix, Inc.
  awardeeStateCode: FL
  awardeeZipCode: '328075304'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843789'
  piEmail: hooman@everix.co
  piFirstName: Esmaeil
  piLastName: Banaei
  piPhone: '4076372987'
  poName: Rick Schwerdtfeger
  date: 01/31/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'SBIR Phase I:  Thermal Drawing of Hybrid Organic-InorganicMulti-Material
    Dielectric Filters'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is the potential to deploy a powerful tool for carbon
    capture.  CO2-capture is the foundation of greenhouse gas mitigation.  The high
    cost of current processes for CO2-capture have prevented their widespread deployment.
    \ High-pressure, Density-driven Separator (HDS) technology efficiently and continuously
    captures CO2 from gas streams, including both flue gas and fuel gas.  An HDS module
    produces nearly Pure High-pressure CO2 (PH-CO2).  HDS technology has transformational
    operating expense enabled by innovative strategies for compression, expansion,
    energy recovery, and subsequent use of the dense and light fractions.  An HDS
    module has no moving parts, membranes, pressure swings or temperature swings.
    \ Therefore, HDS technology has the potential for very low capital expense.  These
    low costs allow access to financial markets.  Other revenue sources are also facilitated
    by low capture cost.  For instance, PH-CO2 is food grade, valued in excess of
    $100/ton.  PH-CO2 is suitable for enhanced oil recovery.  HDS technology separates
    CO2 from fuel gas, producing a valuable high-pressure vapor, in addition to PH-CO2.
    \ HDS technology dramatically reduces the CO2-capture cost and provides a purity
    that enables a profitable B2B model. \n\nThis STTR Phase I project proposes to
    develop HDS technology.  Quantitative metrics will be refined and employed to
    develop detailed capital expense and operating cost models.  Two technical hurdles
    must be overcome to reduce these costs.  These hurdles are also opportunities
    for innovation.  The first opportunity is to achieve sufficient volumetric efficiency
    in the pressure vessel for commercial deployment.  The equilibrium state inside
    the HDS module is perfect separation.  Increasing the rate of approach to that
    equilibrium state reduces the size and cost of the HDS module. This will be accomplished
    by exploiting the synergy between fluid state, surface state, fluid motion, and
    gravity.  This synergy coalesces CO2, allowing its rapid separation from the remaining
    components of flue gas and fuel gas.  The second opportunity is to achieve sufficient
    overall process efficiency for commercial deployment.  The power required for
    compression determines operating expense.  Our strategy involves operating the
    near-isothermal cold compression train and near-isothermal hot expansion train
    as a heat engine (an approximation of the Ericsson cycle).  In this manner, innovative
    gerotor compressors and expanders work together with heat exchangers using waste
    heat to reduce or eliminate operating costs.\n\nThis award reflects NSF's statutory
    mission and has been deemed worthy of support through evaluation using the Foundation's
    intellectual merit and broader impacts review criteria."
  awardeeAddress: 813 Fairway Drive
  awardeeCity: Columbia
  awardeeCountryCode: US
  awardeeName: Liquid Carbonic L.L.C.
  awardeeStateCode: MO
  awardeeZipCode: '652016348'
  fundsObligatedAmt: '224999'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843390'
  piEmail: andy.miller@liqcarb.com
  piFirstName: Andrew
  piLastName: Miller
  piMiddeInitial: J
  piPhone: '3124202601'
  poName: Anna Brady-Estevez
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  High-pressure Density-driven Separation Technology for Carbon
    Capture'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the development of an advanced manufacturing technology that will enable the production of high-quality optical glass lenses that are customizable and affordable, without the use of laborious machining or expensive tooling common in traditional lens manufacturing. The technology aims to reduce lens production costs by at least 5x while increasing throughput by ~6-8x. In addition, the project will address a key industry need to improve integration of optical components with electro-mechanical systems such as those found in compact camera modules. The methods and tools developed here will enable systems integration at a wafer level, thereby simplifying assembly, reducing cost/weight/size and improving the overall performance of many next-generation devices. This outcome will have a significant impact on imaging technology used in smartphones, wearable electronics, miniature aerial vehicles, medical endoscopes, and advanced automotive driver assistance systems. Hence, the project has the potential to benefit a diverse number of industries and strengthen U.S. economic competitiveness within the optics sector. In a broader sense, the technology developed in this project will also help revitalize American manufacturing.

    The proposed project will demonstrate a new method of lens manufacturing by leveraging semiconductor processing techniques and developing an innovative lens fabrication tool. The new tool will measure key optical metrics in real-time during lens creation for on-the-fly process adjustments. Closed-loop feedback during fabrication will improve tolerances and yields and produce higher quality lenses compared to traditional methods. This approach represents a paradigm shift in manufacturing as all commercial lenses today are created through iterations of lens forming and ensuing optical metrology. Furthermore, the tool will enable rapid production of customizable lens shapes, including a novel planar lens. The flat lens will be compatible with surface modification technologies such as those used to create electronics and micro mechanical structures, thus enabling, for example, thin film transistors or sensors to be fabricated with the optics at a wafer level. Specific research activities will include (1) designing and constructing manufacturing tools and fixtures, (2) experimentally correlating tool configurations with lens shapes, (3) constructing and characterizing concave, convex and planar lenses and (4) developing a software model of the lenses based on realistic manufacturing constraints.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2113 SEAWAY COURT
  awardeeCity: LONGMONT
  awardeeCountryCode: US
  awardeeName: MOMENTUM OPTICS, LLC
  awardeeStateCode: CO
  awardeeZipCode: '805037871'
  fundsObligatedAmt: '173673'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1846603'
  piEmail: jeremy@momentumoptics.com
  piFirstName: Jeremy
  piLastName: Goeckeritz
  piPhone: '8018159981'
  poName: Rick Schwerdtfeger
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Scalable Manufacturing Of Optical Lenses For Complex Systems
    Integration'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project will be to bring to the market a faster and cheaper means of gathering highly accurate local air quality.  This will be done through the use of miniaturization of chemical sensors that are carried by UAVs.  Not only will there be technical hurdles that will be overcome through the implementation of this means of gathering data, the use of UAVs in this manner pushes the boundaries of their use in urban areas in a way that has not been done before.  The societal and commercial impact will be to reduce cost and time in obtaining air quality at a point in time and space, thereby making air quality measurements less of a financial and technical burden to governments, organizations and corporations.  This progress will help ensure that communities can address air quality concerns through the data gathered.

    This STTR Phase I project proposes to implement a novel means to couple a low-cost technology to detect when chemical components reach a given threshold in the air with the use of Unmanned Aerial Vehicles as a means of delivering the sensors to a specified location.  The sensor technology utilizes colorimetric detection of chemicals.  Off-the-shelf colorimetric sensors, combined with a unique algorithm, produce color difference maps for toxic industrial chemicals at their permissible exposure level (PEL) concentrations.  The objective of the research is to determine if the proposed approach will allow for accurate chemical sensing for a precise location.  It is anticipated that the technology to be utilized will allow for an accurate capture of a broad range of pollutants and chemical compounds along with concentration levels.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2339 N. Kildare Ave
  awardeeCity: Chicago
  awardeeCountryCode: US
  awardeeName: Kaizen Technologies, Inc
  awardeeStateCode: IL
  awardeeZipCode: '606393655'
  fundsObligatedAmt: '224653'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842686'
  piEmail: uhafeez1@gmail.com
  piFirstName: Usman
  piLastName: Hafeez
  piPhone: '7739343010'
  poName: Anna Brady-Estevez
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Air Quality Analysis by Unmanned Aerial Vehicles'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project arises from bringing new materials to market for making improved rechargeable lithium ion batteries needed by the high-tech economy, medicine, and the military (batteries are the second largest military consumable). In today's world, everything, including medical devices (e.g., wireless implants and sensors), has an app; using apps requires batteries. This project will produce "Safer Energy for the Wireless World"; the resulting improved batteries will incorporate novel, lighter, and safer (no overheating) anode materials that will charge faster and store more energy than current versions. The new anode materials are estimated upon success to yield sales of $1B during the first 10 years from selling the materials to battery manufacturers to incorporate, initially, as composites in lithium ion battery anodes, and, later, as the entire active anode. Broader societal impacts include greater safety because the batteries do not overheat; lighter, more portable devices with longer battery life and faster recharging time; reduced need for backup batteries; and diverse STEM workforce development though applied research and entrepreneurship training.

    This SBIR Phase I project proposes to develop safer, more powerful ways to charge electronic devices by translating fundamental research from university to industry. The opportunity arises from an NSF-supported discovery of the first solid form of carbon monoxide known, a two-dimensional crystal structure: graphene monoxide (GmO). GmO and its first proposed application for anodes in lithium ion batteries are patented. Knowledge gaps to be addressed include identifying tailored materials for optimizing batteries for electronics, using theoretical and experimental approaches to identify the maximum energy storage capacity for lithium batteries, and determining the energy and power densities and safety properties under normal and extreme operating conditions. The technology must be demonstrated in 200-mAh pouch batteries, the first milestone needed for battery manufacturers to consider adopting the innovation through licensing or sales. The second milestone is to scale up materials to produce large quantities. The overall goal is to commercialize the GmO material into an active anode or additive material for extreme batteries. In sum, the project will yield prototype batteries made from the new materials, optimize properties for specific partner applications, simulate interactions between GmO and Li, and identify pathways for scaleup of materials production.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1408 E OLIVE ST
  awardeeCity: SHOREWOOD
  awardeeCountryCode: US
  awardeeName: SAFELI
  awardeeStateCode: WI
  awardeeZipCode: '532111828'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843306'
  piEmail: dr.carol.h@safelimaterials.com
  piFirstName: Carol
  piLastName: Hirschmugl
  piMiddeInitial: J
  piPhone: '4142480846'
  poName: Anna Brady-Estevez
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 08/31/2019
  title: 'SBIR Phase I:  SafeLi: Graphene monoxide anodes for extreme batteries'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is the development and widespread adaptation of next generation
    energy storage devices. With high energy density advanced materials, these devices
    can store significantly higher electric power per single charge. Particularly,
    rechargeable batteries with significantly higher energy density will improve;
    the range of electric vehicles on a single charge, operating time of defense platforms
    (such as aerial drones, naval vessels, exoskeletons, communication devices, etc.),
    amount of renewable energy stored, battery life of medical devices, and the need
    to charge consumer electronics less often.  In addition to improved performance,
    high energy density devices will accelerate commercialization, adaptation, and
    sale of new vehicles or devices that utilize them. In turn increasing investments
    and revenue not only for the advanced material and battery producers, but for
    companies involved in manufacturing and sale of electric vehicles and devices
    within the United Sates. \n\nThis SBIR Phase I project proposes to develop the
    production of novel, pure graphene anode material by Chemical Vapor Deposition
    technique using readily available material resources. Currently, graphite anode-based
    LIBs are the most commonly used and the most reliable energy storage devices for
    portable electronics, electric vehicles and electric grid storage due to their
    stability, low cost, and safety. However, graphite's low capacity (theoretically,
    372 mAh/g) prohibits the development of higher energy density batteries. The problem
    is that graphite's internal structure limits lithium diffusion within interlayer
    spaces. We propose to replace graphite as the anode material. Our material is
    a newly-discovered high-quality graphene network, consisting of incommensurately-stacked
    multilayer graphene (IMLG) assembled in three-dimensional (3D) form. It exhibits
    unique structural and electrical properties that enable the reversible intercalation
    of large amounts of lithium within interlayer spaces of multilayer graphene. IMLG
    anode exhibits an extremely high reversible capacity of up to 1500 mAh/g tested
    as an anode material in LIB cells. Within the scope of this project we plan to
    scale the production of this material, while maintaining high quality, and supply
    IMLG to industry partners for integration testing in commercial batteries.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 2508 River Oaks drive, Unit 5
  awardeeCity: LOUISVILLE
  awardeeCountryCode: US
  awardeeName: Hexalayer, LLC
  awardeeStateCode: KY
  awardeeZipCode: '402063211'
  fundsObligatedAmt: '224999'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843172'
  piEmail: T.Paronyan@hexalayer.com
  piFirstName: Tereza
  piLastName: Paronyan
  piMiddeInitial: M
  piPhone: '5028219439'
  poName: Anna Brady-Estevez
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  HIGH CAPACITY ENERGY STORAGE ANODE MATERIAL'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research Project (SBIR) project is the development of a platform for pathogen identification and other genomic applications that achieves rapid, sensitive, multiplexed single-molecule detection.  The genomic diagnostics market is poised to grow to $40 billion by 2021.  The goal of this platform will be to offer multiplexed detection of more than 1,000 pathogens, allowing accurate point-of-care diagnosis of infectious diseases.  Other genomic applications that also are possible include assessment of the microbiome or monitoring opportunistic infections in pulmonary diseases.  In addition, the platform has the potential for use in genomic sequencing, a market that is expected to reach $9 billion by 2020.

    The intellectual merit of this SBIR Phase I project is to develop a highly multiplexed, bioelectronic, label-free assay platform capable of real-time, label-free detection of thousands of nucleic acid targets without amplification. This will be accomplished  through the use of nanoscale single-molecule field-effect transistors (smFETs) on a complementary metal-oxide semiconductor (CMOS) integrated-circuit platform, which fully leverages the economies of scale of modern semiconductor manufacturing. The initial target application for this technology is multiplexed pathogen identification at the point-of-need. This project will bring the technology to wafer-scale manufacturing, which will both improve device quality and lower the per device cost of manufacture, and demonstrate proof-of-concept for genomic detection (without amplification) on clinical samples.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 180 VARICK ST RM 526
  awardeeCity: NEW YORK
  awardeeCountryCode: US
  awardeeName: QUICKSILVER BIOSCIENCES, INC.
  awardeeStateCode: NY
  awardeeZipCode: '100145429'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843244'
  piEmail: swarren@quicksilverbiosciences.com
  piFirstName: Steven
  piLastName: Warren
  piPhone: '9143932633'
  poName: Ruth Shuman
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Single-molecule field-effect transistor arrays for multiplexed
    genomic identification of infectious diseases'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is as diverse as the laser technology itself.  Lasers have become the true facilitator of the data-based society.  It is tool of choice for future smart factories and on-demand manufacturing.  It serves as the fundamental building block of optical sensing systems used to collect large volumes of critical data to be used for decision making in every facet of society.  The myriad of new applications for laser systems echoes the same demand ? higher power.  The bottleneck in the power generation is often the capability of optical components of the laser to withstand the power without degradation.  So the greater potential of lasers can be unleashed if there would be a way to break through the power handling capability of laser components starting with the nonlinear optical crystals indispensable in creating these powerful energy sources.  This research project is precisely designed to address this need and the successful completion of this project would enable the next generation of miniaturized electronic devices, expand our horizon of biological imagery and precision surgery, and explore our universe with instruments that are currently confined to our laboratories.

    The proposed project targets the most common material used to generate high power visible and UV light ? Lithium Triborate (LBO) crystal.  Able to handle power density up to 45GW/cm2, LBO is currently the material of choice for high energy industrial lasers.  However, optical surfaces where the light enter and exit LBO often get damaged well before the actual bulk material.  Traditional dielectric anti-reflective (AR)  coatings on these surfaces are typically made using a limited selection of materials of lower damage threshold in a process highly susceptible to contamination, resulting in significantly lower damage threshold than the bulk LBO crystal.  In this proposal, state-of-the-art surface-texturing processes on LBO will be developed to eliminate the use of these dielectric films while still providing the necessary AR functionality.  A variety of processes and materials on LBO surfaces will be attempted and studied with resulting surfaces tested for absorption and damage threshold.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2362 Qume Drive
  awardeeCity: San Jose
  awardeeCountryCode: US
  awardeeName: Gamdan Optics, Inc
  awardeeStateCode: CA
  awardeeZipCode: '951311841'
  fundsObligatedAmt: '224667'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1840843'
  piEmail: hanna.cai@gamdan.com
  piFirstName: Hanna
  piLastName: Cai
  piPhone: '4083134578'
  poName: Rick Schwerdtfeger
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  A novel AR on LBO'
- abstractText: "The broader impact/commercial potential of this project is the advancement
    of battery technologies. The race for the perfect battery is intensifying due
    to growing global demand for both the electric vehicle (EV) and stationary storage
    industries. The search is on for new ways to improve energy and power density,
    reduce charging time, and extend battery life. The project will create a diagnostic
    tool that provides an unprecedented glimpse inside the battery and has the potential
    to accelerate scientific understanding of how batteries age. A more accurate assessment
    of battery degradation in real time can inform on-board algorithms, can improve
    overall battery pack efficiency, and has major cost saving impacts for automakers
    and stationary storage users. This predictability enables more cost-effective
    warranty management, improved charging and safety algorithms, and ever more efficient
    battery pack designs.  Having a sense of remaining useful life also enables the
    battery to be re-used in a secondary application - creating new business opportunities
    while a new revenue stream making batteries more sustainable.  Ultimately, this
    reduces costs for both consumers and manufacturers, and contributes to greener
    use of resources for society. \n\nThis Small Business Innovation Research (SBIR)
    Phase I project unlocks key insights for large-format lithium batteries. Today?s
    battery management systems (BMS) do not track a battery?s actual degradation metrics
    so it cannot forecast remaining useful life. This makes it hard to predict the
    ?cliff?, a sudden and steep drop in capacity near a battery?s end of life.  This
    forces battery makers to overdesign battery systems to reduce chances of premature
    failure before the warranty expiration. The proposed research employs electrochemical
    impedance spectroscopy (EIS) onboard a BMS.  EIS is a diagnostic tool that measures
    battery impedance - something only possible in a lab setting today. Tracking impedance
    unlocks a lifetime of degradation data and helps battery engineers better understand
    the long-term degradation behavior of high voltage battery packs. The project
    will focus on 1) minimizing the required hardware to measure impedance of each
    cell in a series-connected battery pack, and 2) reducing the down-time associated
    with the impedance measurement. The proposed innovation blends a unique hardware
    architecture with wide-bandgap semiconductors and adaptive charge-control algorithms
    to minimize hardware size. These help to reduce overall system cost and unlocks
    orders of magnitude improvement in hardware scalability over existing EIS methods.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 7690 Lampson Ave
  awardeeCity: Garden Grove
  awardeeCountryCode: US
  awardeeName: Rejoule Incorporated
  awardeeStateCode: CA
  awardeeZipCode: '928414105'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842957'
  piEmail: schung@rejouleenergy.com
  piFirstName: Steven
  piLastName: Chung
  piPhone: '6572005670'
  poName: Muralidharan Nair
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 11/30/2019
  title: 'SBIR Phase I:  Impedance-Based Battery Health Management for Large Format
    Lithium-Ion Battery Packs'
- abstractText: "The broader impact/commercial potential of this project is mainly
    in the area of machine condition monitoring. Vibration monitoring is an integral
    part of any machine condition monitoring regimen. All equipment that comprise
    belts, gears, bearings, drive motors, or other moving components have a specific
    vibration signature during normal operating cycles. Change in equipment vibration
    serves as an early warning of a decline in operating condition and signals the
    need for preventative maintenance to avoid more serious equipment faults and failure.
    \ Due to extremely small form-factor and wireless signal detection scheme of the
    sensing tag in the proposed vibration monitoring system of this project, simple
    and cost-effective direct measurement of vibration from hard-to-access parts of
    machinery (e.g. rotor in an electric motor) is enabled. This will have a significant
    impact on widespread use of such vibration monitoring techniques, hence improving
    the performance and safety of the equipment, extend their lifetime and avoid any
    unplanned downtime or maintenance across a host of existing and new industries
    and applications. \n\nThis Small Business Technology Transfer (STTR) Phase I project
    will initially focus on developing wireless battery-less accelerometers that can
    achieve very high resolution. The operating principle of the resonant accelerometer
    to be developed has never been demonstrated in the past and it is through this
    novel concept that high-sensitivity wireless measurement of acceleration is made
    possible. The proposed sensor consists of a piezoelectric resonant cavity coupled
    to an antenna that utilizes the piezoelectric stiffening effect to produce an
    acceleration-dependent resonance frequency. The center frequency of the resonator
    is wirelessly interrogated through pulsed excitation signals. One main and particularly
    attractive feature of the sensors is the simplicity of the sensor tag where no
    electronics are required. An acceleration detectivity of less than 50mg for a
    device operating in the 27.12MHz ISM band is targeted in this project which meets
    the requirement for a wide variety of application including motor vibration monitoring.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 2200 CREEKEDGE CT
  awardeeCity: CORINTH
  awardeeCountryCode: US
  awardeeName: LORAND TECHNOLOGIES INC
  awardeeStateCode: TX
  awardeeZipCode: '762103619'
  fundsObligatedAmt: '224916'
  fundProgramName: STTR PHASE I
  id: '1843260'
  piEmail: Moradian@lorandtechnologies.com
  piFirstName: Sina
  piLastName: Moradian
  piPhone: '3213104435'
  poName: Muralidharan Nair
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'STTR Phase I:  Wireless Vibration Micro-Sensors for None Intrusive Real
    Time Monitoring'
- abstractText: |-
    This SBIR Phase I project proposes to commercially develop an in vitro (cell culture) platform to enhance the efficiency of drug discovery. Every drug delivered to a human engages the network of blood vessels for delivery to the target tissue or as part of the removal. An essential feature of the blood vessel network is an extensive network of small vessels surrounded by smooth muscle which can contract and dilate to control blood flow, and thus drug delivery. There are no in vitro human platforms that can mimic this biological function, despite the fact that cardiovascular toxicity is the leading cause of failure in clinical trials. As such, a pre-clinical tool to assess vascular toxicity would significantly impact the drug development process. Developing a successful drug averages 10-12 years and nearly $2.6 billion. Despite the fact that ~60% of the total development costs are spent on human clinical trials, fewer than 1 in 10 entering clinical trials will succeed. There is a significant opportunity to improve the accuracy of preclinical drug screening which, in turn, will generate dramatic cost savings and shorten time-to-market. The company's proposed vasoactive human vascular network represents a leap forward in technology to simulate the human response to new and existing drugs. Furthermore, the platform technology has broad future applications including the incorporation of tissue specific function (e.g, human tumor cells) and patient specificity which will further advance drug development and precision medicine.

    There are currently no in vitro platforms that can mimic vasoconstriction or vasorelaxation, processes which require vasoresponsive smooth muscle cells. Competing technologies line prefabricated tubes or membranes with endothelial cells to mimic the vasculature which will never be able to simulate vasoactivity. Since the company's platform is comprised of living dynamic microvessels, the company is uniquely positioned to create a platform with this functionality. The primary objective is to develop a 3D perfused human vascular network with smooth muscle providing the capacity to characterize vasoactive substances. The company will achieve the primary objective by completing two specific aims: 1) Incorporate human smooth muscle cells into a 3D in vitro vascular network; and 2) Quantify the dose-response of the 3D perfused vessel network to a panel of vasoactive drugs. Achieving vasoactive functionality in an in vitro vascular network will be the first demonstration of this critical biological phenomenon, and will meet an important commercial need in the pharmaceutical industry.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 33 SILVER CRES
  awardeeCity: IRVINE
  awardeeCountryCode: US
  awardeeName: KINO BIOSCIENCES INC.
  awardeeStateCode: CA
  awardeeZipCode: '926033611'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843331'
  piEmail: francis_duhay@kinobio.com
  piFirstName: Francis
  piLastName: Duhay
  piPhone: '9492858170'
  poName: Henry Ahn
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Vasoreactive Perfused in Vitro Vascular Network'
- abstractText: |-
    The broader impact/commercial potential of this project is the development of drone-based technology to manage fires more safely, efficiently, and effectively.  Wildfires cause hundreds of billions of dollars in annual damages in the United States. As the size and number of wildfires increases, prescribed fires have emerged as one of the most cost-effective tools to reduce catastrophic damage by removing excess fuel for wildfires and controlling their evolution. Yet, to be most effective, prescribed fires require putting people in the proximity of fire and are often limited by the unavailability (due to cost or demand) of fast delivery mechanisms such as those provided by helicopters. This effort will result in technology that directly addresses both pain points by improving the intelligence of drone-based fire monitoring and ignition systems. This project has the potential to shape how fire management is conducted in the future, making it safer for fire personnel and enabling cost-effective prescribed fire practices that can help society to control catastrophic wildfires and better manage landscapes.

    This Small Business Innovation Research (SBIR) Phase I project will enable the development of drone-based technology that will transform fire management. Current drone-based ignition and monitoring systems have the potential to change the field but are hampered by their extensive reliance on human controllers. This lack of automation limits these systems? potential applicability, scale, effectiveness, and unnecessarily increases their risk. The proposed work aims to make monitoring and ignition more intelligent and scalable through: 1) specialized machine learning pipelines to characterize fire fronts and identify ground assets; 2) light-weight fire simulation engine that can provide short-horizon prediction of the fire front evolution while executing on limited computer power; and 3) distributed planning algorithms that adjust the drone's trajectory and sphere drop strategy to manipulate fire intensity while keeping ground assets, vehicles, and personnel safe. These challenges are especially difficult to address given the harsh fire environment, the weight and power constraints of commercial drones preferred for these activities, and the integration of two distinct domains, drone navigation and fire management.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1811 S Pershing Rd
  awardeeCity: Lincoln
  awardeeCountryCode: US
  awardeeName: Drone Amplified, Inc.
  awardeeStateCode: NE
  awardeeZipCode: '685024840'
  fundsObligatedAmt: '224999'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843735'
  piEmail: carrick@droneamplified.com
  piFirstName: Carrick
  piLastName: Detweiler
  piPhone: '5313332828'
  poName: Muralidharan Nair
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Intelligent Drone Ignitions To Manage Fires'
- abstractText: "This SBIR Phase I project seeks to commercialize new sensor technologies
    that enable the rapid measurement of the handedness of molecular mixtures.   Like
    screws and keys, many molecules possess a certain handedness that can be important
    when interacting with living systems.  This issue is vital to pharmaceutical research,
    where one handed form of a drug may result in benefits while the opposite form
    may cause harmful side effects.  Consequently, measuring the handedness of molecular
    mixtures is of paramount importance in modern pharmaceutical research.  However,
    conventional approaches to making these measurements are often too slow for modern
    pharmaceutical discovery and development research where high-throughput experiments
    on hundreds or even thousands of samples per day are performed.  This project
    aims to remove this bottleneck by leveraging a recently introduced new instrument
    and commercializing reagent kits that have been shown in academic laboratories
    to achieve a much faster and simpler method for measuring the handedness of molecular
    mixtures.  Making this improved technology widely available to the greater research
    and development community has the potential to streamline drug development efforts
    at reduced cost and minimized waste production, which is expected to increase
    profit margins and create new jobs in research, development and manufacturing,
    resulting in substantial benefit to the health and economy of the United States.
    \ \n\nThe innovation of this project comprises a series of optical sensors, developed
    during a decade of fundamental research in the participating laboratories, which
    will allow rapid eescreening of a variety of asymmetric reactions. The focus of
    this unprecedented enterprise is to validate selected sensors against pharmaceutically
    relevant compounds, determine the error of the optical assays by comparison with
    traditional techniques such as chiral HPLC, to evaluate the robustness in the
    presence of potential interferants, and to apply a sensor in the analysis of an
    asymmetric reaction using multi-well plate technology. The development of a user-friendly
    kit will include the testing of different methods for the creation of pre-dispensed
    dried sensors that can be reconstituted without leaving behind residues that might
    increase the error margin beyond a few percent which is generally acceptable for
    high-throughput screening applications. The final outcome will be a convenient
    mix-and-measure protocol that enables rapid analysis of hundreds of small-scale
    asymmetric reaction mixtures.\n\nThis award reflects NSF's statutory mission and
    has been deemed worthy of support through evaluation using the Foundation's intellectual
    merit and broader impacts review criteria."
  awardeeAddress: 1900 SIMOND AVE APT 1064
  awardeeCity: AUSTIN
  awardeeCountryCode: US
  awardeeName: ENANTIOSENSE LLC
  awardeeStateCode: TX
  awardeeZipCode: '787234648'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843626'
  piEmail: justin.dragna@gmail.com
  piFirstName: Justin
  piLastName: Dragna
  piMiddeInitial: M
  piPhone: '5125603231'
  poName: Henry Ahn
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  A chemical assay kit for the high-throughput screening of
    chiral amine enantiomeric excess'
- abstractText: "The broader impact/commercial potential of this project includes
    the development and proof-of-concept prototype demonstration of a new wirelessly-enabled
    and distributed battery energy storage system technology which can result in significant
    contributions to wide range of applications that critically depend on energy storage
    systems and energy availability. These applications include electrification of
    transportation via Electric Vehicles (EVs) and Electric Aircraft (EA), off-power-grid
    homes, green homes, and other buildings. This technology seeks to and supports
    the adoption increase of EVs, EA, and renewable energy sources. As a result, the
    project contributes to the increase in energy efficiency, the reduction in greenhouse
    gas emissions and the reduction in the dependence on foreign oil imports. The
    project enhances scientific and technological understanding by demonstrating the
    visibility, robustness, and stability of distributed wireless control methods
    and power electronics architecture for the wirelessly enabled and distributed
    energy storage system. The results of the project will be used to evaluate and
    determine the technical and commercial feasibility of the wirelessly enabled and
    distributed battery energy storage systems. \n\nThis Small Business Technology
    Transfer (STTR) Phase I project will focus on conducting research and development
    tasks that will address key technical challenges that are crucial to successful
    commercialization of the wirelessly-enabled and distributed energy storage system
    such as robust and stable controller realization, wireless communication link
    realization for continuous wireless control, realization of efficient light-weight
    multi-link wireless power transfer, high-density light-weight power electronics
    with high-efficiency, and electrical and mechanical integration of the overall
    system. A proof-of-concept prototype for Electric Vehicles application will also
    be developed under this project and used for several demonstrations to potential
    partners, customers, and investors. This proof-of-concept demonstration prototype
    will be used to demonstrate the feasibility of the system and related desired
    functionalities such as fast, easy and safe exchange of modules in the system
    without the need for specialized personnel and distribution infrastructure.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 800 22ND AVE THE EDGE
  awardeeCity: TUSCALOOSA
  awardeeCountryCode: US
  awardeeName: JAQ ENERGY LLC
  awardeeStateCode: AL
  awardeeZipCode: '354012142'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1843319'
  piEmail: jaq.energy.llc@gmail.com
  piFirstName: Amer
  piLastName: Abu Qahouq
  piPhone: '2056143066'
  poName: Muralidharan Nair
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'STTR Phase I:  Wirelessly Enabled and Distributed Energy Storage Systems
    Technology'
- abstractText: |-
    The broader impact/commercial potential of this project is to enable a new generation of collaborative robots that are capable and safe. Collaborative robotics is poised to revolutionize manufacturing where they will enable better utilization of factory space and machines, reduce energy cost, and mitigate labor shortages. Safe operation is a critical factor for successful operation of collaborative robotics, especially if they are mobile. The proposed project will demonstrate that tactile sensing skins can make robots safer, more collaborative, and manufactured at reasonable cost. The proposed task will also contribute to workforce development and enhance scientific understanding in the critical fields of robotics, soft robotics, and artificial intelligence, as well as providing opportunities for local students.

    This Small Business Innovation Research (SBIR) Phase I project will investigate a novel type of tactile sensing skin to improve robot safety and its ability to interact with human users. Unlike previous work, the proposed skin can detect obstacles from a distance of up to 20cm, as well as measuring contact and force. Also, the ability to detect user gestures such as tapping, rubbing or poking, opens new avenues for human-robot interaction and will enable the study of truly collaborative robots. The proposed research and development project will overcome the following key challenges that stand in the way of commercializing the technology: scaling from single patches to full-body sensing skins, fusing proximity data collected from the skin with those provided by conventional 3D sensors, and demonstrating its benefits in a series of real-world use cases.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1860 38th St
  awardeeCity: Boulder
  awardeeCountryCode: US
  awardeeName: Robotic Materials Inc
  awardeeStateCode: CO
  awardeeZipCode: '803012620'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843188'
  piEmail: ncorrell@colorado.edu
  piFirstName: Nicolaus
  piLastName: Correll
  piMiddeInitial: J
  piPhone: '3034922233'
  poName: Muralidharan Nair
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Whole-body 3D perception for human-safe collaborative robots'
- abstractText: |-
    This Small Business Innovation Research Phase I project will address the challenge of developing students? empathy and emotional self-awareness with a mobile-based platform. Aligning with the NSF's mission to develop innovative education programs to enhance aspects of emotional intelligence, this project will address three major pain points for young learners with far-reaching implications. First, the need to develop emotional intelligence; which has been identified as a 21st-century literacy that is crucial for younger learners to thrive. Current school climate issues with bullying and violence consistently reinforce the need to address social and emotional learning. Next, the need to integrate social and emotional learning into regular classroom activities. With the demands placed on schools for testing, having a program that integrates with what schools are already responsible should support more widespread adoption. Finally, the program addresses a widespread need to combat the deleterious effects of the current uses of social media by young students. This project will bring a positive spin to social networking that can improve the emotional intelligence skills of students


    The proposed innovation is an augmented reality-based experience that immerses fourth and fifth-grade students in activities designed to build their skills of emotional intelligence; namely, emotional self-awareness and empathy, as they interact with a network of peers. The key technical challenges the project must solve include: refining core methods for developing emotional self-awareness and empathy, defining and refining a user experience that teachers/parents will find educationally compelling and with which learners will love to engage, designing a curating process for learner-generated content that will ensure the safety and security of all users and developing virtual interactions that engage students in emotional skill development, and connecting activities with the materials for which students are already responsible.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 501 SW 75TH STREET
  awardeeCity: GAINESVILLE
  awardeeCountryCode: US
  awardeeName: DIVERSE EMERGENT ENGINEERING PROSPECTIVE -DEEP- DESIGNS LLC
  awardeeStateCode: FL
  awardeeZipCode: '326071739'
  fundsObligatedAmt: '224986'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843642'
  piEmail: christin.d.shelton@gmail.com
  piFirstName: Christin
  piLastName: Shelton
  piMiddeInitial: D
  piPhone: '2515549337'
  poName: Rajesh Mehta
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Building Emotional Intelligence Through the Connected Readers
    Program'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be to, firstly, shed light on the benefits and limitations of mm-wave backscatter technologies in challenging industrial environments. More importantly, the lessons learned during this project could, if successful, bring about the emergence of breakthrough energy-autonomous real-time tracking technologies that would significantly increase the efficiency and reduce the costs of worldwide container shipping as well as provide a direct value that could bring about the adoption of the smart container. The container shipping industry stands as one of the unsung heroes of the modern world which, from its birth in the 1960s, cut the cost of shipping goods across the globe by several orders of magnitude, thereby enabling global trade on a massive scale and catalyzing the world?s economic development. Nevertheless, this industry has remained largely unmoved by the advent of big data and Internet of Things (IoT) technologies. This innovation could empower the general introduction and leveraging of such tools, further lower the costs and increase the accessibility of worldwide shipping, and significantly benefit the world and the United States? economies.

    The proposed project will require, on the road towards commercialization, the exploration of the properties of backscatter mm-wave localization approaches and channels in complex highly cluttered environments such as that of metallic-parts-crowded repair facilities and terminals covered with container stacks. While significant research efforts are currently invested in the characterization and mapping of mm-wave transmission channels necessary to the planning and rolling out of upcoming cellular 5G networks, no such work has yet been reported for their backscatter counterparts, nor for localization purposes. In addition, although the influence of channels for standard Radio Frequency IDentification-based localization systems has benefited from decades of investigation, that of its higher-frequency correspondent is virtually unexplored and should display different properties and present novel challenges and opportunities, due to major differences in clutter diffraction and absorption. The work will start with the finalization of tag and reader hardware in view of the gathering of detection data in the aforementioned environments, followed by the formulation of the high-performance signal processing schemes used to retrieve tag positions and identities, developed hand in hand with optimized communications modulation schemes for the tags. Finally, a tuning of the devised numerical processing schemes for high-speed embedded processing will take place.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3076 RANLO DR
  awardeeCity: ATLANTA
  awardeeCountryCode: US
  awardeeName: ATHERAXON, INC.
  awardeeStateCode: GA
  awardeeZipCode: '303404612'
  fundsObligatedAmt: '224996'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843302'
  piEmail: jimmy.gd.hester@gmail.com
  piFirstName: Jimmy
  piLastName: Hester
  piMiddeInitial: G
  piPhone: '2606228730'
  poName: Rick Schwerdtfeger
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Smart Skins for shipping containers tracking and identification'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is to provide software service to correct Earth observation
    satellite (EOS) data to at-ground reflectance. EOS must look through the Earth?s
    atmosphere that induces systematic error in measuring the actual reflectance of
    ground targets through scatter and attenuation of light. Atmospherically-induced
    error affects data utility because the atmospheric aerosol content, i.e., humidity,
    dust, pollen, smoke particles, etc., fluctuates greatly, impacting applications
    for global monitoring, defense and agriculture. The value of data could make this
    a significant and growing market opportunity if the specifications are met successfully.
    \       \n\nThis SBIR Phase I project proposes to correct aerosol-induced error
    in EOS data by reversing the effect, found empirically to be structured, independent
    of aerosol type and potentially predictable through measurement of dark target-reflectance
    ? water bodies clear of aquatic vegetation, entrained sediment and specular reflectance
    from windblown waves. The method of study is extraction and statistical analysis
    of Landsat 8 data, the standard reference for calibration and validation of data
    from all other EOS platforms. This problem is approached through a series of heuristic
    investigations to (1) reconstruct relationships of blue, green and red bands to
    near infrared (NIR) originally fitted using Landsat 5 and 7 data (longer wavelengths
    may not be addressed because they are resistant to atmospheric affects), (2) use
    these relationships to reverse the error, (3) develop methods to select, proof
    and apply dark targets that calibrate the correction, and (4) measure residual
    error by comparing post-algorithm reflectance to at-ground reflectance measured
    by portable spectrometry. The residual error is likely due to uncertainty associated
    with dark targets. Once developed and proofed, the algorithm will be brought to
    the Landsat 8 Cal/Val team for validation.\n\nThis award reflects NSF's statutory
    mission and has been deemed worthy of support through evaluation using the Foundation's
    intellectual merit and broader impacts review criteria."
  awardeeAddress: 407 N VANDEMARK AVE
  awardeeCity: HARTFORD
  awardeeCountryCode: US
  awardeeName: ADVANCED REMOTE SENSING, INC.
  awardeeStateCode: SD
  awardeeZipCode: '570332315'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1840196'
  piEmail: david@advancedremotesensing.com
  piFirstName: David
  piLastName: Groeneveld
  piMiddeInitial: P
  piPhone: '5056906864'
  poName: Anna Brady-Estevez
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 09/30/2019
  title: 'SBIR Phase I:  A Novel Method for Atmospheric Correction of Earth Observation
    Satellite Data'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is empowering the 68 million U.S. natural gas consumers to know their transaction status in real time, have more and continual control of their transactions, settle transactions in increments less than the industry?s current monthly accounting cycle and enjoy an extremely high level of security. Their transaction cost will be reduced and speed increased, freeing industry capacity and resources to be employed elsewhere at greater value. This innovation will allow others in the natural gas industry to better consider transaction processes and themselves innovate - employing many minds on industry efficiency. This innovation will also have application to other industries characterized by multiple complex, multi-party transactions; particularly the electric utility industry and possibly providing the catalyst for more extensive deregulation and consumer control.

    This SBIR Phase I project proposes to discover how to transform complex natural gas utility transaction management processes using Blockchain innovations and related technologies across production, transmission, distribution and consumption functions. The United States utility industry has operated in its present physical form for more than a century. Over the past four decades the industry has evolved through various policy and regulatory actions to open transaction participation to thousands of parties. During the past two decades, digital technologies enabled transaction functions to talk to each other and perform some functions automatically. Despite this progress, utility transaction management processes are essentially those created decades ago. They still require significant human intervention, remain highly segmented and employ little digital intelligence and security technology available today. The various technologies now supporting the industry?s seven step transaction processes will be mapped, assessed for Blockchain technology application and then consolidated into a single platform. The key challenge is to create transformative technology integrating the numerous other existing technology applications and data exchange formats and protocols without succumbing to customization which then mutes the transformative nature of the innovation and renders it ineffective as a platform to subsequent industry innovation by multiple parties.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 13515 SERENITY ST
  awardeeCity: HUNTERSVILLE
  awardeeCountryCode: US
  awardeeName: ENERGYXCHAIN, LLC
  awardeeStateCode: NC
  awardeeZipCode: '280786569'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842614'
  piEmail: rwnorris@icloud.com
  piFirstName: Rob
  piLastName: Norris
  piPhone: '7043405470'
  poName: Anna Brady-Estevez
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Transforming Complex Utility Transaction Management'
- abstractText: |-
    The broader impact/commercial potential of this project enables connectivity in otherwise difficult areas. Broadband access in rural America, for example, has been a lasting problem that inhibits business and education alike. The primary barrier to installation is the cost of trenching cable, which can be $7,000-$30,000 per service location. Similar challenges exist in emerging markets and remote industrial Internet of Things. Networks cannot easily be replaced with today?s wireless technologies due to the losses that occur when forwarding information wirelessly, which can eliminate up to half of the throughput capability at each forwarding location. Low-loss mesh networking, such as that proposed, would enable fully-wireless solutions to last-mile connectivity problems globally by eliminating reliance on cable. The impact of distributed and scalable algorithms extends beyond mesh networking into the decentralization of other technologies to be more secure and robust, but cannot due to performance issues.

    This Small Business Innovation Research (SBIR) Phase I project is focused on low-loss mesh networking that could feasibly cover hundreds or thousands of acres with broadband internet access without laying cable. The primary intellectual merits include scalable aggregation of data, reducing communication interference with a predetermined network structure, and other challenges that arise in very large wireless networks. The objective of this research is a wireless mesh network topology and hardware that can maintain less than 17% throughput loss-per-hop in a network larger than 100 nodes. This will be accomplished through real-world trials, simulations, and iterated testing of different geometries and time-domain multiplexing.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 60 Hazelwood Drive, Suite 206
  awardeeCity: Champaign
  awardeeCountryCode: US
  awardeeName: MeshPlusPlus, Inc.
  awardeeStateCode: IL
  awardeeZipCode: '618207460'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843462'
  piEmail: danny@meshplusplus.com
  piFirstName: Daniel
  piLastName: Gardner
  piMiddeInitial: J
  piPhone: '8474946325'
  poName: Muralidharan Nair
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 09/30/2019
  title: 'SBIR Phase I:  Low-Loss Ad-Hoc Networking for Outdoor WiFi'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to develop a safe, natural, long-lasting and effective mosquito repellent product by exploiting the natural repellent compounds present in the skin microbiome.  Mosquito-borne illnesses affect 700M people worldwide and cause several million deaths each year.  Chikungunya, West Nile, Malaria, Zika, Dengue, are just some of the debilitating vectors spread by mosquitoes. Mosquito-derived diseases cost >$6.8B/year and the market for mosquito repellents is >$3.2B and growing. Many solutions are aimed at killing and disabling mosquitoes, but mosquitoes are a crucial part of the ecological food chain. Further, many repellents are extremely toxic, and mosquitoes are developing resistance. The proposed technology will be used to identify compounds that will drive the endogenous skin microbiome to a more mosquito repellent phenotype. Using these methods, it is possible to harness the biochemistry contained in the native skin microbiome to create an endogenous repellency that is a safe, natural, environmentally friendly, and effective barrier to mosquitoes. It is expected that this repellency approach may be used safely even with children and pregnant women. In addition, it may be possible to use this approach to develop repellents for multiple insects, repellent products for companion animals, and additional over-the-counter skin products.

    The intellectual merit of this SBIR Phase I project is to develop a new class of topical insect repellents by influencing repellency in the skin microbiome.  This will be accomplished by developing and validating a platform technology to identify compounds produced by the microbiome that are associated with biochemical pathways of interest, and use the identified compounds to target those pathways whose end-products comprise natural mosquito-repellent compounds. The goal is to create a topical mosquito repellent product. For this project, the plan is to complete metagenome sequencing on skin samples collected from individuals that are either naturally repellent or attractive to Anopheles mosquitoes (the mosquito that carries Malaria). The next step is to predict metabolite compound turnover and use metabolomics to validate the results. In vitro assays and in silico models will be used to provide proof-of-concept for the use of those predicted compounds to induce the microbiota to produce mosquito repellent metabolites.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3077 N PARK WAY APT 212
  awardeeCity: San Diego
  awardeeCountryCode: US
  awardeeName: Cybele Microbiome Inc
  awardeeStateCode: CA
  awardeeZipCode: '921043675'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843179'
  piEmail: nicole@cybelemicrobiome.com
  piFirstName: Nicole
  piLastName: Scott
  piMiddeInitial: M
  piPhone: '7343556316'
  poName: Ruth Shuman
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Enhancing the skin microbiome for mosquito repellency: Next
    generation mosquito repellent derived from big data analysis'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project will be the development of a robust capillary electrophoresis instrument with mass spectrometry detection for biomedical research, biopharmaceutical development, clinical diagnostics, and system biology.  Capillary electrophoresis (CE) is a powerful liquid separation technology with remarkable potentials for bioanalysis. It was the workhorse tool for the completion of human genome project that, in part, led to the DNA sequencing market.  A CE system with both optical and mass spectrometry detection will enable a deeper understanding of molecular dynamics governing biochemical processes, such as protein expression, deregulation, and interaction with other biochemical species, which could lead to breakthroughs in drug development, early diagnosis, and treatments for deadly human diseases such as cancer, diabetics, and neurodegenerative disorders. The proposed technology will offer benefits to biopharmaceutical drug development companies by increasing the efficiency of product characterization for quality improvement. It also will allow efficient routine proteomics analysis and other bioanalytical applications.

    The intellectual merit of this SBIR Phase I project is to develop a next-generation capillary electrophoresis with electrospray ionization mass spectrometry (CE-ESI-MS) for protein characterization. CE-ESI-MS allows high efficiency separation and characterization of several biochemical species including proteins. However, leveraging the intrinsic advantages of CE-ESI-MS has been difficult due to lack of robust, easy-to-use instrumentation, which has made adoption for routine applications uncommon. This research will develop and evaluate a novel CE-ESI-MS instrument for protein characterization. The proposed instrument will employ original innovations to overcome the limitations of the incumbent technologies and exceed their capabilities. A novel fluidic nanoport for sample and buffer manipulation will be developed to allow analysis from 1 microL or less sample volume. The nanoport will employ a fully automated design with less operator intervention. This will be useful for sample-limited applications such as in clinical analysis. In addition, the instrument will utilize a hybrid electrospray ionization interface for simultaneous optical and MS detection, which no existing technology offers. Combining CE's ultrahigh efficiency with robust quantitative characteristics of optical detection and the molecular identification of mass spectrometry will be a powerful tool for bioanalysis. This combination will represent a significant advancement over the state-of-the-art and enhance the means of interrogating proteins and their biochemical functions in biological samples. The proposed innovations will significantly enhance the robustness and capabilities of CE-ESI-MS for fast, efficient, and deep bioanalysis.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 4820 148TH PL SE
  awardeeCity: EVERETT
  awardeeCountryCode: US
  awardeeName: GMJ TECHNOLOGIES, LLC
  awardeeStateCode: WA
  awardeeZipCode: '982088812'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842394'
  piEmail: tosined@gmail.com
  piFirstName: Oluwatosin
  piLastName: Dada
  piPhone: '4357647464'
  poName: Ruth Shuman
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 09/30/2019
  title: 'SBIR Phase I:  Next-Generation Capillary Electrophoresis with Mass Spectrometry
    for Biopharmaceutical and Biomedical Applications'
- abstractText: "The broader impact/commercial potential of this project focuses on
    the growing multipoint touch sensors estimated at US $94B in 2024. Touch screens
    literally allowed access to the virtual world and its capabilities at our fingertips
    and enabled those who were keyboard illiterates to access the vast world wide
    web capabilities through this natural interface. A ubiquitous cost effective multipoint
    touch sensing technology would make a broader impact beyond consumer electronics
    by improving motor skills and potentially eliminating phantom pain for amputees
    fitted with neuro prosthetics limbs. As the digital world becomes more connected
    and continues to permeate our physical world in the form of the mobile Internet
    of Things, autonomous cars, and other wireless connected smart technologies, it
    is important to reduce the cost barrier for adoption and ease of interaction between
    the device and the human. A society that can enable all its members, youngsters
    to aging elders, to easily interface with connected assistive devices would have
    increased access to information, education, ecommerce and consequently will see
    faster economic growth. \n \nThis Small Business Innovation Research (SBIR) Phase
    I project aims at demonstrating a ubiquitous multipoint touch and force sensing
    on planar or curved surfaces that are either conducting (metals) or insulators
    (glass/plastic). Current multipoint touch sensing technologies are limited to
    transparent, insulating and planar surfaces. These technologies involve patterning
    multiple layers of semitransparent films on a glass or polyamide substrate then
    integrated with the display in a complex manufacturing process. The films? semitransparent
    nature reduces the quality of the display image and requires increasing the display
    brightness which affects the battery life in mobile devices. The high manufacturing
    cost reduces deployment and hence limits access to the wider consumer society.
    This project targets developing a low-cost technology that detects force and location
    of multi touch points on any surface without film patterning. Successful execution
    and deployment of the proposed technology would increase deployment of multipoint
    touch and force sensing in consumer electronics and hence a broader access in
    the society. New opportunities for utilizing the technology both for scientific
    investigation as well as for end user value will evaluated for lower limb fitting
    to reduce phantom pain and in neuro prosthetics as a potential sensory feedback.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 3869 NW 148th Place
  awardeeCity: Portland
  awardeeCountryCode: US
  awardeeName: Surfasense LLC
  awardeeStateCode: OR
  awardeeZipCode: '972291141'
  fundsObligatedAmt: '224212'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843976'
  piEmail: mabdelgm@gmail.com
  piFirstName: Mohamed
  piLastName: Abdelmoneum
  piPhone: '9713407528'
  poName: Muralidharan Nair
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 09/30/2019
  title: 'SBIR Phase I:  Multimodal Tactical Sensing for Consumer electronics & Neuroprosthetics'
- abstractText: |-
    This STTR Phase I project aims to bring together computational thinking, mechanism design, and design process to create a new framework for design-driven robotics education for K-12 schools and camps. This work would result in a platform for 1) teaching students Science, Technology, Engineering, and Mathematics (STEM) topics and 2) providing them critical hands-on experience designing, prototyping, and programming machines. By enabling students to exercise their creativity via an intuitive design interface and a minimalist novel robot kit, this project advances the students' ability to innovate and invent machines and robots. Driven by a need to keep pace with the evolving techno- and socio-economic requirements and remain competitive, schools and camps are increasingly adopting STEM and Robotics programs and products. This framework would fill that void that currently exists in the educational market. This project is closely aligned with the NSF's mandate to support development of a strong STEM workforce. The proposed design-driven educational robotics framework has the potential to fulfill these needs, improve public scientific literacy and engagement with science and technology, and positively impact the U.S. educational robotics market, which is expected to grow to $2.7 billion by 2021.

    The proposed research seeks to develop a novel design-driven educational robotics framework encompassing 1) a modular, customizable, and compatible with off-the shelf electronics hardware kit consisting of rigid and compliant parts for rapid prototyping of robot structures and mechanisms, 2) a multi-modal mobile app for synthesis and simulation of robot motions, 3) a web-based CAD interface for designing users' custom robot parts that interface seamlessly with the kit, and 4) instructional material and curriculum for middle and high-schools. The hardware would provide a suite of planar parts with unique design capabilities to support creation of 3D geometry of robots and structures. The novel structural elements would give rise to a new method of enforcing geometric and kinematic constraints and provide flexibility in choice of material and manufacturing process. While the new connection methods are much more intuitive and simpler, they also closely mirror the way engineered structures are created in practice. The mobile app based on the latest mechanism synthesis research imbued with a multi-modal graphical user interface will allow creation of robot assemblies and their motions before constructing their corresponding physical models and provide necessary skills and experience in the design process.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 133 Village Hill Dr
  awardeeCity: Dix Hills
  awardeeCountryCode: US
  awardeeName: Mechanismic Inc.
  awardeeStateCode: NY
  awardeeZipCode: '117468335'
  fundsObligatedAmt: '224959'
  fundProgramName: STTR PHASE I
  id: '1843476'
  piEmail: purwar@gmail.com
  piFirstName: Poyu
  piLastName: Chuang
  piPhone: '6319432268'
  poName: Rajesh Mehta
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'STTR Phase I:  Robotics Launchpad - A Design-Driven Educational Robotics
    Framework'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the demonstration of the technical and economic feasibility of a photonic crystal enabled thermophotovoltaic (TPV) system at scales over 10 watts, which would have transformative effects in power generation for portable and remote applications. A small, high energy density TPV power source has the potential to transform multiple markets that currently rely on battery power by reducing the battery weight by 75%. For example, remote scientific instrumentation stations in polar regions rely on 1000-2000 pounds of batteries to operate through the six-month polar night, resulting in high installation costs. Dismounted warfighters carry 10-20 pounds of batteries and would have greater capability if they could carry ammunition and water instead. Small unmanned aerial vehicles would be more effective if they could fly themselves to remote and inaccessible locations, perform their mission for longer, and then return.

    The proposed project will develop a new approach to photonic crystal fabrication to greatly improve the efficiency of TPV energy generation - the conversion of fuel into electricity with heat and light as intermediaries. A TPV generator works by burning fuel to heat a selective emitter to incandescence, leading to infrared radiation which drives specialized photovoltaic cells to generate electricity. A photonic crystal selective emitter greatly improves the efficiency of the generator by almost perfectly matching its emission spectrum to the photovoltaic cell. Our photonic crystal is a square array of cylindrical micro-cavities etched into a refractory metal substrate. The research objectives of this project address the technical hurdles that limit the use of photonic crystals in TPV: scalable substrate preparation from commercial foils using a novel high-throughput process; nanofabrication over large flexible substrates using traditional semiconductor manufacturing tools; and integration with the generator by brazing. The anticipated technical results of this project are to develop a process capable of a breakthrough fifty-fold increase in photonic crystal emitter area, to enable photonic crystal fabrication on flexible substrates, and to reduce photonic crystal cost - all leading to a practical TPV generator that meets market demands.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 5 LESTER TER
  awardeeCity: SOMERVILLE
  awardeeCountryCode: US
  awardeeName: MESODYNE INC.
  awardeeStateCode: MA
  awardeeZipCode: '021442715'
  fundsObligatedAmt: '224362'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843687'
  piEmail: stelmakh@mesodyne.com
  piFirstName: Veronika
  piLastName: Stelmakh
  piPhone: '6175003138'
  poName: Rick Schwerdtfeger
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Scalable Photonic Crystal Fabrication for Mesoscale Fuel
    to Electricity Conversion'
- abstractText: |-
    This SBIR Phase I project will develop new methods for training and assessing the skill of providing and receiving constructive feedback in collaborative environments. The United States higher education system is failing to train collaboration skills, despite companies listing it as one of the most important skills for new hires to have. Past research has identified specific types of feedback that most effectively encourage peers to improve, but today's higher education instructors have no ready means to effectively assess students' abilities to use these peer feedback strategies. This project will develop simple-to-use software tools to help instructors train peer feedback skills and new methods for automatically assessing student ability to provide and receive constructive feedback. By democratizing the training of the collaborative skills most sought after by today's employers, this project aims to reduce underemployment of college graduates and increase the economic output and tax revenues of the United States by building a better trained and more productive workforce.

    This project will develop an innovative peer-assessment tool coupled with novel natural language processing methods producing accurate measurements of student ability to give and receive constructive feedback based on written feedback. The natural language processing methods will combine word vectors for efficient language processing, a generalizable neural net structure for sentence categorization outlined in existing research literature, and manually defined features based on existing peer feedback research. Research efforts will focus on gathering a large training dataset from partnering higher education classrooms, and iteratively refining a deep-learning natural language processing algorithm to achieve a target 90% accuracy. Automating this assessment process will allow broad and continuous assessment of student collaborative ability without requiring expensive and time-consuming retraining of the United States instructor workforce.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 5033 E TURQUOISE AVE
  awardeeCity: PARADISE VALLEY
  awardeeCountryCode: US
  awardeeName: BEAGLE LEARNING LLC
  awardeeStateCode: AZ
  awardeeZipCode: '852531014'
  fundsObligatedAmt: '224690'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842746'
  piEmail: turner@beaglelearning.com
  piFirstName: Turner
  piLastName: Bohlen
  piMiddeInitial: K
  piPhone: '5082022866'
  poName: Rajesh Mehta
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Creating the Critical University-to-Workforce Connection:
    Providing Quantitative Evidence of Collaboration Skills'
- abstractText: "This SBIR Phase I project will advance the development of a novel
    arteriovenous graft that will minimize injury and decrease the probability of
    serious complications for chronic hemodialysis patients. Hemodialysis is a life-sustaining
    therapy for patients suffering from kidney failure; it requires that blood be
    withdrawn and cycled through a dialysis machine that performs the function of
    the failed kidneys. This process must be performed at regular intervals and requires
    access to the blood with large bore needles. Graft failure complications, many
    directly attributable to  needle injury, cost the healthcare system billions of
    dollars per year and lead to significant morbidity and even mortality for patients.
    There are nearly 2.5 million patients with kidney failure who receive dialysis
    worldwide, and this population is growing at a rate of 8% per year. Currently,
    no technology on the market addresses dialysis graft needle injury or graft material
    degradation due to needle trauma. InnAVasc Medical's novel graft design has the
    potential to reduce complications associated with aggressive graft compression
    and inadvertent punctures, thus reducing adverse events and dramatically improving
    patient outcomes and quality of life while significantly reducing health care
    costs related to chronic dialysis graft injury. \n\nThis project will substantially
    advance the development of an innovative device that will simultaneously allow
    for immediate cannulation following graft implantation (typical is to allow 4
    weeks to heal prior to cannulation) and eliminate complications associated with
    repeated cannulation during maintenance hemodialysis. The ultimate goal of this
    proposal is to identify and engineer a suitable biocompatible material that will
    provide the desired mechanical strength to withstand passage of the dialysis needle
    into undesirable areas, while being sufficiently flexible to allow for optimal
    blood flow through the device and adequate conformity for patients of all shapes,
    sizes, and skin integrity. The first technical objective will focus on identifying
    candidate materials and testing their strength, flexibility and durability. The
    second objective will take promising candidate materials and develop prototype
    devices to assess manufacturability and performance. These aims will identify
    a suitable material that will enable the InnAVasc graft to be marketable to the
    broadest patient population. Successful completion of this project will provide
    a prototype device constructed of materials that will simultaneously optimize
    the desired ratio of mechanical strength to flexibility.\n\nThis award reflects
    NSF's statutory mission and has been deemed worthy of support through evaluation
    using the Foundation's intellectual merit and broader impacts review criteria."
  awardeeAddress: 110 SWIFT AVE
  awardeeCity: DURHAM
  awardeeCountryCode: US
  awardeeName: INNAVASC MEDICAL, INC.
  awardeeStateCode: NC
  awardeeZipCode: '277054880'
  fundsObligatedAmt: '224975'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1841131'
  piEmail: joseph.knight@innavasc.com
  piFirstName: Joseph
  piLastName: Knight
  piMiddeInitial: A
  piPhone: '8139022228'
  poName: Henry Ahn
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Development of a novel graft to provide safe and reliable
    vascular access for hemodialysis patients'
- abstractText: |-
    This SBIR Phase I project advances a novel medical optical spectroscopy device to facilitate accurate diagnosis of middle ear infections.  The device uses a custom multi-LED microchip and photodetectors to illuminate the middle ear and collect reflected light in a familiar otoscope form-factor.   Reflected light signatures are analyzed to determine the presence or absence of middle ear fluid - a hallmark of middle ear infection.  The focus is to optimize product design and algorithm to enable gold standard accuracy across thousands of mass manufactured devices and millions of patients.  The device will be a cost effective means to achieving improved ear infection diagnosis in primary care where it is most needed.  Roughly 90% of children experience at least one ear infection before age 5 and misdiagnosis of suspected ear infection is the leading cause of unnecessary pediatric antibiotic use in the US.  Collectively, ear infection results in at least $5B direct healthcare costs annually in the US and billions more in lost parent productivity.  Improving ear infection diagnosis has the potential to eliminate millions of unnecessary antibiotic prescriptions - a crucial step in mitigating development of resistant microorganisms.  Addressing this challenge requires a product that is cost-effective and consistently accurate.

    This project will enable the first commercially available optical spectroscopy product for middle ear effusion and the only known method capable of accurately assessing ear health in very waxy ears.  Although optical spectroscopy as a scientific method is widely practiced, comparatively few commercial medical products exist.  High-cost, bulky spectrometer units are a primary limitation restricting development of products tailored to primary care and other low margin medical specialties where there is great need.  The proposed work enables cost-effective manufacture and deployment of the proposed device for ear infection and will be a platform for other next-generation, LED-based optical spectroscopy medical devices.  The investigators will develop an algorithmic scheme to correct variability in mass manufactured LED and photodiode components and design and construct test systems to automatically apply corrections to each completed medical device assembly.  The resultant methods and systems will enable deployment of medical optical spectroscopy systems at up to 100X lower unit cost as compared to spectrometer based systems.  The resultant device for ear infection will enable clinicians to more easily adhere to American Academy of Pediatrics and American Academy of Family Physicians guidelines for treating ear infections in primary care where there is greatest need.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2062 BUSINESS CNTR DR STE 250
  awardeeCity: IRVINE
  awardeeCountryCode: US
  awardeeName: CACTUS MEDICAL,LLC
  awardeeStateCode: CA
  awardeeZipCode: '926121147'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1841005'
  piEmail: jweidlin@gmail.com
  piFirstName: John
  piLastName: Weidling
  piPhone: '9134817142'
  poName: Henry Ahn
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 10/31/2019
  title: 'SBIR Phase I:  Handheld Device for Detection of Otitis Media'
- abstractText: |-
    This SBIR Phase I project seeks to develop a novel text simplification technology that will personalize text to the reading level of students. There is a demand for such tools in inclusive and integrated K- 12 classrooms to cater to the needs of students with varying reading levels. This is especially pertinent to English language learners (Els), international students, and Special Education students with learning disabilities such as dyslexia, ADHD, and other cognitive impairments that impede their reading abilities. Existing tools offer one-size-fits-all solutions offering no control over the simplification process. The proposed Personalized Text Simplifier (PeTeS) will adapt texts to the reading levels of individual students, thereby filling a much-needed gap in the marketplace. With over 60% of U.S. K-12 students reading below grade level, the broader impact of the proposed technology will be in improving the literacy of a diverse population. The expected outcomes of using PeTeS will be improved vocabulary acquisition and improved reading and comprehension of texts by ELs and international students. Using PeTeS for reading may lead to better grades and higher graduation rates. PeTeS will also save teachers time on not having to explain texts or translate for students. PeTeS, will complement the instructor and provide additional support to ELs and international students, especially, in content areas, where these students have very little support.

    The proposed PeTeS is envisioned to be an adaptive reading assistant for personalizing instruction. The key innovation of PeTeS is in the application of natural language processing algorithms to perform automatic text simplification to dynamically meet specific reading levels - simplification being defined as an adaptation of any given text in a way that maximizes the likelihood that the student will understand its content. The key idea here is to replace a word that is presumed to be not known by the student with a word that is presumed to be known, i.e., the replacement criteria is the student?s knowledge and not the word complexity. Towards that, the proposed PeTeS technology will maintain a student knowledge model representing the reading level of the student. PeTeS will rely on the model not only to simplify the text to the student's level and improve comprehension, but also to challenge the student to learn unfamiliar words while reading whatever they need to read.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1500 Stony Brook Road
  awardeeCity: Stony Brook
  awardeeCountryCode: US
  awardeeName: Charmtech Labs LLC
  awardeeStateCode: NY
  awardeeZipCode: '117944600'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843807'
  piEmail: borodin@charmtechlabs.com
  piFirstName: Yevgen
  piLastName: Borodin
  piPhone: '5163137356'
  poName: Rajesh Mehta
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  PeTeS: Personalized Text Simplification For English Language
    Learners'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is the development of a unique cloud computing platform
    with a novel database and bioinformatic software package to address the strong
    demand for transformative foundational resources crucial to interpret the biological
    function of DNA variation sequestered within and between genomes. The goal is
    to target a broad scope of laboratories investigating human genomics and disease,
    comparative and evolutionary genomics, systems biology, animal health and veterinary
    sciences, and wildlife biodiversity and conservation. The product will offer opportunities
    to advance cross-disciplinary research to keep pace with the accelerating rate
    of DNA sequence variant discoveries driving the extraordinary growth of the genomics
    industry.  This vision is founded on the continued rapid growth projections (in
    billions of dollars) for the genomics market and the concomitant increase in the
    need for integrative tools and services.  The technology will allow customers
    to save time and research costs, experience substantial increases in efficiency
    and accuracy, and explore, in precise detail, complex gene networks and pathways.
    \ \n\nThe intellectual merit of this SBIR Phase I project is to resolve a critical
    impasse in genomic workflow where inconsistent or unreliable identification of
    DNA variant function prevents actionable discoveries. Using the customized suite
    of bioinformatic tools provided by this technology development, the customer will
    be able to interrogate the database for any gene or gene system of interest, determine
    the normal range of DNA changes tolerated by the gene within functional space,
    and screen their own data against this baseline to identify variants causative
    in altered biological function and phenotypic traits. The research objectives
    include: Compiling proprietary and novel DNA sequences from thousands of genes,
    establishing and confirming the precise arrangement of these gene sequences guided
    by shared common ancestry to create the database framework, establishing a plan
    for product software and content to guide the user through proper use of the database
    and interpret variant function, and developing strategies to ensure product security
    and cloud-computing service data visualization and display to protect the processing
    of user data when passed within the software.\n\nThis award reflects NSF's statutory
    mission and has been deemed worthy of support through evaluation using the Foundation's
    intellectual merit and broader impacts review criteria."
  awardeeAddress: 17590 MILLERS SAWMILL RD
  awardeeCity: SHARPSBURG
  awardeeCountryCode: US
  awardeeName: CORNERSTONE GENOMICS LLC
  awardeeStateCode: MD
  awardeeZipCode: '217821611'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843341'
  piEmail: jill@cornerstonegenomics.com
  piFirstName: Jill
  piLastName: Pecon-Slattery
  piPhone: '3015142886'
  poName: Ruth Shuman
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Innovative software and database tools for targeted genomics'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is to accelerate the commercialization of organic
    light-emitting diode (OLED) technology.  For color displays (TV, cell phone, computer,
    virtual reality, watches, etc.) OLED is superior to all existing technologies
    in terms of energy usage, display color space, viewing angle, etc.  For lighting,
    OLED fixtures use very low energy, the light is soft, casts no shadow, and is
    architecturally flexible.  OLED is the display and lighting technology of the
    future.  However cost and short device lifetime has retarded commercial advancement.
    \ The introduction of an entirely new class of materials for OLED manufacturing
    will enable this advancement. \n\nThe proposed project will reduce OLED cost and
    improve performance by utilizing a new class of photoelectric materials for the
    nanometer thick layers that comprise an OLED.  OLED layers utilize single-component
    small molecules for the charge transporting and light-emitting layers.  These
    molecules tend to crystallize and are poor solvents for the emitting molecules
    leading to decreased light emission efficiency and shortened device lifetime.
    \ The innovation is using isomeric mixtures of designed molecules that are amorphous
    and non-crystallizable in all three layers.  These molecules are chemically designed
    to meet all the required photophysical and electrical characteristics necessary
    for superior OLED performance.  Preliminary device fabrication and testing has
    confirmed that these new materials dramatically improve both emission efficiency
    and device lifetime with the standard emitter molecules.  Due to the physics of
    charge recombination in the emitter layer there is only one technology which has
    the potential to harvest 100% of the injected charge as emitted light:  thermally
    activated delayed fluorescence (TADF).  OLEDs using TADF technology have demonstrated
    high efficiency but with very short device lifetime.  This project will couple
    the new non-crystallizable technology with TADF to design and fabricate OLED devices
    with both high efficiency and long life to meet commercialization requirements.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 16 CARDOGAN SQ
  awardeeCity: ROCHESTER
  awardeeCountryCode: US
  awardeeName: Molecular Glasses, Inc.
  awardeeStateCode: NY
  awardeeZipCode: '146252509'
  fundsObligatedAmt: '224958'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843233'
  piEmail: dweiss2@rochester.rr.com
  piFirstName: David
  piLastName: Weiss
  piPhone: '5852102861'
  poName: Rick Schwerdtfeger
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Non-crystallizable charge transporting organic materials
    as OLED functional layers and thermally activated delayed fluorescence emitter-layer
    hosts'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to provide the biomedical research community with a new tool for next-generation tissue culture platforms, including those derived from patient samples.  If successful, this technology will enable researchers to automate and standardize 3D cell culture techniques in a format that is broadly compatible with current laboratory infrastructure.  It would bridge a gap between commercial biomanufacturing/pharmaceutical development and the academic state-of-the-art.  Moreover, the proposed technology will provide the scientific community with novel tools to perturb and observe how individual cells interact with each other and with their microenvironment.  Probing biological signatures at single-cell resolution underpins major current trends in biomedical research, from clinical applications in cancer therapy, diagnostics, and immunology, to global basic science initiatives such as the Human Cell Atlas project.  The goal of this grant is to facilitate commercialization of a single-cell handling instrument for use in research universities and pharmaceutical R&D laboratories.

    The intellectual merit of this SBIR Phase I project is to develop an automated instrument for seeding organoids or other 3D tissue cultures with single-cell resolution.  Organoids have the potential to transform personalized medicine and disease modelling, but current culture methods are poorly controlled, leading to wide variability between individual samples and across labs.  It is recognized that standardization, reproducibility, and tight control of cell seeding parameters will be paramount for drawing predictive value from organoids in the clinic, particularly when many statistical replicates are required.  The technology developed is a high-resolution robotic cell printing instrument capable of rapidly and deterministically seeding single cells contained within sub-nanoliter liquid volumes.  The goal is to evaluate the feasibility of implementing the proposed cell printing technology to seed organoid cultures with complete control of the type and number of constituent cells in each organoid.  Using Lgr5+ stem cell-derived intestinal organoids as a model culture system, protocols will be developed for preparing "printer-ready" input single stem cells from primary tissue.  Then, the plan is to evaluate the effects of cell seeding state on organoid morphology by varying cell number, cell type and ECM components, to test the hypothesis that controlled seeding will result in improved morphological reproducibility, as assessed by high-content imaging.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 120 Pierce St.
  awardeeCity: San Francisco
  awardeeCountryCode: US
  awardeeName: Scribe Biosciences, Inc.
  awardeeStateCode: CA
  awardeeZipCode: '941173371'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843954'
  piEmail: christian.siltanen@scribebiosciences.com
  piFirstName: christian
  piLastName: siltanen
  piPhone: '5419108277'
  poName: Ruth Shuman
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Controlled Organoid Synthesis with Fluorescence-Activated
    Cell Printing'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the development of a cost-effective high-performance platform to monitor and characterize phytoplankton and other microorganisms in water. Some of these aquatic microorganisms may be toxic or even fatal resulting in significant public health concerns (such as recent "red tide" events in Florida, USA) and drastic economic consequences (i.e. deadly effects of harmful algal blooms on the aquaculture industry). The current state of the art in monitoring technology includes laborious and expensive manual sample collection and evaluation using a benchtop microscope or optical digital imaging system. In contrast, the proposed platform will be transformative by enabling low-cost, portable and fast monitoring and automated characterization of aquatic microorganisms. Therefore, this platform will revolutionize monitoring of aquatic microorganisms and, being low cost, it will enable a much wider application of the technology to other markets. Some of these future applications include more efficient biofuels research and development (via algae monitoring), marine biology science and education, general monitoring of particles and pathogens at the water treatment facilities, production algae monitoring. Therefore, the potential societal impact and commercial potential of the proposed technology is transformative.

    The proposed project aims to develop and evaluate a portable, rapid, durable and environmentally-stable imaging flow-cytometry technology that will automatically monitor microorganisms, such as phytoplankton and pathogens present in the flowing water, and will be capable of specific classification. Existing optics-based flow-cytometry solutions are expensive and not durable for field use. Unlike lab-based flow cytometers or hand-held assays, the proposed system will not rely on reagents or labeling, and therefore will not need an expert/professional, and will keep the evaluated water unchanged. Thus, it can be installed for continual unattended operation and will be much more cost-effective per test due to elimination of an expert's time, costly reagents and fluorophores. Furthermore, the proposed system will also be integrated with a machine learning engine capable of automated identification of microorganisms as well as other micro-objects of interest. Finally, the proposed system will be evaluated on pre-collected samples of local coastal ocean water to determine the presence of three example types of phytoplankton microorganisms and to provide statistical distribution of all of the detected micro-objects. Therefore, the proposed system will be transformative and provide an innovative and unique capability to expediently survey samples of water and automatically characterize identified micro objects.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2115 Stradella Rd
  awardeeCity: Los Angeles
  awardeeCountryCode: US
  awardeeName: LUCENDI, INC.
  awardeeStateCode: CA
  awardeeZipCode: '900772324'
  fundsObligatedAmt: '224926'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843093'
  piEmail: mbatalin@lucendi.org
  piFirstName: Maxim
  piLastName: Batalin
  piPhone: '8584058319'
  poName: Rick Schwerdtfeger
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 11/30/2019
  title: 'SBIR Phase I:  Cost-effective, portable and fast platform for automated
    characterization of aquatic microorganisms and other particles for aquaculture,
    public health and marine res'
- abstractText: |-
    This SBIR Phase I project will study and develop methods to provide adult professionals and young adult students with the skills and self-confidence to pursue studies and careers in Science, Technology, Engineering, and Math (STEM) fields. Today, a large segment of society identifies as being underrepresented in the technology sector. Some individuals experience low technology-related self-confidence as a result. At a time when the United States has an increasing demand for technology workers, the country needs contributions from all segments of society, and not simply those segments which have been privileged in the past, to meet this demand and maintain U.S. competitive advantage in the global innovation economy. Engaging people from the full spectrum of the United States population will enable innovative companies to leverage more diverse sources of creativity, build better solutions to today's problems, and create more jobs. When people see themselves as future practitioners of a technical skill, it is possible to learn topics in a deeper, more fulfilling, and more enduring manner. Commercializing this invention will increase online learning platform retention rates, driving revenue not only within educational companies but within the companies who hire the resulting talent.


    The proposed technology is innovative because no commercially-available software tools exist which support metacognitive development in tandem with technical skill acquisition. This innovation is risky because no one has proven that having a positive influence on metacognition through automated software is even possible during single learning session. The goal of this research is to deliver techniques for enhancing the self-efficacy of STEM learners within the context of online learning platforms. The project combines best practices in digital personalization and educational psychology research to deliver customized content responsive to learner preferences and learner attitude attributes. The proposed research will demonstrate, via a random trial, increased levels of motivation and engagement in students who receive targeted interventions as compared with a control population. Using survey instruments, the researchers will measure changes in self-efficacy, challenge-seeking, and goal-setting behavior. Because the research team has unique experience in developing proven educational interventions which enhance self-efficacy across a variety of learning domains, the algorithms and methods inside the proposed technology will be difficult for competitors to replicate. This SBIR project will deliver algorithms and automated, web-based interventions to help all STEM learners experience personal engagement with STEM topics and find empowerment in the task of learning.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 14 Spring St
  awardeeCity: Waltham
  awardeeCountryCode: US
  awardeeName: Central Inventions, Inc.
  awardeeStateCode: MA
  awardeeZipCode: 024514429
  fundsObligatedAmt: '224995'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843795'
  piEmail: rca@team-ci.com
  piFirstName: Robyn
  piLastName: Allen
  piPhone: '6177022471'
  poName: Rajesh Mehta
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Stackmaps: A Metacognitive Learning Support Tool To Empower
    Students In STEM'
- abstractText: |-
    The broader impact/commercial potential of this project is significant. Agriculture is one of the most important industries impacting the economy, society, and the environment. By automating harvesting of fresh produce, society's ability to grow healthy and sustainable food will increase substantially. The innovation will enhance scientific and technological understanding of how to deploy commercially viable multi-robot coordinated groups performing complex automated tasks, in agriculture and beyond. The long-term opportunity for agricultural robotics is $150B+. This innovation focuses on controlled-environment methods, which are more intensive in terms of capital and labor, but far less intensive in terms of water, chemical use, and fertilizer use. If robots can reduce manual labor of large-scale production, and enhance human management precision, it will enable intensive agriculture practices to compete with, and in some cases supplant, traditional chemical-, labor-, and water-intensive approaches. This will make the US a more competitive global producer of high-quality produce, increase food security, increase access to healthy food for all people, and protect natural resources and the environment.

    This Small Business Innovation Research (SBIR) Phase I project will advance the fields of Robotic Applications, including computer vision/machine learning and robotics controls, by solving critical problems faced when operating in highly dynamic yet precise biological environments like farms. 1) By evolving and combining approaches from the forefront of computer vision, the project will improve environment sensing of e.g. clusters of fruit, their locations, conditions, precise locations of stems and obstacles. 2) Using that information, the project will develop innovative approaches to complex planning problems where leaves, stems, and obstacles interfere with optimal harvesting but are movable. This will be done with millimeter-level precision, where current autonomous planning approaches operate on multi-centimeter precision. 3) Lastly, the project will combine environmental data with 3D reconstructions of grow operations and individual fruit tracking in order to provide better sampling data to forecast production on a 1-4-week basis, and eventually build a deep learning model. This project is critical to achieving the commercial threshold of performance for robotic harvesting services, including high percent of berries picked, acceptable speed of picking, and the provision of climate sensing and forecast information.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 7727 West 6th Avenue
  awardeeCity: LAKEWOOD
  awardeeCountryCode: US
  awardeeName: Tortuga Agricultural Technologies
  awardeeStateCode: CO
  awardeeZipCode: '802146408'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843162'
  piEmail: tim@tortugaagtech.com
  piFirstName: Tim
  piLastName: Brackbill
  piPhone: '7177253473'
  poName: Muralidharan Nair
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Autonomous harvesting, mapping, and forecasting for fresh
    produce through application of robotics, computer vision, and machine learning'
- abstractText: |-
    This SBIR Phase I project focuses on developing an educational platform for improving motivation levels in students with respect to the STEM disciplines, especially Mathematics. The core activity consists of live academic competition, students answering questions in a game-based, online arena. The platform will borrow the features and structures found in popular athletic sports, from points and rankings to leagues and championships, and reproduce them online so that students can compete academically in the classroom just like they compete athletically on the sports field, with similar performance gains and improvements to peer dynamics expected to follow. Leveraging classic game mechanics in an exciting online format, the platform has the potential to motivate students across the skill and demographic spectra where offline academic competitions have historically failed and input or output focused efforts have produced disappointing results. This project offers the chance to approach learning improvement from a new perspective. By focusing directly on student motivation with a structure only recently made possible by the advent of the internet age, this project leverages the power of competition to advance the stated NSF missions of developing a globally competitive STEM workforce and increasing economic competitiveness in the United States.


    This project entails the development of a web and mobile platform with the ability to host and engage every student across the U.S. in robust, online competition activity. As such, the proposed activity is expansive in its breadth and scope and therefore presents an immense challenge, both from a technical and a design perspective. Three distinct roles are imagined: an administrator of the platform will have the ability to create leagues, tournaments, and championships, team-based and individual-based, for students across the school district/network; a teacher on the platform will be able to arrange matches for a team/class of students by dividing them into multiple teams that play against each other or challenging another team in the same school district/network to a match; a student on the platform will be able to arrange individual-based matches with other students in the same school district/network or play against a personal best avatar. Bringing all such activity together into a single platform, one that can be integrated with existing online education platforms and replicated from school district to school district across the U.S. will seamlessly blending together the experiences of very different users.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 6117 N. Kirkwood
  awardeeCity: Chicago
  awardeeCountryCode: US
  awardeeName: Interstellar Inc.
  awardeeStateCode: IL
  awardeeZipCode: '606465023'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1840917'
  piEmail: timothy@aretelabs.com
  piFirstName: Timothy
  piLastName: Kelley
  piPhone: '3129520436'
  poName: Rajesh Mehta
  date: 01/28/2019
  startDate: 01/01/2019
  expDate: 06/30/2019
  title: 'SBIR Phase I: Online Platform to Host Intra-District, Game-Based Math Competition'
- abstractText: |-
    This SBIR Phase I project will develop Virtual Reality (VR) based curriculum for first year university science courses. VR has the potential to create a step change in the way STEM education is taught and ultimately the way students learn. This project aims to build VR science curriculum to make science education more accessible, engaging and effective, and turn traditional STEM leavers into stayers which will positively impact STEM retention to meet the U.S. workforce demand. The VR science curriculum will be used alongside the existing curriculum at universities, with students participating in one 30-minute virtual lesson a week. The effect of these lessons on the students' performance will be measured to validate the ability of VR to positively impact learning outcomes. This project supports the NSF mission by progressing the science of education, by developing education tools using the scientific method, and measuring effectiveness. Moreover, the focus on improving university science education will improve the workforce pipeline, creating more and better prepared scientists. The products resulting from the proposed work will make science more accessible preparing today's students to be tomorrow's inventors, problem solvers and next great minds.

    The intellectual merit of this project is in the approach to developing VR curricula, and continually validating each curriculum by using data science to correlate student performance in the lesson to their performance in the classroom. Each lesson combines exposition, active learning, problem-based inquiry and assessment into self-contained modules which can be added to any existing curriculum. Student actions, and concept mastery are tracked within each lesson; ultimately, to correlate what the student is doing in a VR lesson to their learning outcome in real time. This enables the project team to validate which components of each lesson are working to improve student learning outcomes, and continually refine the VR pedagogy. This approach to developing each lesson and the cycle of refinement is the key innovation of the project team. The goal of the proposed research is to evaluate the magnitude of learning outcome improvement achieved when VR lessons are added to existing curricula, correlate the student actions in the VR lesson to their learning outcome as measured through in-class assessments, and evaluate perceived implementation hurdles for use of VR by instructors. This will be accomplished by integrating VR lessons in university curriculum and measuring the results against a control group. Instructor feedback will be gathered through a mixed methods study.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 118 NURSERY ST
  awardeeCity: NEVADA CITY
  awardeeCountryCode: US
  awardeeName: SAMA LEARNING, INC.
  awardeeStateCode: CA
  awardeeZipCode: '959592308'
  fundsObligatedAmt: '224938'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1844018'
  piEmail: barb@samalearning.net
  piFirstName: Barbara
  piLastName: DeHart
  piPhone: '5305594369'
  poName: Rajesh Mehta
  date: 12/21/2018
  startDate: 01/01/2019
  expDate: 12/31/2019
  title: 'SBIR Phase I:  Virtual Reality Based Curriculum for Increased STEM Engagement'
- abstractText: |-
    This SBIR Phase I project is focused on continued development of a software platform that is used by students for peer to peer homework and studying help. After school help has historically been delivered by tutors and homework hotlines but those avenues have been proven to be inadequate in closing learning gaps for students after they exit the classroom. The proposed technology is expected to further democratize homework and studying help. Being peer to peer, the proposed technology can radically shrink the cost of personalized homework and studying help for students at their own time and pace - especially the ones from economically or socially more challenged backgrounds. The project will also explore use of an innovative business model to optimize commercial viability with impacting a broad range of students irrespective of their backgrounds. It is expected that when fully developed, the technology would emerge as a scalable low-cost option to help improve student learning outcomes both nationally and globally.

    The key intellectual merit of this project is in the development of a Smart Study Recommendations Engine. This involves harvesting the data from the class notes uploaded by students, analyze it to surface predictive insights and automatically deliver the notes or wide-ranging peer-reviewed study materials directly to the student users based on their learning styles, learning abilities, and learning gaps, without requiring them to perform a search. It will also provide them with an ability to connect them with peers who can provide additional support. Thus, this project seeks to provide personalized study playlists based on a student profile and pair them with a peer mentor who can provide deeper clarifications as required. The key outcome to be demonstrated is that 1 in 5 students engages favorably with the auto delivered math notes, helped by a peer who can provide clarity and tutoring as needed.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 12020 SWALLOW FALLS CT
  awardeeCity: SILVER SPRING
  awardeeCountryCode: US
  awardeeName: CIRCLEIN, INC.
  awardeeStateCode: MD
  awardeeZipCode: '209047818'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843409'
  piEmail: gerald@circleinapp.com
  piFirstName: Gerald
  piLastName: Meggett
  piPhone: '2402865722'
  poName: Rajesh Mehta
  date: 12/21/2018
  startDate: 01/01/2019
  expDate: 12/31/2019
  title: 'SBIR Phase I:  The Smart Study Recommendations Engine'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project will provide new opportunities for purifying waters that cannot be economically treated using existing commercial membranes.  Increased market growth to include recycle and re-use of contaminated water that is currently slated for disposal or long term environmentally risky storage will increase water availability for industry and agriculture and reduce environmental impact from these same users.  More available water, especially in higher demand locations, will lead to higher production and lower costs for industrial and agriculture based consumers, leading to job growth.

    This SBIR Phase I project proposes to validate a new method of thin film composite membrane fabrication using new materials strategies to produce game changing anti-fouling and chlorine resistant reverse osmosis membranes.  Current market dominating polyamide thin film composite (TFC) membranes are inherently susceptible to fouling and degraded by chlorine disinfectants used to mitigate bio-fouling, which is the greatest challenge to membrane operation.  The established TFC production technique provides very thin active layers on the order of 100?s of nanometers but is limited to polyamides.  The proposed technology will produce TFCs with alternative polymers.  Polymers that are chlorine resistant and inherently non-fouling are targeted for use but the unmet challenge has been the opportunity to manufacture them with membrane thicknesses down to the 100?s of nm thickness regime necessary to challenge the flux properties of current commercial membranes.  Combining this new fabrication technology and new polymers is the technological breakthrough needed to develop innovative membranes.  The project will synthesize a target polymer composition, develop the formulation and fabrication parameters within the new process and produce TFC samples for testing.  TFC samples will undergo comparative testing of fouling and chlorine resistance, water flux and salt rejection in a variety of simulated test waters.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 202 COLFAX DR
  awardeeCity: CHAPEL HILL
  awardeeCountryCode: US
  awardeeName: NALA SYSTEMS, INC.
  awardeeStateCode: NC
  awardeeZipCode: '275164654'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843587'
  piEmail: jriffle@nalasystems.com
  piFirstName: Judy
  piLastName: Riffle
  piMiddeInitial: S
  piPhone: '5404499876'
  poName: Anna Brady-Estevez
  date: 12/21/2018
  startDate: 01/01/2019
  expDate: 12/31/2019
  title: 'SBIR Phase I:  Chemically Resistant Membranes for Water Purification'
- abstractText: |-
    The proposed broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is the reduction of waterborne disease from drinking water in low-income populations.  2.1 billion people drink fecally-contaminated water, 50% of hospitalization in developing countries are due to waterborne diseases, and contaminated drinking water causes >500,000 diarrheal deaths each year. Low-income populations not only pay for water, but pay anywhere from 30% to 10 times more in absolute terms than the wealthy. This proposed technical innovation will provide: a consumer packaged goods water filter, i.e. a product priced as a consumable and sold through food/beverage retail grocery stores.  This is a different business model than water filters which are sold as durable good appliances through specialty stores. If successful a new consumer water filter category reaching a fraction of 2.1 B people has potential to represent a $1B+ category. This proposed project would bring the innovation closer to commercialization by creating a more robust performing antimicrobial filter paper through challenge water stress testing.


    This SBIR Phase I project proposes to develop a nano-silver antimicrobial filter paper through mass-production methods, e.g. paper machines, that is formulated to be biocidal in a wide variety of water sources.  Technical hurdles include the reliability of technology scaling, developing frameworks for quality and stress testing, broader antimicrobial efficacy, and longer use life.  The project goals include engineering a paper formulation with increased silver uptake, more uniform nanoparticle synthesis, synergistic antimicrobial chemicals, and reliable filter paper pore size and flow rate.  The project plan to address these technical challenges include rigorous stress testing with specific challenge chemicals and high microbial loads, development of new formulations based on adding synergistic antimicrobial chemicals, absorbent chemicals to increase silver uptake, and process variations in the operation of the paper machine (speed, temperature, pressing, etc).  These experiments will require new formulations to be evaluated following the same quality and stress tests with each iteration at the bench scale and pilot scale.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1401 FORBES AVE STE 302
  awardeeCity: PITTSBURGH
  awardeeCountryCode: US
  awardeeName: FOLIA WATER, INC.
  awardeeStateCode: PA
  awardeeZipCode: '152195152'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843411'
  piEmail: teri.dankovich@foliawater.com
  piFirstName: Theresa
  piLastName: Dankovich
  piMiddeInitial: A
  piPhone: '3155592135'
  poName: Anna Brady-Estevez
  date: 12/21/2018
  startDate: 01/01/2019
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Affordable point-of-use water disinfection through mass-produced
    nano-silver embedded paper filters'
- abstractText: |-
    This SBIR Phase I project is focused on demonstrating the feasibility of an innovative crowdfunding process to effectively support and grow the fourth sector economy at the local community level. This fourth sector economy, a blend of three traditional economic sectors (public, private and nonprofit) is poised to solve many of the world's most difficult and complex social problems; however, this sector cannot work effectively without a supportive ecosystem that enables the creation, funding, and operation of organizations within it. This project proposes an innovative Fourth Sector Ecosystem incubator that brings a coordinated suite of services to local communities to engage them, educate them, and provide financial capital through a crowdfunding platform. This project will engage four communities in a pilot study designed to engage and educate key leaders, energize advocacy for fourth-sector growth, and catalyze fourth-sector social enterprises by offering capital access through crowdfunding. The validation of this grass-roots scalable educational and participatory incubator will enable communities to support local for-benefit businesses who will improve the quality of life in their communities, create jobs, and contribute to the economy, leading to expansion of this model across the nation and globally.


    The innovation inherent in this educational platform is the synergy between the components of its scalable, turnkey process to provide a catalyst for fourth-sector business growth. Innovative components include a robust, secure crowdfunding platform, educational training for community leaders and businesses in fourth-sector principles, assessment methods to evaluate/provide continuous improvement of the process, gamification that rewards fourth-sector-supporting behaviors; and network-building processes. The goals of this research are to determine the performance, design and educational training specifications that will address the needs of all stakeholders (e.g., entrepreneurs, community leaders, contributors), and demonstrate the feasibility of this platform through a pilot study in four communities. Methods will focus on continuous evaluation and feedback from stakeholders in the four communities to determine best methods to teach communities to manage their incubators, activate their communities to participate, achieve campaign success, demonstrate improved learning outcomes from the training, and increase the density and reciprocity of networks in the pilot communities. Surveys and data will be collected and analyzed to determine the effectiveness of each component in the process, from planning to implementation to assessment, as shown through survey results, expansion of networks, and funding raised by fourth sector enterprises using the crowdfunding tool.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 4218 CHEYENNE DR
  awardeeCity: LARAMIE
  awardeeCountryCode: US
  awardeeName: LOCAL CROWD, LLC, THE
  awardeeStateCode: WY
  awardeeZipCode: '820726914'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842729'
  piEmail: diane@thelocalcrowd.com
  piFirstName: Diane
  piLastName: Sontum
  piMiddeInitial: L
  piPhone: '3077607373'
  poName: Rajesh Mehta
  date: 12/21/2018
  startDate: 01/01/2019
  expDate: 12/31/2019
  title: 'SBIR Phase I:  Incubating A Fourth-Sector Ecosystem With A Scalable Educational
    Crowdfunding Platform'
- abstractText: |-
    This SBIR Phase I project will provide children ages 7-11 years with an interactive learning program that cultivates core leadership skills. This project goes deeper than many traditional socio-emotional programs by fortifying children with the behavioral skills and mindset they need to evolve as effective leaders. The educational curriculum was developed by psychologists who specialize in leadership development, and is based on cutting-edge child developmental, leadership, and educational research. This project aims to research the engagement and effectiveness of the program and its ability to enhance ten core leadership behaviors in youth, at home, in the community, and in academic settings. This program has the potential to make a long-term impact on the next generation of youth, promoting resilience in the face of adverse events, such as school violence and cyberbullying, and to positively shape the next generation of leaders, helping them form lifelong commitments to personal and professional development. The project has philanthropic aspirations to make the educational curriculum available to all children and schools, regardless of socio-economic standing, supporting the mission of NSF to promote the health, prosperity and welfare of the nation through science.


    This project is focused on the development of an interactive leadership program for children, that is proven to make a positive impact on leadership behaviors and that is also fun and engaging for youth and their adult caregivers and educators. What sets this program apart from others is that the research will provide evidence that the program builds the critical skills it intends on developing in children. The program is designed to be self-led or facilitated by an adult caregiver or educator, either using an online platform or physical materials.  As children move from one leadership competency to another, they are extrinsically and intrinsically rewarded for their efforts. Adult caregivers and educators are encouraged to participate and are provided mastery building exercises that help them take the child?s leadership understanding and skill to the next level. A database has been developed to track real-time participant feedback as curriculum elements are developed. The testing of educational content will focus on three aspects, which include maximizing content appropriateness, validating learning and skill retention, and assessing variances and preferences for mode of delivery. Results will be used to make modifications to the curriculum and product design for commercialization.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 525 S 4TH ST STE 471
  awardeeCity: PHILADELPHIA
  awardeeCountryCode: US
  awardeeName: EQUILIBRIA LEADERSHIP CONSULTING LLC
  awardeeStateCode: PA
  awardeeZipCode: '191471582'
  fundsObligatedAmt: '223996'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1842707'
  piEmail: nlipkin@equilibrialeadership.com
  piFirstName: Nicole
  piLastName: Lipkin
  piPhone: '2153705564'
  poName: Rajesh Mehta
  date: 12/21/2018
  startDate: 01/01/2019
  expDate: 12/31/2019
  title: 'SBIR Phase I:  Young Leader Project'
- abstractText: "This SBIR Phase I Project will productize a quantitative data processing
    technology in dynamic positron emission tomography (PET). Dynamic PET's distinction
    from its static counterpart is in the fact that it collects time-dependent tracer
    concentration data. It is a highly sensitive and accurate way of functional and
    molecular imaging of protein targets such as biomarkers of Alzheimer's disease,
    Parkinson's disease, or brain trauma. Unfortunately, dynamic PET is rarely used
    in clinic because of long imaging time and complex processing. The technology
    to be developed in this proposal will shorten the required imaging time and simplify
    the analysis, allowing for accurate and reliable imaging of disease biomarkers
    for aiding drug development, clinical diagnostics, and treatment monitoring. The
    proposed analytic workflow will be offered as a cloud-based service that can be
    used by the customers to analyze new or historical PET datasets. In order to overcome
    the established practice of relying on less accurate and informative static PET
    imaging, the grant recipients plan to conduct a thorough validation of the new
    technology using a dedicated physical phantom and human subject images acquired
    in the past. The largest impact of the new technology is expected in medical research
    and drug development. \n\nThe accepted practice of analyzing dynamic PET datasets
    involves reconstruction of the parameters of implied compartment model describing
    the tracer biochemistry, which involves several accuracy-degrading approximations
    and requires lengthy acquisition. The alternative approach proposed in this project
    relies on decomposing the dynamic PET image sequences using a combination of several
    processing techniques that incorporate the essential features of tracer pharmacokinetics
    without making explicit assumptions about the model parameters or about the underlying
    anatomy. The key part of the proposed methodology is factor analysis of dynamic
    structures, a non-negative matrix decomposition technique with successful past
    applications in radionuclide image analysis. The result of the workflow is a 3D
    concentration of tissues that exhibit specific-binding of the radiotracer. In
    order to validate the quantitative accuracy of the approach, the researchers will
    build and image a dedicated physical phantom capable of producing overlapping
    distributions with different tracer dynamics. In order to validate the scan-time
    reduction claims, the new workflow will be used to analyze existing dynamic PET
    human subject datasets using increasingly shorter input time windows.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 1080 Shady Creek Pl
  awardeeCity: Danville
  awardeeCountryCode: US
  awardeeName: SolvingDynamics, Inc.
  awardeeStateCode: CA
  awardeeZipCode: '945264355'
  fundsObligatedAmt: '224981'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819453'
  piEmail: grantgullberg@gmail.com
  piFirstName: Grant
  piLastName: Gullberg
  piMiddeInitial: T
  piPhone: '4152657397'
  poName: Henry Ahn
  date: 09/06/2018
  startDate: 09/01/2018
  expDate: 08/31/2019
  title: 'SBIR Phase I:  Improving Accuracy and Reducing Scan Time of Dynamic Brain
    PET'
- abstractText: "The broader impact/commercial potential of this Small Business Technology
    Transfer (STTR) project is the advancement of improved lithium ion batteries.
    The project will evaluate new battery chemistry enabling more rapid charging rates
    then currently available in the worldwide energy storage marketplace. Such high
    power density batteries would cater to a major emerging battery segment where
    current lithium ion battery technologies fall dramatically short. Successful development
    of this innovation will provide benefits to both current and future applications.
    Clearly, large scale deployment of a markedly superior energy storage device will
    have significant societal benefits by accelerating the move away from fossil fuel
    in many applications and products. For instance, a viable regenerative braking
    energy storage technology based on the proposed technology would result in a tremendous
    reduction in electricity used by subway trains, with a concomitant reduction of
    CO2 emissions. \n\nThis STTR Phase I project proposes to address the core of the
    microstructure - performance relations in energy storing materials, answering
    a series of fundamental questions regarding how a charge carrier is reversibly
    or irreversibly stored at high rates in manganese oxide - carbon nanocomposite
    anodes. In conventional LIBs, it is the graphite-based anode that limits charging
    rates, with catastrophic lithium metal plating and dendrite growth occurring at
    increased currents. It is expected that many of the existing \"Graphite - Inherited\"
    paradigms regarding fast rate in anodes would be done away with, or substantially
    redefined with the proposed approach for designing high power lithium ion batteries
    based on an inexpensive hemp-derived carbon nanosheets and nanostructured manganese
    oxide anodes. A much clearer understanding of the synthesis - structure - property
    relations in such nanocomposites will have wide-reaching scientific and technological
    implications. Research and development activities will focus on structural optimization
    and manufacturing scalability along with fabrication and testing of near-commercial
    pouch cell form factors in order to demonstrate device-level performance and commercial
    viability of the proposed technology.\n\nThis award reflects NSF's statutory mission
    and has been deemed worthy of support through evaluation using the Foundation's
    intellectual merit and broader impacts review criteria."
  awardeeAddress: 51 Orchardview Drive
  awardeeCity: Clifton Park
  awardeeCountryCode: US
  awardeeName: EnerMat Technologies, Inc.
  awardeeStateCode: NY
  awardeeZipCode: '120653810'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1819877'
  piEmail: rahul.mukherjee@enermat-tech.com
  piFirstName: Rahul
  piLastName: Mukherjee
  piPhone: '2177783410'
  poName: Anna Brady-Estevez
  date: 07/20/2018
  startDate: 08/01/2018
  expDate: 07/31/2019
  title: 'STTR Phase I:  Manganese Oxide-Carbon Nanosheet Anodes for Extreme High
    Power Lithium Ion Batteries'
- abstractText: "This SBIR Phase I project uses novel technologies to produce an attractive,
    affordable and commercial product and service, RestEaZe translating to the home
    the sleep lab evaluations of restless sleep for millions of adults with insomnia
    and children with ADHD and RLS. An analysis of significant sleep features that
    should be evaluated for at-home sleep monitoring indicated that at least these
    should include total sleep time, brief arousals, wake during sleep, sleep efficiency,
    periodic leg movements in sleep and sleep position. Moreover these need to be
    developed and validated for adults as well as children. The analyses indicate
    that sleep monitoring should be based on leg and not arm movement. \n\nRestEaZe,
    for the first time ever, both phenotypes and also measures the leg movements of
    sleep (LMS) and using logistic regression and advanced machine learning identifies
    LMS characteristics that accurately predict these significant sleep measures.
    RestEaZe translates advanced sleep science from the lab to the home. The user
    gets an immediate scientifically accurate view of quiet vs. restless sleep and
    changes in sleep over several nights in relation to user entered sleep behavior.
    RestEaZe also provides professionally developed interactive guides for improving
    sleep based on RestEaZe results. The doctor gets advanced movement and sleep analyses
    with interactive graphic and numeric summaries of the patient's sleep over several
    days. The analyses will reveal both sleep quality, circadian pattern and PLMS.
    The PLMS reveal possible medical conditions such as sleep apnea, restless legs
    syndrome (RLS), cardiac morbidity and REM behavior disorder.\n\nThis award reflects
    NSF's statutory mission and has been deemed worthy of support through evaluation
    using the Foundation's intellectual merit and broader impacts review criteria."
  awardeeAddress: 502 Scrimshaw Way
  awardeeCity: Severna Park
  awardeeCountryCode: US
  awardeeName: TANZEN MEDICAL, INC.
  awardeeStateCode: MD
  awardeeZipCode: '211461423'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819626'
  piEmail: cfeltch@tanzenmed.com
  piFirstName: Cody
  piLastName: Feltch
  piPhone: '4435435475'
  poName: Henry Ahn
  date: 07/19/2018
  startDate: 07/15/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  In-home Monitoring of Sleep Fragmentation and Micro-Arousals
    by Characterizing Leg Movements'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project is to develop an external stent that can improve the quality and length of life for dialysis patients. Dialysis is the primary lifeline for End-Stage Renal Disease patients. Unfortunately, our current standard of care, which provides no additional support or treatment to the artery-vein connections surgically created in the arm to initiate dialysis (i.e. access sites), results in 40-60% failure rates within the first year. Consequences of these failures are dire: significant pain, suffering, and death for dialysis patients, hospital readmission penalties, and more than $1B in direct costs to Medicare. An external stent that wraps around the vein-artery/-graft junction of dialysis patients at the time of access site creation surgery has been developed to reduce these failures in a preventative fashion. In order to maximize the impact that it can have on the lives of dialysis patients by providing favorable flow conditions (i.e. hemodynamics) through the access site, it is imperative to first optimize device design on the bench with the aid of computational modeling. Findings from this grant will further scientific understanding of external supports and the role that hemodynamics play in access site failures.

    This STTR Phase I project proposes to create a computational fluid dynamic (CFD) model that successfully predicts flow and deformation conditions at the access site in the presence or absence of an external stent, and to use this model to identify external stent design parameters that promote the most favorable hemodynamic environment for preventing access site failures. First, a 3D printing method of manufacture will be optimized to enable the fabrication of external stents in a highly-repeatable manner conducive to large-scale, FDA-compliant production. A CFD model will be created from empirical results in which surgically-constructed anastomoses (e.g. vein-graft junctions) are exposed to arteriovenous-mimetic pressure and flow conditions in the absence or presence of external stent designs. Empirical ex vivo data to validate the CFD model simulation results will be collected from quantitative measurements of dynamic deformation (e.g. magnitude of expansion) and flow patterns (i.e. velocity fields) in the presence or absence of various external stent designs via 4D flow MRI, which provides spatial and temporal information on 3D flow over the entire anastomosis. This work should result in the identification of a few designs that assert hemodynamic effects conducive to reducing neointimal hyperplasia, the primary culprit of access site failures.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1710 Linden Ave
  awardeeCity: Nashville
  awardeeCountryCode: US
  awardeeName: VenoStent, Inc
  awardeeStateCode: TN
  awardeeZipCode: '372125112'
  fundsObligatedAmt: '224482'
  fundProgramName: STTR PHASE I
  id: '1819996'
  piEmail: tim.boire@venostent.com
  piFirstName: Timothy
  piLastName: Boire
  piPhone: '6039309407'
  poName: Henry Ahn
  date: 07/19/2018
  startDate: 07/15/2018
  expDate: 06/30/2019
  title: 'STTR Phase I:  Hemodynamic Effects Inform Design of an External Stent to
    Reduce Dialysis Access Failures'
- abstractText: "This SBIR Phase I project aims to identify optimal doses of blue
    light required to inactivate common clinical pathogens known to cause surgical
    site infections, and test a prototype antimicrobial light emitting dressing that
    uses the bactericidal effects of blue light to inactivate surface colonizing bacteria
    and disinfect surgical sites. The potential outcomes of the proposed activity
    are the development of a thin reusable blue light-emitting bandage that provides
    effective post-operative site disinfection, ultimately reducing nosocomial related
    infections. The proposed activity would further the development of antimicrobial
    blue light therapy devices, providing novel solutions to surgical site infections,
    Central Line Bloodstream Associated Infections, and wound infections, because
    of blue light therapy's proven ability to inactivate a wide range of clinical
    pathogens regardless of their resistance to antibiotics, ability to improve wound
    healing, and ability to inactivate bacteria in the biofilm state. The outcomes
    of this project will aid in providing a cost saving solution to Healthcare Associated
    Infections by reducing their occurrence, reducing the risks of human error, and
    improving accountability, quality and workflow. \n\nOptimization of blue light
    therapy is needed for clinical application for killing bacteria on the surface
    of patient's surgical sites, because of a radiant energy threshold that must be
    passed to inactivate bacteria. Due to the variation in devices and doses used
    in previous studies, combined with the clinical need for a device which can be
    easily incorporated into standard infection prevention protocols, further experimentation
    is needed with a device designed as a wearable for clinical implementation.  Objective
    1: Determine optimal light dose (fluence) of blue light (405 nm) required to inactivate
    common gram positive and gram negative bacteria known to cause SSIs. Using in
    vitro techniques, determine the total fluence of light and treatment times required
    to achieve bacterial disinfection of at least a one log reduction in bacteria
    colony forming units.  Objective 2: Optimize device to deliver the effective irradiance
    while maintaining surface temperature below 43 Degree Celsius for safe use on
    tissue. The device is to not exceed 43 Degree Celsius on the surface of the device's
    therapeutic surface while delivering effective irradiance, from Objective 1, for
    inactivation of bacteria on surfaces.  Objective 3: Test the device's infection
    prevention and tissue response in a SSI porcine model. Evaluate the device in
    a porcine SSI model with surface-inoculated sutured incisions, made to the depth
    of the fascia, with optimized light-emitting antimicrobial bandage. Success criteria
    for bacterial disinfection is at least a 90% reduction of CFU per gram of tissue
    or a multiparametric and semiquantitative score (0-3 range) no greater than 1,
    based on standard subjective clinical markers, including fever, erythema, induration,
    and suppuration.\n\nThis award reflects NSF's statutory mission and has been deemed
    worthy of support through evaluation using the Foundation's intellectual merit
    and broader impacts review criteria."
  awardeeAddress: 216 West 26th street
  awardeeCity: Bryan
  awardeeCountryCode: US
  awardeeName: SABER Corporation
  awardeeStateCode: TX
  awardeeZipCode: '778033268'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820310'
  piEmail: dr.glow@voyagerbiomedical.com
  piFirstName: Alan
  piLastName: Glowczwski
  piPhone: '9032357198'
  poName: Henry Ahn
  date: 07/16/2018
  startDate: 07/15/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Light Emitting Antimicrobial Bandage'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Technology Transfer (STTR)
    project is to improve outcomes and decrease costs in the mental health space by engaging
    patients starting with their first therapy session through objective progress reporting and
    post-session motivation. Patients and clinicians alike will be able to track and assess treatment
    progress through self-reported and physiological measures. This innovation builds upon the
    strong academic, government, and industry partnerships that will advance research and
    innovation in the field of biotechnology. By demonstrating improved outcomes and decreased
    costs associated with the utilization of technology, this will pave the way for insurance
    reimbursement (using existing CPT codes) to accelerate market adoption. Additionally, as
    education of patients and the public improves regarding mental health and PTSD in particular,
    the negative stigma surrounding these conditions will decrease and more people in need will
    seek help rather than resorting to unhealthy behavior or even suicide.

    This STTR Phase I project proposes to represent an innovative approach that provides easy to
    interpret results tailored to mental health providers, patients, and other non-technical users.
    Current mental health treatment and assessment has lacked qualitative, scientifically-based
    measurement. The need for a scientific measurement is evident, as about 8 percent of all
    adults - 1 of 13 people in this country will develop PTSD during their lifetime. Currently, 60%
    of adults diagnosed with a mental illness don't receive mental health treatment; using proven
    science and physiologic measurements as the foundation for improving treatment and
    monitoring progress for PTSD can help to alleviate some of the stigma surrounding mental
    illnesses. This project aims to demonstrate how implementing a web-based platform can
    improve PTSD treatment by providing physiologically relevant feedback to the patient and by
    providing a tool for the clinician to tailor the therapy to the individual patient. Patients will have
    their subjective measures and physiological data visualized throughout treatment on a software
    platform, with progress being tracked through validated assessment scales. Patients will be
    compared to others in treatment as usual. Results should yield improved quality of life and
    decrease long term healthcare costs for those that use the platform.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1635 Market St
  awardeeCity: Philadelphia
  awardeeCountryCode: US
  awardeeName: NeuroFlow, Inc.
  awardeeStateCode: PA
  awardeeZipCode: '191031095'
  fundsObligatedAmt: '224510'
  fundProgramName: STTR PHASE I
  id: '1820209'
  piEmail: adam@neuroflowsolution.com
  piFirstName: Adam
  piLastName: Pardes
  piMiddeInitial: M
  piPhone: '2676717316'
  poName: Henry Ahn
  date: 07/09/2018
  startDate: 07/15/2018
  expDate: 06/30/2019
  title: 'STTR Phase I:  Implementation of a Biometric Data Software Platform to Augment
    Mental Health Treatment'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project extends from years of research into the impact of Harmful Algal Blooms (HABs), and yet there is still no direct, field assay for toxic cells. The identification of HABs is critical to determine their patterns of occurrence, to protect water and food supplies, and to alert the general public when there is a problem. Harmful Algal Blooms are a world-wide fresh water, brackish water and marine phenomena that occur in every coastal and inland country and annually cause significant economic damage and take human lives. The detection of HABs and their toxins is currently completed by complex, expensive, and time consuming microscopic analyses that do not necessarily provide the critical and timely information that water quality mangers require. Raman spectroscopy provides a strong and distinct fingerprint of HAB cells and their toxins without the need for sample preparation, and can be used on-site at beaches, drinking water reservoirs, or within distributed networks of Raman sensors all communicating through the cloud to provide managers immediate and spatially distinct information on the presence and concentration of potentially toxic cells.

    This STTR Phase I project proposes to develop and market an in-situ 3D microscope with on-axis Raman spectroscopy to provide both morphological information and a chemical signature for identification of HAB cells to species, and in some cases specific strains, along with the presence and concentration of toxin on a per cell basis. The novel technical specifications include: 1) the use of Light Field (LF) microscopy to maximize the depth of field to allow for detection of low cell concentrations (< 1 cell/ mL). LF microscopy also provides a 3D image for more complete and accurate morphological assessment of cells and particulates, 2) Advanced software for color and texture feature extraction and classification of cells using Gabor wavelets and a novel color angle feature, which provide 100% classification accuracy in many cases, 3) the use of Resonance Micro-Raman Spectroscopy (RMRS) to collect spectral fingerprints on the inorganic and organic content of cells, particulates and dissolved compounds, and 4) the integration of these technologies into sensor packages as part of the IoT cloud computing thrust that is sure to gain traction over the next few years, and will provide regional protection of both large and small drinking water reservoirs, globally.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 10 Edgerton Dr
  awardeeCity: North Falmouth
  awardeeCountryCode: US
  awardeeName: CoastalOceanVision, Inc
  awardeeStateCode: MA
  awardeeZipCode: 025562821
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820074'
  piEmail: sgallager@coastaloceanvision.com
  piFirstName: scott
  piLastName: gallager
  piMiddeInitial: m
  piPhone: '5084725520'
  poName: Anna Brady-Estevez
  date: 07/02/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Real-Time Assessment of Water Quality, Harmful Algal Blooms,
    and Toxins from Distributed, Networked Sensor Arrays'
- abstractText: "The broader impact/commercial potential of this STTR project stems
    from the costs to U.S. food producers of outbreaks of animal diseases.  Producers
    of poultry, pork, and other food proteins lose more than $1B each year to infectious
    diseases, including some that are transmitted through the air.  For diseases having
    an airborne transmission route, protective technologies that are available are
    few and can be costly to implement and operate.  This project furthers the development
    of a new alternative technology, non-thermal plasmas, for the simultaneous removal
    and inactivation in air of the organisms responsible for the transmission of disease
    to livestock.  This project evaluates how conditions in the environment typically
    found near livestock affect the performance of non-thermal plasmas.  This project
    also pursues a technique for accelerating the process of improving non-thermal
    plasma performance, upon the completion of which new and improved non-thermal
    plasma devices can be developed for applications such as this more rapidly than
    is possible now.  Completion of the project will enable the development of lower-cost
    protective technologies for maintaining livestock health, making such technologies
    economically accessible to a larger segment of food protein producers, ultimately
    lowering food costs and increasing domestic food security.  \n\nThis STTR Phase
    I project proposes to experimentally demonstrate and evaluate the effectiveness
    of a non-thermal plasma (NTP) as a means of preventing disease-carrying particles
    in outside air from infecting livestock housed in animal confinement buildings.
    \  NTPs are stable electrical discharges that simultaneously contribute to the
    removal of airborne particles while also subjecting them to chemical attack capable
    of killing harmful viruses.  While NTPs have been demonstrated for disinfection
    of fixed surfaces, and to a lesser degree for the destruction of chemical contaminants
    or biological pathogens in air, the intellectual merit of this project stems from
    its evaluation of trace gases commonly present in the air around livestock, ammonia
    and hydrogen sulfide, and their potential to both enhance and diminish the performance
    of NTPs used in farm environments.   Additionally, this project will identify
    non-biological tracers suitable for use in NTP optimization testing which will
    accelerate the development of improved designs.  Two separate lab-scale NTP reactors
    will be used in the execution of the project.\n\nThis award reflects NSF's statutory
    mission and has been deemed worthy of support through evaluation using the Foundation's
    intellectual merit and broader impacts review criteria."
  awardeeAddress: 2628 Pin Oak Drive
  awardeeCity: Ann Arbor
  awardeeCountryCode: US
  awardeeName: Taza Aya LLC
  awardeeStateCode: MI
  awardeeZipCode: '481032369'
  fundsObligatedAmt: '224982'
  fundProgramName: STTR PHASE I
  id: '1820091'
  piEmail: eric.monsu@gmail.com
  piFirstName: Eric
  piLastName: Lee
  piMiddeInitial: M
  piPhone: '7344179639'
  poName: Anna Brady-Estevez
  date: 07/02/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'STTR Phase I:  Protecting Livestock from Airborne Disease Transmission Using
    Non-thermal Plasma Airstream Disinfection'
- abstractText: |-
    Broader Impacts: The broader impact of this Small Business Innovation Research (SBIR) project include improving food security, while at the same time enhancing the economic viability and environmental sustainability of large-scale production agriculture. In order to improve crop varieties, agricultural production, and sustainability of farming, there is an urgent need for better technologies to acquire under-canopy plant trait and health data. Examples of high-value under-canopy data include emergence, stem width, corn ear height, plant life-cycle events like flowering and fruiting, and symptoms of pathogens, diseases, and nutrient deficiency. Because these data cannot be obtained by aerial imaging, under-canopy data collection has dramatically greater actionability and value compared to aerial data. However no cost-effective, scalable ways of collecting this data are currently available. In fact, the state of the art is manual data collection by crop scientists (and their students or interns), agronomists, crop-scouts or farmers - an extremely labor intensive, and therefore expensive way of collecting this highly valuable data. Our work will greatly enhance the availability of under-canopy data from field crops. The commercial value of the field data for crop breeding is in excess of $50 Million/year for breeding major row-crops in the US.

    Intellectual Merits: This SBIR Phase I project will demonstrate the technical feasibility of autonomously collecting under-canopy data from field crops using TerraSentia, our low-cost ground robot. In preliminary work, we have built the robot hardware, demonstrated its ability to collect high-value plant data from row-crop fields, and analyze it to generate plant-trait information. In the proposed work, we will enable and demonstrate the ability of TerraSentia to collect data autonomously throughout the season. We will demonstrate the technical feasibility of fusing information from low-cost LIDAR, GPS, and vision. We will also demonstrate the feasibility using real-time control algorithms to adapt camera perspective and robot path in order to obtain the highest quality information from the complex and dynamic under- canopy field environments. These high-risk innovations will together enable long-term deployment of TerraSentia for effective data collection and phenotyping, benefiting crop scientists and agricultural product development professionals.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 60 Hazelwood Drive
  awardeeCity: Champaign
  awardeeCountryCode: US
  awardeeName: EarthSense, Inc.
  awardeeStateCode: IL
  awardeeZipCode: '618207460'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820332'
  piEmail: chinmay@earthsense.co
  piFirstName: Chinmay
  piLastName: Soman
  piPhone: '2174024767'
  poName: Anna Brady-Estevez
  date: 06/29/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I: TerraSentia: Ultra-compact, Autonomous, Teachable Under-canopy
    Phenotyping Robot for Plant Breeders and Crop Scientists'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is to address the most common causes of blindness worldwide.
    Retinal diseases account for vision loss in over 25 million Americans. Worldwide,
    the prevalence of blindness in children is determined largely by socioeconomic
    development and availability preventative care. By 2020, the World Health Organization
    estimates that visual impairment among children age 14 and under will reach almost
    19 million, and adults will reach almost 266 million.  \n \nThis SBIR Phase I
    project proposes a SMART surgical tool to enable safe and precise delivery of
    stem cells and genes to help repair and restore the vision of patients with retinal
    degeneration. Studies have shown cell transplant technology and injectable therapeutics
    improve vision in afflicted patients. However, due to the delicate nature of retinal
    tissue, this procedure is challenging to perform successfully. The proposed tool
    addresses the unmet need for better visualization and targeted delivery of therapeutic
    agents. Precise delivery of treatment is expected to deliver benefits in preventing
    and correcting retinal diseases.\n\nThis award reflects NSF's statutory mission
    and has been deemed worthy of support through evaluation using the Foundation's
    intellectual merit and broader impacts review criteria."
  awardeeAddress: 14917 Meriwether Drive
  awardeeCity: Glenelg
  awardeeCountryCode: US
  awardeeName: LIV Medical Technology Inc.
  awardeeStateCode: MD
  awardeeZipCode: '217379628'
  fundsObligatedAmt: '224973'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819719'
  piEmail: lokie20xx@gmail.com
  piFirstName: Lok
  piLastName: Chu
  piMiddeInitial: M
  piPhone: '4104184644'
  poName: Henry Ahn
  date: 06/29/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Optical Coherence Tomography(OCT)-Sensor Guided Sub-Retinal
    Injector'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is that it provides unique secure, tamper resistant record keeping and logging services that leverage blockchain technology for a wide range of IoT applications. The solution will provide significant benefits in terms of performance, cost (e.g., total ownership cost), cyber attack resilience, security and privacy assurance for both IoT device owners, operators, and industries utilizing IoT technology such as transportation, smart city, logistics, supply chain management, manufacture, energy, critical infrastructures.

    This STTR Phase I project proposes to develop a scalable auditing, record keeping, and logging system for internal/external operations and data interactions of IoT devices, which are fundamental components to support other critical properties and operations of IoT enabled infrastructures. The record keeping and logging system solves several critical challenges in distributed IoT environment: transaction ordering and data distribution. In addition, the logging and transactional system can be the centric component for producer-consumer style applications.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 5826 Petty Steet
  awardeeCity: HOUSTON
  awardeeCountryCode: US
  awardeeName: Saguaro Innovation LLC
  awardeeStateCode: TX
  awardeeZipCode: '770071024'
  fundsObligatedAmt: '224968'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819962'
  piEmail: shisunny.yang@gmail.com
  piFirstName: Yang
  piLastName: Lu
  piPhone: '6784297787'
  poName: Anna Brady-Estevez
  date: 06/29/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Blockchain based Logging Management System for IoT Devices'
- abstractText: |-
    The broader impact/commercialization potential of this project is to address the need for a small, low-cost, and high-accuracy angular rate and angular orientation sensor (also known as a gyroscope) for a wide range of applications.  Gyroscopes are desired by many emerging applications such as inertial measurement units for small satellites such as CubeSats, autonomous vehicles, drones, and high-end wearable electronics.  These applications require a gyroscope with a similar price (< $10) but ~10,000 times better accuracy than those currently used in smartphones.  The birdbath resonator gyroscope (BRG) is a novel micro-electro-mechanical systems (MEMS) gyroscope with a strong potential to satisfy the needs of these applications due to significantly better resonance quality and mechanical symmetry than current silicon gyroscopes.  The economic impact of BRGs will be enormous since many industries can utilize high-performance gyroscopes to monitor the dynamics of their systems, provide positional awareness, and improve the performance of other parts of these systems.  Availability of low-cost and high-performance gyroscopes will enable users to further understand their applications and explore their limits and applicability across a broad range of societal needs.

    This Small Business Innovation Research (SBIR) Phase I project aims to develop a new batch-level microfabrication technology to enable the commercialization of low-cost, very high-performance MEMS gyroscope from fused-silica.  Gyroscopes available today are either accurate but large and expensive (example: hemispherical resonator gyroscope), or small and cheap but inaccurate (example: smartphone gyroscopes).  High-accuracy silicon MEMS gyroscopes in research are small and accurate but expensive.  This is because silicon has fundamentally low mechanical resonance quality factor (Q) so it is difficult to manufacture high-accuracy gyroscopes with a high yield.  The BRG is a gyroscope made from fused-silica and capable of having low cost, small size, and high performance.  Its fused silica micro mechanical resonator can achieve significantly higher Q than silicon, which allows the BRG to be manufactured with a high yield.  The BRG fabrication process uses a blowtorch to reflow-mold a fused silica substrate into three-dimensional hollow shells with dimensions of several 10s of micrometers to several millimeters with high geometrical accuracy.  The proposed research will significantly enhance our understanding of the relationships among size, design, and process on the performance of the BRG as well as the relationship among detailed process parameters, yield and reproducibility on cost.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2972 Barclay Way
  awardeeCity: Ann Arbor
  awardeeCountryCode: US
  awardeeName: Enertia Microsystems Inc.
  awardeeStateCode: MI
  awardeeZipCode: '481059463'
  fundsObligatedAmt: '224903'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819893'
  piEmail: jycho@umich.edu
  piFirstName: Jae Yoong
  piLastName: Cho
  piPhone: '7346788600'
  poName: Muralidharan Nair
  date: 06/29/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Commercialization of low-cost micro birdbath resonant gyroscope'
- abstractText: "This SBIR Phase I project will develop a very long-acting buprenorphine
    formulation to increase patient compliance and address the opioid crisis. Poor
    medication compliance is a significant driver of health care costs. The US would
    save an estimated 290 billion dollars yearly or 13% of the total health care budget
    if patients took their medications as directed. Patients with chronic diseases
    are the least compliant with medication. There is an evolving consensus that Opioid
    Misuse Disorder (OMD) is also a chronic disease, and its treatment is also plagued
    by poor compliance. There are an estimated 2.5 million people in the United States
    with OMD. Complete abstinence therapy fails about 80% of the time. Medication-assisted
    therapy using methadone, naltrexone or buprenorphine is far more successful. More
    opioid misuse patients are treated with buprenorphine than methadone, and retention
    in treatment is up to 78% with additional counseling. Still, 80% of all people
    who misuse opioids never obtain any therapy for their disorder, risking overdose,
    other diseases, including HIV and Hepatitis, and amyloidosis. Extended-release
    medications for opioid maintenance therapy would open up more options to get people
    into therapy. A 3-month release formulation of buprenorphine would be a part of
    that strategy.  \n\nBuprenorphine is a partial agonist opioid drug that is used
    for treatment of pain in human and animal patients and for opioid addiction maintenance.
    A platform technology has been developed that can be used to formulate extended-release
    preparations of drugs that are weak bases and are mildly lipophilic. Preparations
    of buprenorphine, naltrexone and doxycycline have been developed using this method.
    The initial proposed product is an injectable formulation of buprenorphine that
    releases over a period of 3 months. This project will address the occurrence of
    a brief peak of early drug release in the 3-month duration buprenorphine formulation.
    The experiments in the current proposal will examine three different methods of
    decreasing the early peak by manipulating the amount of lipid engulfed by macrophages
    at a given dose of drug or by preventing macrophage engulfment of the lipid particles
    entirely by coating the lipid particles with chemicals that make them unlikely
    to be phagocytized. Preliminary results indicate that changing the drug to lipid
    ratio as described in the current proposal will reduce the peak of early release.
    Reducing the early peak will prevent sedative effects, improve the pharmacokinetics
    of the preparation and make dose escalation studies easier and more straight forward.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: Ann St.
  awardeeCity: Madison
  awardeeCountryCode: US
  awardeeName: Plumb Pharmaceuticals, LLC
  awardeeStateCode: WI
  awardeeZipCode: '537132410'
  fundsObligatedAmt: '224850'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819943'
  piEmail: timheathcca@gmail.com
  piFirstName: Timothy
  piLastName: Heath
  piMiddeInitial: D
  piPhone: '6083337617'
  poName: Henry Ahn
  date: 06/26/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Refining a 3-month release buprenorphine, advancing a drug
    delivery platform'
- abstractText: |-
    This Small Business Innovation Research Phase I project scales the production of renewable monomers that give access to performance nylon polyamides with tailorable functional properties for applications in the automotive, food & beverage packaging, textiles, and other industries. The revolutionary technology will be a disruptive force to the $40 billion nylon polyamide industry by addressing nylon?s weaknesses such as undesired moisture adsorption, which results in loss of dimensional stability and tensile strength. These shortcomings lead industries to make compromises in selecting their materials; for instance, longer chain polyamides are used for moisture resistance but at the expense of desired viscoelastic properties. The proposed bio-advantaged monomers will 1) help ease reliance on petroleum-based chemicals resulting in greener production processes and a cleaner environment, 2) present new opportunities for innovation and use of performance plastics due to the platform that bio-advantaged monomers offer. This is expected to generate new jobs at multiple points in the value chain. Demand for agricultural goods by fermentation facilities will increase. Sumatra Biorenewables and its partners will create jobs to meet demand for monomer production and purification. Finally, polymer producers and the manufacturing industry will produce superior products, increasing the competitiveness of the U.S. chemical industry.

    The intellectual merit of this project is to combine fermentation and chemical conversion for the production of bio-advantaged monomers and their corresponding performance-enhanced polyamides. The inexpensive, robust, and efficient monomer production process in conjunction with the customizable nature of bio-advantaged monomers to yield nylon derivatives that are hydrophobic, flame retardant, anti-static, or otherwise tailorable, afford opportunities to meet a number of needs in the manufacturing sector. The innovation?s success hinges on a monomer production process that utilizes an inexpensive electrochemical conversion that operates near 100% efficiency and that only uses water as a reactant and electricity as an energy source. In addition, the monomer production process is insensitive to the feedstock source and the impurities present in fermentation broths. Therefore, separation and purification is only required after monomer production, resulting in huge cost savings. Laboratory-tested samples of hydrophobic nylon perform equally well as dry nylon, but without the disadvantage of moisture sensitivity. This project will enable Sumatra Biorenewables to transition to a continuous flow, kilogram-scale, production process and supply potential customers with samples for performance testing.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2590 Meadow Glen Rd
  awardeeCity: Ames
  awardeeCountryCode: US
  awardeeName: Sumatra Biorenewables LLC
  awardeeStateCode: IA
  awardeeZipCode: '500148237'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820147'
  piEmail: nacu23@gmail.com
  piFirstName: Nacu
  piLastName: Hernandez
  piMiddeInitial: B
  piPhone: '5157080336'
  poName: Linda Molnar
  date: 06/25/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Bio-Advantaged Monomers for the Production of Function-Tailorable
    Polyamides'
- abstractText: "This Small Business Innovation Research Phase I project will assess
    the commercial viability of using new non-precious metal catalysts to produce
    hydrogen by splitting water.  Electrolyzers made with these new catalysts have
    the potential to deliver higher efficiencies and lower capital costs than currently
    available systems. The market for hydrogen today is $115 billion per year.  Currently,
    hydrogen is primarily produced via steam reformation of methane. Hydrogen production
    via steam reformation emits millions of tons of CO2 into the atmosphere annually.
    There is broad agreement that water electrolysis can play a significant role in
    future hydrogen production if cost reductions can be realized.  In addition, hydrogen
    has the potential to store energy produced by renewable energy systems like solar
    and wind and make it available on demand. The initial market entry point for these
    new electrolyzers is to supply hydrogen for fuel cell powered forklifts used in
    material handling. A life cycle cost analysis by the National Renewable Energy
    Laboratory (NREL) has shown that the total life cycle costs of hydrogen fuel cell
    forklifts are 10% cheaper than those using lead acid batteries. \n\nThe intellectual
    merit of this project is focused on the ability of new earth-abundant non-precious
    metal catalysts for both the hydrogen evolution reaction (HER) and oxygen evolution
    reaction (OER) to dramatically lower costs while improving efficiency in water
    splitting. The HER electrocatalyst is composed of hyper-thin FeS2 nano-discs and
    the OER electrocatalyst is nanoamorphous Ni0.8:Fe0.2 oxide. The preferred operating
    pH for the catalysts are different (pH 7 for the hyper-thin FeS2 nano-discs and
    pH 14 for the nanoamorphous Ni0.8:Fe0.2 oxide). Preliminary data shows that these
    two catalysts with the dual-pH membrane can effectively split water with a total
    overpotential of only 300 mV (1.53 V in a two electrode configuration). This is
    more than 50 mV lower than the best-known precious metal catalysts, Pt and IrOx,
    used in current commercial electrolyzers. The project will continue the optimization
    of these catalysts in the dual-pH electrolyzer stack and also determine if stability
    and lifetime meet commercial requirements\n\nThis award reflects NSF's statutory
    mission and has been deemed worthy of support through evaluation using the Foundation's
    intellectual merit and broader impacts review criteria."
  awardeeAddress: 1714 W 26th St
  awardeeCity: Lawrence
  awardeeCountryCode: US
  awardeeName: Avium, LLC
  awardeeStateCode: KS
  awardeeZipCode: '660464206'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1819766'
  piEmail: barforoushj@gmail.com
  piFirstName: Joseph
  piLastName: Barforoush
  piPhone: '9135235819'
  poName: Linda Molnar
  date: 06/25/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'STTR Phase I:  Dual-pH Water Splitting Device Comprising Earth-Abundant
    Electrocatalysts'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is a system that provides improved reservoir productivity through a novel, inexpensive, and environmentally friendly method. This method will use an electric impulse to increase reservoir permeability, and decrease industry reliance on alternative methods like hydraulic fracturing, which requires hazardous chemicals to be pumped into the subsurface. Residents in regions where fracking techniques are utilized have commonly been impacted by induced seismicity and landslides as a consequence of pumped in chemicals lubricating faults, making earth ruptures more likely to occur. Additionally, the material and operation time for reservoir stimulation techniques makes the current process expensive. The ability to increase permeability with an electric impulse will avoid the environmental concerns associated with current methods, and will proved a cost competitive reservoir stimulation solution due to a short operational time.

    This SBIR Phase I project proposes to develop a novel low-frequency impulse method (LFIM) that increases reservoir permeability for petroleum and geothermal applications, without requiring pumping of material into the subsurface. Fluid mobility is increased due to viscosity reduction and reservoir permeability is increased in the direction of interest from the vibrational removal of particles within sediment pores.  This program will 1) simulate the processes taking place in the reservoir using computer simulation model, 2) perform experimental analysis of the effects of the electric treatment on different core samples, and 3) determine applicability of the method to different types of the reservoirs located in the United States.  Therefore, this project will identify the optimum sites, where LFIM can boost geothermal performance and oil & gas production.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 444 Somerville Avenue
  awardeeCity: Somerville
  awardeeCountryCode: US
  awardeeName: Eden GeoPower, LLC
  awardeeStateCode: MA
  awardeeZipCode: '021430000'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820135'
  piEmail: mehrdad@edengeopower.com
  piFirstName: Mehrdad
  piLastName: Mehrvand
  piPhone: '9298889029'
  poName: Anna Brady-Estevez
  date: 06/25/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Directional Permeability Enhancement Using Electric Well
    Treatment'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is the reuse of rubber compounds from spent tires in high performance products including new tires without significant loss in product performance. Only a very small portion of those tires are currently being ground up for this purpose because of the detrimental impact  on product properties. However, larger quantities could potentially be used if the ground rubber is treated by the process of our invention. This would have several benefits.  Manufacturers could reduce material cost, the rubber recycling industry would enjoy significant growth and unsightly tire dumps with associated pollution problems would disappear. Additionally, the tire industry will become more sustainable and other unacceptable uses of old tires currently practiced, such as their use as fuels in low cost operations, would be financially challenged as novel, more profitable uses that retain the integrity of the polymer matrix emerge.

    This SBIR Phase I project proposes to build upon studies conducted by our company during the last few years. While it was widely known that recycled ground rubber will significantly reduce physical properties, limited information and understanding existed on the basic causes. Much hope was pinned by many companies and academic institutions on the potential merit of the ground up rubber but no significant commercial process previously emerged. This work aims to develop a recycling process which does not require a devulcanization step. This was first demonstrated with model sample geometries that simulate the environment which ground rubber particles experience when added to and being co-vulcanized with fresh rubber compounds.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1765 Brookwood Dr.
  awardeeCity: Akron
  awardeeCountryCode: US
  awardeeName: Appia LLC
  awardeeStateCode: OH
  awardeeZipCode: '443130000'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820122'
  piEmail: gbohm@att.net
  piFirstName: Georg
  piLastName: Bohm
  piPhone: '3302123661'
  poName: Anna Brady-Estevez
  date: 06/25/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Development of a Novel Rubber Recycling Process Not Involving
    Devulcanization'
- abstractText: "This Small Business Innovation Research Phase I project is focussed
    on developing a  plasma jet printing technology to serve the printed electronics
    industry. Printed electronic devices including flexible electronics and flexible
    hybrid electronics (FHE) are next generation smart devices that have applications
    in both consumer and industrial segments. These devices combine the flexibility
    and low cost of printed substrates made of plastic with the performance of semiconductor
    devices to create a new category of electronics. The main challenge in FHE is
    integration of semiconductor die to the flexible substrate and interconnects.
    Plasma jet printing has high potential to address the problems associated with
    printed electronics manufacturing, in particular the interconnects. The plasma
    process control allows printing metallic materials with required electronic properties
    by in-situ treatment, thereby eliminating the need for post processing. The global
    market for printed electronics equipment is $1.5 billion in 2017 and is estimated
    to reach $4 billion globally in 2020 and growing at a compound annual growth rate
    of 38%. Immediate industrial application of our technology is in replacing wire
    bonding with direct write printing of metallic interconnects for flexible hybrid
    electronics. \n\n\nThe intellectual merit of this project is in developing a plasma
    jet print head hardware for direct write printing of conducting metallic interconnects
    with reduced process steps.  The project focus will be on technological de-risking
    of the print head hardware and process de-risking for reliable and re-producible
    printing. Developing the plasma process that can be used for pre-treatment of
    substrate, in-situ treatment of nanoparticles, printing and post processing all
    in one tool and simultaneously can reduce the process steps, number of equipments
    needed and time taken for manufacturing. Oxidation of metal nanoparticle ink and
    its limited shelf life is currently being addressed by polymer capping of the
    nanoparticles and thermal/laser processing. Developing a plasma process that can
    be used to print high quality conducting patterns using in-situ treatment can
    take the technology closer to adoption by printed electronics industry. The anticipated
    outcome of this project is a robust plasma jet print head and a process that can
    reliably and reproducibly print conducting metal films with tailored oxidation
    state and electronic structure.\n\nThis award reflects NSF's statutory mission
    and has been deemed worthy of support through evaluation using the Foundation's
    intellectual merit and broader impacts review criteria."
  awardeeAddress: 1035 Aster Ave Unit 1120
  awardeeCity: Sunnyvale
  awardeeCountryCode: US
  awardeeName: Space Foundry Inc
  awardeeStateCode: CA
  awardeeZipCode: '940862215'
  fundsObligatedAmt: '224830'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819676'
  piEmail: ram@spacefoundry.us
  piFirstName: Ramprasad
  piLastName: Gandhiraman
  piPhone: '4086886978'
  poName: Linda Molnar
  date: 06/25/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Direct Write  Printing of Metals by In-Situ Plasma Jetting
    for Flexible Hybrid Electronics'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to enable accurate electronic health record (EHR)-based studies to support precision medicine. The country is embarking on a journey of using real world evidence (RWE) to adjust the existing standard of care. EHR-based subgroup analytics and comparative effectiveness studies will increasingly be used to augment regulatory and reimbursement approval. These efforts require accurately recognizing clinical outcomes in real world scenarios. Studies attempting to identify real world outcomes, such as pain and disease free survival, have shown low accuracy rates in claims and EHR discrete data. This proposal aims to accurately detect challenging outcomes from EHR data using advanced semantic technologies. The goal is to enable accurate RWE studies to achieve safer and more effective use of RWE in clinical practice.

    This SBIR Phase I project proposes to create an application to extract clinical outcomes from real world data to enable EHR-based pragmatic clinical trials (PCTs). The approach uses natural language processing (NLP) to dive deep into the health record for exposure, intervention, and outcome data that do not exist or are inaccurate in claims and EHR discrete data. Project objectives include extracting features from clinical data using NLP and ontologic mapping, developing a knowledge database that reflects common outcomes in observational and clinical trials, and inferring outcome from extracted features using clinical data. The project will validate the outcome detection engine using de-identified longitudinal clinical data to assess accuracy of feature extraction and inferred outcome.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 113 BARKSDALE PROFESSIONAL CTR
  awardeeCity: Newark
  awardeeCountryCode: US
  awardeeName: VMT, Inc.
  awardeeStateCode: DE
  awardeeZipCode: '197113258'
  fundsObligatedAmt: '224793'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819388'
  piEmail: grants@vmt.com
  piFirstName: Daniel
  piLastName: Riskin
  piMiddeInitial: J
  piPhone: '6507777978'
  poName: Henry Ahn
  date: 06/25/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Determination of complex outcome measures using narrative
    clinical data to enable observational trials'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I is the improvement of public transportation services for people with disabilities, specifically people with visual impairments. Individuals with visual impairments are heavily dependent on public transit as an essential service for engaging in daily life and social activities. However, they often face challenges with (1) determining which bus to board, especially at busy bus stops when multiple buses approach, and (2) boarding the correct bus in a timely fashion before they leave the stop. By developing an advanced notification service for alerting bus drivers, SeeingBus will address the societal and market needs to mitigate these challenges and thereby promote independent use of public transportation among people with visual impairments. Improving accessibility of public transportation to people with disabilities along with enhancing perception of their service will boost ridership resulting in increased revenue for agencies. The project will contribute to the scientific community as well as society in general by advancing understanding of Smart City services needed for independent travel of people with disabilities.

    The proposed project will develop and commercialize a Smart City service to improve public transportation for people with visual impairments. The service, SeeingBus, provides an advanced notification to bus drivers about users waiting at their next stop. People with visual impairments often miss buses due to challenges they face with boarding the correct bus. SeeingBus aims to improve accessibility of public transportation by engaging bus drivers even before the bus arrives at the stop where riders with visual impairments are waiting. As part of the smart city vision, SeeingBus will enhance connectivity of public transportation systems through greater communication between riders, bus stops, and bus drivers by means of smart sensors. Using big data, SeeingBus alerts bus drivers about users with disabilities, so the drivers can assist individuals in boarding the bus safely. The research objective of this project is to develop and test the feasibility of the SeeingBus system. Advancing public transportation, essential to promoting the travel and independence of individuals, aligns with the NSF mission to advance prosperity and welfare through scientific advancements.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 2416 Stone Road
  awardeeCity: Ann Arbor
  awardeeCountryCode: US
  awardeeName: ILANS, Inc.
  awardeeStateCode: MI
  awardeeZipCode: '481052541'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819920'
  piEmail: glazer18@gmail.com
  piFirstName: Yariv
  piLastName: Glazer
  piPhone: '7349268160'
  poName: Rick Schwerdtfeger
  date: 06/25/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  SeeingBus: Improving Public Transportation Services for the
    Blind'
- abstractText: |-
    This SBIR Phase I project takes a deeper look at the concept of 'purpose' and its relationship to the marketplace, unemployment, and start-up incubators. It intends to develop a multi-question self-assessment tool to help individuals find meaningful purpose through free, online, live and self-paced hybrid course instruction. The coursework will use augmented reality and 3-D video to motivate individuals to re-think purpose as a central motivation to employment and entrepreneurship. This project aligns with the NSF?s mission to advance national health, prosperity, and welfare with science and technology. These outcomes could potentially generate a new generation of business owners that are dedicated to meaning and money through a double bottom-line approach to entrepreneurship.

    This project combines the educational work of finding purpose through self- help and the technology of 3-D video and augmented reality for the first time. This unique project provides free online live synchronous education combined with hybrid self-paced online course work to help individuals find meaningful self-employment solutions. This project utilizes a proprietary training method designed to quickly help individuals find their purpose in life and invent a useful business or nonprofit to solve problems in the world. This research can help students re-center their motivations to chart a meaningful life course through a business or nonprofit start-up. The curriculum starts with this activity and extends to provide students an opportunity to enter the marketplace through micro-enterprise or nonprofit creation. The courses will utilize predictive analytics to synthesize student data (such as the answers each student inputs for the four questions in the purpose activity). The data will be reorganized and automated into a clear and targeted purpose proposition statement for the student.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 315 E CHAPEL HILL STREE
  awardeeCity: Durham
  awardeeCountryCode: US
  awardeeName: DRAKEFORD SCOTT & ASSOCIATES
  awardeeStateCode: NC
  awardeeZipCode: '277013317'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820018'
  piEmail: ddrakeford@drakefordassociates.org
  piFirstName: Derrick
  piLastName: Drakeford
  piMiddeInitial: R
  piPhone: '9193601053'
  poName: Rajesh Mehta
  date: 06/25/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:   Online curriculum for creating purpose-driven Start-ups'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is the commercialization of a fermentation bioprocess that can bring significant benefits for the dairy industry - called the WheyAway system. By initially addressing the problem of handling acid whey, a waste stream generated by all Greek yogurt and cottage cheese producers - the WheyAway can convert the cost of waste handling into a revenue by producing valuable bio-oil platform chemicals. The WheyAway can economically convert the acid whey waste stream to bio-oil on-site, allowing our customers to effectively install biorefineries at each of their plants. In comparison to anaerobic digestion, the WheyAway system can provide several multiples greater economic value. These bio-oils can be used as biofuel feedstocks, animal feed additives, and specialty chemicals. Converting acid whey yields a significant market opportunity with projected impact that could simultaneously offset ~435,000 gallons of diesel used to truck this waste off-site and eliminate ~18,000 tons of greenhouse gases from being emitted to the atmosphere. In the future, this bioprocess can be tuned to address other dairy processing streams, allowing the WheyAway to provide value to stakeholders across the entire dairy production value chain.

    This SBIR Phase I project proposes to scale-up and optimize a novel fermentation bioprocess called the WheyAway system, and can economically convert acid whey waste into valuable platform chemicals, to provide value to Greek yogurt and cottage cheese producers. Plan is to scale to maximize bio-oil production and conversion efficiency through system optimization. A key focus will be to lower the capital cost for the extraction process. Through the tasks proposed for this SBIR, objectives to scale to a 5x larger reactor, lower operating expense by 20%, and lower the capital cost of the currently expensive bio-oil extraction process by 10x. Additionally, potential to convert other dairy process streams, such as sweet whey, will be evaluated, which could unlock larger opportunities in the dairy production value chain.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 915 N Tioga St
  awardeeCity: Ithaca
  awardeeCountryCode: US
  awardeeName: Capro-X
  awardeeStateCode: NY
  awardeeZipCode: '148503669'
  fundsObligatedAmt: '224868'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820211'
  piEmail: guzman.juan@capro-x.com
  piFirstName: Juan
  piLastName: Guzman
  piMiddeInitial: J
  piPhone: '5083539514'
  poName: Anna Brady-Estevez
  date: 06/19/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Microbial Fermentation Bioprocess to Produce and Extract
    Platform Chemicals from the Dairy Industry Acid Whey Waste Stream.'
- abstractText: |-
    This Small Business Innovation Research Phase I project will develop customizable cell/tissue culture platforms using a new class of 3D printable bisphenol A-free polycarbonate (BFP) materials and a rapid 3D printing system. The 3D cell culture market was valued at $683 million in 2017 with an exponential projected growth in revenue valued at $1.7 billion by 2022. The rapid growth in this sector is primarily driven by the demand for custom-made 3D cell/tissue models that more accurately recapitulate the human in vivo biology in comparison to conventional animal models and planar cell culture systems. 3D cell/tissue models have the potential to provide more physiologically relevant responses for the drug discovery industry which is estimated to reach $86 billion in 2022. The proposed strategy of using BFP and a fully integrated benchtop 3D printing system will facilitate the production of different cell/tissue culture platforms on demand and enable rapid iteration of different designs to drive forward the development of more clinically relevant cell/tissue models for a broad market in pharmaceuticals, biotechnology, and biological studies.

    The intellectual merit of this project lies in: (1) the development of novel 3D printable BFP materials with tunable material properties using green chemistry, and (2) the rapid 3D printing of customizable cell/tissue culture prototypes to support various 3D cell/tissue models. The material development will include the establishment of a reagent library and optimization of the green chemistry process. The relevant material properties such as stiffness, elasticity, optical transparency, and small molecule adsorption will be characterized and optimized. These materials will then be printed using a rapid light-based 3D printer to prototype cell/tissue culture platforms followed by evaluation of their performance. In particular, 3D printing precision and resolution will be characterized and optimized by varying a range of fabrication parameters such as light exposure time and intensity. Next, the efficacy of the prototypes under cell culture conditions will be assessed based on device integrity, material degradation, as well as changes in mechanical and optical properties. Various cells/tissues will also be cultured on these prototype devices to evaluate biocompatibility. These achievements will provide customized culture platforms to facilitate the engineering of more physiologically relevant in vitro models for accelerating drug discovery and biological studies in both industry and academia.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 6404 Nancy Ridge Dr.
  awardeeCity: San Diego
  awardeeCountryCode: US
  awardeeName: Allegro 3D, Inc
  awardeeStateCode: CA
  awardeeZipCode: '921212248'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819239'
  piEmail: wzhu@allegro3d.com
  piFirstName: Wei
  piLastName: Zhu
  piPhone: '8589977741'
  poName: Linda Molnar
  date: 06/19/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I: 3D Printing of Bisphenol A-free Polycarbonates for Customizable
    Cell/Tissue Culture Platforms'
- abstractText: |-
    This SBIR Phase I project will develop text, speech and image analysis technologies to transform a set of educational lecture videos into an interactive learning companion. A lecture video will be presented as a series of topically cohesive sections, each represented by a textual summary, a visual summary, and a video segment. Students will be able to query a series of lecture videos with the answers presented as a combination of text, images, speech with transcript, and video, along with links to additional relevant resources. These technological enhancements will drive the development of the lecture video management system with capabilities well beyond commercial state of the art. The students will gain the ability to instantly access any information in a semester long course, with little overhead for the instructor. The business plan focuses on a freemium model designed for wide adoption with no cost to instructors and a very low cost to students. The ultimate potential societal benefit is a significantly better learning experience and learning outcomes for higher education students.


    The key innovations in this project are summarization of video segments and a Questions & Answers (QA) system customized for a series of lecture videos. These are formidable challenges despite existing substantial related research in text mining and image analysis. The information content of a lecture video spans multiple modalities, specifically, screen text, images, and speech. Further, each modality has unique characteristics. Screen text is typically unstructured and includes Optical Character Recognition errors. Transcripts from classroom lecture videos contain informal classroom interactions and suffer from speech recognition errors. The images in a lecture video can represent a variety of concepts including illustrative examples, graphs and charts, and camera images. Innovative approaches to topic modeling will be developed to handle the unique nature of the input compared to most documents. The project will employ representation learning approaches to map from each modality to a common semantic space that will drive the matching between student questions and the content of lecture videos. Since the best answer to a student question may not be fully contained in a lecture video, external resources including textbooks, message boards, and actual quizzes and exams will also be analyzed to drive the QA module.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3615 Graustark St
  awardeeCity: Houston
  awardeeCountryCode: US
  awardeeName: Videopoints LLC
  awardeeStateCode: TX
  awardeeZipCode: '770064225'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820045'
  piEmail: ioannis.konstantinidis@videopoints.org
  piFirstName: Ioannis
  piLastName: Konstantinidis
  piPhone: '8325120348'
  poName: Rajesh Mehta
  date: 06/19/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  VideoPoints: A Companion for Classroom Learning'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is that it holds the promise of significantly reducing the over fertilization of crop fields with poultry litter and at the same time provide poultry farmers with greater profits.  Currently poultry litter (excrement, feathers, bedding and other waste) is used as fertilizer on crop fields. The litter is excessively high in phosphorous which is not well adsorbed by crops and ends up in waterways causing excessive algae growth resulting in dead zones with no aquatic life.  This project expects to prove the practicality of a high efficiency burn system that is low enough in cost to be affordable by individual farmers. The system will burn poultry litter and convert the resulting heat energy to electricity and hot water for heating the farmer's chicken houses. The energy savings will increase farmer's net profits (including the amortized cost of the system) by, on average, 25%.  Thus poultry farmers will be incentivized to eliminate environmentally dangerous poultry litter by converting their farm waste to energy.


    This SBIR Phase I project proposes to design, produce and test a scaled prototype version of the lab test system.  The lab test system is expected to provide burn efficiencies as high as ~97% with particulate emissions well within EPA standards. The scaled system will be designed to process ten times the litter as the lab system.  The primary question this SBIR project will answer is: can the lab results be replicated in a full scale system capable of handling the requirements of an average poultry farm.  The patent pending technology upon which the lab system was designed uses computer controlled fuel (poultry litter) feed rates coupled with a multilevel air injection system to produce optimal efficiency. There are several variables that will be tested to ensure upscaling the size will be successful. These include combustion chamber size and design, air injection locations, pressures and CFM, and fuel feed rates.  Successful commercialization will require optimization of these variables in a full scale system.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1200 Shore Road
  awardeeCity: Baltimore
  awardeeCountryCode: US
  awardeeName: CykloBurn Technologies LLC
  awardeeStateCode: MD
  awardeeZipCode: '212205526'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819593'
  piEmail: rob@techcomventures.com
  piFirstName: Robert
  piLastName: Meissner
  piPhone: '4433103888'
  poName: Anna Brady-Estevez
  date: 06/18/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Biomass to Energy Conversion'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is to develop a protein replacement for soy-based marine
    animal diets to improve yield through effective nutrition and enhanced animal
    welfare. Aquafeeds represent >50% of the cost of production, and losses due to
    mortality can be as high as 50% in certain commercial species. A novel feed ingredient
    that contains immuno-nutritional properties to address these inefficiencies could
    be considered a game-changer to the industry. Fish are the most resource-efficient
    sources of animal protein, a healthy source of food for people, and will be one
    of the ways to address food security. As the surface of the planet is greater
    than two-thirds ocean, one estimate suggests, if managed properly, just 2% of
    this vast resource could produce enough food for all of mankind. \n\nThis SBIR
    Phase I project proposes to expand previous studies that suggested a novel single
    cell protein (SCP) is a significant candidate to serve as a fishmeal alternative.
    In addition, SCP also may contain functional properties that improve growth performance
    and survival. The SCP tested previously supported improved feed conversion ratios
    (FCR) as compared to conventional diets, while at the same time, statistically
    relevant improvements in survival of carnivorous fish and shrimp.  It also was
    observed that SCP relieved secondary disease complications associated with diets,
    such as gastro-enteritis. With hundreds of marketable species in aquaculture,
    and an industry that is just 50 years old, the collective understanding of aquatic
    animal nutrition is in its infancy. In this project, a carnivorous Seriola species
    will be used as a model organism to serve as an additional reference point beyond
    salmon. Targeted components of the SCP will be enhanced (or deleted) to determine
    the effect of leading immuno-nutritional candidates on the animals' ability to
    digest more completely inputs like soy bean meal (SBM). The effectiveness of SCPs
    in emerging commercial fish diets has yet to be fully elucidated, and the results
    of this study may have implications towards lower-cost feed formulations and optimized
    nutrition.\n\nThis award reflects NSF's statutory mission and has been deemed
    worthy of support through evaluation using the Foundation's intellectual merit
    and broader impacts review criteria."
  awardeeAddress: 142 Still River Rd
  awardeeCity: Harvard
  awardeeCountryCode: US
  awardeeName: KnipBio Inc
  awardeeStateCode: MA
  awardeeZipCode: '014511501'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819652'
  piEmail: lfeinberg@knipbio.com
  piFirstName: Larry
  piLastName: Feinberg
  piPhone: '4136278149'
  poName: Ruth Shuman
  date: 06/18/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Novel Immuno-Nutrition Properties of a Single Cell Protein
    to Abate Soy-Induced Enteritis in Aquafeeds'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to further the development of a patent pending technology aimed at producing flexible, lightweight, and low-cost semiconductor substrates. These flexible semiconductor films represent the next evolution of the silicon wafer, the foundation of over 90% of today's electronic devices, including computer chips, solar panels, microelectronics, and a wide range of sensors and similar 'internet of things' devices. The silicon wafer, in its current form, is essentially unchanged since its inception over 60 years ago. These wafers, although larger today, remain thick, rigid, fragile, and are limited to circular forms no larger than 450 millimeters (18 inches) in diameter. The ability to produce large-area, high-throughput quantities of this material, in a flexible, more durable format would be truly disruptive, and help to usher in the next generation of affordable, flexible, and pervasive electronic devices. Accelerating the commercialization of this 'wafer 2.0' will help to shape America's high-tech semiconductor manufacturing industry for the 21st century.

    The proposed project will focus on the development of this innovative technology at a simulated roll-to-roll prototyping scale, to enhance film crystal quality, repeatability, and electronic properties, while preparing the process for integration into large scale manufacturing. To date, no techniques exist that can produce large-area, highly crystalline silicon or other semiconductor films, that are suitable for high-throughput manufacturing. The technique in this proposed work is a novel, patent pending process, suitable for high-throughput roll-to-roll manufacturing and has several technical advantages that favor high-uniformity crystallization. Low-cost, flexible, wafer-like substrates will open the door for a wide range of electronic devices and fully integrated system-on-chip designs, including sensors, displays, lighting, processors, memory, microelectronics, and photovoltaics. Specific research activities will include optimization of the crystallization process via exploration of operating parameters; improvements and refinements to the prototype chamber equipment; evaluation of intermediate thin-film layers to provide ideal electronic properties and to promote more favorable recrystallization; and, finally, characterization of the resulting semiconductor films using state of the art semiconductor tools at the world's largest nanotechnology focused institute.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1400 Washington Ave
  awardeeCity: Albany
  awardeeCountryCode: US
  awardeeName: Lux Semiconductors
  awardeeStateCode: NY
  awardeeZipCode: '122220000'
  fundsObligatedAmt: '224949'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819961'
  piEmail: ghousser@outlook.com
  piFirstName: Graeme
  piLastName: Housser
  piPhone: '5187887245'
  poName: Rick Schwerdtfeger
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Roll-to-Roll Manufacturing of Highly Crystalline Thin Film
    Semiconductor Substrates for Flexible Electronics'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is to use self-assembling nanoparticle systems made from
    renewable, bio-based materials to replace manufacturing processes that conventionally
    rely on high-energy reaction conditions and petroleum-based chemicals.  This innovation
    will enhance technical understanding of the property-performance relationship
    between chemistry formulations, nanoparticle morphology, and product performance.
    \ This project will enable US manufacturers to reduce their production and disposal
    of toxic waste and utilize locally produced feedstocks and inputs in manufacturing
    process that are lower in carbon intensity, and will also create new markets for
    US produced feedstocks and materials.\n \nThis SBIR Phase I project proposes to
    optimize a green nanoparticle-forming solvent system that self-assamble to function
    as \"microreactor\" vessels that can produce cathode materials which are used
    in rechargeable battery systems for the growing energy storage market. Solution-based
    synthesis methods have been used to prepare different cathode materials, but control
    over product structure and quality requires detailed understanding of the solution
    chemistry, which can be obscured by downstream variables that are introduced during
    electrode formation.  This screening process will be streamlined by characterizing
    and quantifying the properties of intermediates produced in order to determine
    optimal chemistry formulation, particle size, and calcination conditions for battery
    performance.  The approach will use rapid characterization methods that require
    only microscale quantities of material in order to develop a sensitivity matrix
    that relates the impact of renewable composition inputs and reaction variables
    on cathode material size and morphology, allowing prediction of overall battery
    performance.\n\nThis award reflects NSF's statutory mission and has been deemed
    worthy of support through evaluation using the Foundation's intellectual merit
    and broader impacts review criteria."
  awardeeAddress: 927 Thompson Place
  awardeeCity: Sunnyvale
  awardeeCountryCode: US
  awardeeName: Sylvatex Inc.
  awardeeStateCode: CA
  awardeeZipCode: '940854518'
  fundsObligatedAmt: '224063'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819697'
  piEmail: vklausmeier@sylvatex.com
  piFirstName: Virginia
  piLastName: Irwin Klausmeier
  piPhone: '5412211362'
  poName: Anna Brady-Estevez
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Development of Renewable Nanoparticle Platform for Green
    Energy Production and Storage Applications'
- abstractText: "The broader impact/commercialization potential of this SBIR project
    is an electrochemical water treatment technology which has the potential for minimizing
    cost, requiring little to no maintenance, and comprehensively treating harmful
    contaminants such as pathogens, toxic organics, and metals in drinking water.
    \ About 80M U.S. homeowners are seeking a water purification solution for fear
    of their water quality. They are unsatisfied with the high maintenance, long-term
    costs, and lack of comprehensive treatment capabilities of existing systems. \n\nThis
    SBIR Phase I project proposes to optimize, demonstrate, and scale an electrochemical
    water purification system for residential point-of-entry application. Existing
    water purification systems are largely ineffective in comprehensively treating
    contaminants such as pathogens, toxic organics, and metals, and also require frequent
    maintenance which contributes to high costs and waste generation. To address these
    concerns, the treatment effectiveness, cost, and feasibility of treating water
    contaminated with pathogens and toxic organic compounds by the proposed electrochemical
    technology will be studied in laboratory and pilot scale applications. Design
    parameters will be optimized for highest treatment capability and lowest costs
    and maintenance needs. Prototypes will be scaled for pilot evaluation at flow
    rates for residential point-of-entry application and evaluated for robustness.
    The laboratory and pilot units will be evaluated for perfluorinated compound (PFC)
    removal consistent with NSF/ANSI P473 and for pathogen disinfection following
    EPA Purifier Standard Certification. PFC removal and disinfection are keys to
    proving a comprehensive water purification solution for decentralized treatment.
    The end result will be a small product automated by sensors that connects directly
    in-line with a building's plumbing.\n\nThis award reflects NSF's statutory mission
    and has been deemed worthy of support through evaluation using the Foundation's
    intellectual merit and broader impacts review criteria."
  awardeeAddress: 10 Chestnut Hill Rd.
  awardeeCity: North Oxford
  awardeeCountryCode: US
  awardeeName: Aclarity, LLC
  awardeeStateCode: MA
  awardeeZipCode: '015371103'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819438'
  piEmail: info@aclaritywater.com
  piFirstName: Julie
  piLastName: Mullen
  piMiddeInitial: B
  piPhone: '7745516213'
  poName: Anna Brady-Estevez
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Performance and Feasibility Evaluation of Electrochemical
    Advanced Oxidation Technology for Water Purification'
- abstractText: |-
    This Phase I SBIR project will investigate cure-in-place materials for filling and stabilizing open wounds to promote healing. Chronic wounds represent a significant and debilitating burden to patients, affecting more than 6.5 million people in the US alone. The incidence of chronic wounds is expected to rise with increasing rates of obesity and diabetes, but current treatment options show limited clinical efficacy. To address this unmet need, new materials that stimulate the body's healing mechanisms must be developed. This project will evaluate a promising new material that can be applied to a wound as a liquid and cured to a solid in contact with the wound. This cure-in-place process is expected to promote healing by ensuring intimate contact between the pro-healing material and the wound bed, mechanically stabilizing the wound area, and stimulating the body's healing responses. There are few cure-in-place materials in clinical use, so this project will also generate new fundamental engineering knowledge about these materials and their potential applications in human health. The advanced wound care market is currently valued at more than $8 billion, and it is growing. Therefore, innovative technologies in this space represent significant business opportunities that create economic growth.

    This project will investigate a novel cure-in-place process for generating a polysaccharide biomaterial that mimics the mechanical and structural properties of native extracellular matrix to stimulate wound healing. The material is generated by curing two aqueous precursor solutions to form a biodegradable, solid, and hydrated polymer matrix. This project will investigate a cure-in-place process by which the precursor solutions will be applied to the wound as liquids and cured in contact with the wound bed. If the extracellular matrix replacement biomaterial can be cured inside of a wound bed, then its pro-healing effects may be amplified due to its ability to fill an irregularly-shaped wound with complete contact with tissue and its capacity to mechanically stabilize the wound bed and stimulate pro-healing biochemistry. The scope of this effort will include developing an optimized formulation for the cure-in-place precursor solution, determining curing conditions for the biomaterial in contact with tissue, evaluating the material properties of the cure-in-place product, and evaluating cure-in-place application and wound healing efficacy in a porcine excisional wound model.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 180 W Ostend St.
  awardeeCity: Baltimore
  awardeeCountryCode: US
  awardeeName: Gemstone Biotherapeutics, LLC
  awardeeStateCode: MD
  awardeeZipCode: '212303755'
  fundsObligatedAmt: '224563'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819788'
  piEmail: eenglish@gemstonebio.com
  piFirstName: Emily
  piLastName: English
  piPhone: '6084694907'
  poName: Henry Ahn
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I: Cure-in-Place Extracellular Matrix Replacement Scaffolds for
    Wound Healing'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is a 25% cost reduction in solar panel manufacturing
    and the elimination of up to 2.1 Gigatons of annual CO2 generation. As silicon
    wafers are the most expensive component in the $50BN solar panel industry, our
    low-cost wafer manufacturing technology presents the strongest opportunity to
    reduce global solar panel production costs. This cost reduction drives the compelling
    economics needed for increasing solar market penetration. As context, the solar
    market has historically doubled for every 20% cost reduction created by the industry.
    Our single crystal wafers are further significantly higher quality, and therefore
    can enable up to 10% higher effective efficiency using existing commercial solar
    panel manufacturing lines. Further, as the incumbent silicon wafer production
    process is extremely energy- and material-intensive and thus constitutes 80% of
    the solar industry?s carbon footprint, our direct and high efficiency technology
    has the potential to reduce the solar industry's 2026 carbon footprint by over
    50%. \n\nThe proposed project develops the systems needed for our process to produce
    silicon wafers with commercial dimensions and demonstrates to solar manufacturers
    (our customers) that our wafers can be processed by commercial solar cell lines.
    As our process produces a continuous ribbon of silicon, this work will develop
    a cutting system that laser cuts discrete wafers with the edges and dimensions
    needed for commercial solar cell processing. This involves developing the laser
    cutting recipes, the wafer handling systems, and verifying with a third party
    that the edge quality does not interfere with cell processing. Our project then
    investigates and optimizes our wafers' performance during each critical step of
    commercial solar cell processing, including chemical etching and screen printing.
    A successful demonstration that our low-cost wafer can 'drop-in' to an existing
    cell line to deliver equivalent (or better) performance compared to the incumbent
    technology would gate our working with industry partners to commercialize this
    process.\n\nThis award reflects NSF's statutory mission and has been deemed worthy
    of support through evaluation using the Foundation's intellectual merit and broader
    impacts review criteria."
  awardeeAddress: 98 Prospect Street
  awardeeCity: Somerville
  awardeeCountryCode: US
  awardeeName: Leading Edge Crystal Technologies, Inc.
  awardeeStateCode: MA
  awardeeZipCode: 021434109
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820028'
  piEmail: greenlee@lectechnologies.com
  piFirstName: Alison
  piLastName: Greenlee
  piPhone: '8572256214'
  poName: Rick Schwerdtfeger
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 09/30/2019
  title: 'SBIR Phase I: Refinement of the Floating Silicon Method to Produce Drop-In
    Silicon Wafers for High Efficiency Solar Cells'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is that it will enable technologies on the cutting-edge
    like Spin Torque Transfer-Random Access Memory (STT-RAM) and high efficiency solar
    cells to permeate the marketplace. Currently, semiconductor applications like
    these technologies face significant nanomanufacturing challenges. In fact, fabricating
    semiconductor devices is so challenging that 55% of new semiconductor products
    fail to meet their original launch date and over 40% of development projects exceed
    the planned budgets. With its proposed virtual recipe development environment,
    this SBIR project will allow semiconductor chip and equipment manufacturers to
    save up to 66% of process development costs, gain market share through three times
    faster development cycles, and enable the process development of next-generation
    of high performance, energy efficient electronic devices. \n\nThe proposed project
    will use statistical self-learning inference algorithms, sophisticated process
    models, and the vast amount of available fab data to make high accuracy process
    predictions and enable high volume manufacturing of innovative nanotechnologies.
    Three key components will be developed: (1) A recipe analytics engine capable
    of performing process predictions and process design for multiple process objectives,
    (2) A topography simulator for profile prediction of nanofeatures, and (3) A commercial
    platform interface for real-time process development decision making. The components
    will be devised to accurately capture large process systems and multiple process
    objectives, reduce computational expense, and facilitate commercial adoption.
    These innovations will be accomplished by: (a) Using parallel computing to reduce
    computational expense, (b) Developing reduced-order plasma and surface kinetic
    models, (c) Employing adaptive algorithms to accelerate recipe optimization, and
    (d) Using uncertainty analysis techniques for recipe co-optimization.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 4600 W Guadalupe St
  awardeeCity: Austin
  awardeeCountryCode: US
  awardeeName: SandBox Semiconductor Incorporated
  awardeeStateCode: TX
  awardeeZipCode: '787512959'
  fundsObligatedAmt: '224826'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819610'
  piEmail: meghali.chopra@sandboxsemiconductor.com
  piFirstName: Meghali
  piLastName: Chopra
  piMiddeInitial: J
  piPhone: '2142887926'
  poName: Rick Schwerdtfeger
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Disruptive Semiconductor Software Tool for Recipe Optimization
    for Deposition and Etching Processes'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be the establishment of the analytical framework and software for a global bathymetry mapping system based upon freely available satellite imagery, three independent extraction methods, and ongoing data collection to create geospatial products for a wide range of applications.? Shallow water zones are crucial to the world?s ecology, economy, and culture.  An estimated 70% of the world?s littoral zone is not mapped to modern standards, and traditional methods of mapping these areas are prohibitively expensive and dangerous. Through remote sensing techniques, this innovation will produce detailed bathymetric data for shallow water areas around the globe at far lower costs than traditional methods. This is particularly significant for impoverished remote, low-lying islands which have scarce resources for mapping the natural environment on which their economies heavily rely. ?Additionally, shallow water bathymetry data is vital to geospatial intelligence and to accurately assessing the feasibility and environmental impact of projects relating to global trade/port development, aquaculture, tourism, and resource development.? The results of this innovation will provide a modern baseline of seabed topography for future scientific analysis, change detection, and greater understanding of the marine environment.

    The proposed project addresses the budgetary and health and safety challenges of nearshore bathymetry mapping by advancing three distinct methods of calculating satellite derived bathymetry. These methods rely on different parameters of measurement for water depth retrieval, enabling the advantages of one method to overcome the shortcomings of another. This will create a self-validating method for leveraging advanced remote sensing algorithms in an integrated software platform with ongoing data collection to produce 10-30m resolution bathymetry elevation models.? Extraction methods utilize underwater stereophotogrammetry from multiple overlapping images, wave kinematic detection from multispectral imagery, and measurement of variable attenuation of multispectral signals through the water column.? Research will be conducted on computer vision applications for assessing and allocating images based upon metocean and atmospheric parameters; seafloor spectral segmentation techniques and effects on subsequent multispectral depth retrieval; automation of stereophotogrammetric seafloor target identification and correlation, and integration and automation of wave kinematic derived depth values with multispectral depth retrieval values.? Statistical analysis of resulting data from this combined processing method, evaluated against in situ data for trial locations, will provide direct comparisons for accuracy reporting, algorithm refinements, computational optimization, and determine overall technical and commercial feasibility of future global implementation.?

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3015 W 9th Ave
  awardeeCity: Denver
  awardeeCountryCode: US
  awardeeName: TCarta Marine, LLC
  awardeeStateCode: CO
  awardeeZipCode: '802043109'
  fundsObligatedAmt: '223655'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819367'
  piEmail: kg@tcarta.com
  piFirstName: Kyle
  piLastName: Goodrich
  piPhone: '3032846144'
  poName: Rick Schwerdtfeger
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Project Trident: A Three-Pronged Automated Solution to Satellite
    Derived Littoral Bathymetry Mapping'
- abstractText: |-
    The broader impact/commercial potential of this project covers a myriad of domains including wireless health-care, remote education, supply-chain management, public safety, anti-poverty initiatives, market-places, and entertainment. However, a more immediate work product from this effort is a powerful fully-digital mmWave software defined radio (SDR) platform that will be made available to academic researchers at very affordable rates; this will spur further research and make mmWave testbed experimentation within the reach of lightly-funded academic research groups. The ambitious goal of making this transformative technology the reference design of future mmWave radios represents a massive commercial opportunity which is not limited to the cellular ecosystem (base station, tablets and smartphones), but rather extends to new connected players such as cars, drones, virtual reality (VR) headsets and beyond.

    This Small Business Technology Transfer (STTR) Phase I project focuses on the development of millimeter-wave (mmWave) radio technologies for next generation wireless systems. The mmWave frequencies of above 28 GHz are necessary to alleviate the spectrum crunch in the traditional cellular bands, and to make ultra-fast 5th Generation (5G) cellular a reality. However, the uniquely challenging propagation characteristics at these frequencies necessitates the use of transceivers that not only operate over low power budgets, but also deliver the robustness that the cellular ecosystem demands. While existing transceivers allow the radio to look (i.e., transmit or receive) in only one direction or a small number of directions at a time, the proposed transceiver design allows the radio to look in all directions simultaneously. While seemingly simple, this unique ability - combined with a top-down implementation ? will provide enormous benefits to cellular systems at reasonable power budgets. The proposed technology forms the key technological bridge between the theoretical promise of mmWave and actually achieving it in the real world.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 95 LINDEN BLVD APT 65A
  awardeeCity: BROOKLYN
  awardeeCountryCode: US
  awardeeName: PI RADIO INC
  awardeeStateCode: NY
  awardeeZipCode: '112263291'
  fundsObligatedAmt: '224493'
  fundProgramName: STTR PHASE I
  id: '1821150'
  piEmail: mezzavilla.marco@gmail.com
  piFirstName: Marco
  piLastName: Mezzavilla
  piPhone: '3475931161'
  poName: Muralidharan Nair
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'STTR Phase I:  A Fully-Digital Transceiver Design for mmWave Communications'
- abstractText: |-
    The broader impact/commercial potential of this project is the practical deployment of a low-cost and low-power real-time perception system in self-driving consumer cars. This edge computing functionality in sensors enables higher reliability and lower cost of overall sensing and computing needed for truly autonomous self-driving. Such innovation will contribute significantly to the early and widespread availability of safety and convenience benefits to consumers. Furthermore, the advanced perception system will have a potential long-term impact on robotics in general, which can lead to creation of new markets and new lifestyles.

    This Small Business Innovation Research (SBIR) Phase I project aims to develop efficient algorithms and software implementation of a real-time perception system to enable the use of low-cost computing systems for self-driving cars. The algorithms provide a novel way of using image features to perform simultaneous localization and mapping (SLAM) with 100 times less computational costs than the existing algorithms. They also include a truly novel neural network to fuse the image feature and light detection and ranging (LiDAR) features and perform object detection, which has 100 times less complexity compared to the state-of-the-art method. These reduced-complexity algorithms can be implemented on low-power and low-cost SoC processors.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 1267 Willis Street, STE 200
  awardeeCity: Redding
  awardeeCountryCode: US
  awardeeName: Apollo AI Inc.
  awardeeStateCode: CA
  awardeeZipCode: '960010400'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820462'
  piEmail: kojiseto@apolloaisystems.com
  piFirstName: Koji
  piLastName: Seto
  piPhone: '4087581593'
  poName: Muralidharan Nair
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Low-cost real-time perception system for self-driving consumer
    cars'
- abstractText: |-
    The broader impact/commercial potential of this project includes increased range, increased efficiency, and decreased size of wireless charging systems, which will provide value to consumer devices (e.g., mobile phones and tablets), transportation, and medical industries. In consumer devices, improved and widely adopted wireless power transfer can lead to more rugged designs of the devices by eliminating charging ports, which are a common mode of device failure. Widely adopted wireless charging can improve convenience for consumers, and, with a unified charging solution across a number of devices, eliminate the need for dedicated, device-specific chargers. Increased charging range will increase the number of use cases in all three industries, leading to greater commercial opportunities for this this technology and wireless power transfer in general. In transportation, high-efficiency wireless charging allows for fast charging that is adaptable to varying vehicle heights, which makes electric vehicles more convenient, increases their rate of adoption, and allows charging that is integrated into infrastructure. Increased efficiency reduces the energy costs associated with charging across all three industries.  Furthermore, this project will enhance the scientific understanding of the power handling capabilities of the multilayer self-resonant structure, and the resonant frequencies achievable with various manufacturing techniques.

    This Small Business Technology Transfer (STTR) Phase I project addresses the technical challenges keeping a new wireless power transfer coil technology, called the multilayer self-resonant structure (MSRS), from the market.  In order to commercialize the MSRS, the technology must advance beyond a proof-of-concept, and interface with commercial wireless power transfer systems, specifically those that adhere to existing device standards.  The technical hurdles that need to be addressed include 1) reducing the resonant frequency to meet current standards, 2) understanding the power handling limits, and 3) developing electronic interfaces.  These challenges will be overcome by, respectively,  1) building on existing manufacturing techniques used to handle thin layers of material in other industries and adapting them to  develop a scalable manufacturing approach to construct MSRSs with resonant frequencies in the range needed. 2) Analyzing, measuring, and modeling the power handling capabilities of the MSRS.  Finally, 3) Developing impedance matching circuitry required to interface the MSRS with commercial systems. Successful completion of these task will results in a low cost, high-Q wireless power transfer coil, which can be integrated into commercial systems to increase the capable range, efficiency, and power handling of wireless charging.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 34 Ralston ln
  awardeeCity: West Lebanon
  awardeeCountryCode: US
  awardeeName: Resonant Link LLC
  awardeeStateCode: NH
  awardeeZipCode: 037841026
  fundsObligatedAmt: '224997'
  fundProgramName: STTR PHASE I
  id: '1820089'
  piEmail: aaron.stein21@gmail.com
  piFirstName: Aaron
  piLastName: Stein
  piMiddeInitial: L
  piPhone: '7346455347'
  poName: Muralidharan Nair
  date: 06/15/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'STTR Phase I:  Self-resonant Structures for Long-Range High-Efficiency Wireless
    Power Transfer'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the creation of flexible passenger identification displays for ride-hailing and automotive applications. This is a distinct pain point as many drivers choose the same model cars. Our first application is to solve ride-hailing passenger identification, but this becomes more critical with autonomous vehicles -- the only method of visual communication between an autonomous car and its target passenger will be via display. By helping to enable autonomous fleets of service vehicles, our displays will impart significant societal benefits, including reduced emissions, improved mobility for the elderly and disabled, and fewer traffic accidents. Beyond automotive, researchers estimate that in 2017 there are 20 billion devices connected to the Internet that are not computers, growing to 125 billion by 2025. These will influence many areas, including health and wellness, factory production, public safety, retail, agriculture, homes, and offices. They will enable better resource allocation, predictive maintenance, operations management, worker training, task automation, energy management, and safety. Not all of these ?Internet of Things? devices need displays, but those that do use them for input and information relay ? the exact uses for which our displays are designed.

    The proposed project will develop roll-to-roll printed passive matrix OLED (PMOLED) display technology. PMOLED displays are built upon a patterned transparent conductive anode that defines the pixels. To date, the only method used in industry to create this anode is photolithography. This is a slow and expensive batch process, but it is the only method that can produce the required results. Our high-resolution printable anode replaces both the incumbent material and the lithographic process to create a continuous roll of plastic covered in OLED anodes that can be loaded into a printing press. This lays the foundation for fully printed displays, fabricated using flexography, the same technique used to print newspapers. Through this work, we will produce fully printed PMOLED display prototypes. These thin, flexible displays will have extremely high contrast while using only 20% of the power required by a backlit LCD, with wide viewing angles for easy readability and flexibility to conform to any surface. If successful, we will be able to print displays 1000 times faster than the industry standard throughput while reducing materials waste by 80%. Such cost savings will make our displays the obvious choice for information display use, especially in design-driven applications.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 247 Santa Ana Ct.
  awardeeCity: Sunnyvale
  awardeeCountryCode: US
  awardeeName: Sinovia Technologies
  awardeeStateCode: CA
  awardeeZipCode: '940854511'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819843'
  piEmail: whitney@sinoviatech.com
  piFirstName: Whitney
  piLastName: Gaynor
  piPhone: '6507048629'
  poName: Rick Schwerdtfeger
  date: 06/14/2018
  startDate: 06/15/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Flexible Printed OLED Displays for Automotive and Ride-Hailing'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is the development of an effective and sustainable alternative
    to antibiotics and biocides used in animal feed, which will help mitigate the
    global health threat of multidrug-resistant bacteria. The beef cattle industry
    is under increasing regulatory and public pressure to reduce or eliminate the
    use of antibiotic feed additives as they are considered a major factor driving
    the proliferation of antibiotic-resistant bacteria. However, in-feed antibiotics
    provide significant economic and animal welfare benefits to the cattle industry
    by reducing the incidence and severity of liver abscesses. This project provides
    an alternative for these conflicting concerns by providing a cost-effective alternative
    to in-feed antibiotics. Further, with sufficient understanding of how the rumen
    microbiome impacts animal physiology and performance, this technology could be
    easily adapted to selectively target microbial species that reduce animal growth
    or feed efficiency, or that produce methane, increasing the economic and environmental
    sustainability of livestock agriculture. \n\nThis SBIR Phase I project proposes
    to develop a low-dose, bacteriophage-based feed additive that can be prophylactically
    administered to control the growth of pathogenic Fusobacterium necrophorum in
    cattle rumen. F. necrophorum is a causative agent of liver abscesses in grain-fed
    cattle, and antibiotics are currently added to feed to prevent its growth and
    limit abscess occurrence. However, in-feed antibiotics promote the proliferation
    of antibiotic resistant bacteria, and can cause undesirable off-target effects
    to the rumen microbiome. This research seeks to develop broad host-range (polyvalent)
    bacteriophages as an economical means of controlling cattle pathogens. Polyvalent
    bacteriophages will be isolated using specialized methods that select for those
    with a predetermined host-range based on rumen microbial composition. Each bacteriophage
    will then be characterized and tested for efficacy within a bioreactor operated
    to simulate the cattle rumen. Bacteriophage cocktails will be formulated and tested
    for their ability to minimize the development of bacteriophage resistance. The
    expected outcome of the proposed research is a library of polyvalent bacteriophages
    that can effectively control F. necrophorum under rumen-like conditions, and which
    will be further tested in animal studies.\n\nThis award reflects NSF's statutory
    mission and has been deemed worthy of support through evaluation using the Foundation's
    intellectual merit and broader impacts review criteria."
  awardeeAddress: 5250 Jackwood St
  awardeeCity: Houston
  awardeeCountryCode: US
  awardeeName: Sentinel Environmental Group LLC
  awardeeStateCode: TX
  awardeeZipCode: '770961313'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820015'
  piEmail: jmathieu@senviron.com
  piFirstName: Jacques
  piLastName: Mathieu
  piMiddeInitial: M
  piPhone: '7033075802'
  poName: Ruth Shuman
  date: 06/14/2018
  startDate: 07/01/2018
  expDate: 12/31/2019
  title: 'SBIR Phase I:  Polyvalent Bacteriophages as Livestock Feed Additives and
    Alternatives to Antibiotics for Pathogen Control and Improved Animal Performance'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to develop single cell analysis technology to provide insight into cellular mechanisms, which has the potential to transform drug development and manufacturing. Single-cell analysis, or the ability to decipher cell-to-cell heterogeneity, is a limiting factor in biotechnology and clinical applications. This project aims to further develop a transformative platform technology for integrated single-cell analysis capable of addressing existing challenges with the current state-of-the-art. The platform will potentially shift the paradigm of drug development and manufacturing, enabling quick iteration and evaluation of new therapeutic compounds. This approach could significantly reduce the time and cost to bring new drugs to market and reduce the overall cost of treating patients, which is a substantial benefit to society. Beyond this initial application, this single-cell analysis platform could become a readily implemented research tool, enhancing our basic understanding of biology, facilitate engineering of cell function, as well as evaluating safety and efficacy of new drugs and treatments.

    This SBIR Phase I project proposes to develop a robust and cost effective commercial prototype technology platform for integrated single-cell analysis. A key feature of the platform technology is the unprecedented sensitivity in measuring quantitatively secreted molecules from single cells. This is achieved by incubating single cells in extremely small volumes, and enabling analytics on an unprecedented scale in these microscopic bioreactors. The proposed work will lead to the development of a consumable prototype microfluidic chip, enabling quick and resource efficient adaptation of the platform to the marketplace. The proposed prototype will be validated through relevant studies, addressing a confirmed market need in cell line development. Commercial adaptation of this prototype will potentially provide deep insight into biological and physiological processes on a single-cell level, and transform drug development and manufacturing, therapeutic treatment, as well as clinical diagnostics.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 99 North St
  awardeeCity: Somerville
  awardeeCountryCode: US
  awardeeName: ONECYTE BIOTECHNOLOGIES, INC.
  awardeeStateCode: MA
  awardeeZipCode: 021441129
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819932'
  piEmail: kosta.tsioris@gmail.com
  piFirstName: Konstantinos
  piLastName: Tsioris
  piPhone: '6179107825'
  poName: Ruth Shuman
  date: 06/14/2018
  startDate: 07/01/2018
  expDate: 09/30/2019
  title: 'SBIR Phase I:  A High Throughput Microfluidics Platform to Measure Secretion
    from Single Cells'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to increase the returns of grain storage for farmers and reduce overall postharvest loss due to toxin and insect damage.  Ten billion bushels, over half of US grains, are stored on-farm each year for 3-12 months.  During this period, grain is susceptible to spoilage, infestation, and moisture loss?all of which impacts the price a farmer receives at the time of market delivery.  There is no easy way to monitor grain quality changes throughout the storage season to optimize for best times to run aeration controls to preserve, condition or maintain the grain.  This leaves farmers with a ?gut check? system of driving to each grain bin site and climbing up and inside units.  Since grain is priced based on moisture baselines, farmers are essentially selling water and weight, their final price outcome can vary significantly based on how well they managed grain conditions throughout the storage period.  In the US, an annual $3 to $ 5 billion dollars (3 ? 5%) of crop value is lost due to toxin, insect and moisture mismanagement that could be prevented through the introduction of affordable and accessible monitoring technology.

    The proposed project would advance internet of things automation and wireless sensor applications as applied to production agriculture and the postharvest supply chain.  There are certain, manual processes of farm production that are strenuous due to time burdens and the lack of obtainable information to make decisions.  Monitoring grain assets, the product of farmers? toil and the safety net of global food supply, in farm bins, commercial storage, and barges is one such process. Sensing for when loss and spoilage risks occur, but more importantly connecting and turning the data into automation opportunities before they exist is the aim of this proposal.  Cable-based monitoring solutions exist, but adoption is restricted due to physical installation limitations, electricity/power constraints, and investment costs.  This project will validate the feasibility of a low-power, wireless sensor that can detect grain conditions and last a full postharvest cycle (18 months).  Such a device will create opportunities to track grain qualities across the agriculture value chain, beginning with its use to monitor and automate farm grain storage.  By characterizing, and testing against cable systems and within grain science 3D models, this project will prove the wireless sensor?s direct functionality within this first farm application.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3033 E Stillwater Landing
  awardeeCity: Urbana
  awardeeCountryCode: US
  awardeeName: Amber Agriculture
  awardeeStateCode: IL
  awardeeZipCode: '618027632'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819370'
  piEmail: lucas@amber.ag
  piFirstName: Lucas
  piLastName: Frye
  piPhone: '3094725659'
  poName: Rick Schwerdtfeger
  date: 06/14/2018
  startDate: 06/15/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Low-Power, Wireless Crop Quality Sensors for Grain Quality
    Preservation and Storage Automation'
- abstractText: |-
    This SBIR Phase I project will develop Natural Language Voice-Controlled Lab Assistant technology that enables students to control and interact with hands-on science lab equipment using natural language dialog. The lab assistant technology will connect with science equipment hardware, a mobile or computer app, and cloud-based software for speech recognition and data analysis. A student can perform hands-on experiments, ask questions like "How high did my rocket go?" or "What was the force of the cart collision?", and receive audible responses based on their own experimental measurements. The lab assistant is designed for students that encompass (1) students who are blind or low vision, (2) students with disabilities affecting physical skills, (3) students that would benefit from multi-sensory learning methods as required in Individualized Education Plans (IEPs), and (4) generally students that would benefit from increased engagement in Science, Technology, Engineering, and Mathematics (STEM). The broader impacts of the lab assistant technology will be to promote teaching and learning through professional development of K-12 educators in STEM, and enable broad participation of under-represented groups of people in authentic science inquiry.


    The proposed Lab Assistant will be the first application of state-of-the-art voice recognition technology for educational science experiments. The Lab Assistant will integrate with sensor hardware and mobile apps to enable hands-on experiments in physics, earth science, chemistry, and engineering. The intellectual merits of the Lab Assistant are (1) the development of software that can respond to a wide spectrum of natural language questions and (2) the systems integration of many cutting-edge technologies (wireless sensors, mobile apps, voice recognition software, cloud-based data analysis algorithms) into a simple user interface for science education. The voice interactions will help students overcome disabilities with traditional touch and visual technology, work more independently due to the presence of auditory help, work more effectively in groups, and gain confidence in their STEM abilities. For teachers, the Lab Assistant will provide an "expert in the room" to help guide the hands-on activities that they already do, and provide technical support. The Lab Assistant will be especially useful to teachers without formal science training, that nevertheless need to lead hands-on STEM activities.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 505 Cypress Point Dr.
  awardeeCity: Mountain View
  awardeeCountryCode: US
  awardeeName: Myriad Sensors
  awardeeStateCode: CA
  awardeeZipCode: '940434849'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819287'
  piEmail: clifton.roozeboom@gmail.com
  piFirstName: Clifton
  piLastName: Roozeboom
  piMiddeInitial: L
  piPhone: '7196513764'
  poName: Rajesh Mehta
  date: 06/14/2018
  startDate: 06/15/2018
  expDate: 04/30/2019
  title: 'SBIR Phase I:  Natural Language Voice Controlled Science Equipment'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is to develop technology to prevent seafood fraud through
    enabling wholesalers, restaurants, and consumers to rapidly identify mislabeled
    fish product outside of controlled laboratory settings. U.S. consumers are subjected
    to mislabeling errors one out of every three times they consume seafood. Species
    that are cheaper and easier to source are commonly swapped for higher value fish
    such as tuna, snapper, and grouper. This substitution occurs at multiple points
    in the supply chain, from producers/processors to wholesalers to restaurants.
    U.S. consumers pay approximately $32 billion for mislabeled seafood on an annual
    basis. Additionally, this seafood may pose a serious health concern or counteract
    regulatory efforts focused on managing vulnerable fish populations and illegal
    fishing. Current seafood identification efforts are insufficient to eradicate
    mislabeling because they require controlled laboratory settings and highly trained
    personnel.  A few portable tests are becoming available but they lack the ability
    to screen large numbers of samples cost-effectively. The platform proposed here
    will enable more widespread seafood identification testing by delivering identification
    within 45 minutes, on-site, and for a lower per sample cost than existing technologies.
    \n\nThis SBIR Phase I project proposes to address seafood mislabeling by developing
    a fast and portable DNA-based screening platform to allow for accurate seafood
    identification to address concerns from consumers, retailers, and regulators regarding
    seafood mislabeling.  The key component of the platform to be developed is a nanopore-based
    sensor technology, which is an amplification-free method for direct counting of
    target nucleic acids. It has been demonstrated in preliminary results that the
    technology is able to distinguish grouper DNA from catfish with single-nucleotide
    specificity. This technology also has achieved multiplexed detection, distinguishing
    36 sequences with one sensor. This project will advance this detection assay towards
    a commercial-ready product by expanding the multiplexing strategy to cover 200+
    sequences, designing probes to distinguish 20+ fish species, and then completing
    a full commercial proof-of-principle by identifying seafood species in blinded
    samples in work done on-site.\n\nThis award reflects NSF's statutory mission and
    has been deemed worthy of support through evaluation using the Foundation's intellectual
    merit and broader impacts review criteria."
  awardeeAddress: 4320 Forest Park Ave
  awardeeCity: Saint Louis
  awardeeCountryCode: US
  awardeeName: Nanopore Diagnostics, LLC
  awardeeStateCode: MO
  awardeeZipCode: '631082979'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819757'
  piEmail: cohentl@gmail.com
  piFirstName: Thomas
  piLastName: Cohen
  piPhone: '3144774334'
  poName: Ruth Shuman
  date: 06/14/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  A handheld sensor for seafood identification'
- abstractText: |-
    The broader impact/commercial potential of this project is the ability to sustainably produce more food with fewer water and energy resources. To feed nine billion people on this planet by 2050 we need to develop new systems of agriculture. Indoor agriculture has the potential to transform the way we grow and source our food, enabling locally-sourced crops at higher yields. Food crops can be grown sustainably year-round near all major urban centers if the energy and water consumption of greenhouses could be reduced. This research will lead to the creation of a suite of water management products and services for indoor farming applications thereby making indoor agriculture environmentally sustainable and economically viable.

    This Small Business Innovation Research Phase I project will commercialize a novel metal organic framework (MOF) material that enables a new class of compact, energy-efficient cooling and dehumidification systems for greenhouses. Recent discoveries at MIT have revealed a novel MOF material with unprecedented water adsorption capacity. Moreover, the MOF material may be readily synthesized from low-cost, bulk commodity chemicals. A dehumidifier operating with this material can harvest waste heat to provide optimal temperature and humidity conditions for controlled environment agriculture. To translate the MOF material from research lab into large scale production, the material must demonstrate sufficient durability under cycling conditions, be designed to afford low cost processing and be integrated into a cost-efficient climate control system that takes advantage of its unique properties. The goal of the proposed R&D is to accelerate durability testing, design a process chemistry to enable low-cost manufacturing and develop system-level models to
    analyze lifecycle performance and cost sensitivity in an indoor farming application.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 291 Pearl St
  awardeeCity: Cambridge
  awardeeCountryCode: US
  awardeeName: Transaera, Inc.
  awardeeStateCode: MA
  awardeeZipCode: 021394715
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819345'
  piEmail: sorin@transaera.com
  piFirstName: Sorin
  piLastName: Grama
  piPhone: '6172307715'
  poName: Muralidharan Nair
  date: 06/14/2018
  startDate: 06/15/2018
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Using Metal-Organic Framework Materials to Increase Sustainability
    of Indoor Farming'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project will be to develop a preclinical drug characterization platform capable of profiling the effect of a drug candidate on whole protein-protein interaction (PPI) networks. PPIs play a pivotal role in most diseases, and are considered high-impact therapeutic targets for cancers, autoimmune diseases, infectious diseases, and more. Over 40 clinically relevant PPIs have been disrupted successfully with small molecules, and several have entered clinical trials. One recently approved cancer drug, Venetoclax, is expected to reach $2.2B in sales by 2020. Despite the enormous clinical and commercial potential of PPI disrupting drugs, preclinical characterization remains a major challenge. Pharmaceutical companies are limited by slow and laborious techniques to measure protein interactions that require each protein to be purified, and each PPI to be measured separately. As a result, only a small subset of relevant interactions are tested during preclinical drug development, which leads to a high incidence of failure during clinical trials. The proposed platform for PPI network characterization is expected to have a major commercial and societal impact by enabling more thorough preclinical screening of PPI inhibiting drugs, reducing the overall cost and time associated with drug development.

    This SBIR Phase I project proposes to develop and commercialize a novel platform for screening PPI disrupting drugs that provides quantitative accuracy, enables simultaneous characterization of whole PPI networks, and eliminates the need for protein purification. This platform combines the throughput of a cell-based assay with the accuracy of a bioanalytical technique by linking yeast haploid mating efficiency to the affinity of proteins displayed on the cells' surfaces. Preliminary results demonstrate that next generation sequencing of diploid cells may be used to accurately measure many PPI strengths simultaneously. The goal of this project is to demonstrate that the proposed platform can correctly recapitulate whole disease-relevant PPI networks and accurately characterize well-studied inhibitors in a format that is compatible with existing high-throughput screening workflows. To demonstrate feasibility, the well-studied BCL2 PPI network, which contains unstable proteins and considerable complexity, will be analyzed to identify each pairwise PPI and compared to known interactions from the literature. The yeast strains and assay parameters will then be optimized for screening water insoluble small molecule drugs and 96-well plate compatibility. The ultimate goal of this project is to establish a new platform technology for the preclinical characterization of PPI inhibiting drug candidates.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 3946 W Stevens Way NE 3rd Fl
  awardeeCity: Seattle
  awardeeCountryCode: US
  awardeeName: A-Alpha Bio, Inc.
  awardeeStateCode: WA
  awardeeZipCode: '981051654'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819398'
  piEmail: dyounger@gmail.com
  piFirstName: David
  piLastName: Younger
  piMiddeInitial: A
  piPhone: '2068909704'
  poName: Ruth Shuman
  date: 06/14/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Developing a Platform for Multiplexed Drug Profiling Using
    Yeast Synthetic Agglutination'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is in improving the quality of general and task lighting and reducing the amount of wasted light, thus reducing energy consumption. Solid state lighting has caused a paradigm shift in the lighting industry. However, the rapid growth of the LED has surpassed our understanding of its effects on human health and productivity, as well as the environment. Developing systems that put light only where it is needed can reduce energy consumption and improve well-being by eliminating glare and wasted light. Full control over where artificial lights shine may also reduce the disruption of natural ecosystems and agriculture caused by light pollution.? Unfortunately, a compact and low-cost solution to spatially controllable illumination is not available. Should one be brought to market, the industry could be tailored to meet the needs of each street lamp, each office worker and the entertainment industry among others. The ubiquitous nature of artificial illumination provides a unique commercial opportunity with multiple market segments for growth potential.

    The proposed project will focus on a microsystems solution to steerable lighting using a low-power, low-cost, silicon-based mirror less than 1 mm in diameter. The mirror is capable of real-time adjustments that will steer incident light with significant angular range. It is controlled using digital electronics and easily combined with traditional smart home electronics. The objective of the research is to measure the optical output of varying system setups and optical components to determine what optics are necessary for proper light output shape, uniformity, and color temperature. The project will rely heavily on a combination of test measurements and simulations to cycle through experiments rapidly and efficiently in order to converge on a manufacturing plan.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 344 Howard Ave.
  awardeeCity: Piedmont
  awardeeCountryCode: US
  awardeeName: Helux Technologies, Inc.
  awardeeStateCode: CA
  awardeeZipCode: '946114360'
  fundsObligatedAmt: '224247'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819751'
  piEmail: jess@heluxtech.com
  piFirstName: Jessica
  piLastName: Morrison
  piPhone: '5109821813'
  poName: Rick Schwerdtfeger
  date: 06/13/2018
  startDate: 06/15/2018
  expDate: 12/31/2019
  title: 'SBIR Phase I:  Dynamic Solid State Lighting with Micromachines'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to provide the capability to affordably and reliably connect underserved or unserved Americans to high speed internet using surface-mounted optical fiber, whether they live in a suburban neighborhood or in a remote rural area. The lack of high speed internet access is largely due to an inability to economically distribute broadband communications over the 'last mile' to businesses, homes, schools, and medical or government entities. An understanding of the installed durability of fiber using this technique will usher in new developments to deploy surface-mounted fiber nationwide. More accessible high-speed internet provides more information, opportunity, and economic productivity regardless of the locale. The digital divide between urban and rural Americans could be reduced or eliminated. Lower cost fiber deployments will make it easier to deploy new technologies, like 5G antennas and connected vehicles, and will shrink the cost to make cities smarter with ubiquitous sensors and cameras.

    The proposed project will demonstrate that optical fibers under protective coatings bonded to paved surfaces can provide reliable high speed communications while subjected to weather and traffic. It will allow estimation of the predicted life time of surface mounted fiber on pavement. The testing will place asphalt samples in an environmental test chamber to evaluate competing fiberoptic installations and to identify the best performers for a series of follow-on field and lab tests. This will allow the future targeting of financial resources on the most promising material and profile combinations. Test samples will undergo wide ranging temperature and humidity cycles and repetitive tire impacts under controlled conditions. This testing will identify statistical life predictions in years after only a few months of actual test time. The longer the predicted life, the larger the customer pool, and the wider the potential market penetration. Understanding the predicted lifetime of a fiber installation will open the door to more early adopters, to more pilot program users, and eventually to fiberoptic installers and long term customers.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 6148 Mint Springs Dr.
  awardeeCity: Warrenton
  awardeeCountryCode: US
  awardeeName: TRAXyL, Inc.
  awardeeStateCode: VA
  awardeeZipCode: '201874485'
  fundsObligatedAmt: '224992'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819964'
  piEmail: phillip@traxyl.com
  piFirstName: Phillip
  piLastName: Turner
  piPhone: '7035850269'
  poName: Rick Schwerdtfeger
  date: 06/13/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  An Economic Optical Fiber Solution to the Last Mile Problem'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project views an IoT firearms detection system in the lens of the military due to their immediate need of such a device and associated data. In addition, a foothold in the military will allow for and influence the adoption in downstream markets such as private security and law enforcement who have already expressed interest in piloting and adopting this technology once fully developed. However, the broader goal and impact of this system more importantly grants the potential to save lives. Whether this system will be used in the military, law enforcement, or private citizens in cases of home and self defense, successful implementation and commercialization of the first firearms detection system will grant the capabilities to objectively monitor and leverage firearm usage data.

    The proposed project aims to research, develop, and commercialize an integrated IoT system dedicated to detecting and processing small arms firearm discharges. The challenge in achieving the goals of this project is two-fold: one to create an IoT system that satisfies the stringent and high standards of the customer and two, to create value within the data collected by these IoT sensors. The proposed research and development covers the creation of a prototype device as well as generating a roadmap based on product and user feedback towards effective use of the data to ensure commercial success.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 6422 Broad St
  awardeeCity: Bethesda
  awardeeCountryCode: US
  awardeeName: Armaments Research Company, Inc.
  awardeeStateCode: MD
  awardeeZipCode: '208162608'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819949'
  piEmail: williamdeng@armaments.us
  piFirstName: William
  piLastName: Deng
  piPhone: '2063954868'
  poName: Rick Schwerdtfeger
  date: 06/13/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  IoT System for Small Arms Detection and Response'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is the development of yeast fermentation technologies that enable conversion of sugars abundant in pectin-rich agricultural waste into useful specialty chemicals. The U.S. is a leading producer of pectin-rich agricultural wastes including citrus peels (>5 million tons annually), sugar beets (>37 million tons annually), and grape pomace (>1 million tons annually). These peel and pulp byproducts lack value, however, the proposed technologies developed in this project will allow for significantly higher valued products to be produced from these waste streams. The initial target chemical product is used as a chelator in cleaning products and a precursor to plastics. Other chemical products potentially may be produced using this platform. Implementation of this fermentation process offers a lower carbon footprint and emissions compared to petroleum or even other sugar-derived products, and has impact in reducing waste and combating climate change. When implemented at scale, these fermentation processing plants will be co-located with rural agricultural processing plants, adding high-tech jobs in these areas, and offering a means to de-risk historically volatile crop harvests by accessing alternative markets.

    This SBIR Phase I project proposes to engineer yeast strains capable of converting sugars in pectin-rich agricultural wastes into valuable specialty chemicals. Currently, the fermentation rates for utilizing the primary sugar in pectin, D-galacturonic acid, limits production of these chemicals, including the proposed first product, which is a biodegradable metal chelator. Previous characterization has identified that uptake of the pectin sugars by a transporter as the limiting step. Accordingly, the first objective of this proposal is to characterize this class of transporter to identify new transporters with improved rates. The second objective is to improve the best transporter through protein engineering. Using this improved transporter, the final objective will assess the cellular energy requirements for the fermentation process using bioreactors to control fermenter conditions, as product synthesis and transport is energy-demanding. If successful, this project will enable production of specialty chemicals from pectin-rich agricultural waste.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: '2715 Hillegass Avenue, Unit #1'
  awardeeCity: Berkeley
  awardeeCountryCode: US
  awardeeName: ZestBio, Inc.
  awardeeStateCode: CA
  awardeeZipCode: '947051229'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820038'
  piEmail: latimer@zestbio.com
  piFirstName: Luke
  piLastName: Latimer
  piMiddeInitial: N
  piPhone: '3033287284'
  poName: Ruth Shuman
  date: 06/13/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Microbial conversion of pectin-rich agricultural waste into
    specialty chemicals'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to develop a drug discovery platform for preclinical cancer drug testing using a 3D tumor model technology. The technology is designed to reduce time and costs associated with the high failure rate (~95%) of cancer drugs by increasing the likelihood that candidate drugs advancing to animal studies will be effective. The robotic technology will provide a biologically relevant tumor model to test libraries of cancer drugs in the preclinical stage, and replace currently used 2D cancer cell models. This project aims to scale up the 3D tumor model technology to accommodate large drug libraries tested in the pharmaceutical industry, and verify that it meets industry standards and customer needs. The technology will expedite the introduction of effective cancer drugs into the market for patient use, and help reduce the more than half a million of lives that cancer claims annually. The proposed work will significantly facilitate the introduction of the technology into the market as a preclinical cancer drug screening tool by demonstrating its competitive advantages and capabilities to improve cancer drug discovery efforts.

    This SBIR Phase I project proposes to develop and validate a 3D tumor model technology for high-throughput cancer drug screening in the pharmaceutical industry. Despite widespread interest in 3D cancer cell cultures, existing methods are not currently used in the industry due to their many disadvantages. The proposed technology provides a robust, high-throughput, and cost-effective approach to generate 3D cancer cell cultures for rapid drug screening, beyond what is currently available. This work will evaluate quantitatively the reliability and robustness of 3D cancer cell cultures and costs of cancer drug testing while considering competitive techniques. A major goal is to adapt the technology to a 1536-microwell plate format for highly efficient drug screening, which is not currently available on the market, and validate the capabilities of the technology to predict cancer drug responses in animal studies. This work will involve robotic protocol optimization, imaging analysis of 3D cultures for consistency, proof-of-concept cancer drug screening, and statistical evaluation of robustness. It is anticipated that the work will demonstrate the advantageous capacity and speed of the technology for drug testing, industry-level robustness, compatibility with different cancer cell types, ability to predict animal study drug responses, and low cost.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 526 S Main St Suite 1001
  awardeeCity: Akron
  awardeeCountryCode: US
  awardeeName: OncoSolutions LLC
  awardeeStateCode: OH
  awardeeZipCode: '443114401'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819594'
  piEmail: stephanie.ham@oncosolutionsllc.com
  piFirstName: Stephanie
  piLastName: Ham
  piMiddeInitial: L
  piPhone: '4406375810'
  poName: Ruth Shuman
  date: 06/13/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  3D Tumor Model Microtechnology for High Throughput Drug Screening'
- abstractText: |-
    This SBIR Phase I project aims to demonstrate the technical feasibility of a first-of-its-kind injectable gel for treating osteoarthritis. Osteoarthritis, a disease of the body's joints, affects greater than 27 million Americans, and the proposed activity will de-risk the proprietary gel technology to warrant continued development of a medical device for treating osteoarthritis. The product is a bioinspired polymer gel solution, to be administered by injection into the joint, which will lubricate, cushion, and protect the joint's cartilage from wear, and thereby slow the progression of osteoarthritis. Upon successful completion of this project, the company aims to complete the preclinical and clinical studies required to gain regulatory approval for the product emanating from the proposed activity. From this project, a deeper fundamental understanding of body-biomaterial interactions will be gained, benefiting engineers, clinicians, and ultimately patients. The anticipated commercial success of this product will result in job creation both before and after completion of product development. As joint pain is one of the leading causes of missed work, disability, and general depreciation of quality of life, successful completion of the proposed high-technical-risk project will lay the foundation for development of an impactful medical device which will treat the highly prevalent disease osteoarthritis.

    The innovation of this project's technology lies in the patented synthetic techniques and composition of a tissue-protective gel solution that remains in the joint capsule at therapeutic concentrations for significantly longer than current injectable gels remain. All injectable viscoelastics approved in the United States for treating osteoarthritis are comprised of hyaluronic acid, a biopolymer which degrades rapidly upon injection; in contrast, the product in this project uses a synthetic, bioinspired polymer which resists degradation and maintains effective viscoelastic properties for four months, whereas current products' viscoelasticity is degraded after one week. The project's first objective will, through a radiolabeled biodistribution study, ascertain the gel's distribution throughout the body following injection into rodent knees, to demonstrate 100% clearance out of the animal and no accumulation within any tissues or organs. The project's second objective will develop the material processing techniques and syringe filling protocol for formulating the gel into its final product form and ensuring product performance and safety specifications are met. Completion of these objectives will allow product to be made under FDA-compliant Design Control for a pivotal large animal study to be conducted following this project, along with completion of formal biocompatibility testing for submission to FDA to seek approval for a First-in-Human clinical trial.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 189 Tappan St
  awardeeCity: Brookline
  awardeeCountryCode: US
  awardeeName: Articulate Biosciences, LLC
  awardeeStateCode: MA
  awardeeZipCode: 024455819
  fundsObligatedAmt: '224945'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819435'
  piEmail: benjamin.cooper@articulatebio.com
  piFirstName: Benjamin
  piLastName: Cooper
  piMiddeInitial: G
  piPhone: '8604631368'
  poName: Henry Ahn
  date: 06/13/2018
  startDate: 06/15/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Bioinert Viscoelastic Gels as Diseased Soft Tissue Lubricants'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is the development of a microalgae-based commercial hydrogen
    production process that will surpass current or developing technologies. By 2022,
    the global hydrogen generation market by value is projected to reach $154.7 billion.
    A technology for low-cost, high purity, renewable, scalable hydrogen production
    will accelerate transition to a hydrogen economy, thus facilitating domestic energy
    independence and creating new economic opportunities. Many industries, such as
    the petro-chemical, chemical, and electronics industries, would benefit from low
    cost industrial hydrogen. Transportation and electric power generation industries
    also would benefit from increased fuel efficiency. Environmental benefits include
    replacement of fossil fuels, switching hydrogen production from natural gas to
    sunlight and water, and substantial reduction of harmful emissions. The goal of
    this project is to incorporate proprietary, metabolically engineered, photosynthetic
    algae in combination with recent advances in bioprocessing and hardware engineering
    to manufacture clean, renewable hydrogen. \n\nThis Small Business Innovation Research
    Phase I project proposes to develop microalgae strains that generate high hydrogen
    yields using a novel metabolic engineering strategy. To pursue this strategy,
    a suitable parental strain must be developed, combining intact hydrogen production
    genes with improved stability of introduced genes (transgenes). Despite the availability
    of genetic transformation methods, transgene stability in wild type strains remains
    poor. This seriously limits development of commercial strains. Two algal UV mutants
    with greatly improved transgene stability are available, but both have impaired
    hydrogen production genes. The proposed investigation will assess the feasibility
    of creating a suitable parental strain. The objectives are: 1) determine differences
    between genes of the best wild type hydrogen producing strain and the UV mutants;
    2) introduce candidate genes into the UV mutants to restore hydrogen production
    metabolism; 3) knock out candidate genes involved in transgene inactivation in
    the wild type strain; and 4) test the ability of the engineered strains to generate
    hydrogen and retain transgenes. This project will produce the desired parental
    strain and enable implementation of the innovative strategy for developing production
    strains with greatly increased hydrogen rates in the target commercial process.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 612 Highlnad Knoll Ct.
  awardeeCity: Baton Rouge
  awardeeCountryCode: US
  awardeeName: BHO Technology, LLC
  awardeeStateCode: LA
  awardeeZipCode: '708105200'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819274'
  piEmail: svoard@gmail.com
  piFirstName: Svetlana
  piLastName: Oard
  piPhone: '2252704499'
  poName: Ruth Shuman
  date: 06/08/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Novel microalgae for high yield hydrogen production'
- abstractText: |-
    This SBIR Phase I project is intended to develop a noninvasive, ultra-sensitive molecular
    detection system for Tuberculosis (TB). Although the prevalence of TB has diminished, it still
    remains the second leading cause of death from an infectious disease. The latest global TB report
    from the World Health Organization with data compiled from 205 countries put the figures at 1.5
    million fatalities and 9.6 million infections annually. The proposed technology uses the nano-
    Plasmonic Grating (P-GRAT) properties to enhance the detection signal of the TB biomarker by
    more than 100X. This results in detecting concentrations in femto-gram/milliliter range resulting
    in early detection and treatment. The specificity, faster results, low cost/test and ease of use,
    makes this system a substantive innovation in the TB diagnostic market. The TB testing market
    accounts for $1.5 billion annually of which North America is the second largest in terms of
    generated revenue due to the higher pricing for TB detection. The proposed technology will
    benefit the patients with early diagnosis and provide the health care professionals with early
    treatment options. With all the advantages this technology has to offer, it is expected to gain a
    significant share in the market place and generate a revenue stream.

    The main limitation of the immunoassays is their inability to detect extremely small fluorescence
    signals that are associated with ultra-low concentrations of biomarkers. The proposed nano-
    Plasmonic Grating (P-GRAT) technology can overcome this limitation due to its exceptionally
    efficient light coupling, reduced scattering, high signal-to-noise ratio and directional
    excitation/emission. As a result, a fluorescence enhancement of P-GRAT is 100X or higher
    compared to a glass substrates or polyurethane well plates. Such enhancements translate to ultrasensitive
    detection and early diagnosis. Commercial immunoassays require hours to days to
    achieve pg/ml sensitivity. In comparison, P-GRAT can detect pg/mL range concentrations in less
    than three hours. P-GRAT utilizes a simplified design to exclude expensive optics like laser
    sources, high-magnification objective lenses and filter cubes. The use of 3-D printed parts to
    fabricate the system and use a smartphone as the detector further reduces the cost. We intend to
    develop and commercialize a noninvasive, ultra-sensitive (fg/ml) molecular detection system for
    Tuberculosis (TB). TB specific biomarkers Lipoarabinomannan (LAM) and Interferon gamma
    (IFN-g) will be detected in urine and saliva. P-GRAT is a platform technology and can easily be
    adapted for the ultra-sensitive detection and diagnosis of other diseases, such as Zika, Ebola,
    HIV and Cancer.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 5006 Newbury Way
  awardeeCity: Columbia
  awardeeCountryCode: US
  awardeeName: Plasmonic Diagnostics LLC
  awardeeStateCode: MO
  awardeeZipCode: '652038482'
  fundsObligatedAmt: '224876'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1818796'
  piEmail: syed.barizuddin@gmail.com
  piFirstName: Syed
  piLastName: Barizuddin
  piPhone: '5735296676'
  poName: Henry Ahn
  date: 05/29/2018
  startDate: 06/01/2018
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Ultra-sensitive Detection of Lipoarabinomannan (LAM) and
    Interferon-Gamma (IFN-g) as Biomarkers for Detection of Tuberculosis (TB)'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to develop protein purification technology that will provide access to inexpensive, purified proteins for biological and life science applications by removing the purification bottleneck in biopharmaceutical production, and leveraging the innovative breakthroughs in protein engineering and gene editing.  Scale-up of this technology will transform the large-scale purification of biopharmaceuticals and lower prescription drug costs - the most important factor contributing to rising healthcare costs.  The major factor influencing the rising cost of healthcare is the skyrocketing costs of pharmaceuticals - up to 40% of the medical plan cost will be drugs by 2025.  Prescription drug costs are the fastest rising component of healthcare and are contributing to the dramatic increase in healthcare costs.  The worldwide focus of pharmacy and biotechnology is now on biopharmaceutical development and production to address this issue.  Direct benefits of this project include low-cost, use of green reagents, and the absence of heavy metal impurities in the purified protein.  In addition, the development of immobilized enzymes using this technology will open new frontiers in biocatalysis, biosensors, diagnostics and protein delivery.

    This SBIR Phase I project proposes to develop protein purification kits for small-scale and research-scale research. Bringing these kits to market will enable researchers to further validate the technology on a broader range of proteins in preparation for scale-up for biopharmaceutical production.  Synthetic biology has quickly begun to revolutionize drug discovery and design by providing a better overall molecular understanding of disease.  However, this potential has yet to be fully realized due to the challenges associated with purifying the target recombinant protein from the thousands of naturally-occurring proteins produced by the expression system.  The three specific aims of the project are: 1) validation of protein tag performance for multiple protein classes and expression systems, 2) development of low-cost methods for protein tag removal from purified proteins, and 3) development of solutions for the purification of low-expressing proteins and the parallel purification of small amounts of proteins.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 580 Wilderness Peak Dr. NW
  awardeeCity: Issaquah
  awardeeCountryCode: US
  awardeeName: Proteios, LLC
  awardeeStateCode: WA
  awardeeZipCode: '980275621'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820325'
  piEmail: bob@proteios.com
  piFirstName: Bob
  piLastName: Snyder
  piPhone: '5037133339'
  poName: Ruth Shuman
  date: 05/24/2018
  startDate: 07/01/2018
  expDate: 04/30/2019
  title: 'SBIR Phase I: Removing the Purification Bottleneck in Biopharmaceutical
    Production'
- abstractText: |-
    The broader impact / commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to enable electrification of remote oil & gas processes to reduce methane emissions, improve on-site safety, and provide leak-detection and monitoring capabilities. This will be achieved by developing a robust, efficient, small-scale power generator capable of converting on-site fuel to electricity. Beyond the entry opportunity in the oil & gas sector, this technology has other applications in large markets such as residential and commercial power generation and heating, transportation, and military. For example, our proposed generators would allow consumers in moderate/cold climates to efficiently match their time-dependent heating and electrical demands using natural gas (accessible to 70 million households). For a typical household in those regions, we estimate a 45% reduction in primary energy use and CO2 emissions by deploying our generators. The energy reduction translates to an annual savings of about $650 per household. Widespread deployment of our technology would grow the domestic natural gas economy, strengthen the US technological lead in semiconductor manufacturing, and facilitate renewables by providing a dispatchable supply.?

    The proposed project will investigate the fundamental heat-to-electric conversion process and address key issues around the stability and robustness of the technology, through a synergistic effort to develop generators capable of high performance and a manufacturing process to reduce cost. The project will focus on device optimization and durability, and process repeatability. This involves the fabrication and integration of multiple frequency-selective components including a thermal emitter, optical filter, photovoltaic cell, and back surface reflector. Each component, as well as the integrated system, will undergo rigorous thermal testing to prove both resistance to elevated temperatures and temperature swings. Additionally, novel manufacturing techniques will be developed to enable cost-competitive devices relative to conventional generators. If the technical objectives are met, this project will demonstrate record-breaking performance for thermophotovoltaics and accelerate the commercialization of thermophotovoltaic devices in many different markets.?

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 4385 SEDGE ST
  awardeeCity: Fremont
  awardeeCountryCode: US
  awardeeName: Antora Energy, Inc.
  awardeeStateCode: CA
  awardeeZipCode: '945551159'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1820395'
  piEmail: david@marigoldpower.com
  piFirstName: David
  piLastName: Bierman
  piPhone: '8186244127'
  poName: Rick Schwerdtfeger
  date: 05/22/2018
  startDate: 06/01/2018
  expDate: 12/31/2019
  title: 'STTR Phase I:  Advanced Thermophotovoltaic Generators for High-Value Remote
    Power'
- abstractText: "This Small Business Innovation Research Phase I project proposes
    development and optimization of a surface tension mediated lyoprocessing technique
    for long-term storage of biologically active surfaces and other biological materials
    at ambient or above cryogenic temperatures. Stabilization of temperature sensitive
    biological materials at ambient temperatures can address significant bottlenecks
    that prevents economic distribution of pharmaceutically relevant biomolecules
    worldwide. In addition, the implementation of this technology has the potential
    to greatly improve global health, particularly in developing regions where many
    advanced treatments are unavailable as a result of their temperature sensitivity.
    Overall, this project aims at offering an alternative technology platform to stabilize
    temperature sensitive biological materials at non-cryogenic temperatures. \n\nThe
    intellectual merit of this project lies primarily in the approach used to achieve
    stable desiccated storage. The project aims at translating a newly developed drystate
    biopreservation processing methodology into a commercially viable, mechanized,
    long-term biopreservation technique. The newly developed biopreservation technology
    provides a way to efficiently process biologically active surfaces containing
    bioactive components, assay reagents, cells and cellular components, and other
    biomolecules for long-term stability at non-cryogenic temperatures.\n\nThis award
    reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 14281 Richfield
  awardeeCity: Livonia
  awardeeCountryCode: US
  awardeeName: Otzi Bio LLC
  awardeeStateCode: MI
  awardeeZipCode: '481544938'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820032'
  piEmail: quinn@otzibio.com
  piFirstName: Quinn
  piLastName: Osgood
  piMiddeInitial: A
  piPhone: '7347489444'
  poName: Steven Konsek
  date: 05/22/2018
  startDate: 06/01/2018
  expDate: 01/31/2020
  title: 'SBIR Phase I: Marangoni Processing for the Stabilization of Biologically
    Active Surfaces'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Technology Transfer(STTR) project is to develop a bio-based manufacturing process for glucaric acid and its intermediate, glucuronic acid. Microbial fermentation represents an attractive option for production of fuels and valuable chemicals from renewable resources, and glucaric acid can be produced from glucose, a renewable biomass-derived resource.  The glucaric acid market was estimated at $550M in 2016, and has a plethora of uses ranging from detergents to food ingredients, corrosion inhibitors, and de-icing applications.  The proposed project will engineer improved productivity of the microbe using C5/C6 sugars, thus accelerating the production of low-cost, high-purity glucaric acid. Achieving these bioprocess improvements will facilitate widespread adoption of bio-based glucaric acid in a variety of markets, broadening opportunity for US products. These applications include coatings, foams and foaming aids, electrolytes, gels, polymers, and polymer additives.

    This STTR Phase I project proposes to perform multi-omics studies to characterize the physiology of E. coli strains producing glucaric acid via fermentation, and develop strain engineering strategies to enable high yield and productivity. Most fermentation products are highly reduced compared to the starting sugar, and care must be taken to maintain cells in a reduced state, meaning high NADH/NAD ratio, to drive the NADH-consuming biosynthetic reactions. Products that are derived from sugar oxidation, in contrast, pose a much different challenge, and have been explored to a much lesser extent. Here, additional oxygen is needed to accept the excess electrons generated during glucose oxidation. It is well known that both S. cerevisiae and E. coli, two of the most common organisms for industrial application, are limited in their electron transport chain capacity, resulting in overflow products from high glucose uptake rates. Regardless of the oxygen transfer ability of the fermentation equipment, there is an inherent maximum production rate of these organisms. In this project, the plan is to develop E. coli strains with increased respiration capacity, thus increasing the maximum glucose oxidation rate. Glucaric acid, which can be produced from glucose via 3 enzymatic reaction steps, is an exemplary product.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 92 Elm St.
  awardeeCity: Milton
  awardeeCountryCode: US
  awardeeName: Kalion, Inc.
  awardeeStateCode: MA
  awardeeZipCode: 021863111
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1819514'
  piEmail: darcy@kalioninc.com
  piFirstName: Darcy
  piLastName: Prather
  piMiddeInitial: D
  piPhone: '2409888011'
  poName: Ruth Shuman
  date: 05/22/2018
  startDate: 07/01/2018
  expDate: 06/30/2019
  title: 'STTR Phase I:  Low-Cost, High-Purity Biobased Glucaric Acid'
- abstractText: |-
    This Small Business Innovation Research Phase I project will explore a novel materials processing technology that progresses the state-of-the-art of carbon fiber composites while leveraging mature and cost-efficient manufacturing methods. The processing technology of interest produces a material that approaches the isotropic properties of high-performance metal alloys while retaining the light-weight and stiffness of carbon fiber composites. Components that are fabricated from this new composite will have higher impact strength and reduced susceptibility to delamination, compared to commercially-available carbon fiber composites. The broader impact of this project includes providing engineers with a new tool to implement previously unfeasible designs that drastically improve performance while reducing energy consumption and material waste. The rapid adoption of carbon fiber composites in the wind energy, aerospace, and defense industries provides an opportunity for the novel material developed in this project to disrupt the $25-billion global carbon fiber composite market. Effective scale-up to industrial production of the novel carbon fiber composite can revitalize the Massachusetts textiles manufacturing ecosystem and increase the competitiveness of the U.S. advanced materials manufacturing base.

    The intellectual merit of this project is the continuous production of a three-dimensionally (3-D) reinforced carbon fiber prepreg that features a carbon fiber fabric reinforced with vertically aligned short carbon fibers. This novel material provides a laminated composite part with dense through-thickness and interlaminar reinforcement. Conventional carbon fiber laminates lack through-thickness reinforcement and rely on an unfilled polymer matrix to bind the layers of the laminate together, resulting in poor impact performance and frequent delamination. This project involves the roll-to-roll fabrication of 3-D reinforced carbon fiber prepregs and characterization of the produced composite material. The anticipated result of the project is the repeatable fabrication of a 3-D reinforced carbon fiber prepreg with enhanced performance compared to commercially-available prepregs. Successful completion of this project will enable further scale-up of the associated manufacturing technology and the commercial-launch of novel 3-D reinforced carbon fiber prepregs to produce stronger, lighter, and more durable composite structures.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 26 Hasenfus Circle
  awardeeCity: Needham
  awardeeCountryCode: US
  awardeeName: Boston Materials LLC
  awardeeStateCode: MA
  awardeeZipCode: 024941358
  fundsObligatedAmt: '218992'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1820051'
  piEmail: ms@bomaterials.com
  piFirstName: Michael
  piLastName: Segal
  piPhone: '6173062396'
  poName: Steven Konsek
  date: 05/22/2018
  startDate: 06/01/2018
  expDate: 04/30/2019
  title: 'SBIR Phase I:  Carbon Fiber Composites for Next-Gen Wind Turbines'
- abstractText: "This Small Business Technology Transfer Phase I project advances
    a cost-effective and scalable direct recycling method for producing battery-grade
    cathode materials from end-of-life (EOL) lithium-ion batteries. The commercialization
    of the proposed direct lithium-ion battery recycling technology will lower the
    energy consumption and emissions associated with battery production, reduce demand
    for raw battery materials and decrease lithium-ion battery manufacturing cost.
    Using directly recycled materials instead of raw battery materials will diminish
    or even avoid the negative environmental impacts from mining and processing ores
    and from disposal of hazardous waste. Reducing battery cost will facilitate the
    implementation of more efficient electrified vehicles, thus reducing petroleum
    demand and vehicle emissions. Finally, research on the end-of-life lithium-ion
    battery cathode, on the direct recycling process and on the recycled materials
    will advance the understanding of intercalation chemistry in nonaqueous and aqueous
    media and of electrode degradation during electrochemical cycling. \n\nThe intellectual
    merit of this project is to advance the direct recycling technology through the
    design and demonstration of a scalable electrochemical flow system capable of
    non-destructive relithiation and the optimization of post treatment operation
    for the recovered materials. The electrochemical flow system is capable of restoring
    the lost lithium in the EOL cathode material at any state of charge (SOC) and
    can be scaled to a commercially viable size. The cathode materials recovered in
    the proposed direct recycling process retain the same structure and morphology
    and exhibit equivalent electrochemical performance compared to the commercial
    virgin cathode materials. The recovery of high-value cathode materials substantially
    improves the profitability of lithium-ion battery recycling and is a key element
    of the business plan.\n\nThis award reflects NSF's statutory mission and has been
    deemed worthy of support through evaluation using the Foundation's intellectual
    merit and broader impacts review criteria."
  awardeeAddress: 2200 Kraft Drive
  awardeeCity: Blacksburg
  awardeeCountryCode: US
  awardeeName: Li Industries, Inc
  awardeeStateCode: VA
  awardeeZipCode: '240606702'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1819982'
  piEmail: nolan.schmidt@li-ind.com
  piFirstName: Nolan
  piLastName: Schmidt
  piPhone: '6073726436'
  poName: Steven Konsek
  date: 05/22/2018
  startDate: 06/01/2018
  expDate: 05/31/2019
  title: 'STTR Phase I:  A Direct Lithium-Ion Battery Recycling Process Yielding Battery-Grade
    Cathode Materials'
- abstractText: "This Small Business Innovation Research Phase I project focuses on
    finding a practical and cost-effective protective cap for baseball pitchers susceptible
    to serious head injuries from impacts of batted baseballs. The new cap design
    satisfactorily addresses the shortcomings of previous commercialization efforts
    that were unable to meet the prescribed protective requirements; failed to pass
    both the players' fashion expectations and comfort evaluation; and carried a hefty
    purchase price. The acceptance and use of the new cap by professional baseball
    players will create widespread demand from collegiate, high school and Little
    League players, a market that is estimated to generate annual revenues of more
    than $18M. These market projections exclude consideration of the technology's
    Broader Impact potential in other sports or vocational and military applications,
    where there is a growing recognition of the need for improved head protection
    for athletes, soldiers, law enforcement officials and construction workers. Sports
    injuries are now highly scrutinized, especially those causing long-term medical
    issues from brain injury, blunt force trauma and repetitive concussive injury.
    The societal value of this innovation will be found in safer sports and work environments.
    Such equipment represents a rapidly growing segment of the apparel market and
    a unique commercial opportunity for the company. \n\nThe intellectual merit of
    this project is based on the company's patented design that provides head protection
    from the impact of a baseball. The novelty of the protective cap headliner is
    its flexible outer hard shell made with highly rigid interconnecting truncated
    icosahedron panels. This allows the headliner to conform to the shape of the head
    while maintaining the stiffness needed to diffuse impact loads.  Since the impact
    of a baseball represents a short duration point load, the energy-absorbing capacity
    of the layer beneath the outer shell can be minimized. The objective is to identify
    the material characteristics required to dissipate the impact load associated
    with a Severity Index of 1200 or greater when a head-form is struck by a baseball
    traveling at speeds up to 125 mph; and to identify the material combination(s)
    best suited to achieve this goal. Traditional foam materials as well as state-of-the-art
    material compositions will be used in unique configurations to produce solutions
    that are not too heavy, not too bulky nor too hot to wear. The outcomes of this
    study will determine the availability of materials that can be used within the
    ergonomic and mechanical constraints of the patented design to protect the head.\n\nThis
    award reflects NSF's statutory mission and has been deemed worthy of support through
    evaluation using the Foundation's intellectual merit and broader impacts review
    criteria."
  awardeeAddress: 1846 E. Greentree Drive
  awardeeCity: Tempe
  awardeeCountryCode: US
  awardeeName: Harvest Moon Inventions, LLC
  awardeeStateCode: AZ
  awardeeZipCode: '852843434'
  fundsObligatedAmt: '221366'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819390'
  piEmail: mynorjc@gmail.com
  piFirstName: Mynor
  piLastName: Castro
  piPhone: '6022847006'
  poName: Steven Konsek
  date: 05/21/2018
  startDate: 06/01/2018
  expDate: 08/31/2019
  title: 'SBIR Phase I:  Truncated Icosahedrons Protect Pitchers from Line-Drive Baseball
    Strikes to the Head'
- abstractText: "This Small Business Innovation Research Phase I project will enable
    fast focusing and zoom in microscopy with an optomechanical system consisting
    of micro-electro-mechanical systems (MEMS) mirrors. The microscope add-on will
    enable fast 3D imaging in wide-field microscopes and increase focusing and zoom
    speeds by 100x when compared with conventional methods in confocal and multiphoton
    microscopy. The technology allows the sample stage and objective lens turret to
    remain stationary during experiments. It will increase throughput, preserve sensitive
    samples, enable observation of dynamic events, and reduce training time. The innovation
    will spur significant discovery in understanding dynamic reactions that occur
    in in vivo and in vitro microscopy. The initial target market has an estimated
    gross revenue of $75M. The technology also promises to benefit 3D imaging systems
    for manufacturing or machine vision, optical coherence tomography, and endoscopic
    imaging systems by providing high speed and agile focus control. While MEMS are
    ubiquitous in mobile platforms and the automotive industry for motion sensing,
    they have not yet permeated other markets or imaging systems to the same extent.
    With recent advances in fabrication and performance of optical MEMS devices, bringing
    this type of technology to other platforms can spark greater commercialization
    of the technology in non-traditional areas. \n\nThe intellectual merit of this
    project is foremost the demonstration of a novel optomechanical system with MEMS
    mirrors for independent control of focusing and zoom in microscopy. MEMS mirrors
    are a type of varifocus element. They remain stationary while their voltage-controlled,
    configurable surface shapes allow for fast focusing and attendant correction of
    spherical aberration. Fast MEMS mirrors, with sufficient diameters for 2x zoom
    and significant focusing capability, have not previously been demonstrated in
    literature or commercially. By producing and characterizing fast, large-diameter
    MEMS mirrors for this project, knowledge of varifocus elements will be advanced.
    This project will also continue to define standard optical design practices to
    best utilize varifocus elements, since traditional optical analyses assume fixed
    focal length lenses or mirrors. The project objectives are three-fold: 1) fabricate
    large-diameter MEMS mirrors with greater than 40% yield, 2) characterize their
    focusing range and dynamic behavior, and 3) demonstrate them in a focus and zoom
    system suitable as a microscopy add-on component.\n\nThis award reflects NSF's
    statutory mission and has been deemed worthy of support through evaluation using
    the Foundation's intellectual merit and broader impacts review criteria."
  awardeeAddress: '280 W Kagy Blvd Ste D #215'
  awardeeCity: Bozeman
  awardeeCountryCode: US
  awardeeName: Agile Focus Designs, LLC
  awardeeStateCode: MT
  awardeeZipCode: '597156056'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1819493'
  piEmail: slukes@agilefocusdesigns.com
  piFirstName: Sarah
  piLastName: Lukes
  piPhone: '4065819228'
  poName: Steven Konsek
  date: 05/21/2018
  startDate: 06/01/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Fast Focus and Zoom in Microscopy'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to significantly increase the efficiency and reduce operating costs for water produced by membrane-based desalination.  Water scarcity is an increasingly important global-scale issue that has significant negative impacts on health, security and economies.  Recent forecasts show a dramatic increase in the number of countries that will soon be affected by water scarcity given that global water consumption is expected to significantly increase due to population growth.  Membrane-based water desalination, which at large scale requires a huge capital investment, is recognized as a primary technology that can significantly improve supply to meaningfully offset scarcity and its impacts.  A critical factor in desalination plant operations is energy consumption, which increases due to membrane fouling, thus making fouling one of the most significant factors controlling the efficiency of these plants.  The proposed in-situ, real-time sensing system can be the enabling technology to allow implementation of advanced plant control algorithms based upon accurate detection of fouling at its earliest stages.  Such active detection capability will enable the most effective implementation of fouling mitigation strategies that can be optimized to save energy and reduce cost.

    This SBIR Phase I project proposes to develop a novel time-reversal waveguide sensor for detection of early-stage (ES) fouling in reverse osmosis (RO) membrane desalination, which is the dominant technology for desalinating brackish water and seawater.  Fouling in RO systems has inorganic (scaling) and organic (biofouling) components and can be a highly variable process that depends on operational parameters as well as environmental conditions.  Efficient implementation of real-time control of RO desalination for fouling mitigation requires real-time sensing.  The overall objective of the proposed work is to develop sophisticated ultrasonic sensor technology that can reliably detect scaling and biofouling in the challenging multi-layer, spiral-wound (SW) geometry of commercial-scale RO systems.  The proposed work will make use of time-reversal mirrors to produce a simple signal from a multi-mode waveguide independent of the geometry of the waveguide configuration, thus overcoming the exceedingly complex and difficult to interpret signals associated with the use of a standalone waveguide.  The goals of the project are to demonstrate the capability to detect both early-stage inorganic and organic fouling under realistic operating conditions, the reliability and the robustness of the technology, and the ability to adapt the technology to the larger size modules that are increasingly important for commercial operation.
  awardeeAddress: 616 W. Third Street
  awardeeCity: Lexington
  awardeeCountryCode: US
  awardeeName: SepSense Racing Testing LLC
  awardeeStateCode: KY
  awardeeZipCode: '405081243'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746358'
  piEmail: alan.greenberg@colorado.edu
  piFirstName: Alan
  piLastName: Greenberg
  piMiddeInitial: R
  piPhone: '3034926613'
  poName: Anna Brady-Estevez
  date: 01/23/2018
  startDate: 01/15/2018
  expDate: 04/30/2019
  title: 'SBIR Phase I:  Commercial Scale Separation Modules with Integrated Sensors
    for Cost-Effective, Real-time Detection of Membrane Fouling'
- abstractText: |-
    The broader impact/commercial potential of this project is to develop smart software to plan and control Electric Vehicle (EV) charging infrastructure in commercial facilities, such as workplaces, hotels, car rental centers, parking garages, etc. The EV planning software finds the optimal design balancing design tradeoffs such as EV customer satisfaction, grid stability limits and financial constraints. This software will help facility operators to optimize their EV charging infrastructure by minimizing their operating costs and maximizing their revenue by utilizing intelligent scheduling and pricing strategies. The software leverages the latest developments in stochastic optimization for designing an optimal configuration of EV infrastructure that is robust to variations in mobility behavior of the users. This will enable public utilities to save billions of dollars by deferring expensive upgrades to their existing infrastructure. It will also empower small consulting businesses, facility managers and electrical contractors to design and build EV infrastructure without any specialized knowledge of optimization or modeling.

    This Small Business Technology Transfer (STTR) Phase I project addresses the problem of planning and controlling EV charging infrastructure to meet the rapidly growing energy demands of EV owners. EVs are expected to comprise 30% of all cars globally by 2030. This forecasted increase over the next 10 years is of major concern for utilities, and commercial real estate owners. Given the long commute distances, driving habits, time taken to charge using home-based chargers and range anxiety, there is a need for charging locations at workplaces, hotels, and car rental centers. Chargers at these locations will generally be medium power Level 2 chargers, which are 5 to 10 times the size of typical home chargers. Simultaneous uncontrolled charging of several EVs at these locations will easily overload the local electrical infrastructure. The software mitigates this problem by designing an optimal EV infrastructure together with optimally sized onsite generation and storage. The controlling solution ensures that the grid impacts are minimized by scheduling the installed EV chargers together with onsite generation and storage with optimal set points in real time.
  awardeeAddress: 903 Grogans Mill Drive
  awardeeCity: Cary
  awardeeCountryCode: US
  awardeeName: Microgrid Labs Inc.
  awardeeStateCode: NC
  awardeeZipCode: '275197175'
  fundsObligatedAmt: '224475'
  fundProgramName: STTR PHASE I
  id: '1746858'
  piEmail: sankar@microgridlabs.com
  piFirstName: Narayanan
  piLastName: Sankar
  piPhone: '9199854723'
  poName: Muralidharan Nair
  date: 01/02/2018
  startDate: 01/01/2018
  expDate: 04/30/2019
  title: 'STTR Phase I:  Intelligent Planning and Control Software for EV Charging
    Infrastructure'
- abstractText: "This Small Business Innovation Research Phase I project aims to develop
    a disk jockey (DJ) musician's instrument for synchronizing digital media data
    to a specific location on a device and using this technology for inspiring and
    educating middle and high school students in Science, Technology, Engineering,
    Art, and Mathematics (STEAM). Global expanding markets for DJ gear, a $1.587B
    dollar growth industry, over the past 3 years grew in sales by 21%. As technology
    and entertainment converge, DJs represent the new \"Superstar\" for today's youth.
    Thus, this research represents an incentivizing gateway for students to learn
    how math, engineering and science intellectual assets can contribute to musical
    and artistic innovation. Additionally, middle and/or junior high school students'
    analysis of the data derived from a performance and entertainment-related technology
    can be an incentivizing and engaging entrance into STEM academic subjects such
    as systems design, acoustics, and computer coding.  Given the DJ tool's relation
    to these topics as well as music's inherent link with physics and math, its integration
    into the curriculum of after-school programming options are expected to foster
    more interdisciplinary STEM learning. Afterschool turntable academies as thematic
    contexts for STEM learning function as supportive and assistive educational venues.
    Collectively, the broader impact of this project should produce economic competitiveness
    in the music/technology industry for the U.S. overall and, specifically for youth,
    enhanced engagement in STEM fields.\n \nThe intellectual merit of this project
    stems from the necessity for individuals to seamlessly interface with the digital
    world without losing creativity, artistry or individuality. The technical innovation
    emerges from determining the coordinate location of an analog audio occurrence,
    tracking the change in occurrences, and matching it to a digital counterpart to
    follow the changes created. The sensor data points are utilized to metamorphose
    the turntable, the musical instrument of the DJ, into a complete analog/digital
    educational tool. This technology can offer critical insights to STEM learning
    and educational opportunities to students who may feel that STEM concepts or careers
    are separate from their personal interests and cultural context. Anticipated outcomes
    include advancements in the arts, sciences and education by contributing to entertainment's
    most recent and broadly recognized musical instrument and making it more available
    in middle and high school STEM educational curricula and after school activities.
    The proposed research intends to investigate, identify and resolve current liabilities
    connected with the transient acoustic degradation, deleterious latency introduction,
    and physical performance loss by systems intended to mimic the analog turntable.
    The research objective will be to create novel interface models to analyze the
    elements captured from the DJ musician and translate these into a commercially
    and educationally viable platform."
  awardeeAddress: 2756 Silver Hill terrace SE
  awardeeCity: Atlanta
  awardeeCountryCode: US
  awardeeName: ThinkLive! INC.
  awardeeStateCode: GA
  awardeeZipCode: '303166701'
  fundsObligatedAmt: '224999'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746869'
  piEmail: cspencer@tliveinc.com
  piFirstName: Charles
  piLastName: Spencer
  piPhone: '4047594525'
  poName: Rajesh Mehta
  date: 12/29/2017
  startDate: 01/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Digital Media Synchronization, Performance and Urban Education
    Enhancement'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project will be to develop and test feasibility of a web-based
    software and machine learning technology that is able to empower healthcare teams
    with community resource information as well as facilitate coordination of post-treatment
    care. Lack of access to community resources such as housing, food and transportation
    (also known as social determinants of health) has been associated with negative
    health outcomes such as unplanned hospital readmissions and emergency room visits.
    This leads to high healthcare costs. Therefore, healthcare teams (i.e. social
    workers, case managers and discharge planners) spend a significant amount of time
    to locate appropriate community resources for their patients. Our innovation will
    leverage a community of healthcare professionals and the resource providers to
    ultimately find community resources for patients in a faster and less costly manner.
    The machine learning technology supported by this award will connect healthcare
    professionals with relevant community resources that ultimately reduces the cost
    and time associated with this process. A successful implementation of this technology
    will lead to improved post-treatment care outcomes for the patients and reduced
    cost of care.  \n\nThe proposed project will develop and test the feasibility
    of a web-based software platform to empower healthcare professionals to share
    community resources. Novel machine learning technology will be developed to facilitate
    appropriate and efficient exchange of community resources. Healthcare professionals
    using the platform will be able to get onto the platform as well as search and
    share resources. The machine learning algorithm leverages the relationships of
    healthcare professionals and resource providers to coordinate community resource
    sharing. A successful implementation of this algorithm will provide substantial
    improvements on the ability to acquire timely community resources as compared
    current methods. The goal of this research is to validate whether the machine
    learning technology is able to help healthcare professionals identify appropriate
    community resources."
  awardeeAddress: 10707 Holly Springs
  awardeeCity: Houston
  awardeeCountryCode: US
  awardeeName: Medical Innovators Company, LLC
  awardeeStateCode: TX
  awardeeZipCode: '770421411'
  fundsObligatedAmt: '224935'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746170'
  piEmail: tomlee6750@hotmail.com
  piFirstName: Tom
  piLastName: Lee
  piMiddeInitial: L
  piPhone: '7132480311'
  poName: Henry Ahn
  date: 12/26/2017
  startDate: 01/01/2018
  expDate: 07/31/2019
  title: 'SBIR Phase I:  A software product that empowers healthcare teams with community
    resource information and facilitates post-treatment care coordination.'
- abstractText: "The broader social impact and commercial potential of this Small
    Business Innovation Research (SBIR) Phase I project reflects the increasing importance
    and proliferation of artificial intelligence and algorithmic systems in the educational
    arena and in other domains of human resources. This places the project strategically
    at the vanguard of scientific discovery, in building a technology tool that will
    serve society?s goals. In the post-secondary education and training domains, market
    inefficiencies require excess spending on both sides of the transaction, adversely
    affecting both supply and demand. As the nation continues to deliberate the value
    of higher education in the face of $1.3 billion in student loan debt, streamlining
    the college application process by matching students and institutions based on
    an applicant?s career goals can reduce costs for students, their families, and
    institutions alike. Outside the field of education, this project will impact workplaces
    where employer-employee matching algorithms will be used in recruiting, hiring,
    training, and team building, across the domains of health, innovation, national
    defense, and beyond. Ultimately, people analytics platforms have unlimited potential
    for national and international commercialization, thus generating tax revenue,
    creating jobs, and otherwise bolstering the economy. \n \nThe proposed project
    focuses on the deployment of people analytics in the domain of college and career
    readiness and success. While talent evaluation through such innovative software
    is in its infancy, the small company's approach to college match will revolutionize
    how students identify their professional goals and then optimize their college
    experience for successful life launch. The small company's team of behavioral
    and data scientists, game designers, and software engineers, are creating video
    games that provide insights into a college applicant's career potential. Their
    platform captures massive amounts of micro-behavioral data -- how long players
    hesitate before making a move, persistence in the face of challenge or frustration,
    ability to parallel process -- to create a psychographic profile of the player's
    career-critical characteristics, including traits like competitiveness, extroversion,
    risk tolerance, and other enduring, personal traits difficult to discern through
    resumes and traditional, college application materials. Once a student's career
    objectives become clear, the company's proprietary recommendation engine suggests
    educational institutions and curricula best suited to attain the player?s career
    goals. In addition to expanding the game platform and collecting player data to
    develop and fine tune predictive algorithms, this project also will examine factors
    that influence a player's response to the insights and recommendations the platform
    provides. This work will investigate the impact of transparency, or \"scrutability\",
    of game-based assessments and implement visualization tools that promote the player's
    understanding of why specific recommendations are made."
  awardeeAddress: 1906 8th Ave. W
  awardeeCity: Seattle
  awardeeCountryCode: US
  awardeeName: posed2, Inc.
  awardeeStateCode: WA
  awardeeZipCode: '981192004'
  fundsObligatedAmt: '224885'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1747381'
  piEmail: allisonrosenberg@live.com
  piFirstName: Allison
  piLastName: Rosenberg
  piPhone: '2065574955'
  poName: Rajesh Mehta
  date: 12/26/2017
  startDate: 01/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Game-Based Psychometric Assessments for College and Career
    Match'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project include enabling the minimally invasive treatment of a large variety of conditions. This is expected to be achieved through the development of a steerable needle that can reach arbitrary positions in the human body that are not reachable by a straight needle from a simple needle hole. The long term impact of the proposed technology is in targeted delivery of medicine, or the removal of tissue such as biopsies, or treatment mechanisms such as ablation devices. An overarching goal of the proposed project is the availability of minimally invasive procedures that can replace more drastic surgery options. The development of this device has the potential to also save lives, treating what otherwise would be inoperable conditions due to the location of tumors blocked by sensitive organs or bones.


    The proposed project, if successful, will lead to demonstrating the application of a device that utilizes the buckling behavior of semi-curved beams to controllably alter the stiffness in a needle for cancer treatment and measure its efficacy in terms of the advantages over straight needles. The objectives of this research include: developing a prototype and match to surgeon use cases (interventional radiologist) and testing and characterizing the steerability performance while delivering the medical payload. Specifically, it is expected that the first therapeutic application of this technology will be microwave ablation of cancer tumors.
  awardeeAddress: 3401 Grays Ferry Ave
  awardeeCity: Philadelphia
  awardeeCountryCode: US
  awardeeName: Greppo Technologies LLC
  awardeeStateCode: PA
  awardeeZipCode: '191462701'
  fundsObligatedAmt: '224592'
  fundProgramName: STTR PHASE I
  id: '1746583'
  piEmail: koch.eza@gmail.com
  piFirstName: Eza
  piLastName: Koch
  piPhone: '9736538374'
  poName: Henry Ahn
  date: 12/23/2017
  startDate: 01/01/2018
  expDate: 12/31/2019
  title: 'STTR Phase I:  A steerable needle to enable precise and minimally invasive
    delivery of treatments, ablation therapy and tissue biopsies.'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is in enabling additional energy savings in buildings by harvesting natural daylight and using it for illuminating the interior space with high efficiency and without glare, thus offsetting the need for electrical lighting. This will make building operations more sustainable and help improve the energy security of the U.S, create jobs, and reduce greenhouse gas emissions. Additionally, when commercially available, this new technology will bring all of the well-known benefits of enhanced natural lighting for occupants of millions of residential and commercial buildings across the U.S., such as connection to outdoors and improved comfort, productivity and well-being, thus benefiting many groups of consumers.

    The proposed project will demonstrate the feasibility of a novel, non-prismatic optical film material and its use for enhanced daylighting harvesting in buildings. This material employs thousands of microscopic reflective surfaces embedded into the bulk of the material and operates by capturing the incident sunlight and projecting it deep into the building interior. Commercial buildings alone consume about 20 percent of all energy used in the United States at an estimated cost of nearly $180 billion. Building interior lighting accounts for around 30% of that cost. By applying the daylight-harvesting optical material to windows of building facades, a significant fraction of that energy consumption can be offset using the natural light captured throughout the day. The project will provide the critical design, testing, and experimental validation needed to transition the technology into the commercial sector. The primary objective of the project is to develop the core light-redirecting material and associated micro-optical fabrication technology that can be subsequently scaled for low-cost mass production. A second objective is to develop, test and demonstrate a prototype daylight-harvesting window film product based on this material.
  awardeeAddress: 1832 Tribute Road, Suite C
  awardeeCity: Sacramento
  awardeeCountryCode: US
  awardeeName: Lucent Optics, Inc.
  awardeeStateCode: CA
  awardeeZipCode: '958154309'
  fundsObligatedAmt: '224997'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746140'
  piEmail: svasylyev@lucentoptics.com
  piFirstName: Sergiy
  piLastName: Vasylyev
  piPhone: '9162261763'
  poName: Rick Schwerdtfeger
  date: 12/23/2017
  startDate: 01/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Internally Microstructured Optical Films for Natural Lighting
    of Building Interiors'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project will be to develop protein purification nanotechnology
    and materials for biopharmaceutical applications. Over 150 different protein or
    small peptide-based drugs have received FDA approval to treat an array of diseases
    (e.g., biologics, monoclonal antibodies, and blood clotting factors).  Protein
    purification remains a challenge as the number of synthetic peptides entering
    clinical trials continues to grow. The global protein and peptide drug market
    is projected to exceed $140 billion in 2017 with an annual growth rate of ~5%.
    Demonstration of the feasibility of the proposed new protein purification resins
    is expected to provide a transformational tool for drug research and development,
    enhance research in protein/peptide structure and function, and enable the discovery
    of new proteins/peptides. \n\nThis SBIR Phase I project proposes to develop and
    commercialize new protein purification resins based on nanomaterials that will
    afford capacity independent of protein size, minimal metal leaching, and better
    stability with respect to existing immobilized metal affinity chromatography (IMAC)
    resins for protein purification. The new resins will ensure greater purity and
    activity of isolated proteins with control of epitope-tag specificity, and minimize
    non-specific interactions. The new resins will be compatible with current manufacturing
    processes and applicable in batch, microplate, sensor chip, and column formats.
    The goal is to demonstrate that the proposed technology is superior to existing
    commercial resins, as suggested by theoretical predictions and preliminary results.
    The new IMAC resins will be synthesized and characterized in terms of metal content
    and leaching, protein loading capacity, purity and activity of proteins isolated,
    and stability. These resins will be optimized for each mode of operation. The
    goal is to establish a new platform technology for analytic and preparative drug
    protein isolation."
  awardeeAddress: 190 Millerick Avenue
  awardeeCity: Lawrenceville
  awardeeCountryCode: US
  awardeeName: Bionanotech LLC
  awardeeStateCode: NJ
  awardeeZipCode: 086483643
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746198'
  piEmail: bnvsdinesh151@gmail.com
  piFirstName: NVS DINESH K
  piLastName: BHUPATHIRAJU
  piPhone: '6095834191'
  poName: Ruth Shuman
  date: 12/23/2017
  startDate: 01/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  A New Class of Immobilized Metal Affinity Chromatography
    Resins'
- abstractText: |-
    The broader impact/commercial potential of this project is the first time commercial development of a copper cable which can transmit and store energy. Currently, copper cables are used for transmitting electricity. Adding energy storage capability to these cables is transformative and has the potential to be employed in a myriad of electrical and electronic applications. Making these cables into spools of wires and custom sliced into a certain length to achieve a required capacitance will be very attractive to commercial applications. The proposed study enables to understand how energy transmission and storage can be simultaneously performed without mutual interference. These cables can find niche applications in the automotive, energy, defense, and IT industries. Moreover, when made into thin wires, it can be weaved into a matrix which can be used to charge wearable devices. For example, currently, a soldier carries about 30-40 pounds of battery for a three-day mission. However, if energy storage devices like the one proposed here can be made into an advanced textile form and can be worn as a uniform, the weight currently carried by the soldiers can be considerably reduced. A cable energy storage device developed can also be beneficial for storing energy for clean-energy technologies such as wind and solar.

    This Small Business Technology Transfer (STTR) Phase I project fills the gap of a cable-type capacitor which saves space and fits well with electrical and electronic devices. The objective of this proposal is to use nanotechnology-based fabrication techniques to grow nanowhiskers with a high surface area on a copper cable to make cable-type capacitors. These nanostructures considerably enhance the surface area necessary for the storage of electrical charges. Since nanostructures are developed only on the outside of the electrical cable to store energy, the inner part of the cable can still be used for electrical transmission. The focus of the proposed research is to develop the processes which can be used to make these nanostructured electrodes into a cable capacitor. The fabrication techniques for growing nanostructures will be so designed that making long lengths of the cables are feasible. The performance of the cable-based capacitors will be tested in terms of capacitance, cycle life, voltage output, etc. In addition, the flexibility of the cable will be tested at different bend-angles to evaluate its applications in flexible energy storage applications.
  awardeeAddress: 3259 Progress Drive
  awardeeCity: Orlando
  awardeeCountryCode: US
  awardeeName: Capacitech Energy LLC
  awardeeStateCode: FL
  awardeeZipCode: '326283230'
  fundsObligatedAmt: '224905'
  fundProgramName: STTR PHASE I
  id: '1746740'
  piEmail: i.oladeji@sisomtf.com
  piFirstName: Isaiah
  piLastName: Oladeji
  piMiddeInitial: O
  piPhone: '4079249083'
  poName: Muralidharan Nair
  date: 12/23/2017
  startDate: 01/01/2018
  expDate: 12/31/2019
  title: 'STTR Phase I:  Supercapacitors for Power Supplies'
- abstractText: |-
    The broader impact/commercial potential of this project is that it will enable the automated harvesting of fragile produce such as strawberries to help offset a shrinking workforce and increased labor costs. The world population is expected to grow from 7.3 billion to 11.2 billion by 2100, this population growth and a rising middle class will place more demand on the agricultural industry. Presently, the agricultural industry relies solely on manual labor to harvest its fragile produce. There is no mechanized option that can reliably and cost effectively harvest these crops. Consequently, the industry is struggling to harvest its crop, maintain quality and control its costs. High quality and lower costs can only be maintained if robotic harvesters are utilized that can pick fragile produce without damage. One of the key elements on the automated harvester is a gripper that can grab and pick the produce without damage. There is a market for a reliable and low cost robotic gripper that can gently pick and handle strawberries and other fragile produce.

    This Small Business Innovation Research (SBIR) Phase I project involves the development of a robotic end effector that can be used to harvest and handle fragile produce. Advances in machine vision and robotics has made it possible to commercially harvest fragile produce such as strawberries, however, the key component that still needs to be developed is an end effector that can pick the fruit without damage and be reliable and cost effective. Design and development of this end effector will use a new and novel method for grabbing the strawberry with advances in design, materials and actuation. The proposed R&D plan will involve repeated testing of the interaction between the fruit and the end effector. Analytical studies using a series of thin film load sensors mounted on the end effector will provide real time load profiles that can be used to optimize the design and performance of the end effector. Shelf life testing of the fruit will be used to assess the success of the end effector in properly picking and handling the fruit without damage.
  awardeeAddress: 19 Franklin Road
  awardeeCity: Winchester
  awardeeCountryCode: US
  awardeeName: Harvest Moon Automation
  awardeeStateCode: MA
  awardeeZipCode: 018904014
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746212'
  piEmail: harvestmoonautomation@gmail.com
  piFirstName: Stephen
  piLastName: Jens
  piMiddeInitial: C
  piPhone: '7819295161'
  poName: Muralidharan Nair
  date: 12/23/2017
  startDate: 01/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Robotic Gripper for Fragile Produce'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project will be to enable early mass vision screening
    of preverbal children by primary care physicians as a result of the development
    of a reliable, rapid, mobile and affordable vision screening tool.  That tool
    will allow the integration of early vision screening during the well baby care
    visits.  Early childhood vision problems are a major public health issue, affecting
    3-5% of infants in the US alone.  The vision screening tools currently available
    for young children are only indirect measures of vision, have limited sensitivity,
    are not quantitative, too complex and, time-consuming to allow all children to
    benefit.  Early detection and treatment of vision impairments improve vision treatment
    outcomes and prevents early learning development deficits.  This SBIR project
    will increase access to vision screening at an earlier age, resulting in improved
    treatment and visual outcomes, allow screening in more situations and locations,
    and result in a commercially viable, clinically reliable measure of visual function
    in young children. \n\nThe proposed project will enhance the vision screening
    digital platform for preverbal children and validate testing performance and reliability
    against the current clinical standard (Teller Acuity Card procedure).  That digital
    platform functionality includes user interface, scalable testing patterns, and
    video output.  That platform leverages the innate optokinetic response (OKN),
    the mobility of a tablet computer and the access and computational capability
    of the cloud.  Cost and complexity of existing vision screening solutions and,
    lack of cooperation from those young patients have limited access and use of many
    current testing methods for young children.  Two thirds of all preschool children
    in the US have never had an eye examination or vision screening before starting
    school.  The proposed solution will increase the access of preverbal children
    to early mass vision screening in the primary care practices during the well baby
    care visits."
  awardeeAddress: 3401 Grays Ferry Ave
  awardeeCity: Philadelphia
  awardeeCountryCode: US
  awardeeName: Vifant LLC
  awardeeStateCode: PA
  awardeeZipCode: '191462701'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746353'
  piEmail: edesouza@comcast.net
  piFirstName: Beth
  piLastName: DeSouza
  poName: Henry Ahn
  date: 12/23/2017
  startDate: 01/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Novel Vision Screening Digital Platform for Preverbal Children'
- abstractText: |-
    This SBIR Phase I project will study the development of a digitally configurable shape around which a shoe can be created. The results of this project will enable the mass-customization of shoes so they can precisely fit the feet of the individuals who wear them. Properly fitting shoes are intended to improve the quality of life of customers through reduced pain and improved musculoskeletal health. This development in shoe-making technology is of broad interest to the population of the United States, but particularly important to women, who often suffer from physical deformities and injuries caused by ill-fitting shoes. The proposed innovation relies on mass-customization methods and flexible robotics technology. Its anticipated success will provide additional jobs in the shoe industry and related fields, and improve productivity nationwide through reduced healthcare costs.


    The strong technical innovation in this project will be the adaptation of granular jamming technology for use in programmable shape technology. The driving goal of the proposed project is to develop a last for use in the mass-customization of shoes that is capable of changing shape in response to a digital representation of the customer's foot shape. After changing shape, it will lock into a rigid but smooth form appropriate for use in traditional shoe manufacturing methods. The scope of the research will cover the development of the last in a manner appropriate for use in manufacturing conditions (in terms of both physical and temperature durability) and the creation and implementation of algorithms for transforming foot shape data into an appropriately fitting shoe shape and for transforming a standard shoe pattern onto an arbitrary foot shape. Iterative design practices and just-in-time manufacturing techniques will facilitate the development of this new technology and manufacturing methodology.
  awardeeAddress: 49 Cayuga St
  awardeeCity: Rochester
  awardeeCountryCode: US
  awardeeName: RE Shoes, LLC
  awardeeStateCode: NY
  awardeeZipCode: '146202142'
  fundsObligatedAmt: '224995'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746887'
  piEmail: pmberkeley@gmail.com
  piFirstName: Pamela
  piLastName: Berkeley
  piPhone: '5089819918'
  poName: Benaiah Schrag
  date: 12/21/2017
  startDate: 01/01/2018
  expDate: 12/31/2019
  title: 'SBIR Phase I:  Flexible Robotics for Mass Customization of Shoe Sizing'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to revolutionize the healthcare industry by developing computing solutions for precision medicine.  Next-Generation Sequencing (NGS) now produces a large amount of genome data at an affordable cost. Analyzing large volumes of genome data from diverse populations will lead to a better understanding of the causes of various diseases ranging from cancer to rare genetic disorders, and develop better cures. By sequencing a patient's genome, it is possible to more specifically determine his/her condition and devise an individualized treatment plan. And, if every newborn's genome was sequenced, it would allow for proactive identification of disease risks, and early intervention. Understanding viruses and bacteria will help us gain a better understanding of infectious diseases, and thereby enable us to develop better immunization and disease control methods. In addition to health-care, genomics also may help engineer better food crops and attain food security.  This project will develop novel computing hardware solutions that are customized for genomics sequencing software. These computing solutions can help realize an exponential growth in the digital genomics market and bring affordable personalized medicine to all.

    This SBIR Phase I project proposes to accelerate Whole Genome Sequencing (WGS) by building a customized processor for genomics automata.  Over the last decade, the production cost of sequencing has plummeted from ten million dollars to a thousand dollars, and is soon expected to go below a hundred dollars per genome. Advancements in processor performance, however, have not kept pace. It can take several days on a computing cluster to sequence a genome. For genome sequencing to become as affordable as a routine medical test, computing solutions are required that can sequence a genome in minutes, and cost only a few dollars per genome. This project is developing a novel ASIC hardware accelerator for computing finite state automata, which supports approximate string matching, a computational kernel widely used in genomics applications such as sequencing. The design is based on a novel in-memory hardware technology for efficiently implementing state transitions. The goal is the improve efficiency of genomics automata by two orders of magnitude compared to modern processors.
  awardeeAddress: 1819 Meadowside Dr
  awardeeCity: Ann Arbor
  awardeeCountryCode: US
  awardeeName: Sequal Inc
  awardeeStateCode: MI
  awardeeZipCode: '481044266'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746731'
  piEmail: kgoliya@umich.edu
  piFirstName: Kush
  piLastName: Goliya
  piPhone: '6462402606'
  poName: Ruth Shuman
  date: 12/21/2017
  startDate: 01/01/2018
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Genomics Accelerator'
- abstractText: |-
    The broader impact/commercial potential of this project includes a new, low-cost approach to 3D millimeter wave image sensors enabling non-destructive evaluation in construction, as well as other fields such as robotics, security, and quality control. Millimeter wave imaging uses human-safe, radio frequency signals to make high resolution images of objects that cannot be seen with conventional optical sensors. Because of their long wavelength, millimeter waves pass through many materials that are opaque to visible light, including common construction materials such as drywall, brick, tile, cement, and wood. For example, in the construction market, dramatic cost savings and faster, safer, and more accurate construction work could be achieved using millimeter wave imaging for structural evaluation as well as observing hidden utilities such as wiring and plumbing that should be avoided while drilling, and detecting hazards such as water leaks behind wall surfaces. This project will also provide entrepreneurial opportunity to a new generation of scholars/innovators as the technology matures toward commercial practice.

    This Small Business Innovation Research (SBIR) Phase I project aims to advance the state of the art in millimeter wave imaging and enable low-cost, standalone 3D millimeter wave imagers. Prior work in a laboratory environment has demonstrated the promise of millimeter wave imaging for applications such as structural analysis in construction, however commercialization requires an image sensor that is fast, portable, low power, and low cost. This project will enable low cost hardware/software platforms for millimeter wave imaging using commercial chipsets with novel general purpose graphics processing unit (GPGPU)-accelerated image reconstruction algorithms.
  awardeeAddress: 3000 Mason Rd
  awardeeCity: Seattle
  awardeeCountryCode: US
  awardeeName: Thruwave LLC
  awardeeStateCode: WA
  awardeeZipCode: '981950001'
  fundsObligatedAmt: '224957'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1747275'
  piEmail: claire.marie.watts@gmail.com
  piFirstName: CLAIRE
  piLastName: WATTS
  piMiddeInitial: M
  piPhone: '2067993080'
  poName: Muralidharan Nair
  date: 12/21/2017
  startDate: 01/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Low-Cost 2D and 3D Millimeter Wave Image Sensors'
- abstractText: "The broader impact/commercial potential of this project addresses
    a great demand for in-situ chemical sensor technology with ability to (1) Measure
    with high resolution the environmental footprint of agricultural and urban development,
    and (2) Identify potential safety issues related to drinking water quality. High
    concentrations of nutrients (e.g. nitrate, nitrite, orthophosphate) in surface
    waters are the source of environmental, public health, and economic issues. Active
    monitoring of nutrient concentrations in surface waters such as estuaries, lakes
    and rivers is critical in assessing their health and implementing timely action
    to minimize ecosystem degradation. This SBIR project aims at developing a disruptive
    new type of highly miniaturized autonomous water quality chemical sensor, that
    can be operated remotely and autonomously, has minimal installation and maintenance
    requirements, is capable of performing thousands of measurements directly in-situ,
    in both reagent-based and reagent-less configuration, on a single battery charge.
    Applications that will greatly benefit from such sensors range from scientific
    research, to estimating nutrient loads, establishing discharge limits, predicting
    eutrophication conditions and demonstrating compliance with regulatory reporting
    requirements. Independently, the drinking water industry has its own requirements
    for autonomous chemical sensors for monitoring reservoirs and distribution networks,
    optimizing treatment processes and identifying tank nitrification issues early-on.
    \n\nThis Small Business Innovation Research (SBIR) Phase I project aims to achieve
    the highest level of miniaturization and functionality attempted in a commercial
    water quality sensor. The core innovation of this proposed e-CHEM system is in
    the microfluidic chemical analysis module, combining a novel highly-efficient
    mixing mechanism to homogenize minute volumes of reagent with the fluid sample
    with a microfluidic implementation of dual reagent-based and reagent-less chemical
    measurement capability, the possibility of controlling relevant chemical reactions
    in-situ via precise on-chip temperature management, and finally the potential
    of overcoming the important hurdle of bio-fouling via novel surface nano-engineering.
    The parameters measured will include a selection from: ortho-phosphates, nitrites,
    nitrates, dissolved organic carbon, total and/or free chlorine, free ammonia,
    and pH. The system will include bidirectional wireless telemetry to enable automatic
    alert generation and data transmission to remote servers for visualization, analysis
    and interpretation. Target accuracy and response times are superior to traditional
    measurement techniques due to full process automation, elimination of sample degradation
    and transit times, reduction of human error, and automatic data centralization."
  awardeeAddress: 396 S San Marino Ave
  awardeeCity: Pasadena
  awardeeCountryCode: US
  awardeeName: FLUIDION US Inc.
  awardeeStateCode: CA
  awardeeZipCode: '911075050'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1747293'
  piEmail: j.wong@fluidion.com
  piFirstName: Joyce
  piLastName: Wong
  piPhone: '6267651386'
  poName: Anna Brady-Estevez
  date: 12/20/2017
  startDate: 01/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  e-CHEM: A fully-autonomous connected in-situ chemical sensor'
- abstractText: |-
    This SBIR Phase I project develops chemical tools and platforms to produce valuable chemical building blocks that can be used to produce synthetically challenging compounds on large scales. These compounds belong to the class of polypropionates which is known for its diverse and powerful biological activities across multiple indications within the pharmaceutical, agrochemical, and veterinary industries. The high impact of the polypropionate class is hampered by the inefficiencies of current chemical processes to fully tackle their complex structures. Importantly, the lack of scalability adds another severe complication to the development process. To fully unlock the potential of this class, improved chemistries with greater efficiencies are required to successfully identify high impact candidates for further development. Moreover, the new tools are excellent substrates for polyketide?{enhanced drug discovery. This project is a prelude to the development of a novel class of compounds against rare and unmet needs in cancer in collaboration with the NCI/NIH. Such cancers pose a huge burden on the healthcare system and the economy in general. Inspired by the NSF mission, this project describes an innovative chemical process that can deliver highly valuable compounds. Such an approach will enable accelerated discoveries across multiple medicinal and agrochemical needs.

    This project aims to provide all sixteen possible stereotetrad building blocks (in the form of chiral lactones) for construction of polypropionates on practical scales. Those chiral building blocks can serve as common precursors for synthesis of polypropionates, as tools for rational design and structure activity relationship (SAR) studies, or as entries for more diverse and complex library of analogs. The chemistry platform used to produce those building blocks is referred to as the Chiral Carbon Catalog (CCC). The CCC platform is a synthetic tool box that allows stereoselective large scale economic synthesis of various complex polypropionate building blocks from simple starting materials. The unified process has been carefully designed to employ highly diastereoselective substrate directed transformations while avoiding expensive and impractical chiral auxiliary overheads or expensive catalysts. The high efficiencies of transformations allow the elimination of tedious and expensive purifications such as column chromatography. The crystalline natures of key intermediates enable facile production on scale and allow the synthetic routes used by the platform to be easily adopted by the industry for large scale production. This ensures adequate supply of those building blocks for development of complex chiral products within several industries (e.g. pharmaceutical and agrochemical fields).
  awardeeAddress: 3495 Kent avenue, Suite E-100
  awardeeCity: West Lafayette
  awardeeCountryCode: US
  awardeeName: Akanocure Pharmaceuticals, Inc.
  awardeeStateCode: IN
  awardeeZipCode: '479061074'
  fundsObligatedAmt: '224996'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746311'
  piEmail: mnoshi@akanocure.com
  piFirstName: Mohammad
  piLastName: Noshi
  piPhone: '7654096062'
  poName: Henry Ahn
  date: 12/20/2017
  startDate: 01/01/2018
  expDate: 09/30/2019
  title: 'SBIR Phase I:  Novel Stereo-enriched Libraries as Commercial Complex Building
    Blocks for Facile Development of Biologically Active Compounds on Large Scale'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) project is the development of sustainably produced, effective
    natural sunscreen compound found in marine organisms for skincare applications.
    \ The World Health Organization estimates that one in every three cancers diagnosed
    is a skin cancer.  The prevalence of skin cancer, and the threat of photoaging,
    is driving growth in the global market for sun protection products, which is predicted
    to reach over $7 B by 2020.  However, many chemical sunscreen ingredients on the
    market today have been shown to be harmful to the environment and/or to have adverse
    health effects.  The goal is to produce a previously identified marine sunscreen
    compound, gadusol, in an economical and sustainable yeast biomanufacturing system,
    and replace problematic sunscreen ingredients in current use. \n\nThis SBIR Phase
    I project proposes to develop a sustainable means of producing a natural, marine-based
    sunscreen ingredient for skincare applications. This project focuses on increasing
    yields and recovery of gadusol, a fish-derived UV-B-absorbing sunscreen, by using
    the tools of microbial fermentation and synthetic biology. The gadusol biosynthetic
    pathway was recently introduced into yeast.  The key technical objectives of his
    project are to improve gadusol yields, evaluate yeast-produced gadusol use in
    skin care products, and develop methods for purification that will be applicable
    to large-scale production.  The anticipated outcome of this project is a new and
    underutilized sunscreen compound derived from natural sources that has the potential
    to provide UV protection without the health and environmental risks associated
    with current commercial ingredients."
  awardeeAddress: 750 SW C Avenue Apt 4
  awardeeCity: Corvallis
  awardeeCountryCode: US
  awardeeName: Seaceuticals Inc
  awardeeStateCode: OR
  awardeeZipCode: '973334335'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1747347'
  piEmail: khaled@gadusollabs.com
  piFirstName: Khaled
  piLastName: Almabruk
  piMiddeInitial: H
  piPhone: '5416029436'
  poName: Ruth Shuman
  date: 12/19/2017
  startDate: 01/01/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Production of natural sun-protective compounds'
- abstractText: "The broader impact/commercial potential of this Small Business Innovation
    Research (SBIR) Phase I project is to increase treatment options and to improve
    health outcomes for patients using a comprehensive algorithm-based behavior health
    intervention. It can address Institute of Health Improvement's Triple AIM to improve
    population health, improve patients' experience of care, and reduce per capita
    healthcare cost. The proposed platform is aimed at optimizing treatment outcomes
    by enhancing motivations, maximizing treatment adherence, engaging families and
    natural supports, and supporting self-care management for individuals with chronic/serious
    behavioral health conditions. The proposed technology is expected to enable patients
    to receive an ancillary, active treatment that keeps them functioning in daily
    life. By enhancing the clinical experience for patients and clinicians, individuals
    with behavioral health conditions can self-monitor and communicate their experiences
    to their clinician and record them in real time, allowing monitoring and assessment
    by the behavioral health provider.   \n\nThe proposed project will develop and
    test a novel behavior health technology intervention on improving patients? ability
    to feel in control of their treatment and improve their well-being.  The technology
    is expected to enable ongoing, real-time feedback to the both the patient's personal
    and professional care team to monitor the impact of enabling/impending factors
    on treatment progress to continually refine the care plan and interventions so
    that optimal results can be achieved. The platform consists of a secure mobile
    and web platform used to provide proactive interventions, advanced algorithms
    used to personalize care and provide insights to the behavioral health provider.
    The team plans to assess whether the combination of personal support effectively
    in the patients' care together with advanced correlations using deep learning
    can help in predicting interventions including crisis episode, improve patient's
    treatment planning and wellness."
  awardeeAddress: 651 Pinot Blanc Way
  awardeeCity: Fremont
  awardeeCountryCode: US
  awardeeName: SageSurfer Inc
  awardeeStateCode: CA
  awardeeZipCode: '945398014'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1747845'
  piEmail: anupam@sagesurfer.com
  piFirstName: Anupam
  piLastName: Khandelwal
  piPhone: '5103531045'
  poName: Henry Ahn
  date: 12/19/2017
  startDate: 01/01/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I: Comprehensive Online Platform to Enhance Care Coordination
    and Improve Behavioral Health Outcomes'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to develop a new class of cancer therapeutics that involves the re-directing of the body's pre-existing immune response obtained through previous childhood vaccination to target tumor cells for cancer eradication. Globally, cancer continues to be a top 5 leading cause of death resulting in a high unmet need for novel therapies and treatments. Immune checkpoint inhibitor drugs have emerged as a potent solution with demonstrated clinical benefits. However, such treatments are expensive and toxic, and up to 70% of cancer patients do not respond to such drugs due to the absence of an anti-tumor response. In contrast, the proposed strategy tailors the patient's tumor to become susceptible towards their own pre-existing childhood vaccine immunity. This approach will change treatment outcomes for many cancer patients previously un-targetable by current immuno-therapeutic drugs. This also circumvents the risky and costly R&D challenges in identifying and/or producing potent immune responses against cancer.

    This SBIR Phase I project proposes to develop a platform technology to mobilize immunity generated from childhood vaccines and re-direct this activity towards tumors to eradicate cancer. This will be done via two development aims.  The first aim will demonstrate the ability of the proposed technology to mobilize existing childhood vaccine responses from mice (with relevant human genetics) vaccinated with childhood vaccines (MMR, HepB, Chickpox vaccines). The second aim will be to test whether cancers with known metastasis challenges, such as ovarian and breast cancer, may be eradicated. Specifically, mice will be vaccinated with an appropriate childhood vaccine, then injected with relevant syngeneic tumors. Once the tumor is established, the proposed therapeutic will be injected to see if it can induce pre-existing immunity developed from the childhood vaccine and redirected towards the tumor. Therapeutic effect will be assessed based on the number of metastases and tumor weight/volume. If successful, this platform will provide both tumor specificity and broad applicability to a wide variety of cancers.
  awardeeAddress: 1812 ashland avenue
  awardeeCity: baltimore
  awardeeCountryCode: US
  awardeeName: PathoVax
  awardeeStateCode: MD
  awardeeZipCode: '212051506'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746588'
  piEmail: jwang@pathovax.com
  piFirstName: Joshua
  piLastName: Wang
  piPhone: '4434498836'
  poName: Ruth Shuman
  date: 12/19/2017
  startDate: 01/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Anti-Tumor Immune Redirectors (AIRs) for cancer treatment'
- abstractText: |-
    This STTR Phase I project will undertake the development of iron coordination complexes as alternatives for gadolinium contrast agents which are currently used in clinical MRI diagnostic exams.  New MRI contrast agents are needed to serve the segment of the population who cannot tolerate Gd(III) agents.  This includes patients with kidney disease and those who have frequent MRI scans and may accumulate Gd(III).  The proposed research involves the study of new trivalent iron coordination complexes based on those initially studied in the co-PI?s university laboratory. New iron complexes will be prepared and studied as contrast agents in live mice to improve characteristics of the agents such as clearance from the body.  Fundamental studies of the iron complexes will add to the body of knowledge on the paramagnetic properties of iron.
    For the most promising Fe(III) contrast agents, the synthetic procedures will be adapted for large scale preparation and purity determination.  Iron MRI contrast agents may also be beneficial to society by reducing gadolinium in water supply.  Furthermore, iron as an abundant element is less expensive and more readily available in the USA than is gadolinium. The commercialization of iron MRI contrast agents will create jobs in chemical manufacturing, sales, and in health-related occupations.

    The lead Fe(III) coordination complex on which this project is based produces longitudinal (T1) relaxivity of water protons that rival clinically used Gd(III) complexes at 4.7 Tesla, both under in vitro conditions and also in live mice. Importantly, these complexes contain macrocyclic ligands that stabilize iron in the trivalent state (negative redox potentials versus NHE) and do not produce reactive oxygen species even in the presence of ascorbate as a reductant and peroxide.  The importance of outersphere water and innersphere water interactions will be studied by varying the coordinating pendent groups on the macrocyclic ligand which is bound to Fe(III).   The ancillary group will be varied to increase binding to serum proteins and to modify the clearance route of the contrast agents either through kidneys or through hepatobiliary routes.  The complexes will be optimized for kinetic inertness towards release of iron under biologically relevant conditions.  Toxicity studies in cell culture will be carried out on each of the new complexes. This research will focus on both pilot scale preparation for the study of the Fe(III) complexes in vitro and also on larger scale preparations and HPLC analysis of the most promising new derivatives.  In vivo MRI scans in mice on a 4.7 T scanner will be used to track the distribution and clearance of the iron contrast agents as a function of time.
  awardeeAddress: Baird Research Park
  awardeeCity: Amherst
  awardeeCountryCode: US
  awardeeName: Ferric Contrast, Inc.
  awardeeStateCode: NY
  awardeeZipCode: '142282710'
  fundsObligatedAmt: '225000'
  fundProgramName: STTR PHASE I
  id: '1746556'
  piEmail: patrickburns@ferric-contrast.com
  piFirstName: Patrick
  piLastName: Burns
  piMiddeInitial: J
  piPhone: '5189295825'
  poName: Henry Ahn
  date: 12/18/2017
  startDate: 01/01/2018
  expDate: 04/30/2019
  title: 'STTR Phase I:  Relaxivity mechanisms of Fe(III) MRI contrast agents'
- abstractText: |-
    The broader impact/commercial potential of this project is that it will serve as a one-stop power conversion solution across the power conversion industries. The proposed Power Converter can convert power directly from AC-DC, DC-DC, DC-AC and AC-AC in a single stage without an interim AC or DC link. The said power converter can take fixed frequency, variable frequency or DC voltage as input and can deliver another fixed frequency, variable frequency or DC voltage at the output. The voltage can be stepped up or down and the power can flow back and forth in the said power converter. Having all the power conversion features in one hardware can serve almost all power conversion applications such as aircraft/spacecraft/ship, hybrid/electrical vehicle, renewable energy, automation industry and almost all other power conversion needs by a mere change of software. Such technology has a potential to become a mass-produced commodity and in effect the cost of the power converter can be dramatically reduced across all industries, Market research organization has estimated that by 2020, the power converter market will be valued at $65 billion. Therefore, the commercial impact of this one stop power converter solution will be significant.

    This Small Business Innovation Research (SBIR) Phase I project will introduce a multifunctional power converter with single stage power conversion. By employing bi-directional 4-quadrant wide band gap switch, intelligent filters at input and output, advanced pulse width modulation and commutation scheme a more efficient, robust, smaller foot print, low-weight power converter will be realized which will convert power from input to output much faster with reduced loss and at the same time it will not need any bulky DC or AC link in between. By operating less number of semiconductor switches at a given time the loss and size of the power converter will be reduced. By having intelligent filter, high power quality at the input and output will be achieved. The multifunctional use of this power converter will cut down the number of on board power converters in aircraft/spacecraft/ship in a system level which will provide multi-fold benefit in terms of fuel economy. By having less loss, the power consumption will be reduced and by having smaller size and weight the payload will be less, which will improve the fuel economy. By reducing number of on board power converters the on-board weight will be reduced further. Therefore, overall fuel economy will be significantly improved.
  awardeeAddress: 5525 S Nicolet Dr
  awardeeCity: New Berlin
  awardeeCountryCode: US
  awardeeName: Universal Real Time Power Conversion LLC
  awardeeStateCode: WI
  awardeeZipCode: '531518306'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1747029'
  piEmail: dpanda68@yahoo.com
  piFirstName: Debiprasad
  piLastName: Panda
  piPhone: '4408403393'
  poName: Muralidharan Nair
  date: 12/18/2017
  startDate: 01/01/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Universal Power Converter for AC-DC, DC-DC, DC-AC and AC-AC
    Applications'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to drive the next generation of advanced computing power and performance, by manufacturing integrated circuits, the fundamental units of electronic systems, at length scales of 7 nm and smaller. Today?s central processing units (CPUs) each contain 7.2 Bn chips and over 1.2 sextillion chips are manufactured per year to meet computing demands. Next generation technology is expected to enable artificial intelligence and machine learning through both conventional computing and potentially neuromorphic paradigms, bringing to reality transformative applications such as self-driving cars and smart buildings. As Moore?s law continues to set the pace of technological advancement, chipmakers will deploy new EUV (Extreme Ultraviolet) lithography tools, using light of 13.5 nm to pattern integrated circuits or chip architecture into silicon wafers, for the next three generations of technology. Chipmakers strive to bring about the readiness of EUV technology in 2019. The global demand for next generation electronics is forever increasing as the population grows above 7 Bn. However, the global supply of electronics constantly faces challenges to reduce costs and deliver technology beyond Moore?s Law.

    The proposed project addresses the challenges related to high volume manufacturing at the 7 nm node for lithography tools and its components. For example, an EUV photomask, a high commodity component, patterns and replicates integrated circuit design into silicon wafers. Current EUV photomasks have a sub-optimal manufacturing yield of ~60% and suffer from defectivity which arises during fabrication of its architecture. During operational use the photomask sustains damage from the debris generated by the EUV plasma light source that implants in the mask and inevitably replicates in the wafer, destroying the integrated chip pattern. In high volume manufacturing, these issues manifest in the wafer yield, the reusability of a mask, and drive the need for high cost real-time inspection and metrology. A new EUV photomask which promises greater robustness to defects, a higher manufacturing yield, more reusability of masks in operations and a longer lifetime is presented. The goals of the project are to evaluate new integrated architecture for the EUV mask design, develop a higher yield fabrication process and characterize the EUV performance. More robust photomasks reduce the capital outlay required for in-situ metrology and inspection and ultimately bring down the cost of next generation electronics.
  awardeeAddress: 4225 Executive Sq Ste 490
  awardeeCity: La Jolla
  awardeeCountryCode: US
  awardeeName: Astrileux Corporation
  awardeeStateCode: CA
  awardeeZipCode: '920378411'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1747341'
  piEmail: supriya@astrileux.com
  piFirstName: Supriya
  piLastName: Jaiswal
  piPhone: '8585312432'
  poName: Rick Schwerdtfeger
  date: 12/18/2017
  startDate: 01/01/2018
  expDate: 06/30/2019
  title: 'SBIR Phase I:  High Fidelity EUV PhotoMasks'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is a substantial reduction of leakage in high-density polyethylene (HDPE) pipes. HDPE is a type of plastic commonly used for water, oil, and gas distribution pipe systems. Billions of gallons of treated water are lost daily across the US due to leaking pipes, resulting in massive revenue loss, environmental and property damage, and energy waste. Furthermore, millions of metric tons of methane, a powerful greenhouse gas, escape every year into the atmosphere through leaking pipes. Most leaks occur at pipe joints and by wirelessly monitoring each joint for leaks, as a part of a smart infrastructure network, major leak reduction can be achieved. The commercial impact of the project is extensive, as smart infrastructure networks are increasingly being implemented and expanded, sensor and wireless communication technology has advanced significantly in recent years, and the rate of piping infrastructure installations, replacements, and repairs are accelerating across the US and globally.

    The proposed project aims to demonstrate a prototype capable of detecting a leak in electrofusion joints and wirelessly communicate the leak to an external network. Such joint monitoring system is highly desirable as pipe leaks can go undetected for an extended period of time. Moreover, once detected, leaks can be difficult and expensive to locate, especially as pipes are commonly buried underground or situated at hard-to-reach or remote locations.The challenge that comes with thisis to provide a reliable local power source for the sensing unit that can be on standby for up to 50 years. A second challenge is to generate a signal, powered by the local power source, that can be transmitted to the surface and notify a leak to an external signal receiver. A water-activated battery combined with a radio-frequency identification (RFID) transmitter will be developed for this purpose. RFID technology is extensively used in a broad range of industries due to its low-cost and goodreliability. This technology is, therefore, an excellent candidate for providing an affordable joint leak detection system.
  awardeeAddress: One Boston Pl Ste 2600
  awardeeCity: Boston
  awardeeCountryCode: US
  awardeeName: PROPER PIPE, INC.
  awardeeStateCode: MA
  awardeeZipCode: 021084420
  fundsObligatedAmt: '220688'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746114'
  piEmail: ruben@properpipe-usa.com
  piFirstName: Ruben
  piLastName: Mencos
  piPhone: '6174354571'
  poName: Rick Schwerdtfeger
  date: 12/18/2017
  startDate: 01/01/2018
  expDate: 10/31/2019
  title: 'SBIR Phase I:  Wireless Leakage Monitoring System for Electrofusion Joints'
- abstractText: |-
    This SBIR Phase I project seeks to transform treatment regimens for individuals suffering from malaria infections. Malaria, particularly caused by Plasmodium vivax (P. vivax) and Plasmodium ovale (P. ovale) remain a potential cause of morbidity and mortality amongst the 2.85 billion people living at risk of infection. The only drug currently available for treatment therapy for P. vivax and P. ovale is primaquine, which can cause life-threatening anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Clinicians often do not prescribe primaquine due to the high prevalence (8%) of individuals who are born with G6PD deficiency. The World Health Organization (WHO) and the Program for Appropriate Technology in Health (PATH) are urgently searching for a reliable assay for the diagnosis of G6PD deficiency to effectively treat patients and aid in the eradication of P. vivax and P. ovale malaria. This novel assay proposed will quantify G6PD and hemoglobin (Hgb) concentration simultaneously from a finger stick sample. This system comprises a single test strip coupled with a reflectance-based meter and cell phone application with Blue Tooth connectivity to incorporate a patient?s I.D., test results, global tracking, and history of treatment. It is projected that this point-of-care assay will be used to screen >23 million people for G6PD within 5 years of launch and generate over $27.5 million in compounded revenue. In the long term, the novel assay will create a universal point-of-care platform that can be utilized for other diseases or conditions that affect patients in the Unites States for which point-of-care assays are not currently available.

    The proposed novel platform will quantify both Glucose-6-Phosphate Dehydrogenase (G6PD) and hemoglobin (Hgb) concentrations simultaneously from a single finger stick sample using a point-of-care (POC) reflectance-based meter. There is currently no such device on the market, which is urgently needed to screen patients being treated for P. vivax and P. ovale malaria. A significant portion (8%) of the world population is G6PD deficient, which places these individuals at risk for life-threatening anemia after treatment with current therapeutics such as primaquine against malaria. The POC assay utilizes a novel lysis and reagent layer membrane platform to enable a reflectance-based meter to measure non-over lapping wavelengths to quantify G6PD and Hgb concentrations. In this proposal, a functional prototype reflectance-based meter and data collection software will be constructed and compared to readings obtained using the current ?gold standard? Konica Minolta spectrophotometer. Secondly, the POC assay will be validated through performance testing using a G6PD-deficient whole blood specimen bank provided by the Program for Appropriate Technology in Health (PATH). Concordance of the data obtained from 20 samples for the proposed assay will be compared to the World Health Organization?s (WHO) approved spectrophotometric method for measuring G6PD and an FDA approved method for measuring Hgb. Success will be indicated by an R2 > 0.95, which demonstrates linear equivalency, as well as a demonstration that 90% of the data points fall within 2 sigma of each value. A POC assay that can simultaneously screen patients for both G6PD deficiency and Hgb levels will allow clinicians to treat patients with P. vivax and P. ovale malaria infections effectively and aid in the eradication of malaria.
  awardeeAddress: 8 Abington Rd
  awardeeCity: Mt Laurel
  awardeeCountryCode: US
  awardeeName: Analytical Diagnostic Solutions
  awardeeStateCode: NJ
  awardeeZipCode: 080544719
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746309'
  piEmail: invitrodiagnosticsolutions@gmail.com
  piFirstName: Robert
  piLastName: Harper
  piPhone: '8563435098'
  poName: Henry Ahn
  date: 12/18/2017
  startDate: 01/01/2018
  expDate: 08/31/2019
  title: 'SBIR Phase I:  A user-friendly point-of-care device for simultaneous G6PDH
    and hemoglobin determination'
- abstractText: "This Small Business Innovation Research (SBIR) Phase I project is
    focused on developing a new probe technology for high magnetic field sensing and
    measurement.  The technology utilizes a circuit-free, atom-based field sensing
    element that affords absolute measurements of strong fields with high-speed all-optical
    readout that is free of electromagnetic interference, directly addressing capability
    gaps in existing technologies relevant to a variety of industries.  A broad commercial
    potential is in fault-detection in condition-monitoring systems for motors and
    generators, where faults due to occurrences such as over-fluxing or magnetization
    can lead to major damage, costly repairs and production downtime.  The atomic
    probe addresses an unmet need for reliable, localized measurements up to several
    Tesla of magnetic field within and surrounding conductive components in rotating
    machines for early fault detection.  The technology also promises to expand capabilities
    of laboratory measurement instrumentation and contribute to experimental high
    magnetic field science requiring advanced instrumentation for measurement in the
    1 to 100 Tesla range. The extraordinary opportunities for scientific research
    and technological development represented by investment in high magnetic field
    laboratories were set out in influential reports of the National Academies of
    Science (2004 and 2013). The field probe is expected to contribute to this on-going,
    multi-disciplinary effort.  \n\nThe intellectual merit of this project includes
    the research and demonstration of key components and capabilities of an atomic
    high magnetic field probe.  The innovation lies in a fundamentally new measurement
    approach that provides robust, absolute-standard (atomic) measurement and sensing
    of magnetic fields up to tens of Tesla at high speed and precision with a compact,
    circuit-free, all-optical sensing element.  The probe operates based on atomic
    physics principles that describe the spectroscopic response of atoms in strong
    magnetic fields, and quantum-optics phenomena that serve as a practical means
    to achieve all-optical readout of the atomic spectra, from which information on
    the magnetic field is obtained.  During this project, theoretical atomic spectra
    in strong magnetic fields will be developed, tested and refined.  A vapor-cell
    probe suitable for sensing strong magnetic fields will be designed, fabricated,
    and tested.  Laboratory experiments will be performed to measure the atomic response
    to magnetic fields in the range of 1 Tesla at ppm sensitivity levels.  The method
    will also be tested in time-varying and switching magnetic fields, on timescales
    of <100ms. Miniaturization of probes and read-out units will be initiated, leading
    towards robust and compact, practical sensing elements with higher operation speed
    and improved performance characteristics."
  awardeeAddress: 330 East Liberty, Lower Level
  awardeeCity: Ann Arbor
  awardeeCountryCode: US
  awardeeName: Rydberg Technologies LLC
  awardeeStateCode: MI
  awardeeZipCode: '481042274'
  fundsObligatedAmt: '224994'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1746983'
  piEmail: dave@rydbergtechnologies.com
  piFirstName: David
  piLastName: Anderson
  piPhone: '5857398576'
  poName: Benaiah Schrag
  date: 12/18/2017
  startDate: 01/01/2018
  expDate: 05/31/2019
  title: 'SBIR Phase I:  Atomic High Magnetic Field Probe'
- abstractText: "This Small Business Innovation Research Phase I project will investigate
    isolation pads made of a novel class of metamaterials to reduce seismic vibrations
    of equipment and buildings. Use of traditional seismic isolation materials often
    leads to restricted design spaces and needs expensive full-scale device testing,
    which make the technology unfeasible for extensive application. The internal architecture
    of the high-performance materials to be studied and optimized in this work can
    enlarge the design space to embrace objects as small as an expensive equipment
    and as large as a major bridge. Simplification of testing protocols due to the
    shift of the isolation property from the device to the material level adds to
    the Broader Impacts by making seismic isolation accessible for a wide range of
    applications. The high level of seismic protection provided by this technology
    constitutes an immediate value for commercial activities that require continuity
    of operations after earthquakes. The initial target is the fast growing market
    of data centers, with the potential for follow-on market in residential housing
    construction. The extensive application of the innovation has the potential of
    increasing the resiliency of communities in areas prone to seismic activity and
    reducing related direct and indirect losses. \n\nThe intellectual merit of this
    project derives from the development of an optimization framework for the internal
    architecture of metamaterials for enhanced seismic protection. There has not been
    a fundamental study to optimize metamaterials based on manufacturing tolerances,
    costs, and performance for seismic applications. This work will contribute to
    developing a set of design principles for optimized internal material architectures
    depending on desired seismic performance. Experimental investigations will be
    carried out to validate the methodology and to prove the feasibility of replacing
    device testing with material coupon testing to certify metamaterial pads for seismic
    isolation. This will include the investigation of processing methods to manufacture
    material assemblies with uniform mechanical properties, and will involve both
    static and dynamic testing of the material. The key technical objectives of the
    project are 1) the development of the optimization design framework based on manufacturing
    and seismic performance constraints, and 2) the material testing protocol to verify
    scalability and defect insensitivity of the material property. It is anticipated
    that the metamaterial architecture can be modulated to provide seismic isolation
    property beyond state of the art seismic isolation devices, and can be scaled
    from material coupons to large assemblies without significant property modification."
  awardeeAddress: 5141 California Ave Ste 250
  awardeeCity: Irvine
  awardeeCountryCode: US
  awardeeName: MetaSeismic, Inc.
  awardeeStateCode: CA
  awardeeZipCode: '926173062'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1721975'
  piEmail: bonessio@metaseismic.com
  piFirstName: Noemi
  piLastName: Bonessio
  piPhone: '8583612875'
  poName: Benaiah Schrag
  date: 07/10/2017
  startDate: 07/01/2017
  expDate: 04/30/2019
  title: 'SBIR Phase I:  MetaMaterial for Seismic Energy Absorption'
- abstractText: "This NSF SBIR Phase I project takes a unique holistic approach to
    both tumor imaging and cancer drug delivery.  This approach harnesses cancer cell
    proteins already in the body to allow selective delivery of tumor imaging agents
    or cancer-killing drugs to, and into, cancer cells.  By choosing cancer-specific
    targeting proteins, the drugs will be transported primarily into cancer cells
    and undesirable off-target enrichment will be diminished.  The goal is to mitigate
    drug uptake in non-cancerous fast-growing cells like; heart cells, bone marrow,
    skin or hair follicles.  Treated patients will benefit from improved effectiveness
    of their cancer therapies.  Such selective delivery should permit lower dosages
    of drug to be administered while also lowering the risks of unwanted, problematic
    side-effects. This cost-effective approach is well supported by the NSF?s core
    mission for the technical development of innovative drug delivery systems. \n\nIt
    remains challenging to provide sensitive tumor diagnosis and near-simultaneous
    assessments of response to cancer treatments in treated individuals.  Of all the
    standard monitoring modalities, radiographic examination has been the most widely
    used to measure treatment response.  However, some studies suggest up to 10-40%
    of cancers may not be measurable by currently available technologies.  Various
    delivery approaches have been used to take advantage of endogenous molecules to
    transport imaging agents or drugs with increased specificity into cancer cells.
    \ Most of these approaches utilize macromolecular ligands or cell surface receptor
    binding approaches.  This proposal takes a mechanistically innovative small-molecule
    approach.  By harnessing the activities of endogenous inflammatory proteins produced
    in abundance by cancer cells and by cells within the tumor micro-environment,
    small molecule cancer drugs can be transported with efficiency to the site of
    their intended effect.  Selective and accurate placement of a chemically-related
    diagnostic agent into cancer cells should allow a cost-effective, more personalized
    and exceedingly sensitive view of treatment response."
  awardeeAddress: 3049 NE 95th St
  awardeeCity: Seattle
  awardeeCountryCode: US
  awardeeName: RJS Biologics L.L.C.
  awardeeStateCode: WA
  awardeeZipCode: '981152435'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1720789'
  piEmail: s_mccraith@yahoo.com
  piFirstName: Stephen
  piLastName: McCraith
  piMiddeInitial: M
  piPhone: '2063840339'
  poName: Henry Ahn
  date: 06/28/2017
  startDate: 07/01/2017
  expDate: 04/30/2019
  title: 'SBIR Phase I:  Rationally-designed, modular imaging agents for the targeted
    detection of tumors.'
- abstractText: |-
    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to address the massive unmet need of peripheral arterial disease (PAD) which affects over 12 million Americans and results in over 65,000 amputations each year. This project will provide the proof of concept for a novel drug delivery technique that will improve the durability of procedures to restore blood flow in PAD patients. The result technology will help reduce the burden of disease while reducing the significant societal and health system costs caused by amputations.

    The proposed project will address the challenge of providing controlled drug dose to arteries of varying diameter and length. Peripheral arterial disease (PAD) patients have atherosclerotic lesions that are long and diffuse, requiring treatment to multiple sites with different vessel diameters and lengths. Existing drug delivery platforms require the use of multiple, expensive devices to treat these patients. This project will demonstrate that a single ultrasound-enhanced drug delivery catheter can provide drug delivery to different artery diameters and lengths, providing significant potential cost and time savings during endovascular procedures. In order apply the desired drug dose to arteries of varying size, real time imaging feedback will be used to adjust the treatment settings to compensate for changes in size. To achieve this goal, ex vivo swine arteries of different sizes will be treated under physiological flow conditions while varying the treatment parameters in order to determine the effect of vessel size on delivered drug dose. From this project, algorithms that can control drug dose to match varying artery diameter will be developed for future in vivo animal model studies.
  awardeeAddress: 1110 East Market Street
  awardeeCity: Charlottesville
  awardeeCountryCode: US
  awardeeName: SoundPipe
  awardeeStateCode: VA
  awardeeZipCode: '229025364'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1621681'
  piEmail: kilroy@sound-pipe.com
  piFirstName: Joseph
  piLastName: Kilroy
  piMiddeInitial: P
  piPhone: '4342183394'
  poName: Henry Ahn
  date: 06/24/2016
  startDate: 07/01/2016
  expDate: 06/30/2019
  title: 'SBIR Phase I:  Dose control of intravascular ultrasound guided and enhanced
    drug delivery with microbubbles'
- abstractText: "This SBIR Phase 1 project will advance technology to significantly
    improve the standard of care within corrective surgery for spinal deformity. Approximately
    55,000 patients with spinal deformity seek improvement in their reduced quality
    of life through surgery each year in the US. The goal of these surgeries is to
    mechanically adjust and fix the spine into a biomechanically balanced position.
    \ It is common for surgeons to plan these intensive surgeries before the operation.
    \ However, the operating room environment introduces many challenges that make
    it difficult for the surgeon to measure the contour of the patient's spine as
    it changes during surgery.  Current commercial offerings rely on radiation-based
    imaging which involves significant operative delays, ionizing radiation exposure,
    and narrow 2-dimensional fields of view.  These suboptimal solutions contribute
    to the high rates of continued postoperative deformity along with the need for
    repeated surgeries. This project focuses on the development of imaging technology
    that will enable real-time, 3D, whole-spine assessments of a patient's spinal
    alignment with significant reduction in both time per alignment assessment and
    radiation exposure compared to current standards. By providing real-time, quantitative
    feedback to surgeons during these cases, the technology stands to greatly improve
    surgical outcomes and reduce the need for repeat operations. \n\nThis project
    repurposes the functionality of an off-the-shelf optical tracking system by coupling
    it with novel hardware and software registration algorithms.  When coupled with
    these enhancements, the camera system will enable rapidly-generated, quantitative
    measurements of a patient's spine while in the operating room.  By leveraging
    technology that is already present in the majority of surgical centers, the path
    to commercialization for this innovation is greatly accelerated. This removes
    the need for most centers to purchase additional capital equipment, while also
    integrating seamlessly into a system that is familiar to many surgeons. The expansion
    of this high-precision technology will also enable more data-driven and patient-specific
    decisions to be made for a variety of surgeries The project is led by a multidisciplinary
    team of scientists, engineers, and world-class neurosurgeons with experience in
    translating medical devices into impactful commercial products. The aims within
    this project include the development of novel tracking-system augmentation hardware,
    image-analysis algorithms, optimization of accuracy via benchtop testing, and
    validation via testing with cadaveric specimens.\n\nThis award reflects NSF's
    statutory mission and has been deemed worthy of support through evaluation using
    the Foundation's intellectual merit and broader impacts review criteria."
  awardeeAddress: 8 Market Place
  awardeeCity: Baltimore
  awardeeCountryCode: US
  awardeeName: Spine Align LLC
  awardeeStateCode: MD
  awardeeZipCode: '212024113'
  fundsObligatedAmt: '225000'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843816'
  piEmail: amir@spinealignsurgical.com
  piFirstName: Amir
  piLastName: Soltanianzadeh
  piPhone: '8183009704'
  poName: Henry Ahn
  date: 01/30/2019
  startDate: 02/01/2019
  expDate: 07/31/2019
  title: 'SBIR Phase I:  Novel Method To Quantitatively Assess Spinal Alignment Intraoperatively
    With Reduced Reliance On Radiation-Based Imaging'
- abstractText: |-
    This SBIR Phase 1 project will study how communications feedback loops effect online learning, especially in group settings. The explosion of online learning experiences in recent years, in which many courses fail to engage learners or help them achieve their academic and professional goals, has put focus on the problem of engagement. Interest in online learning remains high, as it presents an opportunity to broaden the reach of institutions and companies, but success rates in broadly available learning experiences are low. Built upon foundational research in computational social science, the project will use specialized video and text chat tools to collect data from groups engaged in synchronous online learning, analyze and categorize patterns of communication, and give feedback to students to help them have better, more successful experiences online. In keeping with NSF's mission to promote the progress of science and advance national welfare, the project applies emerging innovations in artificial intelligence to the problem of delivering high-quality learning at scale. While most applications focus on individual learners and creating new personalized educational pathways, this project highlights the importance of collective learning and the power of peer engagement to help all members of a learning community reach their goals together.


    This project introduces several innovations in data capture and analytics, as well as feedback to learners while they are collaborating online. While many students use online collaboration tools such as discussion boards, chat, and video, this project focuses on providing interventions to change behavior in real-time. During conversations, such as those happening when people brainstorm to solve a problem or work on shared assignments, certain vocal patterns indicate engagement, reveal unstated agreements and discords, and expose individual biases. Using deep learning and data modeling, real-time feedback about conversational dominance is generated and shown to learners while they are speaking. The project further explores the effect of machine-generated insights about what happened during the collaboration, and makes recommendations about behavior modifications, based on predictive models. For more nuanced insights, these data are paired with facial-gestural data, such as nodding or raising one?s eyebrows. Together, these innovations combine data that has never been collected at scale before with social science data models uniquely applied to online learning. The goal of the research project is to prove that insights like these have a net positive effect on learning outcomes and raise the level of satisfaction with online learning experiences that incorporate these tools.

    This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
  awardeeAddress: 44 FENNO RD
  awardeeCity: NEWTON
  awardeeCountryCode: US
  awardeeName: RIFF LEARNING INC
  awardeeStateCode: MA
  awardeeZipCode: 024591408
  fundsObligatedAmt: '223090'
  fundProgramName: SMALL BUSINESS PHASE I
  id: '1843391'
  piEmail: beth@rifflearning.com
  piFirstName: Elizabeth
  piLastName: Porter
  piMiddeInitial: B
  piPhone: '6173409993'
  poName: Rajesh Mehta
  date: 01/29/2019
  startDate: 02/01/2019
  expDate: 01/31/2020
  title: 'SBIR Phase I:  Positive Effects of Feedback and Intervention for Engagement
    in Online Learning'
---

